<SEC-DOCUMENT>0001213900-22-025976.txt : 20220512
<SEC-HEADER>0001213900-22-025976.hdr.sgml : 20220512
<ACCEPTANCE-DATETIME>20220512163159
ACCESSION NUMBER:		0001213900-22-025976
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		79
FILED AS OF DATE:		20220512
DATE AS OF CHANGE:		20220512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyngn Inc.
		CENTRAL INDEX KEY:			0001874097
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		IRS NUMBER:				462007094
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264887
		FILM NUMBER:		22918385

	BUSINESS ADDRESS:	
		STREET 1:		1015 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-924-5905

	MAIL ADDRESS:	
		STREET 1:		1015 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cyngn, Inc.
		DATE OF NAME CHANGE:	20210721
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>ea159355-s1_cyngninc.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu May 12 19:03:26 UTC 2022 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:cyngn="http://cyngn.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace"><head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on May 12, 2022</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></span></p><div>





</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WASHINGTON,
D.C. 20549</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM
<ix:nonNumeric contextRef="c0" name="dei:DocumentType">S-1</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>CYNGN
INC.</b></span></ix:nonNumeric></p><div>





</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 35%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>46-2007094</b></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
or other jurisdiction</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
incorporation)</span></p></td> <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
Employer</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
No.)</span></p></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7371</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary
Standard Industrial Classification Code Number</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cyngn
Inc.<br/>
1015 O&#8217;Brien Dr.<br/>
Menlo Park, CA 94025<br/>
(650) 924-5905</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lior
Tal<br/>
Chief Executive Officer<br/>
Cyngn Inc.<br/>
1015 O&#8217;Brien Dr.<br/>
Menlo Park, CA 94025<br/>
(650) 924-5905<br/>
</b> (Name, address, including zip code, and telephone number, including area code, of agent for service)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gregory
Sichenzia, Esq.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Marcelle
S. Balcombe, Esq.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sichenzia
Ross Ference LLP</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1185
Avenue of the Americas, 31<sup>st</sup> Floor</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
York, New York 10036</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Phone:
(212) 930-9700</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale of the securities to the public: </b>From time to time after the effective date of this
registration statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415
under the Securities Act of 1933 check the following box. &#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering. &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24%; text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</span></td> <td style="width: 35%; text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="width: 25%; text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="width: 16%; text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</span></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</span></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities
Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become
effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until this Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section&#160;8(a), may determine.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>



</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&#160;</p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">The
information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell and is not soliciting an offer
to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
    TO COMPLETION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>DATED
    MAY&#160;12, 2022</b></span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12,903,226
Shares of Common Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to this prospectus, the selling stockholders identified herein are offering on a resale basis an aggregate of 12,903,226 shares
of common stock, par value $0.00001 per share, of Cyngn Inc., of which (i) 3,790,322 shares are issued and outstanding, (ii) 2,661,291
shares are issuable upon exercise of pre-funded warrants, or the &#8220;Pre-Funded Warrants&#8221;, each exercisable into one
share of common stock at an exercise price per share of $0.001, without expiration, and (iii) 6,451,613 shares are issuable upon
exercise of common warrants, or the &#8220;Common Warrants&#8221;, each exercisable into one share of common stock at an exercise
price per share of $2.98, expiring on April&#160;29, 2027. We refer to the Pre-Funded Warrants and the Common Warrants, collectively,
as the &#8220;Private Placement Warrants&#8221;. The outstanding shares of common stock and the Private Placement Warrants were
issued to the selling stockholders in connection with a private placement offering we completed on April&#160;29, 2022, or the
&#8220;Private Placement&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale by the selling stockholders of the common stock. Upon any exercise of the Private
Placement Warrants by payment of cash, however, we will receive the exercise price of the Private Placement Warrants.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may sell or otherwise dispose of the common stock covered by this prospectus in a number of different ways
and at varying prices. We provide more information about how the selling stockholders may sell or otherwise dispose of the common
stock covered by this prospectus in the section entitled &#8220;Plan of Distribution&#8221; on page 67 of this prospectus. For
information on the selling stockholders, see the section entitled &#8220;Selling Stockholders&#8221; on page 28 of this prospectus.
Discounts, concessions, commissions and similar selling expenses attributable to the sale of common stock covered by this prospectus
will be borne by the selling stockholders. We will pay all expenses (other than discounts, concessions, commissions and similar
selling expenses) relating to the registration of the common stock with the Securities and Exchange Commission, or the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed on The Nasdaq Capital Market under the symbol
&#8220;CYN.&#8221; On May 10, 2021, the last reported sale price per share of our common stock was $5.04.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the
entire prospectus and any amendments or supplements carefully before you make your investment decision.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our common stock involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 4 of this prospectus for
a discussion of information that you should consider before investing in our securities.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&#160;</p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
  <tr style="vertical-align: top">
    <td style="width: 90%; text-align: justify; padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: center"><b>Page</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_001">About this Prospectus</a></td>
    <td>&#160;</td>
    <td style="text-align: center">ii</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_002">Prospectus Summary</a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_003">The Offering</a></td>
    <td>&#160;</td>
    <td style="text-align: center">3</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_004">Risk Factors</a></td>
    <td>&#160;</td>
    <td style="text-align: center">4</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_005">Special Note Regarding Forward-Looking Statements</a></td>
    <td>&#160;</td>
    <td style="text-align: center">25</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_006">Use of Proceeds</a></td>
    <td>&#160;</td>
    <td style="text-align: center">26</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_007">Private Placement of Shares of Common Stock, Warrants and Pre-Funded Warrants</a></td>
    <td>&#160;</td>
    <td style="text-align: center">27</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_008">Selling Stockholders</a></td>
    <td>&#160;</td>
    <td style="text-align: center">28</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_009">Our Business</a></td>
    <td>&#160;</td>
    <td style="text-align: center">30</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_010">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></td>
    <td>&#160;</td>
    <td style="text-align: center">45</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_011">Management</a></td>
    <td>&#160;</td>
    <td style="text-align: center">50</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_012">Executive and Director Compensation</a></td>
    <td>&#160;</td>
    <td style="text-align: center">55</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_013">Security Ownership of Certain Beneficial Owners and Management</a></td>
    <td>&#160;</td>
    <td style="text-align: center">58</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_014">Certain Relationships and Related Transactions</a></td>
    <td>&#160;</td>
    <td style="text-align: center">61</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_015">Description of Capital Stock</a></td>
    <td>&#160;</td>
    <td style="text-align: center">63</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_016">Plan of Distribution</a></td>
    <td>&#160;</td>
    <td style="text-align: center">67</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_017">Legal Matters</a></td>
    <td>&#160;</td>
    <td style="text-align: center">68</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_018">Experts</a></td>
    <td>&#160;</td>
    <td style="text-align: center">68</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_019">Where You Can Find More Information</a></td>
    <td>&#160;</td>
    <td style="text-align: center">68</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><a href="#a_020">Index to Financial Statements</a></td>
    <td>&#160;</td>
    <td style="text-align: center">F-1</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABOUT
THIS PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may only rely on the information contained in this prospectus or that we have referred you to. We have not authorized anyone to
provide you with information different from, or in addition to, that contained in this prospectus. This prospectus does not constitute
an offer to sell or a solicitation of an offer to buy any securities other than the common stock offered by this prospectus. This
prospectus does not constitute an offer to sell or a solicitation of an offer to buy any common stock in any circumstances in
which such offer or solicitation is unlawful. Neither the delivery of this prospectus nor any sale made in connection with this
prospectus shall, under any circumstances, create any implication that there has been no change in our affairs since the date
of this prospectus. For investors outside the United States: Neither we nor the selling stockholders have done anything that would
permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required,
other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves
about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus
outside the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context otherwise requires, references to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or the &#8220;Company&#8221;
in this prospectus mean Cyngn Inc., a Delaware corporation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<a id="a_002"></a><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should
consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus,
including our financial statements and the related notes and the information set forth under the headings &#8220;Risk Factors&#8221;
and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in each case included
elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an autonomous vehicle (AV) technology company that is focused on addressing industrial uses for autonomous vehicles. We believe
that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial
industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbent
vehicle manufacturers, and high upfront investment commitment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
sites are typically rigid environments with consistent standards as opposed to city streets that have more variable environmental
and situational conditions and diverse regulations. These differences in operational design domains (ODD) will be major factors
that make proliferation of industrial AVs in private settings achievable with less time and resources than AVs on public roadways.
Namely, safety and infrastructure challenges are cited as roadblocks that have delayed AVs from operating on public roadways at
scale. Our focus on industrial AVs simplifies these challenges because industrial facilities (especially those belonging to a
single end customer that operates similarly at different sites) share much more in common than different cities do. Furthermore,
our end customers own their infrastructure and can make changes more easily than governments can on public roadways.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
these challenges in mind, we are developing an EAS that leverages advanced in-vehicle autonomous driving technology and incorporates
leading supporting technologies like data analytics, fleet management, cloud, and connectivity. EAS provides a differentiated
solution that we believe will drive pervasive proliferation of industrial autonomy and create value for customers at every stage
of their journey towards full automation and the adoption of Industry 4.0.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EAS
is a suite of technologies and tools that we divide into three complementary categories:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DriveMod</i>,
    our modular industrial vehicle autonomous driving software;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cyngn
    Insight</i>, our customer-facing tool suite for monitoring and managing AV fleets (including remotely operating vehicles)
    and aggregating/analyzing data; and</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cyngn
    Evolve</i>, our internal tool suite and infrastructure that facilitates artificial intelligence (AI) and machine learning
    (ML) training to continuously enhance our algorithms and models and provides a simulation framework (both record/rerun and
    synthetic scenario creation) to ensure that data collected in the field can be applied to validating new releases.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
automation providers manufacture specialized industrial vehicles with integrated robotics software for rigid tasks, limiting automation
to narrow uses. Unlike these specialized vehicles, EAS can be compatible with the existing vehicle assets in addition to new vehicles
that have been purpose built for autonomy by vehicle manufacturers. EAS is operationally expansive, vehicle agnostic, and compatible
with indoor and outdoor environments. By offering flexible autonomous services, we aim to remove barriers to industry adoption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
understand that scaling of autonomy solutions will require an ecosystem made up of different technologies and services that are
enablers for AVs. Our approach is to forge strategic collaborations with complementary technology providers that accelerate AV
development and deployment, provide access to new markets, and create new capabilities. Our focus on designing DriveMod to be
modular will combine with our experience deploying AV technology on diverse industrial vehicle form factors, which will be difficult
for competitors to replicate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our technology to generate revenue through two main methods: deployment and EAS subscriptions. Deploying our EAS requires
us and our integration partners to work with a new client to map the job site, gather data, and install our AV technology within
their fleet and site. We anticipate that new deployments will yield project-based revenues based on the scope of the deployment.
After deployment, we expect to generate revenues by offering EAS through a Software as a Service (SaaS) model, which can be considered
the AV software component of Robotics as a Service (RaaS). Although we have not offered, and have no present intention to offer,
the robotic assets ourselves directly to the end customer, our software can be part of a combined offering with third parties,
such as an OEM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RaaS
is a subscription model that allows customers to use robots/vehicles without purchasing the hardware assets upfront. We will seek
to achieve sustained revenue growth largely from ongoing SaaS-style EAS subscriptions that enable companies to tap into our ever-expanding
suite of AV and AI capabilities as organizations transition into full industrial autonomy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
EAS is not yet commercially available and both the components and the combined solution are still under development, components
of EAS have already been used for a paid customer trial and pilot deployments. We have not yet derived any recurring revenues
from EAS and intend to start marketing EAS to customers in 2022. We expect EAS to continually be developed and enhanced according
to evolving customer needs, which will take place concurrently while other completed features of EAS are commercialized. We expect
annual R&amp;D expenditures in the foreseeable future to equal or exceed that of 2019 and 2020. We also expect that limited paid
pilot deployments in 2022 and 2023 will offset some of the ongoing R&amp;D costs of continually developing EAS. We target scaled
deployments to begin in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
go-to-market strategy is to acquire new customers that use industrial vehicles in their mission-critical and daily operations
by (a) leveraging the relationships and existing customers of our network of strategic partners, (b) bringing AV capabilities
to industrial vehicles as a software service provider, and (c) executing a robust in-house sales and marketing effort to nurture
a pipeline of industrial organizations. Our focus is on acquiring new customers who are either looking (a) to embed our technology
into their vehicle product roadmaps or (b) to apply autonomy to existing fleets with our vehicle retrofits. In turn, our customers
are any organizations that could utilize our EAS solution, including OEMs that supply industrial vehicles, end customers that
operate their own industrial vehicles, or service providers that operate industrial vehicles for end customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
OEMs and leading industrial vehicle users seek to increase productivity, reinforce safer working environments, and scale their
operations, we believe we are uniquely positioned to deliver a dynamic autonomy solution via our EAS to a wide variety of industrial
uses. Our long-term vision is for EAS to become a universal autonomous driving solution with minimal marginal cost for companies
to adopt new vehicles and expand their autonomous fleets across new deployments. We have already deployed DriveMod software on
nine different vehicle form factors that range from stockchasers and stand-on floor scrubbers to 14-seat shuttles and 5-meter-long
cargo vehicles demonstrating the extensibility of our AV building blocks. These deployments were prototypes or part of proof-of-concept
projects. Of these deployments, two were at customer sites. For one deployment we were paid $166,000 and the other was part of
our normal R&amp;D activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy upon establishing a customer relationship with an OEM, is to seek to embed our technology into their vehicle roadmap
and expand our services to their many clients. Once we solidify an initial AV deployment with a customer, we intend to seek to
expand within the site to additional vehicle platforms and/or expand the use of similar vehicles to other sites operated by the
customer. This &#8220;land and expand&#8221; strategy can repeat iteratively across new vehicles and sites and is at the heart
of why we believe industrial AVs that operate in geo-fenced, constrained environments are poised to create value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meanwhile,
over $16 billion has been invested into passenger AV development over the last several years with negligible revenues generated
and constant delays. The $200B annual industrial equipment market (projected by 2027) is substantial, but it does not justify
billions of dollars of annual research &amp; development spend. These leading passenger AV companies will need to take the approach
of first capturing the trillion-dollar markets of passenger AV to achieve their desired returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<a id="a_003"></a><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuer</b></span></td>
    <td style="width: 3%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 70%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyngn
    Inc.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
    Offered by the Selling Stockholders</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,790,322
    shares of our common stock, 6,451,613 shares common stock issuable upon the exercise of warrants and 2,661,291 shares of common
    stock issuable upon the exercise of pre-funded warrants or an aggregate of 12,903,226 shares of common stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Market</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    common stock offered in this prospectus is listed on The Nasdaq Capital Market under the symbol &#8220;CYN.&#8221;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock Outstanding Before this Offering</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,894,752
    shares</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock Outstanding After this Offering</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,007,656(1)
    shares</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of Proceeds</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any of the proceeds from the sale of the shares of our common stock being offered for sale by the selling
    stockholders. Upon the exercise of the warrants for an aggregate of 9,112,904 shares of common stock by payment of cash however,
    we will receive the exercise price of the warrants, or an aggregate of approximately $19,228,468 from the investors in the
    Private Placement.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
    of Distribution</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    selling stockholders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby
    from time to time directly or through one or more underwriters, broker-dealers or agents. Registration of the common stock
    covered by this prospectus does not mean, however, that such shares necessarily will be offered or sold. See <i>&#8220;Plan
    of Distribution.&#8221;</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
    Factors</b></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    read <i>&#8220;Risk Factors&#8221; </i>and other information included in this prospectus for a discussion of factors you should
    carefully consider before deciding to invest in the securities offered in this prospectus.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 15%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif">(1)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of common stock shown above to be outstanding after this offering is based on 30,894,752 shares outstanding
    as of the date of this prospectus and assumes the exercise of (i) the warrants into 6,451,613 shares of common stock and (ii)
    pre-funded warrants held by the selling stockholders into 2,661,291 shares of common stock.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
FACTORS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>An
investment in the Company&#8217;s common stock involves a high degree of risk. In determining whether to purchase the Company&#8217;s
common stock, an investor should carefully consider all of the material risks described below, together with the other information
contained in this prospectus before making a decision to purchase the Company&#8217;s securities. An investor should only purchase
the Company&#8217;s securities if he or she can afford to suffer the loss of his or her entire investment.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Autonomous
driving is an emerging technology and involves significant risks and uncertainties.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
develop and deploy a suite of autonomous driving software products that are compatible with existing sensors and hardware to enable
autonomous driving on industrial vehicle platforms manufactured and designed by OEMs and other third-party industrial vehicle
suppliers. Our autonomous driving technology is highly dependent on internally developed software, as well as on partnerships
with third parties such as industrial OEMs and other suppliers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
partner with OEMs that are seeking to manufacture purpose-built industrial vehicles capable of incorporating our autonomous driving
technology. The collaborative partnerships are established through mutually beneficial, non-binding memorandums of understanding
or partnership agreements for the purpose of joint go-to-market efforts. In addition to OEMs, we depend on other third parties
to produce hardware components, and, in some cases adjacent software solutions, that support our core suite of autonomous driving
software products and tools. The timely development and performance of our autonomous driving programs is dependent on the materials,
cooperation, and quality delivered by these partners. Further, we do not control the initial design of the industrial vehicles
we work with and therefore have limited influence over the production and design of systems for braking, gear shifting, and steering.
There can be no assurance that these systems and supporting technologies can be developed and validated at the high reliability
standard required for deployment of autonomous industrial vehicles using our technology in a cost-effective and timely manner.
Our dependence on these relationships exposes us to the risk that components manufactured by OEMs or other suppliers could contain
defects that would cause our autonomous driving technology not to operate as intended.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
autonomous driving technology is currently available as a private beta release, during which phase, we will prepare for scaled
commercialization in 2024. Although we believe that our algorithms, data analysis and processing, and artificial intelligence
technology are promising, we cannot assure you that our technology will achieve the necessary reliability for scaled commercialization
of autonomous industrial vehicles. For example, we are still improving our technology in terms of handling edge cases, unique
environments, and discrete objects. There can be no assurance that our data analytics and artificial intelligence could predict
every single potential issue that may arise during the operation of an autonomous industrial vehicle utilizing our autonomous
vehicle technology. Furthermore, the release and adoption of EAS and our other technologies and products may not be successful
and may take longer than anticipated. If the development of EAS and our other technologies and products is delayed or customers
do not adopt and buy our solutions to the extent we anticipate, our business and operating results will be adversely impacted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have a limited operating history in a new market and face significant challenges as our industry is rapidly evolving.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should consider our business and prospects in light of the risks and challenges we face as a new entrant into a novel industry,
including, among other things, with respect to our ability to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">design,
    integrate, and deploy safe, reliable, and quality autonomous vehicle software products and tools for industrial vehicles with
    our partners on an ongoing basis;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">navigate
    an evolving and complex regulatory environment;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
    produce with OEM partners a line of purpose-built autonomous industrial vehicles on the timeline we estimate;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">improve
    and enhance our software and autonomous technology;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establish
    and expand our customer base;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
    market our autonomous driving solutions and our other products and services;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">properly
    price our products and services;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">improve
    and maintain our operational efficiency;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain
    a reliable, secure, high-performance, and scalable technology infrastructure;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract,
    retain, and motivate talented employees;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">anticipate
    and adapt to changing market conditions, including technological developments and changes in competitive landscape; and</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">build
    a well-recognized and respected brand.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to address any or all of these risks and challenges, our business may be materially and adversely affected. There are
also a number of additional challenges to the execution and adoption of autonomous vehicle technology in industrial markets, many
of which are not within our control, including market acceptance of autonomous driving, governmental licensing requirements, concerns
regarding data security and privacy, actual and threatened litigation (whether or not a judgment is rendered against us), and
the general perception that an autonomous vehicle is not safe because there is no human driver. There can be no assurance that
the market will accept our technology, in which case our future business, results of operations and financial condition could
be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
autonomous industrial vehicle industry is in its early stages and is rapidly evolving. Our autonomous driving technology has not
yet been commercialized at scale. We cannot assure you that we will be able to adjust to changing market or regulatory conditions
quickly or cost-effectively. If we fail to do so, our business, results of operations, and financial condition will be adversely
affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business model has yet to be tested and any failure to commercialize our strategic plans would have an adverse effect on our operating
results and business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should be aware of the difficulties normally encountered by a relatively new enterprise that is beginning to scale its business,
many of which are beyond our control, including unknown future challenges and opportunities, substantial risks and expenses in
the course of entering new markets and undertaking marketing activities. The likelihood of our success must be considered in light
of these risks, expenses, complications, delays, and the competitive environment in which we operate. There is, therefore, substantial
uncertainty that our business plan will prove successful, and we may not be able to generate significant revenue, raise additional
capital, or operate profitably. We will continue to encounter risks and difficulties frequently experienced by early commercial
stage companies, including securing market acceptance for our product and service offerings, scaling up our infrastructure and
headcount. We may encounter unforeseen expenses, difficulties, or delays in connection with our growth. In addition, as a result
of the capital-intensive nature of our business, we can be expected to continue to sustain substantial operating expenses without
generating sufficient revenue to cover expenditures. Any investment in our company is therefore highly speculative and could result
in the loss of your entire investment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future business depends in large part on our ability to continue to develop and successfully commercialize our suite of software
products and tools. Our ability to develop, deliver, and commercialize at scale our technology to support or perform autonomous
operation of industrial vehicles is still unproven.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
technology suite is currently available as a private beta release which will need to be continually developed and enhanced for
scaled commercialization. Our continued enhancement of our autonomous driving technology is and will be subject to risks, including
with respect to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue to enhance our data analytics and software technology;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">designing,
    developing, and securing necessary components on acceptable terms and in a timely manner;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain customers;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to pay for research and development costs;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to attract, recruit, hire, and train skilled employees;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to fund the development and commercialization of our technology; and</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to enter into strategic relationships with key members in the industrial vehicles and industrial automation industries
    and component suppliers.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
operate in a highly competitive market and will face competition from both established competitors and new market entrants.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for autonomous industrial vehicles and industrial automation solutions is highly competitive. Many companies are seeking
to develop autonomous driving and delivery solutions. Competition in these markets is based primarily on technology, innovation,
quality, safety, reputation, and price. Our future success will depend on our ability to further develop and protect our technology
in a timely manner and to stay ahead of existing and new competitors. Our competitors in this market are working towards commercializing
autonomous driving technology and may have substantial financial, marketing, research and development, and other resources.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we also face competition from traditional industrial vehicle and solution companies. Traditional vehicle and solution
providers operating with human drivers are still the predominant operators in the market. Because of the long history of such
traditional companies serving our potential customers and industries, there may be many constituencies in the market that would
resist a shift towards autonomous industrial vehicles, which could include lobbying and marketing campaigns, particularly because
our technology will displace machine operators and drivers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the market leaders in our target industries, such as Industrial Material Handling (IMH) may start, or have already started,
pursuing large scale deployment of autonomous industrial vehicle technology on their own. These companies may have more operational
and financial resources than we do. We cannot guarantee that we will be able to effectively compete with them.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also face competition from component suppliers and other technology and industrial solution companies if they decide to expand
vertically and develop their own autonomous industrial vehicles, some of whom have significantly greater resources than we do.
We do not know how close these competitors are to commercializing autonomous driving systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
established and new market participants have entered or have announced plans to enter the autonomous industrial vehicle market.
Most of these participants have significantly greater financial, manufacturing, marketing, and other resources than we do and
may be able to devote greater resources to the design, development, manufacturing, distribution, promotion, sale, and support
of their products. If existing competitors or new entrants commercialize earlier than expected, our competitive advantage could
be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
collaboration with third parties is subject to risks and these relationships may not lead to significant revenue.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategic
business relationships are and will continue to be an important factor in the growth and success of our business. We have alliances
and partnerships, through mutually beneficial non-binding memoranda of understanding or partnering arrangements with other companies
in the industrial equipment, automation and automotive industries to help us in our efforts to continue to enhance our technology,
commercialize our solutions, and drive market acceptance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
with these third parties is subject to risks, some of which are outside our control. For example, certain agreements with our
partners grant our partner or us the right to terminate such agreements for cause or without cause. If any of our collaborations
with third parties are terminated, it may delay or prevent our efforts to deploy our software products and tools on purpose-built
autonomous industrial vehicles at scale. In addition, such agreements may contain certain exclusivity provisions which, if triggered,
could preclude us from working with other businesses with superior technology or with whom we may prefer to partner with for other
reasons. We could experience delays to the extent our partners do not meet agreed upon timelines or experience capacity constraints.
We could also experience disagreement in budget or funding for joint development projects. There is also a risk of other potential
disputes with partners in the future, including with respect to intellectual property rights. Our ability to successfully commercialize
could also be adversely affected by perceptions about the quality of our or our partners&#8217; vehicles or products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Financial Position and Need for Additional Capital</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Losses
for the foreseeable future.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred net losses of $7.8 million and $8.3 million for the years ended December&#160;31, 2021, and 2020, respectively. We have
not recognized a material amount of revenue to date, and we had accumulated deficit of $116.5 million and $108.7 million as of
December&#160;31, 2021 and December&#160;31, 2020, respectively. We have developed and tested our autonomous driving technology
but there can be no assurance that it will be commercially successful at scale. Our potential profitability is dependent upon
a number of factors, many of which are beyond our control. If we are unable to achieve and sustain profitability, the value of
our business and common stock may significantly decrease.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect the rate at which we will incur losses to be significantly higher in future periods as we:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">design,
    develop, and deploy our autonomous vehicle software products and tools on industrial vehicle platforms with OEM partners and
    end customers.</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
    to achieve and commercialize deployments of level 4 autonomy for industrial vehicles;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
    to expand our commercial deployments, on a nationwide basis in the United States and internationally;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand
    our design, development, maintenance, and repair capabilities;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respond
    to competition in the autonomous driving market and from traditional industrial solution providers;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respond
    to evolving regulatory developments in the nascent autonomous industrial vehicle and industrial automation markets;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
    our sales and marketing activities; and</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
    our general and administrative functions to support our growing operations and for being a public reporting company.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we will incur the costs and expenses from these efforts before we receive any incremental revenue, our losses in future periods
will be significant. In addition, we may find that these efforts are more expensive than we currently anticipate or that these
efforts may not result in revenue, which would further increase our losses. In particular, we expect to incur substantial and
potentially increasing research and development (&#8220;R&amp;D&#8221;) costs as we continue to develop and enhance EAS and other
technology and products for commercialization. While our R&amp;D costs were $5.0 million and $5.1 million during the years ended
December&#160;31, 2021 and 2020, respectively, and are likely to grow in the future, we have no recurring revenues. Further, because
we account for R&amp;D as an operating expense, these expenditures will adversely affect our results of operations in the future.
Our R&amp;D program may not produce successful results, and our new products may not achieve market acceptance, create additional
revenue, or become profitable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have a limited operating history, which makes it difficult to forecast our future results of operations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were founded in 2013. As a result of our limited operating history, our ability to accurately forecast our future results of operations
is limited and subject to a number of uncertainties, including our ability to plan for and model future growth. Our historical
performance should not be considered indicative of our future performance. Further, in future periods, our revenue growth could
fluctuate for a number of reasons, including shifts in our offering and revenue mix, slowing demand for our offering, increasing
competition, decreased effectiveness of our sales and marketing organization, and our sales and marketing efforts to acquire new
customers, failure to retain existing customers, changing technology, a decrease in the growth of our overall market, or our failure,
for any reason, to continue to take advantage of growth opportunities. We anticipate that we will encounter, risks and uncertainties
frequently experienced by growing companies in rapidly changing industries, such as the risks and uncertainties described in this
report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our assumptions regarding these risks and uncertainties and our future revenue growth are incorrect or change, or if we do not
address these risks successfully, our operating and financial results could differ materially from our expectations, and our business
could suffer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
expect fluctuations in our financial results making it difficult to project future results.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations may fluctuate in the future due to a variety of factors, many of which are outside of our control. As a
result, our past results may not be indicative of our future performance. In addition to the other risks described herein, factors
that may affect our results of operations include the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our revenue mix and related changes in revenue recognition;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in actual and anticipated growth rates of our revenue, customers, and key operating metrics;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in demand for or pricing of our offering;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract new customers;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to retain our existing customers, particularly large customers;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">customers
    and potential customers opting for alternative products, including developing their own in-house solutions;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investments
    in new offerings, features, and functionality;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    or delays in development, release, or adoption of new features and functionality for our offering;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in closing sales which may result in revenue being pushed into the next quarter;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in customers&#8217; budgets and in the timing of their budget cycles and purchasing decisions;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to control costs;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount and timing of payment for operating expenses, particularly research and development and sales and marketing expenses;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">timing
    of hiring personnel for our research and development and sales and marketing organizations;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount and timing of costs associated with recruiting, educating, and integrating new employees and retaining and motivating
    existing employees;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effects of acquisitions and their integration;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions, both domestically and internationally, as well as economic conditions specifically affecting industries
    in which our customers participate;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of new accounting pronouncements;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in revenue recognition policies that impact our technology license revenue;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in regulatory or legal environments that may cause us to incur, among other things, expenses associated with compliance;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of changes in tax laws or judicial or regulatory interpretations of tax laws, which are recorded in the period such
    laws are enacted or interpretations are issued and may significantly affect the effective tax rate of that period;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">health
    epidemics or pandemics, such as the COVID-19 pandemic;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes
    in the competitive dynamics of our market, including consolidation among competitors or customers; and</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">significant
    security breaches of, technical difficulties with, or interruptions to, the delivery and use of our offering.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">Any
of these and other factors, or the cumulative effect of some of these factors, may cause our results of operations to vary significantly.
If our quarterly results of operations fall below the expectations of investors and securities analysts who follow our stock,
the price of our common stock could decline substantially, and we could face costly lawsuits, including securities class action
suits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may need to raise additional funds and these funds may not be available to us on attractive terms when we need them, or at all.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
commercialization of autonomous vehicles is capital intensive. This includes autonomous industrial vehicles outfitted with our
technology and purpose-built autonomous industrial vehicles manufactured by OEMs we intend to partner with. To date, we have financed
our operations primarily through the issuance of equity securities in private placements. We may need to raise additional capital
to continue to fund our commercialization activities, sales and marketing efforts, enhancement of our technology and to improve
our liquidity position. Our ability to obtain the necessary financing to carry out our business plan is subject to a number of
factors, including general market volatility, investor acceptance of our business plan, regulatory requirements and the successful
development of our autonomous technology. These factors may make the timing, amount, terms, and conditions of such financing unattractive
or unavailable to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may raise these additional funds through the issuance of equity, equity related, or debt securities. To the extent that we raise
additional financing by issuing equity securities or convertible debt securities, our stockholders may experience substantial
dilution, and to the extent we engage in debt financing, we may become subject to restrictive covenants that could limit our flexibility
in conducting future business activities. Financial institutions may request credit enhancement such as third-party guarantee
and pledge of equity interest in order to extend loans to us. We cannot be certain that additional funds will be available to
us on attractive terms when required, or at all. If we cannot raise additional funds when we need them, our financial condition,
results of operations, business, and prospects could be materially adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to risks associated with potential future acquisitions.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have no current acquisition plans, if appropriate opportunities arise, we may acquire additional assets, products, technology
or businesses that are complementary to our existing business. Any future acquisitions and the subsequent integration of new assets
and businesses would require significant attention from our management and could result in a diversion of resources from our existing
business, which in turn could have an adverse effect on our operations, and consequently our results of operations and financial
condition. Acquired assets or businesses may not generate the financial results we expect. Acquisitions could result in the use
of substantial amounts of cash, potentially dilutive issuances of equity securities, significant goodwill impairment charges,
amortization expenses for other intangible assets and exposure to potential unknown liabilities of the acquired business. Moreover,
the costs of identifying and consummating acquisitions may be significant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business Operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
success depends largely on the continued services of our senior management team, technical engineers, and certain key employees.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on our executive officers and key employees in the areas of business strategy, research and development, marketing, sales,
services, and general and administrative functions. From time to time, there may be changes in our executive management team or
key employees resulting from the hiring or departure of executives or key employees, which could disrupt our business. We do not
maintain key-man insurance for any member of our senior management team or any other employee. We do not have employment agreements
with our executive officers or other key personnel that require them to continue to work for us for any specified period and,
therefore, they could terminate their employment with us at any time. The loss of one or more of our executive officers or key
employees could have a serious adverse effect on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
execute our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense in
the technology industry, especially for engineers with high levels of experience in artificial intelligence and designing and
developing autonomous driving related algorithms. Furthermore, it can be difficult to recruit personnel from other geographies
to relocate to our California locations. We may also need to recruit highly qualified technical engineers internationally and
therefore subject us to the compliance of relevant immigration laws and regulations. We have, from time to time, experienced,
and we expect to continue to experience, difficulty in hiring and retaining employees with appropriate qualifications. Many of
the companies with which we compete for experienced personnel have greater resources than we have and can offer more attractive
compensation packages for new employees. If we hire employees from competitors or other companies, their former employers may
attempt to assert that these employees or our company have breached their legal obligations, resulting in a diversion of our time
and resources and potentially in litigation. In addition, job candidates and existing employees often consider the value of the
share incentive awards they receive in connection with their employment. If the perceived value of our share awards declines,
it may adversely affect our ability to recruit and retain highly skilled employees. If we fail to attract new personnel on a timely
basis or fail to retain and motivate our current personnel, we may not be able to commercialize and then expand our solutions
and services in a timely manner and our business and future growth prospects could be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service, or adequately
address competitive challenges.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to invest in our growth for the foreseeable future. Any growth in our business is expected to place a significant strain
on not only our managerial, administrative, operational, and financial resources, but also our infrastructure. We plan to continue
to expand our operations in the future. Our success will depend in part on our ability to manage this growth effectively and execute
our business plan. To manage the expected growth of our operations and personnel, we will need to continue to improve our operational,
financial, and management controls and our reporting systems and procedures.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely heavily on information technology or IT, systems to manage critical business functions. To manage our growth effectively,
we must continue to improve and expand our infrastructure, including our IT, financial, and administrative systems and controls.
In particular, we may need to significantly expand our IT infrastructure as the amount of data we store and transmit increases
over time, which will require that we both utilize existing IT products and adopt new technology. If we are not able to scale
our IT infrastructure in a cost-effective and secure manner, our ability to offer competitive solutions will be harmed and our
business, financial condition, and operating results may suffer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must also continue to manage our employees, operations, finances, research and development, and capital investments efficiently.
Our productivity and the quality of our solutions may be adversely affected if we do not integrate and train our new employees
quickly and effectively or if we fail to appropriately coordinate across our executive, research and development, technology,
service development, analytics, finance, human resources, marketing, sales, operations, and customer support teams. As we continue
to grow, we will incur additional expenses, and our growth may continue to place a strain on our resources, infrastructure, and
ability to maintain the quality of our solutions. If we do not adapt to meet these evolving challenges, or if the current and
future members of our management team do not effectively manage our growth, the quality of our solutions may suffer and our corporate
culture may be harmed. Failure to manage our future growth effectively could cause our business to suffer, which, in turn, could
have an adverse impact on our business, financial condition, and operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
management team has limited experience managing a public company.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team has limited experience managing a publicly-traded company, interacting with public company investors, and complying
with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage
our transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal
securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will
require significant attention from our senior management and could divert their attention away from the day-to-day management
of our business, which could adversely affect our business, financial condition, and operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to product liability or warranty claims that could result in significant direct or indirect costs, including reputational
harm, increased insurance premiums or the need to self-insure, which could adversely affect our business and operating results.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
technology is used for autonomous driving, which presents the risk of significant injury, including fatalities. We may be subject
to claims if one of our or a customer&#8217;s industrial vehicles is involved in an accident and persons are injured or purport
to be injured or if property is damaged. Any insurance that we carry may not be sufficient or it may not apply to all situations.
If we experience such an event or multiple events, our insurance premiums could increase significantly or insurance may not be
available to us at all. Further, if insurance is not available on commercially reasonable terms, or at all, we might need to self-insure.
In addition, lawmakers or governmental agencies could pass laws or adopt regulations that limit the use of autonomous driving
or industrial automation technology or increase liability associated with its use. Any of these events could adversely affect
our brand, relationships with users, operating results, or financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our autonomous driving software fails to perform as expected our ability to market, sell or lease our autonomous driving software
could be harmed.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
autonomous industrial vehicle software products and tools as well as the vehicles, sensors, and hardware they utilize and are
deployed on may contain defects in design and manufacture that may cause them not to perform as expected or require repair. For
example, our autonomous vehicle software will require modification and updates over the life of the vehicle it is deployed on.
Software products are inherently complex and often contain defects and errors when first introduced. There can be no assurance
that we will be able to detect and fix any defects in the industrial vehicles&#8217; hardware or software prior to commencing
user sales or during the life of the vehicle. Autonomous industrial vehicles utilizing our suite of products and tools may not
perform consistent with users&#8217; expectations or consistent with other vehicles that may become available. Any product defects
or any other failure of our software, supportive hardware, or deployment vehicle platform or to perform as expected could harm
our reputation, result in adverse publicity, lost revenue, delivery delays, product recalls, product liability claims, and significant
warranty and other expenses, and could have a material adverse impact on our business, financial condition, operating results,
and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to establish and maintain confidence in our long-term business prospects among users, securities and industry analysts,
and within our industries, or are subject to negative publicity, then our financial condition, operating results, business prospects,
and access to capital may suffer materially.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Users
may be less likely to purchase or use our technology and the industrial vehicles it is deployed on if they are not convinced that
our business will succeed or that our service and support and other operations will continue in the long term. Similarly, suppliers
and other third parties will be less likely to invest time and resources in developing business relationships with us if they
are not convinced that our business will succeed. Accordingly, in order to build and maintain our business, we must maintain confidence
among users, suppliers, securities and industry analysts, and other parties in our long-term financial viability and business
prospects. Maintaining such confidence may be particularly complicated by certain factors including those that are largely outside
of our control, such as our limited operating history at scale, user unfamiliarity with our solutions, any delays in scaling manufacturing,
delivery, and service operations to meet demand, competition and uncertainty regarding the future of autonomous vehicles, and
our performance compared with market expectations<b><i>.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pandemics
and epidemics, including the ongoing COVID-19 pandemic, natural disasters, terrorist activities, political unrest, and other manmade
problems such as war could have a material adverse impact on our business, results of operations, financial condition and cash
flows or liquidity.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is vulnerable to damage or interruption from pandemics and epidemics, including the ongoing COVID-19 pandemic, natural
disasters, terrorist attacks, political unrest, acts of war, including the current conflict between Russia and Ukraine, and similar
events.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the ongoing global COVID-19 pandemic, the capital markets are experiencing pronounced volatility, which may adversely affect investor&#8217;s
confidence and, in turn may affect our ability to raise additional capital.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the COVID-19 pandemic has caused us to modify our business practices (such as employee travel plan and cancellation
of physical participation in meetings, events, and conference), and we may take further actions as required by governmental authorities
or that we determine are in the best interests of our employees, users, and business partners. In addition, the business and operations
of our manufacturers, suppliers, and other business partners have also been adversely impacted by the COVID-19 pandemic and may
be further adversely impacted in the future, which could result in delays in our ability to commercialize our suite of autonomous
vehicle software products and tools.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of social distancing, travel bans, and quarantine measures, access to our facilities, users, management, support staff,
and professional advisors has been limited, which in turn has impacted, and will continue to impact, our operations, and financial
condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
extent to which COVID-19 impacts our, and those of our partners and potential users, business, results of operations, and financial
condition will depend on future developments, which are uncertain and cannot be predicted, including, but not limited to, the
occurrence of a &#8220;second wave,&#8221; duration and spread of the outbreak, its severity, the actions to contain the virus
or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even if the COVID-19
outbreak subsides, we may continue to experience materially adverse impacts to our business as a result of its global economic
impact, including any recession that has occurred or may occur in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
considerations related to the current conflict between Russia and Ukraine that may affect the Company include possible cyberattacks
and potential disruptions in the banking systems and capital market, as well as supply chain and increased costs and expenditures
on domestic and internationally-sourced materials and services. As an example, we engage third-party software development engineers
who reside in Russia. Due to the current conflict, we may experience an interruption in the services provided by these parties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also vulnerable to natural disasters and other calamities. Although we have servers that are hosted in an offsite location,
our backup system does not capture data on a real-time basis, and we may be unable to recover certain data in the event of a server
failure. We cannot assure you that any backup systems will be adequate to protect us from the effects of fire, floods, typhoons,
earthquakes, power loss, telecommunications failures, break-ins, war, riots, terrorist attacks or similar events. Any of the foregoing
events may give rise to interruptions, breakdowns, system failures, technology platform failures or internet failures, which could
cause the loss or corruption of data or malfunctions of software or hardware as well as adversely affect our ability to provide
services.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Intellectual Property, Information Technology and Data Privacy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may become subject to litigation brought by third parties claiming infringement, misappropriation or other violation by us of
their intellectual property rights.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
industry in which our business operates is characterized by a large number of patents, some of which may be of questionable scope,
validity or enforceability, and some of which may appear to overlap with other issued patents. As a result, there is a significant
amount of uncertainty in the industry regarding patent protection and infringement. In recent years, there has been significant
litigation globally involving patents and other intellectual property rights. Third parties may in the future assert, that we
have infringed, misappropriated or otherwise violated their intellectual property rights. As we face increasing competition and
as a public company, the possibility of intellectual property rights claims against us grows. Such claims and litigation may involve
one or more of our competitors focused on using their patents and other intellectual property to obtain competitive advantage,
or patent holding companies or other adverse intellectual property rights holders who have no relevant product revenue, and therefore
our own pending patents and other intellectual property rights may provide little or no deterrence to these rights holders in
bringing intellectual property rights claims against us. There may be intellectual property rights held by others, including issued
or pending patents and trademarks, that cover significant aspects of our technologies or business methods, and we cannot assure
that we are not infringing or violating, and have not infringed or violated, any third-party intellectual property rights or that
we will not be held to have done so or be accused of doing so in the future. In addition, because patent applications can take
many years until the patents issue, there may be applications now pending of which we are unaware, which may later result in issued
patents that our products may infringe. We expect that in the future we may receive notices that claim we or our collaborators
have misappropriated or misused other parties&#8217; intellectual property rights, particularly as the number of competitors in
our market grows.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
defend ourselves against any intellectual property claims brought by third parties, whether with or without merits, can be time-consuming
and could result in substantial costs and a diversion of our resources. These claims and any resulting lawsuits, if resolved adversely
to us, could subject us to significant liability for damages, impose temporary or permanent injunctions against our products,
technologies or business operations, or invalidate or render unenforceable our intellectual property.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our technology is determined to infringe a valid and enforceable patent, or if we wish to avoid potential intellectual property
litigation on any alleged infringement, misappropriation or other violation of third party intellectual property rights, we may
be required to do one or more of the following: (i) cease development, sales, or use of our products that incorporate or use the
asserted intellectual property right; (ii) obtain a license from the owner of the asserted intellectual property right, which
may be unavailable on commercially reasonable terms, or at all, or which may be non-exclusive, thereby giving our competitors
and other third parties access to the same technologies licensed to us; (iii) pay substantial royalties or other damages; or (iv)
redesign our technology or one or more aspects or systems of our autonomous industrial vehicles to avoid any infringement or allegations
thereof. The aforementioned options sometimes may not be commercially feasible. Additionally, in our ordinary course of business,
we agree to indemnify our customers, partners, and other commercial counterparties for any infringement arising out of their use
of our intellectual property, along with providing standard indemnification provisions, so we may face liability to our users,
business partners or third parties for indemnification or other remedies in the event that they are sued for infringement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also in the future license third party technology or other intellectual property, and we may face claims that our use of such
in-licensed technology or other intellectual property infringes, misappropriates or otherwise violates the intellectual property
rights of others. In such cases, we will seek indemnification from our licensors. However, our rights to indemnification may be
unavailable or insufficient to cover our costs and losses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also may not be successful in any attempt to redesign our technology to avoid any alleged infringement. A successful claim of
infringement against us, or our failure or inability to develop and implement non-infringing technology, or license the infringed
technology on acceptable terms and on a timely basis, could materially adversely affect our business and results of operations.
Furthermore, such lawsuits, regardless of their success, would likely be time-consuming and expensive to resolve and would divert
management&#8217;s time and attention from our business, which could seriously harm our business. Also, such lawsuits, regardless
of their success, could seriously harm our reputation with users and in the industry at large.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business may be adversely affected if we are unable to adequately establish, maintain, protect, and enforce our intellectual property
and proprietary rights or prevent third parties from making unauthorized use of our technology and other intellectual property
rights.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property is an essential asset of our business. Failure to adequately protect our intellectual property rights could
result in our competitors offering similar products, potentially resulting in the loss of our competitive advantage, and a decrease
in our revenue which would adversely affect our business prospects, financial condition, and operating results. Our success depends,
at least in part, on our ability to protect our core technology and intellectual property. We rely on a combination of intellectual
property rights, such as patents, trademarks, copyrights, and trade secrets (including know-how), in addition to employee and
third-party nondisclosure agreements, intellectual property licenses, and other contractual rights, to establish, maintain, protect,
and enforce our rights in our technology, proprietary information, and processes. Intellectual property laws and our procedures
and restrictions provide only limited protection and any of our intellectual property rights may be challenged, invalidated, circumvented,
infringed or misappropriated. If we fail to protect our intellectual property rights adequately, we may lose an important advantage
in the markets in which we compete. While we take measures to protect our intellectual property, such efforts may be insufficient
or ineffective, and any of our intellectual property rights may be challenged, which could result in them being narrowed in scope
or declared invalid or unenforceable. Other parties may also independently develop technologies that are substantially similar
or superior to ours. We also may be forced to bring claims against third parties, or defend claims that they may bring against
us, to determine the ownership of what we regard as our intellectual property. However, the measures we take to protect our intellectual
property from unauthorized use by others may not be effective and there can be no assurance that our intellectual property rights
will be sufficient to protect against others offering products, services, or technologies that are substantially similar or superior
to ours and that compete with our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Litigation
may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Our efforts to enforce
our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability
of our intellectual property. Any litigation initiated by us concerning the violation by third parties of our intellectual property
rights is likely to be expensive and time-consuming and could lead to the invalidation of, or render unenforceable, our intellectual
property, or could otherwise have negative consequences for us. Furthermore, it could result in a court or governmental agency
invalidating or rendering unenforceable our patents or other intellectual property rights upon which the suit is based. We will
not be able to protect our intellectual property if we are unable to enforce our rights or if we do not detect unauthorized use
of our intellectual property. Our inability to protect our proprietary technology against unauthorized copying or use, as well
as any costly litigation or diversion of our management&#8217;s attention and resources, could delay the introduction and implementation
of new technologies, result in our substituting inferior or more costly technologies into our products or injure our reputation.
Moreover, policing unauthorized use of our technologies, trade secrets, and intellectual property may be difficult, expensive,
and time-consuming, particularly in foreign countries where the laws may not be as protective of intellectual property rights
as those in the United States and where mechanisms for enforcement of intellectual property rights may be weak. If we fail to
meaningfully establish, maintain, protect, and enforce our intellectual property and proprietary rights, our business, operating
results, and financial condition could be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are a number of recent changes to the patent laws that may have a significant impact on our ability to protect our technology
and enforce our intellectual property rights. For example, the Leahy-Smith America Invents Act (the &#8220;AIA&#8221;) enacted
in September&#160;2011, resulted in significant changes in patent legislation. An important change introduced by the AIA is that,
as of March&#160;16, 2013, the United States transitioned from a &#8220;first-to-invent&#8221; to a &#8220;first-to-file&#8221;
system for deciding which party should be granted a patent when two or more patent applications are filed by different parties
claiming the same invention. Under a &#8220;first-to-file&#8221; system, assuming the other requirements for patentability are
met, the first inventor to file a patent application generally will be entitled to a patent on the invention regardless of whether
another inventor had made the invention earlier. A third party that files a patent application in the United States Patent and
Trademark Office (&#8220;USPTO&#8221;) after that date but before us could therefore be awarded a patent covering an invention
of ours even if we made the invention before it was made by the third party. Circumstances could prevent us from promptly filing
patent applications on our inventions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
AIA also includes a number of significant changes that affect the way patent applications will be prosecuted and also may affect
patent litigation. These include allowing third party submission of prior art to the USPTO during patent prosecution and additional
procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, <i>inter
partes</i> review, and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary
standard in United States federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence
in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to
invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures
to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in
a district court action. The AIA and its implementation could increase the uncertainties and costs surrounding the prosecution
of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect
on our business, financial condition, results of operations, and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the standards applied by the USPTO and foreign patent offices in granting patents are not always applied uniformly or predictably.
For example, there is no uniform worldwide policy regarding patentable subject matter or the scope of claims allowable for business
methods. As such, we do not know the degree of future protection that we will have on our technologies, products, and services.
While we will endeavor to try to protect our technologies, products, and services with intellectual property rights such as patents,
as appropriate, the process of obtaining patents is time-consuming, expensive, and sometimes unpredictable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the U.S. Supreme Court has ruled on several patent cases in recent years, such as Impression Products, Inc. v. Lexmark International,
Inc., Association for Molecular Pathology v. Myriad Genetics, Inc., Mayo Collaborative Services v. Prometheus Laboratories, Inc.
and Alice Corporation Pty. Ltd. v. CLS Bank International, either narrowing the scope of patent protection available in certain
circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard
to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of
patents, once obtained.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depending
on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change
in unpredictable ways that could weaken our ability to obtain new patents or to enforce our existing patents and patents that
we might obtain in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
patent applications may not issue as patents, which may have a material adverse effect on our ability to prevent others from commercially
exploiting products similar to ours.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot be certain that we are the first inventor of the subject matter to which we have filed a particular patent application,
or if we are the first party to file such a patent application. If another party has filed a patent application to the same subject
matter as we have, we may not be entitled to the protection sought by the patent application. Further, the scope of protection
of issued patent claims is often difficult to determine. As a result, we cannot be certain that the patent applications that we
file will issue, or that our issued patents will be broad enough to protect our proprietary rights or otherwise afford protection
against competitors with similar technology. In addition, the issuance of a patent is not conclusive as to its inventorship, scope,
validity or enforceability. Our competitors may challenge or seek to invalidate our issued patents, or design around our issued
patents, which may adversely affect our business, prospects, financial condition or operating results. Also, the costs associated
with enforcing patents, confidentiality and invention agreements, or other intellectual property rights may make aggressive enforcement
impracticable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to protect our intellectual property rights throughout the world.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing,
prosecuting, maintaining, defending, and enforcing patents and other intellectual property rights on our product candidates in
all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside
the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not
protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not
be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or
importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies
in jurisdictions where we have not obtained patent protection or other intellectual property rights to develop their own products
and may export otherwise infringing, misappropriating, or violating products to territories where we have patent or other intellectual
property protection, but enforcement rights are not as strong as those in the United States. These products may compete with our
product candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from
competing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions.
The legal systems of some countries do not favor the enforcement of patents and other intellectual property rights, which could
make it difficult for us to stop the infringement, misappropriation, or other violation of our intellectual property rights generally.
Proceedings to enforce our intellectual property rights in foreign jurisdictions could result in substantial costs and divert
our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted
narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may
not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
countries, including European Union countries, India, Japan, and China, have compulsory licensing laws under which a patent owner
may be compelled under specified circumstances to grant licenses to third parties. In addition, many countries limit the enforceability
of patents against government agencies or government contractors. In those countries, we may have limited remedies if patents
are infringed or if we are compelled to grant a license to a third party, which could materially diminish the value of those patents.
This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around
the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license,
which could adversely affect our business, financial condition, results of operations, and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
addition to patented technology, we rely on our unpatented proprietary technology, trade secrets, processes, and know-how.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on proprietary information (such as trade secrets, know-how, and confidential information) to protect intellectual property
that may not be patentable, or that we believe is best protected by means that do not require public disclosure. We generally
seek to protect this proprietary information by entering into confidentiality agreements, or consulting, services, or employment
agreements that contain non-disclosure and non-use provisions with our employees, consultants, contractors, scientific advisors,
and third parties. However, we cannot guarantee that we have entered into such agreements with each party that has or may have
had access to our trade secrets or proprietary information and, even if entered into, these agreements may be breached or may
otherwise fail to prevent disclosure, third-party infringement or misappropriation of our proprietary information, may be limited
as to their term and may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information.
We have limited control over the protection of trade secrets used by our third-party manufacturers and suppliers and could lose
future trade secret protection if any unauthorized disclosure of such information occurs. In addition, our proprietary information
may otherwise become known or be independently developed by our competitors or other third parties. To the extent that our employees,
consultants, contractors, and other third parties use intellectual property owned by others in their work for us, disputes may
arise as to the rights in related or resulting know-how and inventions. Costly and time-consuming litigation could be necessary
to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain protection for our proprietary
information could adversely affect our competitive business position. Furthermore, laws regarding trade secret rights in certain
markets where we operate may afford little or no protection to our trade secrets. If any of our trade secrets were to be lawfully
obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that
trade secret to compete with us. If any of our trade secrets were to be disclosed (whether lawfully or otherwise) to or independently
developed by a competitor or other third party, it could have a material adverse effect on our business, operating results, and
financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on physical and electronic security measures to protect our proprietary information, but we cannot guarantee that these
security measures provide adequate protection for such proprietary information or will never be breached. There is a risk that
third parties may obtain unauthorized access to and improperly utilize or disclose our proprietary information, which would harm
our competitive advantages. We may not be able to detect or prevent the unauthorized access to or use of our information by third
parties, and we may not be able to take appropriate and timely steps to mitigate the damages (or the damages may not be capable
of being mitigated or remedied).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
utilize open-source software, which may pose particular risks to our proprietary software, technologies, products, and services
in a manner that could harm our business.</i></b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use open-source software in our products and services and anticipate using open-source software in the future. We utilize a distribution
of the open-source Linux system, and tools such as ROS (open-source publish-subscribe tool) in the technical stack. Professional
open-source license scanning systems such as WhiteSource and ScanCode are used in both places. Both Continuous Integration and
Continuous Deployment (&#8220;CI/CD&#8221;) level open-source scan and overall system opensource scan is performed to protect
the systems and our intellectual property. In the event that our scanning and open-source check protocols fail, the Company could
be negatively affected Some open-source software licenses require those who distribute open-source software as part of their own
software products to publicly disclose all or part of the source code to such software product or to make available any modifications
or derivative works of the open-source code on unfavorable terms or at no cost. This could result in our proprietary software
being made available in the source code form and/or licensed to others under open-source licenses, which could allow our competitors
or other third parties to use our proprietary software freely without spending the development effort, and which could lead to
a loss of the competitive advantage of our proprietary technologies and, as a result, sales of our products and services. The
terms of many open-source licenses to which we are subject have not been interpreted by U.S. or foreign courts, and there is a
risk that open-source software licenses could be construed in a manner that imposes unanticipated conditions or restrictions on
our ability to provide or distribute our products or services or retain our ownership of our proprietary intellectual property.
Additionally, we could face claims from third parties claiming ownership of, or demanding release of, the open-source software
or derivative works that we developed using such software, which could include our proprietary source code, or otherwise seeking
to enforce the terms of, or alleging breach of, the applicable open-source license. These claims could result in litigation and
could require us to make our proprietary software source code freely available, purchase a costly license, or cease offering the
implicated products or services unless and until we can re-engineer them to avoid breach of the applicable open-source software
licenses or potential infringement. This re-engineering process could require us to expend significant additional research and
development resources, and we cannot guarantee that we will be successful.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the use of certain open-source software can lead to greater risks than use of third-party commercial software, as open-source
licensors generally do not provide warranties or controls on the origin of software. There is typically no support available for
open-source software, and we cannot ensure that the authors of such open-source software will implement or push updates to address
security risks or will not abandon further development and maintenance. Many of the risks associated with the use of open-source
software, such as the lack of warranties or assurances of title, non-infringement, or performance, cannot be eliminated, and could,
if not properly addressed, negatively affect our business. We have processes to help alleviate these risks, including a review
process for screening requests from our developers for the use of open-source software, but we cannot be sure that all open-source
software is identified or submitted for approval prior to use in our products and services. Any of these risks could be difficult
to eliminate or manage, and, if not addressed, could adversely affect our ownership of proprietary intellectual property, the
security of our vehicles, or our business, results of operations, and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unauthorized
control or manipulation of systems in autonomous industrial vehicles may cause them to operate improperly or not at all, or compromise
their safety and data security, which could result in loss of confidence in us and our products, cancellation of contracts with
future OEM or supplier partners.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been reports of vehicles of certain automotive OEMs being &#8220;hacked&#8221; to grant access to and operation of the vehicles
to unauthorized persons. Our autonomous vehicle software products and tools as well as the vehicles they are deployed on contain
or will contain complex IT systems and are designed with built-in data connectivity. We are in the process of and will continue
implementing security measures intended to prevent unauthorized access to our information technology networks and systems. However,
hackers may attempt to gain unauthorized access to modify, alter, and use such networks and systems to gain control of, or to
change the functionality of the autonomous industrial vehicles&#8217; running our software, user interface and performance characteristics,
or to gain access to data stored in or generated by our products. As techniques used to obtain unauthorized access to or sabotage
systems change frequently and may not be known until launched against us or our third-party service providers, there can be no
assurance that we will be able to anticipate, or implement adequate measures to protect against, these attacks. Any such security
incidents could result in unexpected control of or changes to the vehicles&#8217; functionality and safe operation and could result
in legal claims or proceedings and negative publicity, which would negatively affect our brand and harm our business, prospects,
financial condition, and operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
costs to comply with, or our actual or perceived failure to comply with, changing U.S. and foreign laws related to data privacy,
security and protection, could adversely affect our financial condition, operating results, and our reputation.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
operating our business and providing services and solutions to clients, we collect, use, store, transmit, and otherwise process
employee, partner, and customer data, including personal data, in and across multiple jurisdictions. We use the electronic systems
within the autonomous industrial vehicles that log information about each industrial vehicle&#8217;s use in order to aid us in
vehicle diagnostics, repair, and maintenance, as well as to help us collect data regarding operators&#8217; use patterns and preference
in order to help us customize and optimize the driving and operating experiences. The integrated autonomous industrial vehicles
leveraging our software products and tools may also collect personal information of drivers, operators and passengers, such as
a voice command of a person, in order to aid the manual operation of our industrial vehicles. When our autonomy enabled industrial
vehicles are in operation, the camera, LiDAR, and other sensing components of the vehicles will collect site and route view, mapping
data, landscape images, and other LiDAR information, which may include personal information such as license plate numbers of other
vehicles, facial features of pedestrians, appearance of individuals, GPS data, geolocation data, in order train the data analytics
and artificial intelligence technology equipped in our industrial vehicles for the purpose of identifying different objects, and
predicting potential issues that may arise during the operation of our integrated industrial vehicles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to utilize systems and applications that are spread over the globe, requiring us to regularly move data across national borders.
As a result, we are subject to a variety of laws and regulations in the United States, and other foreign jurisdictions as well
as contractual obligations, regarding data privacy, protection, and security. Some of these laws and regulations require obtaining
data subjects&#8217; consent to the collection and use of their data, honoring data subjects&#8217; request to delete their data
or limit the processing of their data, providing notifications in the event of a data breach, and setting up the proper legal
mechanisms for cross-border data transfers. Some customers may refuse to provide consent to our collection and use of their personal
information, or may restrict our use of such personal information, and in some cases it is not feasible to obtain consent from
data subjects in the general public whose personal information may be captured by our autonomous industrial vehicles, all of which
may hinder our ability to train our data analytics and artificial intelligence technology, and may harm the competitiveness of
our technology. In many cases, these laws and regulations apply not only to the collection and processing of personal information
from third parties with whom we do not have any contractual relationship, but also to the sharing or transfer of information between
or among us, our subsidiaries and other third parties with which we have commercial relationships, such as our service providers,
partners, and customers. The regulatory framework for data privacy, protection, and security worldwide is continuously evolving
and developing and, as a result, interpretation and implementation standards and enforcement practices are likely to remain uncertain
for the foreseeable future. In particular, some of these laws and regulations may require us to store certain categories of data
collected from individuals residing in a jurisdiction only on servers physically located in such jurisdiction, and may further
require us to conduct security assessments and/or adopt other cross-border data transfer mechanisms in order to transfer such
data outside of such jurisdiction. With the continuously evolving and rapidly changing privacy regulatory regime, our ability
to freely transfer data among our affiliates and with our partners in different jurisdictions may be impeded, or we may need to
incur significant costs in order to comply with such requirements. In addition, the number of high-profile data breaches at major
companies continues to accelerate, which will likely lead to even greater regulatory scrutiny.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scope and interpretation of the laws and regulations that are or may be applicable to us are often uncertain and may be conflicting,
particularly with respect to foreign laws. For example, the E.U. General Data Protection Regulation (the &#8220;GDPR&#8221;),
which became effective in May&#160;2018, greatly increased the European Commission&#8217;s jurisdictional reach of its laws and
added a broad array of requirements for handling personal data with respect to EU data subjects. EU member states are tasked under
the GDPR to enact, and have enacted, certain implementing legislation that adds to and/or further interprets the GDPR requirements
and potentially extends our obligations and potential liability for failing to meet such obligations. The GDPR, together with
national legislation, regulations and guidelines of the EU member states and the United Kingdom governing the processing of personal
data, impose strict obligations and restrictions on the ability to collect, use, retain, protect, disclose, transfer, and otherwise
process personal data with respect to EU and UK data subjects. In particular, the GDPR includes obligations and restrictions concerning
the consent and rights of individuals to whom the personal data relates, the transfer of personal data out of the European Economic
Area or the United Kingdom, security breach notifications and the security and confidentiality of personal data. Among other stringent
requirements, the GDPR restricts transfers of data outside of the EU to third countries deemed to lack adequate privacy protections
(such as the U.S.), unless an appropriate safeguard specified by the GDPR is implemented. A July&#160;16, 2020 decision of the
Court of Justice of the European Union invalidated a key mechanism for lawful data transfer to the U.S. and called into question
the viability of its primary alternative. As such, the ability of companies to lawfully transfer personal data from the EU to
the U.S. is presently uncertain. Other countries have enacted or are considering enacting similar cross-border data transfer rules
or data localization requirements. These developments could limit our ability to launch our products in the EU and other foreign
markets. The GDPR authorizes fines for certain violations of up to 4% of global annual revenue or &#8364;20 million, whichever
is greater. Such fines are in addition to any civil litigation claims by data subjects. Much remains unknown with respect to how
to interpret and implement the GDPR and guidance on implementation and compliance practices is often updated or otherwise revised.
Given the breadth and depth of changes in data protection obligations, including classification of data and our commitment to
a range of administrative, technical and physical controls to protect data and enable data transfers outside of the EU and the
United Kingdom, our compliance with the GDPR&#8217;s requirements will continue to require time, resources and review of the technology
and systems we use to satisfy the GDPR&#8217;s requirements, including as EU member states enact their legislation. Further, while
the United Kingdom enacted the Data Protection Act 2018 in May&#160;2018 that supplements the GDPR, and has publicly announced
that it will continue to regulate the protection of personal data in the same way post-Brexit, Brexit has created uncertainty
with regard to the future of regulation of data protection in the United Kingdom.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal government and various states and governmental agencies also have adopted or are considering adopting various laws,
regulations, and standards regarding the collection, use, retention, security, disclosure, transfer, and other processing of sensitive
and personal information. In addition, many states in which we operate have laws that protect the privacy and security of sensitive
and personal information. Certain state laws may be more stringent or broader in scope, or offer greater individual rights, with
respect to sensitive and personal information than federal, international, or other state laws, and such laws may differ from
each other, which may complicate compliance efforts. State laws are changing rapidly and there is discussion in Congress of a
new federal data protection and privacy law to which we would become subject if it is enacted. All of these evolving compliance
and operational requirements impose significant costs that are likely to increase over time, may require us to modify our data
processing practices and policies, and may divert resources from other initiatives and projects. Furthermore, non-compliance with
data privacy laws and regulations, or a major breach of our network security and systems, could have serious negative consequences
for our businesses and future prospects, including possible fines, penalties, and damages, reduced customer demand for our products,
and harm to our reputation and brand, all of which may have a material and adverse impact on our business, financial condition,
and operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
make public statements about our use and disclosure of personal information through our privacy policy, information provided on
our website and press statements. Also, we enter into contracts with third parties (such as our partners and clients) that contain
provisions regarding the collection, sharing, and processing of personal information. Although we endeavor to comply with our
public statements and documentation as well as our contractual and other privacy-related obligations, we may at times fail to
do so or be alleged to have failed to do so. The publication of our privacy policy and other statements that provide promises
and assurances about data privacy and security can subject us to potential government or legal action if they are found to be
deceptive, unfair or misrepresentative of our actual practices. In addition, from time to time, concerns may be expressed about
whether our products and services compromise the privacy of clients and others. Any concerns about our data privacy and security
practices (even if unfounded), or any failure, real or perceived, by us to comply with our posted privacy policies, contractual
obligations, or any legal or regulatory requirements, standards, certifications, or orders, or other privacy or consumer protection-related
laws and regulations applicable to us, could cause our clients to reduce their use of our autonomous industrial vehicles and could
affect our financial condition, operating results, and our reputation, and may result in governmental or regulatory investigations,
enforcement actions, regulatory fines, criminal compliance orders, litigations, breach of contract claims, or public statements
against us by government regulatory authorities, our partners and/or clients, data subjects, consumer advocacy groups, or others,
all of which could be costly and have an adverse effect on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
enforcement actions and investigations by regulatory authorities related to data security incidents and privacy violations continue
to increase. Non-compliance could result in proceedings against us by data protection authorities, governmental entities or others,
including class action privacy litigation in certain jurisdictions, which would subject us to significant fines, penalties, judgments,
and negative publicity, and may otherwise affect our financial condition, operating results, and our reputation. Given the complexity
of operationalizing the GDPR and other data privacy and security laws and regulations to which we are subject, the maturity level
of proposed compliance frameworks and the relative lack of guidance in the interpretation of the numerous requirements of the
GDPR and other data privacy and security laws and regulations to which we are subject, we may not be able to respond quickly or
effectively to regulatory, legislative, and other developments, and these changes may in turn impair our ability to offer our
existing or planned products and services and/or increase our cost of doing business. In addition, if our practices are not consistent
or viewed as not consistent with legal and regulatory requirements, including changes in laws, regulations, and standards or new
interpretations or applications of existing laws, regulations and standards, we may become subject to audits, inquiries, whistleblower
complaints, adverse media coverage, investigations, loss of export privileges, or severe criminal or civil sanctions, all of which
may affect our financial condition, operating results, and our reputation. Unauthorized access or disclosure of personal or other
sensitive or confidential data of Company (including data about third parties which the Company possesses), whether through systems
failure, employee negligence, fraud, or misappropriation, by the Company, our service providers or other parties with whom we
do business (if they fail to meet the standards we impose, or if their systems on which our data is stored experience any data
breaches or security incidents) could also subject us to significant litigation, monetary damages, regulatory enforcement actions,
fines, and criminal prosecution in one or more jurisdictions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Common Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no established trading market for our shares; further, our shares will be subject to potential delisting if we do not maintain
the listing requirements of the Nasdaq Capital Market.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to our initial public offering in October&#160;2021, there was no public market for our shares of common stock. Although our common
stock began trading on the Nasdaq Capital Market on October&#160;20, 2021, there can be no assurance that an active trading market
for these securities will develop or be sustained.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Nasdaq has rules for continued listing, including, without limitation, minimum market capitalization and other requirements.
Failure to maintain our listing, or de-listing from Nasdaq, would make it more difficult for stockholders to dispose of our common
stock and more difficult to obtain accurate price quotations on our common stock. This could have an adverse effect on the price
of our common stock. Our ability to issue additional securities for financing or other purposes, or otherwise to arrange for any
financing we may need in the future, may also be materially and adversely affected if our common stock is not traded on a national
securities exchange.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Costs
as a result of operating as a public company are significant, and our management is required to devote substantial time to compliance
with our public company responsibilities and corporate governance practices.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we incur significant legal, accounting and other expenses that private companies do not incur, and we expect
these costs to further increase after we are no longer an &#8220;emerging growth company.&#8221; The Sarbanes-Oxley Act, the Dodd-Frank
Wall Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Capital Market, and other applicable securities
rules and regulations impose various requirements on public companies. Our management and other personnel will devote a substantial
amount of time to compliance with these requirements. Moreover, these rules and regulations will increase our legal and financial
compliance costs and will make some activities more time-consuming and costly. We cannot predict or estimate the amount of additional
costs we will incur as a public company or the specific timing of such costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a result of being a public company, we are obligated to develop and maintain proper and effective internal controls over financial
reporting, and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our
company and, as a result, the value of our common stock.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required, pursuant to Section&#160;404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things,
the effectiveness of our internal control over financial reporting.. This assessment will need to include disclosure of any material
weaknesses identified by our management in our internal control over financial reporting. In addition, our independent registered
public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting in our
first annual report required to be filed with the SEC following the date we are no longer an &#8220;emerging growth company.&#8221;
We have commenced the costly and time-consuming process of compiling the system and processing documentation necessary to perform
the evaluation needed to comply with Section&#160;404, and we may not be able to complete our evaluation, testing and any required
remediation in a timely fashion once initiated. Our compliance with Section&#160;404 will require that we incur substantial expenses
and expend significant management efforts. We currently do not have an internal audit group, and we will need to hire additional
accounting and financial staff with appropriate public company experience and technical accounting knowledge and compile the system
and process documentation necessary to perform the evaluation needed to comply with Section&#160;404.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current controls and any new controls that we develop may become inadequate because of changes in conditions in our business.
In addition, changes in accounting principles or interpretations could also challenge our internal controls and require that we
establish new business processes, systems and controls to accommodate such changes. Additionally, if these new systems, controls
or standards and the associated process changes do not give rise to the benefits that we expect or do not operate as intended,
it could adversely affect our financial reporting systems and processes, our ability to produce timely and accurate financial
reports or the effectiveness of internal control over financial reporting. Moreover, our business may be harmed if we experience
problems with any new systems and controls that result in delays in their implementation or increased costs to correct any post-implementation
issues that may arise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
growth and expansion of our business places a continuous, significant strain on our operational and financial resources. Further
growth of our operations to support our customer base, our information technology systems and our internal controls and procedures
may not be adequate to support our operations. For example, we are still in the process of implementing information technology
and accounting systems to help manage critical functions such as billing and revenue recognition and financial forecasts. As we
continue to grow, we may not be able to successfully implement requisite improvements to these systems, controls and processes,
such as system access and change management controls, in a timely or efficient manner. Our failure to improve our systems and
processes, or their failure to operate in the intended manner, whether as a result of the growth of our business or otherwise,
may result in our inability to accurately forecast our revenue and expenses, or to prevent certain losses. Moreover, the failure
of our systems and processes could undermine our ability to provide accurate, timely and reliable reports on our financial and
operating results and could impact the effectiveness of our internal control over financial reporting. In addition, our systems
and processes may not prevent or detect all errors, omissions or fraud.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
sale of a substantial amount of our common stock, including resale of the shares of common stock held by the selling stockholders
in the public market, could adversely affect the prevailing market price of our common stock.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering for resale 12,903,226 shares of common stock, including 9,112,904 shares of common stock issuable upon the exercise
of Private Placement Warrants held by the selling stockholders. Sales of substantial amounts of our common stock in the public
market, or the perception that such sales might occur, could adversely affect the market price of our common stock. We cannot
predict if and when selling stockholders may sell such shares in the public market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
stock price may be volatile, and the value of our common stock may decline.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock may fluctuate or decline significantly in response to numerous factors, many of which are beyond
our control, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
or anticipated fluctuations in our financial condition or results of operations;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variance
in our financial performance from expectations of securities analysts;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in the pricing of the solutions on our platforms;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in our projected operating and financial results;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in laws or regulations applicable to our technology;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
by us or our competitors of significant business developments, acquisitions or new offerings;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
of shares of our common stock by us or our stockholders;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
data breaches, disruptions to or other incidents involving our technology;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
involvement in litigation;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
sales of our common stock by us or our stockholders, as well as the anticipation of lock-up releases;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in senior management or key personnel;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
trading volume of our common stock;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in the anticipated future size and growth rate of our market;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
economic and market conditions; and</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
events or factors, including those resulting from war, incidents of terrorism, global pandemics or responses to these events.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broad
market and industry fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively
impact the market price of our common stock. In addition, technology stocks have historically experienced high levels of volatility.
In the past, companies who have experienced volatility in the market price of their securities have been subject to securities
class action litigation. We may be the target of this type of litigation in the future, which could result in substantial expenses
and divert our management&#8217;s attention.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, the
market price and trading volume of our common stock could decline.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price and trading volume of our common stock may be heavily influenced by the way analysts interpret our financial information
and other disclosures. We do not have control over these analysts. If few securities analysts commence coverage of us, or if industry
analysts cease coverage of us, our stock price would be negatively affected. If securities or industry analysts do not publish
research or reports about our business, downgrade our common stock, or publish negative reports about our business, our stock
price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly,
demand for our common stock could decrease, which might cause our stock price to decline and could decrease the trading volume
of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
executive officers, directors and principal stockholders, if they choose to act together, have the ability and will continue to
have the ability to control or significantly influence all matters submitted to stockholders for approval.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers, directors and principal stockholders (including entities affiliated with Benchmark), beneficially own approximately
46% of our common stock. Such persons acting together, will have the ability to control or significantly influence all matters
submitted to our stockholders for approval, as well as our management and business affairs. This concentration of ownership may
have the effect of delaying, deferring or preventing a change in control, impeding a merger, consolidation, takeover or other
business combination involving us, or discouraging a potential acquiror from making a tender offer or otherwise attempting to
obtain control of our business, even if such a transaction would benefit other stockholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
securities issuances could result in significant dilution to our stockholders and impair the market price of our common stock.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
issuances of shares of our common stock could depress the market price of our common stock and result in dilution to existing
holders of our common stock. Also, to the extent outstanding options and warrants to purchase our shares of our common stock are
exercised or options or other equity-based awards are issued or become vested, there will be further dilution. The amount of dilution
could be substantial depending upon the size of the issuances or exercises. Furthermore, we may issue additional equity securities
that could have rights senior to those of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
anticipate that we will need to raise additional capital, and our issuance of additional capital stock in connection with financings,
acquisitions, investments, our equity incentive plans or otherwise will dilute all other stockholders.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to issue additional capital stock in the future that will result in dilution to all other stockholders. We expect to grant
equity awards to employees, directors and consultants under our equity incentive plans. We may also raise capital through equity
financings in the future. As part of our business strategy, we may acquire or make investments in companies, products or technologies
and issue equity securities to pay for any such acquisition or investment. We may not be able to obtain additional capital if
and when needed on terms acceptable to us, or at all. Further, if we do raise additional capital, it may cause stockholders to
experience significant dilution of their ownership interests and the per share value of our common stock to decline.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends for the foreseeable future and, as a result, your ability to achieve a return on your investment
will depend on appreciation in the price of our common stock.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our capital stock and we do not currently intend to pay any cash dividends in
the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our board of directors.
Accordingly, you may need to rely on sales of our common stock after price appreciation, which may never occur, as the only way
to realize any future gains on your investment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are an &#8220;emerging growth company,&#8221; and we cannot be certain if the reduced reporting and disclosure requirements applicable
to emerging growth companies will make our common stock less attractive to investors.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging-growth company,&#8221; as defined in the JOBS Act, and we have elected to take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies,&#8221;
including the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, or Section&#160;404, reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not
previously approved. Pursuant to Section&#160;107 of the Jumpstart Our Business Startups (&#8220;JOBS&#8221;) Act, as an emerging
growth company, we have elected to use the extended transition period for complying with new or revised accounting standards until
those standards would otherwise apply to private companies. As a result, our consolidated financial statements will not be comparable
to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards
that are applicable to public companies, which may make our common stock less attractive to investors. In addition, if we cease
to be an emerging growth company, we will no longer be able to use the extended transition period for complying with new or revised
accounting standards.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging-growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary
of this offering; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the
date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities;
and (4) the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700 million of equity securities held by
non-affiliates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict if investors will find our common stock less attractive as a result of choosing to rely on these exemptions. For
example, if we do not adopt a new or revised accounting standard, our future results of operations will not be as comparable to
the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common
stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be
more volatile.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-takeover
provisions in our charter documents may discourage our acquisition by a third party, which could limit our stockholders&#8217;
opportunity to sell their shares, at a premium.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated certificate of incorporation includes provisions that could limit the ability of others to acquire control
of our company. These provisions could have the effect of depriving our stockholders of an opportunity to sell their shares at
a premium over prevailing market prices by discouraging third parties from seeking to obtain control in a tender offer or similar
transaction. Among other things, the charter documents will provide:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
amendments to our bylaws that will require the approval of two-thirds of the combined vote of our then-outstanding shares of our common
stock; and</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
board of directors has the authority, without further action by our stockholders, to issue preferred stock in one or more series and
to fix their designations, powers, preferences, privileges, and relative participating, optional, or special rights, and the qualifications,
limitations, or restrictions, including dividend rights, conversion rights, voting rights, terms.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>



</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware and federal court
within the State of Delaware as the exclusive forum for certain types of actions and proceedings that our stockholders may initiate,
which could limit a stockholder&#8217;s ability to obtain a favorable judicial forum for disputes with us or our directors, officers
or employees.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">Our
amended and restated certificate of incorporation provides that, subject to limited exceptions, the Court of Chancery of the State
of Delaware will be exclusive forums for any:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">derivative
action or proceeding brought on our behalf;</span></td>
</tr></table><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">action
asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">action
asserting a claim against us, our directors or officers or employees arising pursuant to any provision of the DGCL, our amended and restated
certificate of incorporation or amended and restated bylaws; or</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
action asserting a claim against us, our directors or officers or employees that is governed by the internal affairs doctrine.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
choice of forum provision does not apply to actions brought to enforce a duty or liability created under the Exchange Act. Our
amended and restated certificate of incorporation to be in effect after this offering also provides that the federal district
courts of the United States are the exclusive forum for the resolution of any complaint asserting a cause of action arising under
the Securities Act. We intend for this provision to apply to any complaints asserting a cause of action under the Securities Act
despite the fact that Section&#160;22 of the Securities Act creates concurrent jurisdiction for the federal and state courts over
all actions brought to enforce any duty or liability created by the Securities Act or the rules and regulations promulgated thereunder.
There is uncertainty as to whether a court would enforce such a provision with respect to claims under the Securities Act, and
our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations
thereunder. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed
to have notice of and to have consented to the provisions of our amended and restated certificate of incorporation described above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
choice of forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable
for disputes with us or our directors, officers, or other employees, which may discourage such lawsuits against us and our directors,
officers and employees. Alternatively, if a court were to find these provisions of our amended and restated certificate of incorporation
inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional
costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SPECIAL
NOTE REGARDING FORWARD-LOOKING</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation,
intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These forward-looking
statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties
known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such
statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, you can identify forward-looking statements by terminology, such as &#8220;expects&#8221;, &#8220;anticipates&#8221;,
&#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221;, &#8220;potential&#8221;, &#8220;possible&#8221;, &#8220;probable&#8221;,
&#8220;believes&#8221;, &#8220;seeks&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;could&#8221;
or the negative of such terms or other similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties
that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified
in their entirety by reference to the factors discussed throughout this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus and the documents that we reference herein and have filed as exhibits to the registration statement,
of which this prospectus is part, completely and with the understanding that our actual future results may be materially different
from what we expect. You should assume that the information appearing in this prospectus is accurate as of the date on the front
cover of this prospectus only. Because the risk factors referred to above could cause actual results or outcomes to differ materially
from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any
forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake
no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement
is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for
us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent
to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking
statements. We qualify all of the information presented in this prospectus, and particularly our forward-looking statements, by
these cautionary statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF PROCEEDS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of the shares of our common stock being offered for sale by the selling stockholders.
Upon the exercise of the warrants for an aggregate of 9,112,904 shares of common stock assuming all payments are made by cash
and there is no reliance on cashless exercise provisions however, we will receive the exercise price of the warrants, or an aggregate
of approximately $19,228,468, from the investors in the Private Placement. We will bear all fees and expenses incident to our
obligation to register the shares of common stock. Brokerage fees, commissions and similar expenses, if any, attributable to the
sale of shares offered hereby will be borne by the selling stockholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no assurance the warrants will be exercised for cash. We intend to use such proceeds, if any, for general corporate and working
capital purposes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRIVATE
PLACEMENT OF SHARES OF COMMON STOCK, WARRANTS AND PRE-FUNDED WARRANTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;28, 2022, we entered into a Securities Purchase Agreement or the Purchase Agreement with certain accredited and institutional
investors or the Investors, for a private placement offering or the Private Placement, of the Company&#8217;s common stock or
Pre-Funded Warrants and Common Warrants. Pursuant to the Purchase Agreement, we sold (i) 3,790,322 shares of our Common Stock
together with Common Warrants to purchase up to 3,790,322 shares of Common Stock, and (ii) 2,661,291 Pre-Funded Warrants with
each Pre-Funded Warrant exercisable for one share of Common Stock, together with Common Warrants to purchase up to 2,661,291 shares
of Common Stock. Each share of Common Stock and accompanying Common Warrant were sold together at a combined offering price of
$3.10, and each Pre-Funded Warrant and accompanying Common Warrant were sold together at a combined offering price of $3.099 for
gross proceeds to the Company of approximately $20,000,000. The Private Placement closed on April&#160;29, 2022 (the &#8220;Closing
Date&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds primarily for working capital and general corporate purposes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants have an exercise price of $0.001 per share, subject to adjustment and no expiration date. The Pre-Funded Warrants
are exercisable immediately (subject to the Beneficial Ownership limitation as set forth in the Prefunded Warrant) and may be
exercised at any time until all of the Pre-Funded Warrants are exercised in full.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants are exercisable for a period of five from the date of issuance and has an exercise price of $2.98 per share, subject
to adjustment as set forth in the Common Warrant for stock splits, stock dividends, recapitalizations and similar customary adjustments.
The investor may exercise the Common Warrant on a cashless basis if the shares of common stock underlying the Warrant or the Warrant
Shares, are not then registered pursuant to an effective registration statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Investors have contractually agreed to restrict their ability to exercise the Private Placement Warrants such that the number
of shares of the Company&#8217;s common stock held by the Investors and their respective affiliates after such exercise does not
exceed the Beneficial Ownership Limitation set forth in the Private Placement Warrant which may not </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exceed
4.99% (or 9.99%, at the election of each Investor) of the Company&#8217;s then issued and outstanding shares of common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, we entered into a registration rights agreement, or the Registration Rights Agreement,
with the investor. Pursuant to the Registration Rights Agreement, we will be required to file a resale registration statement,
or the Registration Statement, with the SEC to register for resale of the Shares, the shares issuable upon exercise of the Pre-Funded
Warrants and the Warrant Shares, within 15 days of the Closing Date, and to have such Registration Statement declared effective
within 30 days after the Closing Date in the event of a limited or full review by the SEC, within 60 days after the Closing Date.
We will be obligated to pay certain liquidated damages to the investor if we fail to file the resale registration statement when
required, fail to cause the Registration Statement to be declared effective by the SEC when required, or if we fail to maintain
the effectiveness of the Registration Statement. The Company is filing this registration statement in satisfaction of its obligation
to file a registration statement under the Registration Rights Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING
STOCKHOLDERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable
to the selling stockholders, upon exercise of the Private Placement Warrants. For additional information regarding the issuances
of those shares of common stock and warrants, see &#8220;Private Placement of Shares of Common Stock, Warrants and Pre-Funded
Warrants&#8221; above. We are registering the shares of common stock in order to permit the selling stockholders to offer the
shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants, the selling stockholders
have not had any material relationship with us within the past three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock
by each of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each selling
stockholder, based on its ownership of the shares of common stock and warrants, as of May&#160;11, 2022, assuming exercise of
the warrants held by the selling stockholders on that date, without regard to any limitations on exercises.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling stockholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the
resale of the sum of (i) the number of shares of common stock issued to the selling stockholders in the &#8220;Private Placement
of Shares of Common Stock, Warrants and Pre-Funded Warrants&#8221; described above and (ii) the maximum number of shares of common
stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised in full as of the
trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading
day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right
agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes the sale of all of the
shares offered by the selling stockholders pursuant to this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
indicated otherwise as set forth in the footnotes below, under the terms of the warrants, a selling stockholder may not exercise
the warrants to the extent such exercise would cause such selling stockholder, together with its affiliates and attribution parties,
to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding common stock following
such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of the warrants which
have not been exercised (the &#8220;Beneficial Ownership Limitation&#8221;). The number of shares in the second and fourth columns
do not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See &#8220;Plan
of Distribution.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Stockholder</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares of Common Stock Owned Prior to Offering</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares of Common Stock Owned After Offering</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Armistice Capital Master Fund Ltd. (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,122,582</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,122,582</td><td style="width: 1%; text-align: left">(2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Iroquois Capital Investment Group LLC (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,580</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,580</td><td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Iroquois Master Fund Ltd. (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,580</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,580</td><td style="text-align: left">(6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Empery Asset Master, LTD (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">726,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">726,112</td><td style="text-align: left">(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Empery Tax Efficient, LP (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,284</td><td style="text-align: left">(10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Empery Tax Efficient III, LP (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">383,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">383,928</td><td style="text-align: left">(12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Sabby Volatility Warrant Master Fund, Ltd. (13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,200,000</td><td style="text-align: left">(14)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Lind Global Fund II LP (15)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">645,160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">645,160</td><td style="text-align: left">(16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>



</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>





</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities are directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the &#8220;Master Fund&#8221;),
and may be deemed to be indirectly beneficially owned by: (i) Armistice Capital, LLC (&#8220;Armistice Capital&#8221;), as the investment
manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. Armistice Capital and Steven Boyd disclaim
beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. The business address for
the Master Fund is c/o Armistice Capital, LLC, 510 Madison Avenue 7<sup>th</sup> Floor, New York 10022.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares consists of (i) 2,500,000 shares of common stock,
(ii) 2,061,291 shares of common stock issuable upon exercise of Pre-funded Warrants, and (iii) 4,561,291 shares of common stock issuable
upon exercise of Common Warrants. Both Pre-Funded Warrants and the Common Warrants are subject to certain beneficial ownership limitations
that prohibit the Master Fund from exercising any portion of them if, following such exercise, the Master Fund&#8217;s ownership of our
common stock would exceed the relevant warrant&#8217;s ownership limitation.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
Abbe is the Managing Member of Iroquois Capital Investment Group, LLC and may be deemed to have voting and dispositive power with respect
to the shares. The business address for Iroquois Capital Investment Group, LLC is 2 Overhill Road, Scarsdale, New York 10583.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares includes (i) 161,290 shares of common stock and (ii) 161,290 shares of common stock issuable upon exercise of Common
Warrants, which are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify">Kimberly
Page is the Managing Member of Iroquois Capital Management LLC, investment advisor to Iroquois Master Fund, Ltd and may be deemed to have
voting and dispositive power with respect to the shares. The business address for Iroquois Master Fund, Ltd. is 2 Overhill Road, Scarsdale,
New York 10583.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares includes (i) 161,290 shares of common stock and (ii) 161,290 shares of common stock issuable upon exercise of Common
Warrants, which are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Empery
Asset Management LP, the authorized agent of Empery Asset Master Ltd (&#8220;EAM&#8221;), has discretionary authority to vote and dispose
of the shares held by EAM and may be deemed to be the beneficial owner of these shares. Martin Hoe and Ryan Lane, in their capacity as
investment managers of Empery Asset Management LP, may also be deemed to have investment discretion and voting power over the shares
held by EAM. EAM, Mr. Hoe and Mr. Lane each disclaim any beneficial ownership of these shares.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares
                                                                                                                                                                includes (i) 363,056 shares of common stock and (ii) 363,056 shares of common stock issuable upon exercise of Common Warrants, which
                                                                                                                                                                are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Empery
Asset Management LP, the authorized agent of Empery Tax Efficient, LP (&#8220;ETE&#8221;), has discretionary authority to vote and dispose
of the shares held by ETE and may be deemed to be the beneficial owner of these shares. Martin Hoe and Ryan Lane, in their capacity as
investment managers of Empery Asset Management LP, may also be deemed to have investment discretion and voting power over the shares
held by ETE. ETE, Mr. Hoe and Mr. Lane each disclaim any beneficial ownership of these shares.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares includes (i) 90,142 shares of common stock and (ii) 90,142 shares of common stock issuable upon exercise of Common Warrants,
which are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Empery
Asset Management LP, the authorized agent of Empery Tax Efficient III, LP (&#8220;ETE III&#8221;), has discretionary authority to vote
and dispose of the shares held by ETE III and may be deemed to be the beneficial owner of these shares. Martin Hoe and Ryan Lane, in
their capacity as investment managers of Empery Asset Management LP, may also be deemed to have investment discretion and voting power
over the shares held by ETE III. ETE III, Mr. Hoe and Mr. Lane each disclaim any beneficial ownership of these shares.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares includes (i) 191,964 shares of common stock and (ii) 191,964 shares of common stock issuable
upon exercise of Common Warrants, which are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>



</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sabby
Volatility Warrant Master Fund, Ltd. is managed by Sabby Management, LLC. Sabby Management, LLC, in its capacity as the investment manager
of Sabby Volatility Warrant Master Fund, Ltd., has the power to vote and the power to direct the disposition of all securities held by
Sabby Volatility Warrant Master Fund, Ltd. Hal Mintz is the Managing Member of Sabby Management, LLC. Each of Sabby Volatility Warrant
Master Fund, Ltd., Sabby Management, LLC and Mr. Mintz disclaim beneficial ownership of these securities, except to the extent of any
pecuniary interest therein. The principal business address of Sabby Management, LLC is 10 Mountainview Road, Suite 205, Upper Saddle
River, NJ 07458.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares includes (i) 600,000 shares of common stock issuable upon exercise of Pre-funded Warrants and (ii) 600,000 shares of
common stock issuable upon exercise of Common Warrants, both of which are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lind Global Fund II LP is managed by The Lind Partners LLC. The Lind Partners
LLC, in its capacity as the investment manager of Lind Global Fund II LP, has the power to vote and the power to direct the disposition
of all securities held by Lind Global Fund II LP. Jeff Easton is the Managing Member of The Lind Partners LLC. Mr. Easton disclaims beneficial
ownership over the securities listed, except to the extent of his pecuniary interest therein. The principal business address of Lind Global
Fund II LP is 444 Madison Ave., 41<sup>st</sup> Floor, New York, NY 10022.</span></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares includes (i) 322,580 shares of common stock and (ii) 322,580 shares of common stock issuable upon exercise of Common
Warrants, which are subject to certain beneficial ownership limitations.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OUR
BUSINESS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
of the industrial vehicle market (utility vehicles, trucks, and tractors utilized heavily in the manufacturing, distribution and
logistics, mining, and construction industries) projects the demand of such vehicles to reach as high as $80 billion by 2023,
according to findings from the &#8220;Global Material Handling Equipment&#8221; report by Freedonia Focus Reports. This growth
will be propelled by the projected rise in global manufacturing, construction, and e-commerce activity. Yet, according to the
&#8220;Trends in Supporting and Scaling Modern Automation&#8221; report by Ricoh &amp; ABI Research Report, historically, less
than 1% of industrial vehicle equipment shipped by top manufacturers has been automated. Despite these low penetration rates,
the benefits of industrial vehicle automation can produce operational efficiency gains of upwards of 50%, according to the &#8220;Industry
4.0: Reimagining manufacturing operations after COVID 19&#8221; article by McKinsey &amp; Company. As automation proliferates,
these industries will gradually shift to service-based models that will decrease upfront capital expenditures and create new revenue
streams while unlocking new value in the supply chain. Our autonomous vehicle (AV)technology is uniquely positioned to capitalize
upon these changes by offering a heterogeneous autonomy solution that can deliver self-driving capabilities and data insights
to nearly every industrial vehicle on the market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
integrate our full-stack autonomous driving software, DriveMod, onto vehicles manufactured by Original Equipment Manufacturer
(OEM) customers either via retrofit of existing vehicles or by integration directly into vehicle assembly. We design the Enterprise
Autonomy Suite (&#8220;EAS&#8221;) to be compatible with sensors and components from leading hardware technology providers and
integrate our proprietary AV software to produce differentiated autonomous vehicles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autonomous
driving has common technological building blocks that remain similar across vehicles and applications. By tapping into these building
blocks, DriveMod is designed to deliver autonomy to new vehicles via streamlined hardware/software integration. This vehicle-agnostic
approach enables DriveMod to expand to new vehicles and novel operational design domains (ODD). In short, almost every industrial
vehicle, regardless of use case, can move autonomously using our technology.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
approach accomplishes several primary value propositions:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brings
autonomous capabilities to vehicles built by proven manufacturers that are already trusted by customers.</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generates
continual customer value by leveraging the synergistic relationship of autonomous vehicles and data.</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creates
consistent autonomous vehicle operation and interfaces for diverse fleets.</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complements
the core competencies of existing industry players by introducing leading-edge technologies like Artificial Intelligence (AI) &amp; Machine
Learning (ML), cloud/connectivity, sensor fusion, high-definition mapping, and real-time dynamic path planning &amp; decision making.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our market positioning as a technology partner to vehicle manufacturers creates a synergy with incumbent suppliers that
already have established sales, distribution, and service/maintenance channels. By focusing on industrial use cases and partnering
with the incumbent OEMs in these spaces, we believe we can source and execute revenue-generating opportunities more quickly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
long-term vision is for EAS to become a universal autonomous driving solution with minimal marginal cost for companies to adopt
new vehicles and expand their autonomous fleets across new deployments. We have already deployed DriveMod software on nine different
vehicle form factors that range from stockchasers and stand-on floor scrubbers to 14-seat shuttles and 5-meter-long cargo vehicles
as part of prototypes and proof of concept projects, demonstrating the extensibility of our AV building blocks.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
recent progress contributes to the validation of EAS with OEM partners and end customers. We also continue to build upon our ability
to scale our products and generate novel technological developments. See figure below for recent highlights:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_001.jpg" src="img_001.jpg" style="height: 363px; width: 750px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
0: Summary of recent Cyngn milestones</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the adaptability of our technology will enable us to incrementally expand into new AV verticals and grow our total
addressable market (TAM) from the billions of dollars we are currently targeting in the industrial markets to the trillions of
dollars that self-driving vehicles can capture across all industries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the ubiquity of our technology will combine with our deep AV experience and enable us to incrementally expand into
new AV verticals. Thus, we could grow our TAM from the billions of dollars we are currently targeting in the commercial and industrial
markets to the trillions of dollars that self-driving vehicles can capture across industries (Source: Ark Invest. &#8220;Mobility-As-A-Service:
Why Self-Driving Cars Could Change Everything.&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Automation
and Autonomy in the Industrial Equipment Market</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automation
has long played a role in industrial sectors. More recently, the larger industrial automation market has grown significantly by
riding the wave of new technology and innovation focused on addressing the needs of what is known as <i>Industry 4.0, </i>the
outcome of the fourth industrial revolution (Source: <i>https://www2.deloitte.com/us/en/insights/focus/industry-4-0.html</i>).
According to the &#8220;Industrial Automation Market by Component, Mode of Operation, and End User&#8221; report by Meticulous
Market Research Pvt. Ltd., in 2020, the industrial automation industry was valued at US$164.2 billion and is expected to grow
at 9.3% compound annual growth rate (CAGR), ultimately reaching a market value of US$306.2 billion by 2027. Autonomous vehicles
represent fundamental technology that will enable the fourth industrial revolution.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_002.jpg" src="img_002.jpg" style="height: 408px; width: 250px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
1: Illustration of the progression from Industry 1.0 to Industry 4.0.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
automation is broadly understood to consist of a wide range of technology solutions that provide varying levels of automation
for critical software control systems and industrial equipment. These components are essential to the operations and growth of
global markets such as manufacturing, distribution, transportation, construction, and mining. The relatively controlled and pre-defined
operational environments industrial companies operate in are what make them such a strong opportunity for companies looking to
develop automation solutions, but enhanced product capabilities will be required to achieve the promise of Industry 4.0 &#8212;
capabilities that will be created by technological advancements in AI/ML, robotics, connectivity, mapping, and interoperability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Automation
Solutions for Industrial Equipment</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Industrial Equipment market covers a broad range of use cases and product categories, with automation solutions targeting Material
Transport Equipment (MTE) heavily utilized by the majority of industry market sectors. For our purposes, we can think of MTE to
include all material handling equipment directly related to material transit (this includes conveying equipment, monorail, hoists,
storage &amp; retrieval, and industrial vehicles). According to the &#8220;Global Material Handling Equipment&#8217; report by
Freedonia Focus Reports, the MTE market is characterized by steady growth, and the increase in global e-commerce activity and
industry mechanization over the past decade are projected to grow the industry to $160 billion in 2023, representing a 3.9% 5-year
CAGR. Our belief is that these strong growth indicators will drive increased need for more advanced technology that will address
gaps in the current capabilities of automated MTE solutions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
MTE automation has been heavily weighted in solutions related to storage/retrieval systems and conveyors because more rigid and
repetitive environments are better suited for the limited capability of existing automation solutions. By contrast, the vehicles
in the MTE category, referred to here as <i>industrial vehicles</i>, are largely still driven manually. As an example, automated
guided vehicles (AGVs) and autonomous mobile robots (AMRs) have illustrated the applicability of automated industrial vehicles
for the manufacturing and distribution industries, yet adoption rates of these technologies are lagging Industry 4.0 growth rates
by as much as 4.5%, according to the &#8220;Global Material Handling Equipment&#8217; report by Freedonia Focus Reports.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Analysis
in the &#8220;Trends in Supporting and Scaling Modern Automation&#8221; report by Ricoh &amp; ABI Research Report estimates that
the top 10 manufacturers of industrial vehicles for manufacturing and distribution shipped approximately 883,000 units in 2019.
However, fewer than 1% of material handling vehicles shipped every year are automated, presenting a significant opportunity to
automate industrial vehicles. The cost to operate a non-autonomous material transport vehicle is reported to be $32.42 per hour,
according to the U.S. Bureau of Labor Statistics compensation data for transportation and material moving full-time employees.
Further, it is estimated that each non-autonomous vehicle is in operation for approximately 4,174 hours per year based on 16-hour
per workday operation. The labor costs associated with humans operating 883,000 non-autonomous vehicles for manufacturing and
distribution yield our current market potential of $119B. The ability to deliver more consistent operations, reduce accidents,
and mitigate personnel issues like attrition and truancy through the use of AVs could create additional market opportunity. Other
relevant statistics we consider when evaluating our market potential are that there are an estimated 20,000 warehouses in the
US (50,000 globally) with an average of 175 employees per warehouse, according to Statista, and there are an estimated 900,000
employees moving material within these US warehouses, according to &#8220;Industries at a Glance: Warehousing and Storage: NAICS
493.&#8221; We believe that technological innovation is needed to enable adoption of autonomous MTE that will address the substantial
industry challenges that exist today.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
challenges include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Labor
shortages</i> &#8212; The hiring and retention of qualified workers is a critical concern for the markets that material transport
vehicles operate within. In fact, Deloitte&#8217;s 2020 and 2021 Material Handling Industry Report showed that over 50% of the
1,000 supply chain and manufacturing leaders surveyed rated hiring and employee retention as their biggest challenge (source:
MHI Deloitte Industry Report). Additionally, in a survey completed in late 2019 prior to the start of the COVID 19 pandemic, 73%
of survey respondents indicated that it takes more than 30 days for their companies to fill open positions. By 2030, the impact
of unfilled open jobs in manufacturing could cost the US economy more than $1 trillion. Compounding the issue further is the industry&#8217;s
projected increase in labor demand and cost. According to IBISWorld&#8217;s 2020 US Industrial Machinery &amp; Equipment Industry
Report, US industry labor needs are expected to increase at an annualized rate of 3.7% to over 375,000 workers through 2025, driven
by higher US industrial and manufacturing activity. Average cost of manufacturing labor in the US has also increased by 20% since
2010 according to McKinsey.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Difficulty
in scaling &#8212; </i>The traditional approaches to vehicle automation make scaling vehicle automation solutions difficult due
to strains caused by service lifecycle management and issues with dynamic deployability. Industrial automation customers are forced
to coordinate operational components from a variety of different vendors and lack a unifying architecture that allows the technology
to scale effectively within and across sites. Significant costs are also associated with expanding the scope of existing automation
solutions as they are tightly coupled to specific vehicles and often require an overhaul of the site infrastructure to overcome
shortcomings in the automation technology. This can be especially true in niche environments like mines, where the deployability
challenges are compounded by unique sites that require heterogeneous fleets. Furthermore, customer service, workforce training,
and repair fall under service lifecycle management and must be taken into account along with the technology in order to scale
efficiently, according to the &#8220;Trends in Supporting and Scaling Modern Automation&#8221; report by Ricoh &amp; ABI Research
Report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lagging
technological advancement </i>&#8212; Manufacturers of material transport vehicles have core competencies in mechanical, electrical,
and control systems while the end users of the vehicles typically specialize in logistics, manufacturing, and material moving.
There is limited expertise throughout the material handling value chain in software algorithms, sensing, and high-performance
computing. Considering the incumbents&#8217; gaps in leading-edge AV and AI technologies and the pressure existing suppliers face
to ship manually-operated vehicles that address the multi-billion dollar demand that already exists, we believe it is unlikely
that existing stakeholders will be able to invest in the technological advancements that will solve the industry&#8217;s fundamental
challenges. Deloitte&#8217;s 2020 Material Handling Industry Report indicates that, through 2023, only 42% of survey respondents
would invest in automation equipment at all, with just 20% reporting that they would invest in either AVs or predictive analytics.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>High
barriers to adoption </i>&#8212; Many solutions for automated material transport require an all-or-nothing commitment from customers:
either make a major upfront investment to overhaul operations for automation, or postpone automation at the risk of falling behind
competition. This all-or-nothing approach to unlocking future return on investment (ROI) can be problematic for risk-averse companies
that seek to adopt automation solutions. Depending on fleet size, traditional automation solutions such as &#8220;robot-in-a-box&#8221;
may command ROI horizons of up to 4 years. Factoring in ancillary costs like installation, maintenance, on-site testing, integration,
and deployment, can also represent a significant annual cost burden, according to findings by Richoh &amp; ABI Research Report.
According to a PwC 2016 Digital Operations survey, &#8220;cost advantage&#8221; was the most prevalent prompt cited (86% of responses)
for adopting advanced industrial mobility technologies, but in conjunction, &#8220;costs are prohibitive&#8221; was the most prevalent
barrier (58% of responses) to adoption of semi-autonomous/autonomous vehicles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
combat these challenges, we have built an Enterprise Autonomy Suite for industrial vehicles that leverages advanced in-vehicle
autonomous driving technology and incorporates leading supporting technologies like data analytics, fleet management, cloud, and
connectivity. EAS provides a differentiated solution that we believe will drive pervasive adoption of industrial autonomy and
create value for customers at every stage of their automation growth.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Enterprise Autonomy Suite for Industrial Vehicles</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
unique value proposition stems from the concept that the growth of industrial autonomy requires an approach that deploys applied
AV solutions within a system of supportive resources rather than a technology feature that is tuned to a specific industrial vehicle.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
companies manufacture standard industrial vehicles then integrate industrial automation software for rigid tasks. Others develop
new vehicle platforms to enable more advanced automation capabilities, limiting the AV technology to a narrow use case. We develop
an advanced autonomous vehicle software, DriveMod, for industrial vehicles. DriveMod is a component of EAS that is operationally
expansive, vehicle agnostic, and compatible with indoor and outdoor environments. EAS centers around DriveMod&#8217;s on-vehicle
AV software and is supported by our Cyngn Insight and Cyngn Evolve technology and tools.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_003.jpg" src="img_003.jpg" style="height: 351px; width: 300px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
2: The core components that make up our EAS product offering.<br/>
EAS is currently available as a private beta release to select customers.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
approach drives value at every stage of a company&#8217;s autonomy journey</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EAS
provides extensible industrial autonomy solutions that can include data-driven actionable insights, partial autonomy to augment
existing workflows and support human drivers, and fully autonomous vehicle mobility. By offering flexible data and autonomous
services through subscription-based business models, we assuage the industry&#8217;s existing challenge of all-or-nothing adoption
for autonomous vehicles. Installing DriveMod onto any vehicle unlocks a collection of valuable product offerings that customers
can activate over the air, creating lower barriers to entry and enabling customers to benefit from novel data insights while adopting
industrial AVs at their own pace.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>EAS
galvanizes the relationship between AVs and data</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
EAS combines core autonomous vehicle technology with a suite of tools and products that strengthen the ties between industrial
business operations and the positive network effects that underpin the relationship between data and AVs. DriveMod uses data from
advanced sensors to navigate AVs, creating a de facto mechanism for rich data collection. Vehicles equipped with DriveMod provide
the means for us to collect data then organize, analyze, and expose customers to novel insights. This makes the data collected
during vehicle operation a new type of asset that adopters of AV technology can take advantage of. Data can be stored in cloud
or on-premises servers, according to customer requirements. We intend to have our customers own the data collected at their facilities
and for Cyngn to have the rights to use that data for certain purposes, such as testing simulation and development. These data
assets present a new opportunity to reveal previously unknown insights about day-to-day operational processes that impact safety,
efficiency, vehicle maintenance, and growth.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_004.jpg" src="img_004.jpg" style="height: 292px; width: 225px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
3: The EAS product flywheel</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the deployment of industrial vehicles with DriveMod scales up, the amount and diversity of data flowing through Cyngn Insight
expands, creating an accelerated feedback loop and powers our ability to use Cyngn Evolve to further enhance DriveMod, and update
the on-vehicle software over-the-air.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><i>Continual
Improvement Drives Technology Advancement</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">DriveMod&#8217;s
building blocks enable a more consistent cadence of upgrades, improvements, and customer-specific feature development that can
be deployed via over-the-air updates. These capabilities ensure that the deployed system stays in sync with the changing application
demands while allowing customers to focus on monetary and operational ROI. Our EAS plugs into business operations by creating
and collecting real-time data and aggregating it into configurable analytics dashboards that inform customer operations as well
as future DriveMod releases, creating a data set specific to each customer from high-resolution data collected during their operations.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
Approach Augments and Upskills Workforces</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
vehicle autonomy represents an opportunity to minimize the adverse impact that talent shortages, employee health, and safety have
on a company&#8217;s core operations. Autonomous vehicles can be relied upon to fill the voids that commonly create human resource
issues like executing repetitive tasks, working during undesirable hours, and operating in uncomfortable or hazardous environments.
One Deloitte case study inspected a parts manufacturing and fulfillment facility that utilized Autonomous Mobile Robots (&#8220;AMRs&#8221;)
to pick products from the back of their expansive distribution center. Introducing the AMRs saved employee time, provided respite
from unstimulating tasks, and improved both morale and productivity overall (Source: Deloitte industry report, 2020).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
existing employees can be exposed to cutting-edge technology and develop new valuable career development opportunities. For instance,
a manufacturing community in Wisconsin successfully retrained their employees to be skilled in AMR maintenance after AMRs were
introduced to replace traditional conveyors, according to the article &#8220;Are Autonomous Mobile Robots at the Tipping Point&#8221;
by AutomationWorld.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
Designed for Scale</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EAS
provides a powerful solution to scalability issues, especially for dynamic deployability and service lifecycle management. DriveMod&#8217;s
modular capability to deploy AV technology on diverse vehicle fleets has been proven through its deployment on nine different
vehicle form factors that we have operated autonomously. These vehicles were deployed as prototypes or as a part of proof-of-concept
project. Of these deployments, two were at customer sites. For one deployment we were paid $166,000 and the other was part of
our normal R&amp;D activities. Our AV development and testing have included road vehicles that navigate complex dynamic environments.
DriveMod is capable of perceiving more than 100 dynamic objects per second and then using that perception information to navigate
autonomously. This capability has been proven via road testing in difficult driving settings like urban streets. In contrast,
the industrial settings of our target market rarely encounter 100 dynamic actors per minute, let alone per second. Scalability
is further strengthened by EAS creating common interfaces and experiences that unify customer data and AV operations within and
across sites. Thus, proliferating our solutions with customers will be achieved by iteratively adding onto an existing EAS, which
minimizes the marginal cost associated with expanding AV operations. Additionally, the deployment of EAS allows for all of the
on-going administration, services, and vendors associated with managing the lifecycle of the system to be integrated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_005.jpg" src="img_005.jpg" style="height: 308px; width: 550px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
4: Illustration of DriveMod&#8217;s ability to utilize key subsystems across multiple environments and vehicle platforms<br/>
(left: off-road utility vehicle; right: indoor material handling vehicle).</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Products</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EAS
is a suite of technology and tools that we divide into three complementary categories: DriveMod, Cyngn Insight, and Cyngn Evolve.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DriveMod:
Industrial Autonomous Vehicle System</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
built DriveMod as a modular software product that is compatible with various sensor and computer hardware components that are
widely used throughout the autonomous vehicle industry. Our software combined with sensors and components from industry leading
technology providers covers the end-to-end requirements that enable vehicles to operate autonomously with leading-edge technology.
The modularity of DriveMod allows our AV technology to be compatible across vehicle platforms as well as indoor and outdoor environments.
DriveMod can be retrofitted to existing vehicle assets or integrated into a manufacturing partner&#8217;s vehicles at assembly,
providing accessible options for our customers to integrate leading-edge technology whether their AV adoption strategies are evolutionary
or revolutionary.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_006.jpg" src="img_006.jpg" style="height: 317px; width: 600px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
5: The major subsystems that make up Cyngn&#8217;s autonomous vehicle technology (DriveMod)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DriveMod&#8217;s
flexibility combines with our network of manufacturing and service partners to support customers at different stages of autonomous
technology integration. This allows customers to grow the complexity and scope of their industrial autonomy deployments as their
business transforms while continually capturing returns throughout their transition to full autonomy. EAS will also grant customers
access to over-the-air software upgrades, ad hoc customer support, and flexible consumption based on usage and scale of operations.
By lessening both the commercial and technical burdens of traditional vehicle automation and industrial robotics investments,
industrial AVs can become universally available to the market, even reaching small and medium-sized businesses that may otherwise
struggle to adopt Industry 4.0 technology.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cyngn
Insight: Intelligent Control Center</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyngn
Insight is the customer-facing tool suite for managing AV fleets and aggregating data to extract business insights. Analytics
dashboards surface data about the system&#8217;s status, vehicle telemetry, and performance metrics. Cyngn Insight also provides
tools to switch between autonomous, manual, and remote operation when required. This flexibility allows customers to use the autonomous
capabilities of the system in a way that is tailored to their own operational environment. Customers can choose when to operate
their DriveMod-powered vehicles autonomously and when to have human operators operate the vehicles manually or remotely based
on their own business needs. When combined, these capabilities and tools make up the Cyngn Insight intelligent control center
that enables flexible fleet management from any location.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_007.jpg" src="img_007.jpg" style="height: 287px; width: 750px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
6: An operator uses the Cyngn Insight control center to operate vehicles remotely</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyngn
Insight&#8217;s tool suite includes configurable cloud dashboards that aggregate diverse data streams at several levels of granularity
(i.e., site, fleet, vehicle, module, and component). We can collect data during &#8220;open loop&#8221; vehicle operation, meaning
that the vehicles can be operated manually while still collecting the rich data enabled by the advanced on-vehicle sensors and
computers. This data can be used for predictive maintenance, operational improvements, educating employees on digital transformation
and more. For example, use cases for performance management analytics driven by automation have experienced productivity increases
of 20 &#8211; 70% according to studies by Deloitte and McKinsey (source: MHI Deloitte Industry report: Industry 4.0: Reimagining
Manufacturing Operations after COVID 19).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cyngn
Evolve: Data Optimization Tools</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cyngn
Evolve is our internal tool suite that underpins the relationship between AVs and data. Through a unifying cloud-based data infrastructure,
our proprietary data tools strengthen the positive network effects derived from the valuable new data created by AVs. Cyngn Evolve
and its data pipelines facilitate AI/ML training and deployment, manage data sets, and support driving simulation and grading
to test and validate new DriveMod releases, using both real-world and simulated data.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="https:||www.sec.gov|Archives|edgar|data|1874097|000121390022014911|image_008.jpg" src="img_008.jpg" style="height: 396px; width: 550px"/></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Figure
7: The Cyngn &#8220;AnyDrive&#8221; simulation is part of the Cyngn Evolve toolchain.<br/>
The simulation environment creates a digital
version of the physical world. This allows for customer data sets to be leveraged<br/>
and augmented to achieve testing and validation
prior to releasing new AV features.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
AV technology expertise matures globally, there may be opportunities to monetize the sophisticated AV-centric tools of Cyngn Evolve.
Currently, we believe that AV development is confined to small groups of experts. Therefore, Cyngn Evolve is currently an internal
EAS tool that we use to advance DriveMod and Cyngn Insight, our customer-facing EAS products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Strategy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><i>360&#176;
Sales and Marketing</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">We
are building a go-to-market ecosystem that we believe will be highly leveraged by using our partners as the foundation of our
growth strategy. We will utilize these relationships to generate and cultivate customer demand, acquire new customers, and deliver
additional services to our customers.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
elements of our market entry and expansion roadmap include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Focus:
manufacturing and distribution material handling vehicles</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
requires the shortest timeline for deployment and the market is expected to account for 52% of new material handling machinery
demand by 2023, according to findings by Freedonia Focus Reports. We have already deployed DriveMod on multiple vehicles that
are commonly used in these applications. These vehicles were deployed as prototypes or as a part of proof-of-concept project.
Of these deployments, two were at customer sites and of which, one was paid.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Broaden:
address other industrial vehicle use cases</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
industries that utilize material transport vehicles share trends, challenges, and opportunities. DriveMod has been architected
to be vehicle agnostic and allow for efficient expansion to industries such as mining, construction, yard operations, and agriculture.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expand:
develop autonomous vehicle technologies across other sectors</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to a CB Insights report, &#8220;33 Industries Other Than Auto That Driverless Cars Could Turn Upside Down,&#8221; autonomous vehicle
technology brings value to at least 33 industries. Because our core autonomous technology is universal, the Company has an opportunity
to generate revenue across a variety of industries. We believe that developing the sales and marketing infrastructure to access
these markets is an essential aspect of driving growth in these areas.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Sources</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although,
we currently have no paying customers, we anticipate that our technology will generate revenue through two main methods: deployment
and EAS subscriptions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deployment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deploying
our EAS requires us and our integration partners to work with a new client to map the job site, gather data, and install our AV
technology within their fleet and site. New deployments yield project-based revenues that are assessed based on the scope of the
deployment. Our major collaborators in this area are our OEM partners, and we reinforce our deployment capability with integration
and services experts like Formel D. Formel D is a globally active service provider to the automotive industry and to manufacturing
supply chains. Working directly with our OEM partners as well as with third party experts ensures that we can deploy our technology
globally and at scale. These collaborative partnerships are established through mutually beneficial, non-binding memorandums of
understanding or partnering agreements for the purpose of joint go-to-market efforts.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>EAS
Subscription</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to ABI Research, the cloud robotics opportunity will grow from $3.3 billion in 2019 to $157.8 billion in 2030, accounting for
30% of the robotic industry&#8217;s total worth (source: Cloud Robotics Market Predicted to Grow to $157.8 billion by 2030, article
by Robotics &amp; Automation News). Sustained revenue growth will come largely from ongoing subscription revenues that enable
companies to tap into an ever-expanding suite of AV and AI capabilities as organizations transition into full industrial autonomy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
operations are extremely rich with data. However, we believe this data is still being put to limited use, especially as it pertains
to equipment transport and autonomy performance. EAS creates a foundation for extracting new and valuable enterprise data insights
by the nature of the advanced sensors, electronic control units, and connectivity that supports DriveMod&#8217;s functionality.
We can monetize the data insights in a variety of ways by offering configurable cloud dashboards for fleet/asset management, operational
performance data, and predictive analytics to customers. In parallel, exposing this fleet and vehicle data will be a boon for
our OEM partners as they evolve to optimize their product roadmaps and better integrate our technology to serve the future needs
of industrial autonomy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Go-to-market</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
go-to-market strategy hinges on strategic collaboration and is based on a set of three basic principles:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborate
with industrial vehicle OEMs</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
&amp; expand with end customers</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Partner
instead of compete on adjacent enabling technology</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Collaborate
&#8212; industrial vehicle OEMs</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
focus is on acquiring new customers who are either (a) looking to embed our technology into their vehicle products or (b) upsell
their existing clients with our vehicle retrofits. We follow a named account coverage approach. After establishing a customer
relationship with an OEM, we seek to embed our technology into their product roadmap and expand our services to their many clients.
We believe this category represents a substantial opportunity to generate revenue as a single relationship with an OEM can lead
to revenue opportunities across the entire marketplace. For example, our partner, Columbia Vehicle Group with whom we have partnered
through a non binding memorandum of understanding, provides over 70 years of vehicle manufacturing experience and customer insight.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Land
&amp; expand &#8212; end customers</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
go-to-market strategy is to acquire new customers that use industrial vehicles in their mission-critical operations. We pursue
this strategy by being hyper-focused on building a robust pipeline of prospective customers (&#8220;land&#8221;) and utilizing
strategic sales channels that will result in coordinated opportunities to accelerate growth (&#8220;expand&#8221;). Our archetypal
customers are corporations that deploy fleets of heterogeneous industrial vehicles across many sites. DriveMod&#8217;s flexibility
is intertwined with the wide-ranging applicability of our EAS and creates the unique leveraged opportunity of expanding across
vehicles and sites with these major customers. After an initial win for a first AV deployment with a customer, we can expand within
the site to additional vehicle platforms, then expand the use of similar vehicles to other sites operated by the customer and
finally repeat across new vehicles and sites.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Partner
instead of compete &#8212; technology</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scaling of Industrial Autonomy will benefit from an ecosystem made up of different enabling technologies and services, such as
hardware manufacturing, connectivity, Internet of Things (IoT), and digital integration. Rather than trying to compete with other
technology suppliers, we intend to rely on our strategic collaborations that give both partners access to new markets and capabilities.
For example, partners like Arilou, Symboticware, and Airbiquity respectively provide complementary solutions in technologies like
cyber security, digital asset management, and connectivity while partners like Formel D and First Transit provide expertise that
aids towards platform scale up and operational services. These collaborative partnerships are established through mutually beneficial,
non-binding memorandums of understanding or partnering agreements for the purpose of joint go-to-market efforts.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Technology</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autonomous
vehicles must integrate a suite of technologies to generate operational value. Our core competencies are in DriveMod, the on-vehicle
AV technology stack that is underpinned by AI and robotics expertise and paramount to enabling autonomous mobility. With Cyngn
Insight, EAS integrates analytics, visual dashboards, connectivity, cloud services, and other traditional software systems that
allow customers to interact with and extract insights out of our advanced AV technology.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mapping
&amp; localization</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
proprietary system design abstracts mapping and localization data so that DriveMod can use a variety of high-accuracy solutions
to create the optimal mapping and localization system for the given environment. Our mapping and localization system distills
sensor data into contextually rich representations of the physical world and extracts common insights like required stops and
navigation boundaries. These common insights help to create consistent AV operation across diverse sites, enabling our AVs to
navigate both indoor and outdoor.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Perception</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granular,
efficient perception forms the basis of advanced AVs. Perception is one of the most complex sub-systems, requiring specialized
data infrastructure and engineering expertise in AI/ML and high-performance computing. We have built a modular sensor fusion pipeline
that runs on a low compute footprint and creates the flexibility to customize our perception stack according to application requirements.
Our perception architecture streamlines DriveMod deployments on new vehicles. Our approach addresses common industry challenges
like integrating different sensor modalities and accounting for different sensor mounting positions. We have now integrated DriveMod
into nine different vehicle platforms, utilizing various combinations of Light Detecting and Ranging (&#8220;LiDAR&#8221;), camera,
radar, and ultrasonic, and positioning sensors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Path
planning</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
system&#8217;s ability to react and adjust to real-time changes creates a more efficient workflow than basic automation solutions
that can only stop/go along a rigid path and require constant human hand-holding. The Cyngn path planning system provides thousands
of trajectory candidates per second, enabling more complex paths to be navigated that may include advanced behavior like carefully
nudging around obstacles or negotiating intersections.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Decision
making</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cyngn decision engine holds the logic and decision-making rules that govern driving behavior. The decision engine pulls together
insights from mapping, perception, and path planning to enable more complex vehicle maneuvers and automated conflict resolution.
The system is extensible to introduce new capabilities with logic that is designed to achieve a high level of abstraction, which
enables us to adopt new driving behaviors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Actuation</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
subsystem of our software stack, Cyngn-by-Wire (CbW), addresses the basic requirements of mechanical vehicle components that must
be met for DriveMod to make a vehicle operate autonomously. Legacy electronic control units (ECU) that do not use Drive-by-Wire
(DbW) technology that enables software commands to electronically control vehicle actuation typically create a hurdle for integrating
AV technology. CbW addresses this issue by decoupling the hardware and software components of DbW systems. For vehicles with legacy
ECU&#8217;s, CbW allows customers to replace existing ECUs with DbW hardware that can be tuned to meet the needs of the selected
vehicle platform using CbW software. When vehicles have DbW ECUs already installed, the CbW software layer is configured and applied
without the need for replacing the hardware. Thus, CbW enables AV actuation across vehicle fleets with varying levels of vehicle
age and sophistication.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competitive
Environment</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is an increasing demand for autonomous vehicle solutions in an effort to increase safety, improve efficiency, and enhance productivity
to meet the goals set out by Industry 4.0. Autonomous vehicles are an enabling technology that gives us the opportunity to add
more value to customers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Industry 4.0 markets, the global management consulting firm McKinsey &amp; Company has published reports indicating that the upswing
in adoption will be dependent on the ability for technology to provide companies with solutions that give customers a pathway
that balances cost constraints with short-term resilience and long-term growth (source: &#8220;Industry 4.0: Reimagining manufacturing
operations after COVID 19,&#8221; by McKinsey &amp; Company). As market participants develop their Industry 4.0 roadmap, technology
partners that have an ability to adapt features to their changing needs will be required. As a result, we believe there will continue
to be a need for technology companies to help push the industry 4.0 markets forward.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for automated vehicle solutions is burgeoning, and the advanced technology required to enable autonomous solutions in industrial
environments is still developing. As a result, we face competition from a range of companies seeking to develop autonomous vehicle
solutions. These competitors include traditional industrial vehicle manufacturers (such as Crown Equipment&#8217;s automated forklifts)
robotics providers (such as Brain Corp for floor care and Outrider for yard operations), and software companies (such as Oxbotica),
as well as large corporate competitors that provide a broad range of software, service, and logistics solutions across many markets.
These competitors are also working to advance technology, reliability, and innovation in their development of new and improved
solutions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will continue to face competition from existing competitors and new companies entering the industrial autonomy landscape. Many
of our competitors either have technical or strategic barriers that limit their product offerings to specific deployment environments,
operations protocols, or vehicle form factors. It is our belief that it will take a substantial period of time to develop features
that satisfy the dynamic needs of industry customers. Additionally, larger corporate competitors are likely to encounter roadblocks
due to competitive overlap with end customers, limiting their ability to address the needs of the broader industrial market. With
specific regard to manufacturing and distribution, a number of competitors have already begun to deploy products, but we believe
the benefits stemming from our modular software-centric approach, technical expertise in the area of autonomous vehicles, and
the ubiquitous applicability of EAS gives us the potential to displace current offerings and capture a significant share of this
rapidly growing market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governmental
and Environmental Regulations</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
considerations contribute to our current strategic position that targets enterprise customers with operations mostly confined
to private property. This decreases our exposure to regulations, which mitigates some deployment risks. Typically, we will satisfy
regulatory requirements by adhering to the protocols of the site operator (the end customer).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulatory environment for autonomous industrial vehicles is still being developed. In 2016, the United States Department of Transportation
(USDoT) issued regulations that require the submission of documentation covering specific topics related to autonomy and government
regulators, but these regulations are targeted towards road vehicles. As the autonomous industrial vehicle regulatory environment
continues to develop, it will be imperative not only to comply with applicable standards but to be an active participant in the
development of new standards. Outside of government standards, third party organizations, industrial workplace advocates, and
industry groups have and will continue to impose self-regulatory standards. In certain cases, these standards may be contractually
applicable to our systems, products, and operations. Thus, we expect and prepare to comply with various standards, including Occupational
Safety and Health Administration (OSHA), International Organization for Standardization (ISO), International Electrotechnical
Commission (IEC), or American National Standards Institute (ANSI) on a case-by-case basis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
and international regulations related to data privacy are also of great importance to our company&#8217;s products, operations,
and culture. Like the autonomous vehicle regulatory environment, the regulatory framework for data privacy, protection, and security
worldwide is continuously evolving and developing. As a result, interpretation and implementation standards and enforcement practices
are likely to remain fluid for the foreseeable future. As our company expands its operations, the collection, use, and protection
of any and all data assets will be internally scrutinized to ensure compliance with this changing landscape.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decreasing
the environmental impact of industrial vehicles is a high priority. Research has shown that equipment utilization rate, configuration,
and operational consistency have a strong effect on the emissions released by industrial vehicle equipment (Source: Journal of
the Air &amp; Waste Management Association). A key focus of Cyngn&#8217;s EAS will be working to minimize the environmental impact
of industrial vehicles through new data insights that can contribute to more sustainable practices. Our historic vehicle platforms
have primarily been electric vehicles (EV). While electric drivetrains are not a requirement for DriveMod&#8217;s technology,
EVs are often an application requirement since the vehicles operate alongside humans in enclosed spaces.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
Property</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to drive impact and growth within the autonomous industrial vehicle market largely depends on our ability to obtain, maintain,
and protect our intellectual property and all other property rights related to our products and technology. To accomplish this,
we utilize a combination of patents, trademarks, copyrights, and trade secrets as well as employee and third party non-disclosure
agreements, licenses, and other contractual obligations. In addition to protecting our intellectual property and other assets,
our success also depends on our ability to develop our technology and operate without infringing, misappropriating, or otherwise
violating the intellectual property and property rights of third parties, customers, and partners.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
software stack has over 30 subsystems, including those designed for perception, mapping &amp; localization, decision making, planning,
and control. As of the date of this prospectus, we have 2 granted patents, 23 pending patent applications, and expect to file
an additional 4 patent applications by the end of 2022. We expect to continue to file additional patent applications with respect
to our technology in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Human
Capital Resources</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
team is composed of energetic, motivated and highly experienced visionaries. They include machine vision, AI, and autonomous software
engineers from the greatest universities in the world. Together with a highly talented and skilled support team, we solve real-world
industrial applications in autonomy. As of the date of this prospectus, we had 48 full-time employees. The majority of our employees
are based in Silicon Valley, California.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
core values include focus on impact, display curiosity, communicate proactively, apply good judgment, and demonstrate selflessness.
We believe these values encourage innovation and a team-oriented culture. Our employees have access to a wide range of training,
different career paths, and, most importantly, challenging and purposeful work. Our culture is also built on diversity, inclusion,
camaraderie, and celebration. We organize regular team building activities and public recognition forums to celebrate our diversity
and invest in strong relationships.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to a positive culture and career development, we offer a robust benefits package. This package includes a flexible vacation
policy, access to a 401(k) plan, premier health plan options and numerous voluntary benefits for employees and their dependents.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Impact
of COVID-19</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic affected our company, partners, customers, and the industry at large in many ways. Namely, we saw decreased
interest in new deployments due to travel restrictions and social distancing precautions. In addition, it was not feasible for
us to engage in new on-site discussions and product demonstrations with the pandemic safety measures that were in place during
most of 2020 and early 2021. Furthermore, many potential customers and partners paused their investment into new technologies
as they focused on keeping their core business running under the extenuating circumstances of the pandemic. These factors delayed
our progress, particular with respect to sales and business development activities. However, we believe this negative impact is
transient. In fact, we believe many of the industries that have positive feedback characteristics to the industrial vehicle market
(e-commerce, construction mechanization, etc.) have entered a new stage of growth during the COVID-19 pandemic. The need to support
these global markets and the desire to reduce human interactions, enable social distancing as a preventative measure in future
operations has spawned new use cases and opportunities for our autonomous vehicle (AV) technology. In the long run, we believe
that the pandemic will have accelerated the AV and automation strategies of many customers and partners.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was originally incorporated in the State of Delaware on February&#160;1, 2013, under the name Cyanogen, Inc. or Cyanogen.
The Company started as a venture funded company with offices in Seattle and Palo Alto, aimed at commercializing CyanogenMod, direct
to consumer and through collaborations with mobile phone manufacturers. CyanogenMod was an open-source operating system for mobile
devices, based on the Android mobile platform.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
2013 and 2015, Cyanogen released multiple versions of its mobile operating system, and collaborated with an ecosystem of companies
including mobile phone OEMs, content providers and leading technology partners.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2016 the Company&#8217;s management and board of directors, determined to pivot its product focus and commercial direction from
the mobile device and telecom space to industrial and commercial autonomous driving. In May&#160;2017, the Company changed its
name to Cyngn Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Available
Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the Nasdaq under the symbol &#8220;CYN&#8221;. We file annual, quarterly, and current reports, proxy
statements and other information with the U.S. Securities Exchange Commission. These filings are available to the public on the
Internet at the SEC&#8217;s website at http://www.sec.gov.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal business address is 1015 O&#8217;Brien Dr., Menlo Park, CA 94025. We maintain our corporate website at <i>https://cyngn.com
</i>(this website address is not intended to function <i>as a hyperlink and the information contained on our website is not intended
to be a part of this prospectus</i>). We make available free of charge on https://investors.cyngn.com/ our annual, quarterly,
and current reports, and amendments to those reports if any, as soon as reasonably practical after we electronically file such
material with, or furnish it to, the SEC. We may from time to time provide important disclosures to investors by posting them
in the Investor Relations section of our website.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF<br/>
FINANCIAL CONDITION AND RESULTS OPERATIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following description of our financial condition and results of operations in conjunction with our consolidated
financial statements and accompanying notes included in this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an autonomous vehicle (AV) technology company that is focused on addressing industrial uses for autonomous vehicles. We believe
that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial
industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbent
vehicle manufacturers, and high upfront investment commitment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industrial
sites are typically rigid environments with consistent standards as opposed to city streets that have more variable environmental
and situational conditions and diverse regulations. These differences in operational design domains (ODD) will be major factors
that make proliferation of industrial AVs in private settings achievable with less time and resources than AVs on public roadways.
Namely, safety and infrastructure challenges are cited as roadblocks that have delayed AVs from operating on public roadways at
scale. Our focus on industrial AVs simplifies these challenges because industrial facilities (especially those belonging to a
single end customer that operates similarly at different sites) share much more in common than different cities do. Furthermore,
our end customers own their infrastructure and can make changes more easily than governments can on public roadways.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
these challenges in mind, we are developing an EAS that leverages advanced in-vehicle autonomous driving technology and incorporates
leading supporting technologies like data analytics, fleet management, cloud, and connectivity. EAS provides a differentiated
solution that we believe will drive pervasive proliferation of industrial autonomy and create value for customers at every stage
of their journey towards full automation and the adoption of Industry 4.0.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EAS
is a suite of technologies and tools that we divide into three complementary categories:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DriveMod</i>,
our modular industrial vehicle autonomous driving software;</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cyngn
Insight</i>, our customer-facing tool suite for monitoring and managing AV fleets (including remotely operating vehicles) and aggregating/analyzing
data; and</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cyngn
Evolve</i>, our internal tool suite and infrastructure that facilitates artificial intelligence (AI) and machine learning (ML) training
to continuously enhance our algorithms and models and provides a simulation framework (both record/rerun and synthetic scenario creation)
to ensure that data collected in the field can be applied to validating new releases.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
automation providers manufacture specialized industrial vehicles with integrated robotics software for rigid tasks, limiting automation
to narrow uses. Unlike these specialized vehicles, EAS can be compatible with the existing vehicle assets in addition to new vehicles
that have been purpose built for autonomy by vehicle manufacturers. EAS is operationally expansive, vehicle agnostic, and compatible
with indoor and outdoor environments. By offering flexible autonomous services, we aim to remove barriers to industry adoption.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
understand that scaling of autonomy solutions will require an ecosystem made up of different technologies and services that are
enablers for AVs. Our approach is to forge strategic collaborations with complementary technology providers that accelerate AV
development and deployment, provide access to new markets, and create new capabilities. Our focus on designing DriveMod to be
modular will combine with our experience deploying AV technology on diverse industrial vehicle form factors, which will be difficult
for competitors to replicate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect our technology to generate revenue through two main methods: deployment and EAS subscriptions. Deploying our EAS requires
us and our integration partners to work with a new client to map the job site, gather data, and install our AV technology within
their fleet and site. We anticipate that new deployments will yield project-based revenues based on the scope of the deployment.
After deployment, we expect to generate revenues by offering EAS through a Software as a Service (SaaS) model, which can be considered
the AV software component of Robotics as a Service (RaaS). Although we have not offered, and have no present intention to offer,
the robotic assets ourselves directly to the end customer, our software can be part of a combined offering with third parties,
such as an OEM.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RaaS
is a subscription model that allows customers to use robots/vehicles without purchasing the hardware assets upfront. We will seek
to achieve sustained revenue growth largely from ongoing SaaS-style EAS subscriptions that enable companies to tap into our ever-expanding
suite of AV and AI capabilities as organizations transition into full industrial autonomy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
EAS is not yet commercially available and both the components and the combined solution are still under development, components
of EAS have already been used for a paid customer trial and pilot deployments. We have not yet derived any recurring revenues
from EAS and intend to start marketing EAS to customers in 2022. We expect EAS to continually be developed and enhanced according
to evolving customer needs, which will take place concurrently while other completed features of EAS are commercialized. We expect
annual R&amp;D expenditures in the foreseeable future to equal or exceed that of 2019 and 2020. We also expect that limited paid
pilot deployments in 2022 and 2023 will offset some of the ongoing R&amp;D costs of continually developing EAS. We target scaled
deployments to begin in 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
go-to-market strategy is to acquire new customers that use industrial vehicles in their mission-critical and daily operations
by (a) leveraging the relationships and existing customers of our network of strategic partners, (b) bringing AV capabilities
to industrial vehicles as a software service provider, and (c) executing a robust in-house sales and marketing effort to nurture
a pipeline of industrial organizations. Our focus is on acquiring new customers who are either looking (a) to embed our technology
into their vehicle product roadmaps or (b) to apply autonomy to existing fleets with our vehicle retrofits. In turn, our customers
are any organizations that could utilize our EAS solution, including OEMs that supply industrial vehicles, end customers that
operate their own industrial vehicles, or service providers that operate industrial vehicles for end customers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
OEMs and leading industrial vehicle users seek to increase productivity, reinforce safer working environments, and scale their
operations, we believe we are uniquely positioned to deliver a dynamic autonomy solution via our EAS to a wide variety of industrial
uses. Our long-term vision is for EAS to become a universal autonomous driving solution with minimal marginal cost for companies
to adopt new vehicles and expand their autonomous fleets across new deployments. We have already deployed DriveMod software on
nine different vehicle form factors that range from stockchasers and stand-on floor scrubbers to 14-seat shuttles and 5-meter-long
cargo vehicles demonstrating the extensibility of our AV building blocks. These deployments were prototypes or part of proof-of-concept
projects. Of these deployments, two were at customer sites. For one deployment we were paid $166,000 and the other was part of
our normal R&amp;D activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy upon establishing a customer relationship with an OEM, is to seek to embed our technology into their vehicle roadmap
and expand our services to their many clients. Once we solidify an initial AV deployment with a customer, we intend to seek to
expand within the site to additional vehicle platforms and/or expand the use of similar vehicles to other sites operated by the
customer. This &#8220;land and expand&#8221; strategy can repeat iteratively across new vehicles and sites and is at the heart
of why we believe industrial AVs that operate in geo-fenced, constrained environments are poised to create value.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meanwhile,
over $16 billion has been invested into passenger AV development over the last several years with negligible revenues generated
and constant delays. The $200B annual industrial equipment market (projected by 2027) is substantial, but it does not justify
billions of dollars of annual research &amp; development spend. These leading passenger AV companies will need to take the approach
of first capturing the trillion-dollar markets of passenger AV to achieve their desired returns.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates and Judgements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States.
The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of
assets and liabilities, disclosure of contingent liabilities at the date of the financial statements, and the reported amounts
of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments. We base our estimates
and judgments on historical experience and other factors that we believe to be reasonable under the circumstances. Materially
different results can occur as circumstances change and additional information becomes known. Besides the estimates identified
below that are considered critical, we make many other accounting estimates in preparing our financial statements and related
disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses,
as well as disclosures of contingent liabilities. These estimates and judgments are also based on historical experience and other
factors that are believed to be reasonable under the circumstances. Materially different results can occur as circumstances change
and additional information becomes known, even for estimates and judgments that are not deemed critical.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the assumptions and estimates associated with the following have the greatest potential impact on our consolidated financial
statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued to its lead underwriter in the IPO, warrants to purchase up to 140,000 shares of its common stock. The Company
accounts for warrants in accordance with ASC 480, <i>Distinguishing Liabilities from Equity</i>, depending on the specific terms
of the warrant agreement. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated
the valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also applied the guidance in ASC 340-10-S99-1, <i>Other Assets and Deferred Costs</i>, that states specific incremental
costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against
the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance
of an equity contract and accordingly, classified the warrants as additional paid-in capital.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based
Compensation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value
of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the
award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the
period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model,
which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest
rates, and expected dividend yield.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Expense</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials,
labor and stock-based compensation related to development of the Company&#8217;s products and services. Research and development
costs are expensed as incurred.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General,
and Administrative Expense</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General,
and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization, travel, and
advertising costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b>Three Months ended March
31, 2022 compared to the Three Months ended March 31, 2021</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b><i>Revenue</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">The Company
has not generated any revenue for the three months ended March 31, 2022 and 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b><i>Research and Development</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Research
and development expense for the three months ended March 31, 2022 increased by $0.7 million or 79.9% to $1.7 million from $1.0 million
for the three months ended March 31, 2021. The increase is attributable to the increase in personnel engaged in the research and development
of our AV technology in 2022 compared to headcount levels in 2021, external R&amp;D contractors, allocated occupancy costs, and R&amp;D
chargeable travel-related costs. The Company plans to continue to restore the appropriate level of engineering and other personnel to
support its research and development efforts and expects research and development costs to increase over time.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b><i>General and Administrative</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">General
and administrative expenses increased by approximately $1.5 million or 247.3% to $2.1 million for the three months ended March 31, 2022
from $0.6 million for the three months ended March 31, 2021.&#160;The increase was attributed to the following factors: i) an increase
in personnel related costs as the Company increased staff to support being a public company during the three months ended March 31, 2022,
compared to the same three-month period ended March 31, 2021; ii) the increase in occupancy costs following the renewal of the lease that
expanded the square footage of the leased area; iii) directors and officers insurance coverage taken by the Company and; iv) professional
fees related to required compliance and regulatory filings following the Company becoming a public company after its IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b><i>Other Income, net</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">Other
income, net consists primarily of interest income earned on the Company&#8217;s cash and cash equivalents, net of interest expense recognized
on its PPP Notes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">For the
three months ended March 31, 2022, other income, net increased by approximately $1,800 compared to the three months ended March 31, 2021.
The increase is attributed to the increase in other income representing the present value interest recognized through March 31, 2022 on
the adoption of lease accounting guidelines under ASC 842 on right-of-use assets and operating liabilities, compared to the interest expense
recognized on the PPP Notes for the three months ended March 31, 2021. There were no subsequent interest expense recognized following
the forgiveness by the SBA of the PPP Notes during the latter part of 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b>Year Ended December 31,
2021 compared to the Year Ended December 31, 2020</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not generated any revenue for the years ended December&#160;31, 2021 and 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expense for the year ended December&#160;31, 2021 decreased by $0.1 million or 2.5% to $5.0 million from $5.1
million for the year ended December&#160;31, 2020. The decrease is primarily attributable to the decrease in personnel engaged
in the research and development of our AV technology in 2021 compared to pre-COVID-19 headcount levels in 2020. The Company plans
to continue to restore the appropriate level of engineering and other personnel to support its research and development efforts
and expects research and development costs to increase over time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses increased by approximately $1.2 million or 36.5% to $4.4 million for the year ended December&#160;31,
2021 from $3.2 million for the year ended December&#160;31, 2020. The majority of the increase was attributed to the increase
in stock-based compensation expense, legal and professional fees, and personnel related costs as the Company increased staff to
support being a public company during the year ended December&#160;31, 2021, compared to the year ended December&#160;31, 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Income, net</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December&#160;31, 2021, other income, net, increased by approximately $1.6 million to $1.6 million from approximately
$35,000 for the year ended December&#160;31, 2020. The increase is attributed to the increase in other income of $1.6 million
representing gains recognized on the forgiveness of the PPP Notes by the SBA during the fourth quarter of 2021 and the disposal
of assets, offset by the increase in interest expense recognized on the second PPP Note for the year ended December&#160;31, 2021
compared to interest expense on a single PPP Note for the year ended December&#160;31, 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><b>Liquidity and Capital
Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">The Company&#8217;s
principal source of liquidity is its cash and cash equivalents. As of March 31, 2022 and December 31, 2021, the Company had cash of approximately
$18.3 million and $21.9 million, respectively. On October 22, 2021, the Company closed its IPO which resulted in net proceeds of approximately
$23.3 million after deducting underwriting discounts, commissions and offering expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">The Company&#8217;s
liquidity is based on its ability to enhance its operating cash flow position, obtain capital financing from equity interest investors
and borrow funds to fund its general operations, research and development activities and capital expenditures. The Company&#8217;s ability
to continue as a going concern is dependent on management&#8217;s ability to successfully execute its business plan, which includes increasing
revenue while controlling operating costs and expenses to generate positive operating cash flows and obtaining funds from outside sources
of financing to generate positive financing cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">Based
on cash flow projections from operating and financing activities and existing balance of cash and cash equivalents, management is of the
opinion that the Company has sufficient funds for sustainable operations and it will be able to meet its payment obligations from operations
and debt related commitments for at least one year from the issuance date of this report. Based on the above considerations, the Company&#8217;s
consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation
of liabilities during the normal course of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><i><span style="text-decoration:underline">Cash Flows</span></i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><i>Operating activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">Net cash
used in operating activities for the three months ended March 31, 2022 was $3.4 million, an increase of $1.7 million or 98.7% compared
to $1.7 million for the three months ended March 31, 2021. The increase is primarily attributed to the level of increases in personnel
costs and professional services related to the Company&#8217;s research and development activities, as well as increases in general and
administrative personnel-related costs and professional services as the Company increased staff to support being a public company, both
of which led to the increase in the Company&#8217;s net loss for the period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><i>Investing activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Net
cash used in investing activities for the three months ended March 31, 2022 was approximately $227,000, an increase of approximately $225,000
compared to approximately $2,000 for the three months ended March 31, 2021. The increase consists of approximately $227,000 in purchases
of R&amp;D-related hardware equipment.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; "><i>Financing activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; ">Cash
provided by financing activities of approximately $89,000 represent proceeds from option exercises for the three months ended March 31,
2022, a decrease of $0.8 million or 90.1% compared to $0.9 million for the three months ended March 31, 2021. The decrease is primarily
attributable to the absence of a comparable PPP Note during the three months ended March 31, 2022 compared to the PPP Note proceeds received
in February, 2021 that was subsequently forgiven by the SBA in November 2021. The Company expects to experience increases in proceeds
from option exercises to supplement the public listing of its common stock shares in future periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company Status</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging-growth company&#8221;, as defined in the JOBS Act, and, for as long as we continue to be an emerging growth
company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies
but not to emerging growth companies, including, but not limited to, not being required to have our independent registered public
accounting firm audit our internal control over financial reporting under Section&#160;404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not
previously approved. As an emerging growth company we can also delay adopting new or revised accounting standards until such time
as those standards apply to private companies. We intend to avail ourselves of these options. Once adopted, we must continue to
report on that basis until we no longer qualify as an emerging growth company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will cease to be an emerging growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary
of the initial public offering; (ii) the first fiscal year after our annual gross revenue are $1.07 billion or more; (iii) the
date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities;
or (iv) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million
as of the end of the second quarter of that fiscal year. We cannot predict if investors will find our common stock less attractive
if we choose to rely on these exemptions. If, as a result of our decision to reduce future disclosure, investors find our common
shares less attractive, there may be a less active trading market for our common shares and the price of our common shares may
be more volatile.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also a &#8220;smaller reporting company&#8221;, meaning that the market value of our stock held by non-affiliates plus the
aggregate amount of gross proceeds to us as a result of the IPO is less than $700 million and our annual revenue was less than
$100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the
market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million
during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million.
If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions
from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company
we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form&#160;10-K
and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive
compensation</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information about our executive officers and directors:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 59%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
<tr style="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior
    Tal</span></td>
    <td style="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td style="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, Chairman of the Board of Directors and Director</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    Alvarez</span></td>
    <td style="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ben Landen</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice-President of
    Business Development</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitch Lasky</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karen Macleod</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen Cunningham</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James McDonnell</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lior
Tal</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Tal has served as the Company&#8217;s Chief Executive Officer and a Director since October&#160;2016. From June&#160;2016 to October&#160;2016,
Mr. Tal served as the Company&#8217;s Chief Operating Officer. Prior to joining the Company, Mr. Tal was the director of international
growth and partnerships at Facebook where he worked from April&#160;2011 to June&#160;2016. Mr. Tal co-founded Snaptu (acquired
by Facebook) in September&#160;2007 and was the vice president of business development until May&#160;2011. During his time at
Snaptu, Mr. Tal helped grow the user base from launch to tens of millions of users. Prior to co-founding Snaptu, Mr. Tal was a
partner at Barzam, Tal, Lerer Attorneys at law &amp; Patent attorneys from March&#160;2004 to August&#160;2007. Mr. Tal has also
held leadership roles at Actimize (acquired by NICE), DiskSites (acquired by EMC), and Odigo (acquired by Comverse). Mr. Tal holds
a law degree from Tel Aviv University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Tal holds an LLB in law and a BA in Business Management from Reichman University. Mr. Tal&#8217;s executive and technology industry
experience qualify him to serve on our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Donald
Alvarez</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Alvarez has served as the Company&#8217;s Chief Financial Officer since June&#160;2021. Prior to joining the Company, Mr. Alvarez
was the vice president of finance of the International Council of Shopping Centers from 2017 to August&#160;2020. During his time
at the International Council of Shopping Centers, Mr. Alvarez helped improve internal controls, increase productivity and reduce
cost. Mr. Alvarez was active in renegotiating merchant credit card fees. Mr. Alvarez also implemented a company-wide, annual budget
process and deployment of a new budgeting software tool. From 2015 to 2017, Mr. Alvarez was vice president of finance of QuVa
Pharma, Inc. (&#8220;QuVa&#8221;), where he helped create an accounting and finance department. From 2011 to 2014, Mr. Alvarez
was the national managing partner, COO and CFO of Tatum, a Randstand Company (&#8220;Tatum&#8221;). During his time with Tatum,
Mr. Alvarez oversaw a business turnaround that significantly improved Tatum&#8217;s financial performance. Mr. Alvarez has held
several other senior financial and operational roles in both private and public companies, including CFO of Broadband Discovery
Systems, Inc., CFO of Fatbrain.com, CFO of Shop.com, and Regional Managing Director of Resources Global Professionals. Mr. Alvarez
began his career in the audit and assurance practice of Deloitte where he spent seven (7) years. Mr. Alvarez holds a BS in Business
Administration from California State University, East Bay.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ben
Landen</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Landen has served as the Company&#8217;s Vice President of Business Development since May&#160;2021. Prior to that, Mr. Landen
served as the Company&#8217;s Senior Director of Product &amp; Partnerships from September&#160;2019 to May&#160;2021. From May&#160;2017
to September&#160;2019, Mr. Landen was the Head of Product &amp; Business Development at DeepScale (acquired by Tesla), a venture-backed
startup that developed AI perception solutions for autonomous vehicles. From August&#160;2015 to April&#160;2017, Mr. Landen was
a Senior Business Manager of Maxim Integrated, where he managed a $100M automotive semiconductor product line and supervised a
team of product managers. Mr. Landen was a Business Manager from September&#160;2013 to August&#160;2015 and an Associate Business
Manager from August&#160;2010 to September&#160;2013. Mr. Landen holds a BS in Electrical Engineering from California Polytechnic
University, San Luis Obispo and an MBA from UC Berkeley&#8217;s Haas School of Business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Executive
Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mitch
Lasky</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Lasky has served as a member of the Company&#8217;s board of directors since March&#160;2013. Mr. Lasky has been a partner of
Benchmark Capital, a venture capital firm, since April&#160;2007. Mr. Lasky has been a co-owner of the Los Angeles Football Club
since January&#160;2016. Mr. Lasky was the EVP, Mobile &amp; Online of Electronic Arts from February&#160;2006 to April&#160;2007.
From November&#160;2000 to February&#160;2006, Mr. Lasky was the CEO and chairman of the board of JAMDAT Mobile, Inc. Mr. Lasky
currently serves as a member of the board of directors of various companies, including: Discord, Manticore Games Inc., Ubiquity6
Inc., and thatgamecompany. Mr. Lasky has previously served as a member of the board of directors of various companies, including:
Snap Inc., PlayFab, Inc., Engine Yard, Outpost Games, Inc., NaturalMotion, Gakai, and Riot Games. Mr. Lasky holds a JD from the
University of Virginia School of Law and a BA in History and Literature from Harvard University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Lasky&#8217;s prior experience serving on the boards of publicly traded companies and his financial and technology industry experience
qualify him to serve on the Company&#8217;s board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Karen
Macleod</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Macleod has served as a member of the Company&#8217;s board of directors since July&#160;2021. Ms. Macleod was the Founder and
CEO of The Arete Group, LLC from 2015 to 2021. Ms. Macleod was the president of Tatum, Randstand Holdings NV Company from 2011
to 2014. Ms. Macleod was the president of Resources Connection, Inc. North America from 2004 to 2009 and previously served in
other capacities after joining the company in 1996. From 1985 to 1994, Ms. Macleod was a senior manager at Deloitte. Ms. Macleod
additionally has served on the Board of Directors of Track Group Inc. (OTCQX &#8212; TRCK) since 2016 and currently chairs the
Audit Committee. She also has served on the Board of the Lakeland Hills YMCA since 2020 and currently serves on the Finance Committee.
Ms. Macleod served as a member of the board of directors and a member of the audit committee of the FWA of New York from 2018
to 2021. From 1998 to 2009, Ms. Macleod served on the board of directors of Resources Connection, Inc. (NASDAQ &#8212; RGP). From
2006 to 2013, Ms. Macleod served on the board of directors of Overland Solutions. Ms. Macleod holds a B.A. in Business Economics
from University of California, Santa Barbara.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Macleod prior board experience and particularly her role serving on audit committees qualify her to serve on the Company&#8217;s
board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Colleen
Cunningham</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Cunningham has served as a member of the Company&#8217;s board of directors since September&#160;2021. Ms. Cunningham has served
as a board member and the treasurer of Northstar Pet Rescue since 2017. From 2012 to 2018, Ms. Cunningham was the senior vice
president and corporate controller of Zoetis, Inc. Prior to that, Ms. Cunningham was the global managing director of Resources
Connection, Inc. from 2007 to 2012. From 2003 to 2007, Ms. Cunningham was the president and chief executive officer of Financial
Executives International. From 2001 to 2003, Ms. Cunningham was the chief financial officer of Havas Advertising, North America.
Ms. Cunningham was chief accountant at AT&amp;T, Inc. from 1999 to 2001. Prior to that, Ms. Cunningham was a division manager
of accounting policy and external reporting for AT&amp;T, Inc. from 1995 to 1999. Ms. Cunningham was the assistant controller
of AT&amp;T Capital Corporation from 1988 to 1995. From 1984 to 1988, Ms. Cunningham was a senior auditor at Touche Ross/Coopers
&amp; Lybrand. Ms. Cunningham has also served on various committees. From 2015 to 2018, Ms. Cunningham served as a member of the
US Chamber of Commerce Financial Reporting Committee. From 2012 to 2018, Ms. Cunningham served as a member of the FEI Committee
on Corporate Reporting. From 2007 to 2012, Ms. Cunningham served as a member of the International Issues Conference Committee
of AICPA. From 2005 to 2009, Ms. Cunningham served as a board member and the chair of the Ethics Resource Center Finance Committee.
From 2005 to 2018, Ms. Cunningham served as a member of the advisory board to the accounting department of Pennsylvania State
University. From 2003 to 2007, Ms. Cunningham served as a member of both the International Accounting Standards Board Standing
Advisory Committee and the Financial Accounting Standards Board Advisory Committee. Ms. Cunningham holds a B.A. in economics from
Rutgers University and an M.B.A. in management from New York University&#8217;s Stern School of Business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Cunningham&#8217;s prior management experience and expertise in corporate reporting, governance and accounting issues qualify
her to serve on the Company&#8217;s board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>James
McDonnell</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
McDonnell has served as a member of the Company&#8217;s board of directors since September&#160;2021. Mr. McDonnell is currently
the Senior Vice President of Sales and Marketing for Vispero, since 2017. Mr. McDonnell was VP of sales at Honeywell from 2013
to 2017. Mr. McDonnell served on the board of Asetek from 2014-2019. Mr. McDonnell was SVP Sales &amp; Marketing at Intermec from
2010 to 2013. Prior to this, Mr. McDonnell was an SVP and served in many executive sales and marketing roles at Hewlett-Packard
from 1983 to 2009. Mr. McDonnell began his career at the General Electric Company from 1977 to 1983. Mr. McDonnell has a BS degree
in Electrical engineering from Villanova University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
McDonnell&#8217;s prior experiences in sales &amp; marketing leadership within various technology companies and his experience
in industrial markets qualify him to serve on the Company&#8217;s board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Composition</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board currently consists of five directors, Lior Tal, Mitch Lasky, Karen Macleod, Colleen Cunningham and James McDonnell. Ms.
Macleod, Ms. Cunningham and Mr. McDonnell are <i>&#8220;independent directors&#8221;</i> within the meaning of the Listing Rules
(the &#8220;Nasdaq Listing Rules&#8221;) of the Nasdaq Stock Market (&#8220;Nasdaq&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
family relationships exist between any of our officers or directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
of Board of Directors in Risk Oversight Process</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors has extensive involvement in the oversight of risk management related to us and our business and accomplishes
this oversight through the regular reporting by the Audit Committee. The purpose of the Audit Committee is to assist the board
of directors in fulfilling its fiduciary oversight responsibilities relating to (1) the integrity of the Company&#8217;s financial
statements, (2) the effectiveness of the Company&#8217;s internal control over financial reporting, (3) the Company&#8217;s compliance
with legal and regulatory requirements, and (4) the independent auditor&#8217;s qualifications and independence. Through its regular
meetings with management, including the finance, legal and internal audit functions, the Audit Committee reviews and discusses
all significant areas of our business and summarizes for the board of directors all areas of risk and the appropriate mitigating
factors. In addition, our board of directors receives periodic detailed operating performance reviews from management.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board evaluates the independence of each nominee for election as a director of our Company in accordance with the Nasdaq Listing
Rules. Pursuant to these rules, a majority of our Board must be &#8220;independent directors&#8221; within the meaning of the
Nasdaq Listing Rules, and all directors who sit on our Audit Committee, Nominating and Corporate Governance Committee and Compensation
Committee must also be independent directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee.
The composition and responsibilities of each of the committees of our board of directors are described below. Members serve on
these committees until their resignation or until otherwise determined by our board of directors. Our board of directors may establish
other committees as it deems necessary or appropriate from time to time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit Committee are Karen Macleod, Colleen Cunningham and James McDonnell, with Ms. Cunningham serving as the Chairperson.
Each of Ms. Macleod, Ms. Cunningham and Mr. McDonnell, is independent under the rules and regulations of the SEC and the listing
standards of the Nasdaq Stock Market applicable to audit committee members. Our board of directors has determined that each of
Ms. Macleod and Ms. Cunningham qualify as an audit committee financial expert within the meaning of SEC regulations and meet the
financial sophistication requirements of the Nasdaq Stock Market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee has the responsibility for, among other things, (i) selecting, retaining and overseeing our independent registered
public accounting firm, (ii) obtaining and reviewing a report by independent auditors that describe the accounting firm&#8217;s
internal quality control, and any materials issues or relationships that may impact the auditors, (iii) reviewing and discussing
with the independent auditors standards and responsibilities, strategy, scope and timing of audits, any significant risks, and
results, (iv) ensuring the integrity of the Company&#8217;s financial statements, (v) reviewing and discussing with the Company&#8217;s
independent auditors any other matters required to be discussed by PCAOB Auditing Standard No. 1301, (v1) reviewing, approving
and overseeing any transaction between the Company and any related person and any other potential conflict of interest situations,
(vii) overseeing the Company&#8217;s internal audit department, (v) reviewing, approving and overseeing related party transactions,
and (viii) establishing and overseeing procedures for the receipt, retention and treatment of complaints received by the Company
regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous submission by Company employees
of concerns regarding questionable accounting or auditing matters.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Compensation Committee are Ms. Macleod, Ms. Cunningham and Mr. McDonnell, with Ms. Macleod serving as the Chairperson.
Our Compensation Committee has the responsibility for, among other things, (i) reviewing and approving the chief executive officer&#8217;s
compensation based on an evaluation in light of corporate goals and objectives, (ii) reviewing and recommending to the Board the
compensation of all other executive officers, (iii) reviewing and recommending to the Board incentive compensation plans and equity
plans, (iv) reviewing and discussing with management the Company&#8217;s Compensation Discussion and Analysis and related information
to be included in the annual report on Form&#160;10-K and proxy statements, and (v) reviewing and recommending to the Board for
approval procedures relating to Say on Pay Votes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
and Corporate Governance Committee</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Nominating and Corporate Governance Committee are Ms. Macleod, Ms. Cunningham and Mr. McDonnell, with Mr. McDonnell
serving as the Chairperson. Our Nominating and Corporate Governance Committee has the responsibility relating to assisting the
Board in, among other things, (i) identifying and screening individuals qualified to become members of our board of directors,
consistent with criteria approved by our board of directors, (ii) recommending to the Board the approval of nominees for director,
(ii) developing and recommending to our board of directors a set of corporate governance guidelines, and (iv) overseeing the evaluation
of our board of director.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a Code of Business Conduct and Ethics (the &#8220;Code&#8221;). The Code applies to all of our
directors, officers and employees. We have made the Code available on our website https://investors.cyngn.com/corporate-governance-documents/.
We intend to disclose future amendments to, or waivers of, our Code, as and to the extent required by SEC regulations, at the
same location on our website identified above or in public filings.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><b>Board
Diversity</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">Each
year, our nominating and corporate governance committee will review, with the board of directors, the appropriate characteristics,
skills and experience required for the board of directors as a whole and its individual members. In evaluating the suitability
of individual candidates, our nominating and corporate governance committee will consider factors including, without limitation,
an individual&#8217;s character, integrity, judgment, potential conflicts of interest, other commitments and diversity. While
we have no formal policy regarding board diversity for our board of directors as a whole nor for each individual member, the nominating
and corporate governance committee does consider such factors as gender, race, ethnicity, experience and area of expertise, as
well as other individual attributes that contribute to the total diversity of viewpoints and experience represented on the board
of directors.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;6, 2021, the SEC approved The Nasdaq Stock Market LLC&#8217;s (&#8220;Nasdaq&#8221;) proposal to adopt listing rules
for Nasdaq-listed companies related to board diversity. The new Rule&#160;5605(f) (Diverse Board Representation) requires Nasdaq-listed
companies, subject to certain exceptions, (1) to have at least one director who self-identifies as a female, and (2) to have at
least one director who self-identifies as Black or African American, Hispanic or Latinx, Asian, Native American or Alaska Native,
Native Hawaiian or Pacific Islander, two or more races or ethnicities, or as LGBTQ+, or (3) to explain why the reporting company
does not have at least two directors on its board who self-identify in the categories listed above. In addition, Rule&#160;5606
(Board Diversity Disclosure) requires each Nasdaq-listed company, again subject to certain exceptions, to provide statistical
information about such company&#8217;s Board of Directors, in a proposed uniform format, related to each director&#8217;s self-identified
gender, race, and self-identification as LGBTQ+.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the State of California has enacted two statutes on the subject of board diversity that apply to all publicly held companies
whose principal executive offices are located in California. In 2018, SB 826 was adopted whereby such companies whose boards of
directors have six or more members were required to have at least one female director by the end of 2019 and are required to have
at least three female directors by the end of 2021. In 2020, AB 979 was adopted which requires all publicly held corporations
headquartered in California to diversify their boards of directors with directors from &#8220;underrepresented communities.&#8221;
Similar to Nasdaq Rule&#160;5605(f), AB 979 defines &#8220;director from an underrepresented community&#8221; as &#8220;an individual
who self-identifies as Black, African American, Hispanic, Latino, Asian, Pacific Islander, Native American, Native Hawaiian, or
Alaska Native, or who self-identifies as gay, lesbian, bisexual, or transgender.&#8221; Covered companies must have at least one
director from an underrepresented community on their boards by December&#160;31, 2021, and covered companies with nine or more
directors must have at least three such directors on their boards by December&#160;31, 2022. The same individual may count for
the purposes of both gender and underrepresented community diversity.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Involvement
in Certain Legal Proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have not been involved in any of the following events during the past ten years:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any bankruptcy petition
    filed by or against such person or any business of which such person was a general partner or executive officer either at
    the time of the bankruptcy or within two years prior to that time;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any conviction in
    a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being subject to
    any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently
    or temporarily enjoining him from or otherwise limiting his involvement in any type of business, securities or banking activities
    or to be associated with any person practicing in banking or securities activities;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being found by a
    court of competent jurisdiction in a civil action, the SEC or the Commodity Futures Trading Commission to have violated a
    Federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being subject of,
    or a party to, any Federal or state judicial or administrative order, judgment decree, or finding, not subsequently reversed,
    suspended or vacated, relating to an alleged violation of any Federal or state securities or commodities law or regulation,
    any law or regulation respecting financial institutions or insurance companies, or any law or regulation prohibiting mail
    or wire fraud or fraud in connection with any business entity; or</span></td></tr>
</table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being subject of
    or party to any sanction or order, not subsequently reversed, suspended, or vacated, of any self-regulatory organization,
    any registered entity or any equivalent exchange, association, entity or organization that has disciplinary authority over
    its members or persons associated with a member.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
AND DIRECTOR COMPENSATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table provides information regarding the compensation earned by or paid to our named executive officers with respect
to the years ended December&#160;31, 2021 and 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left; vertical-align: bottom"><span style="font-size: 8pt">Name and Principal
    Position</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Fiscal<br/>
Year</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Salary<br/>
    ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Bonus<br/>
    ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Stock<br/>
Awards<br/>
($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Option<br/>
    Award<br/> ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Non-Equity<br/>
Incentive<br/>
Plan<br/>
Compensation</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Non-Qualified<br/>
Deferred<br/>
Compensation<br/>
Earnings<br/> ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">All
    Other<br/>
Compensation<br/> ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Total<br/>
    ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 19%; text-align: left; vertical-align: top"><span style="font-size: 8pt">Lior Tal</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 7%; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">350,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">150,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">506,857</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">-</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; text-align: right"><span style="font-size: 8pt">1,006,857</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">CEO</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">350,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">150,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">102,301</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">15,724</span></td><td style="text-align: left"><span style="font-size: 8pt"><sup>(2)</sup></span>&#160;</td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">618,025</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">Donald Alvarez</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">152,885</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">139,336</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">292,221</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">CFO</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">Ben Landen</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">222,454</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">32,256</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">5,000</span></td><td style="text-align: left"><span style="font-size: 8pt"><sup>(2)</sup></span>&#160;</td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">259,710</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-size: 8pt">VP of Business Development</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">208,297</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">3,045</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">211,342</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;  text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts above represent the compensation awarded to or earned by or paid to our named executive officers for the years ended December&#160;31,
2021 and 2020:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
the aggregate grant date fair value of equity compensation awards granted to the named executive officer, computed in accordance with
FASB ASC Topic 718. See Note 9 to our consolidated financial statements included elsewhere in this prospectus for a discussion of the
assumptions made by us in determining the grant date fair value of our equity awards.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
relocation expenses paid by the Company on behalf of Mr. Tal and Mr. Landen.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Employment Agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lior
Tal</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;1, 2022, we entered into an employment agreement with our Chief Executive Officer, Lior Tal, which agreement superseded
and replaced the offer letter entered into by and between the Company and Mr. Tal on April&#160;17, 2016.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, as compensation for his services as Chief Executive Officer of the Company, Mr. Tal will receive:
(1) a salary of $500,000 per annum (the &#8220;Base Salary&#8221;) and commensurate benefits; (2) eligibility, subject to Mr.
Tal&#8217;s continued employment with the Company, to earn an annual performance based bonus in the target of 60% of his Base
Salary; (3) eligibility, also subject to Mr. Tal&#8217;s continued employment with the Company, to participate in the Company&#8217;s
2013 Equity Incentive Plan, the Company 2021 Incentive Plan, or any successor plan, subject to the terms of such plan; and (4)
entitlement, also subject to Mr. Tal&#8217;s continued employment with the Company, to reimbursement for all reasonable and necessary
out-of-pocket business, entertainment, and travel expenses incurred by Mr. Tal in connection with the performance of Mr. Tal&#8217;s
duties as the Company&#8217;s Chief Executive Officer and the Company&#8217;s expense reimbursement policies and procedures.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement also provides for severance to Mr. Tal pursuant to the terms described therein and the extension of the post termination
exercise period of stock options held by Mr. Tal upon the termination of his employment, upon the terms and conditions outlined
in the Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ben
Landen</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;19, 2019, we entered into an immediately effective offer letter with Mr. Ben Landen. Pursuant to Mr. Landen&#8217;s
offer letter, he will serve as our Senior Director of Business and Corporate Development. Mr. Landen&#8217;s offer letter shall
continue until terminated by either the Company or Mr. Landen. Pursuant to Mr. Landen&#8217;s offer letter, he will receive (i)
an annual base salary of $220,000, and (ii) an option to purchase 150,000 shares of the Company&#8217;s common stock at an exercise
price of $0.23 per share, which is based on the Board of Directors-approved fair market valuation as of March&#160;31, 2019, as
determined by an independent financial consultant. The option shall vest and become exercisable over a four-year period with 25%
vesting on the one-year anniversary of Mr. Landen&#8217;s employment start date and the balance vesting equally after each additional
one-month period for continuous service completed over the following 36 months, subject to and in accordance with the terms of
the Company&#8217;s 2013 Stock Incentive Plan. Mr. Landen&#8217;s options expire in November, 2029. The offer letter contains
customary provisions relating to vacation, benefits, and non-compete.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Donald
Alvarez</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;28, 2021, we entered into an offer letter with Mr. Donald Alvarez, effective June&#160;1, 2021. Pursuant to Mr. Alvarez&#8217;s
offer letter, he serves as our Chief Financial Officer. Mr. Alvarez&#8217;s offer letter shall continue until terminated by either
the Company or Mr. Alvarez. Pursuant to Mr. Alvarez&#8217;s offer letter, he will receive (i) an annual base salary of $250,000
for his first year of employment, which annual base salary will increase to $300,000 upon the completion by the Company of an
initial public offering, and (ii) a stock option to purchase 400,000 shares of the Company&#8217;s common stock at an exercise
price of $2.88 per share, which option shall vest and become exercisable over a four-year period with 25% vesting on the one-year
anniversary of Mr. Alvarez&#8217;s employment start date and the balance vesting equally after each additional one-month period
for continuous service completed over the following 36 months, subject to and in accordance with the terms of the Company&#8217;s
2013 Stock Incentive Plan. Mr. Alvarez&#8217;s options will expire in June&#160;2031. The offer letter contains customary provisions
relating to vacation, benefits, and non-compete.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at Fiscal Year-End</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses information regarding outstanding equity awards granted or accrued as of December&#160;31, 2021, for
our named executive officers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="23" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Outstanding Equity Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="9" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Options (#)<br/> Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Options (#)<br/> Unvested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Exercise<br/> Price ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option<br/> Expiration<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> of Shares or<br/>
    Units of Stock<br/> that have not<br/> Vested (#)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Market Value<br/> of Shares or<br/> Units of Stock<br/> that have not<br/> Vested ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Lior Tal (Chief Executive Officer)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,424,215</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.13</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">4/5/27</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">953,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">3/22/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,805,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">181,738</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">5/30/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.88</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">7/25/31</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Donald Alvarez (Chief Financial Officer)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.88</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">7/25/31</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ben Landen (Vice President of Business Development)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,375</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">11/4/29</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.88</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">7/25/31</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>



</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to November&#160;2021, our directors did not receive compensation for board service. On November&#160;16, 2021, our Board of Directors,
upon recommendation of the Compensation Committee, approved and adopted a program for compensating independent directors of the
Board. Each independent director shall receive annual cash compensation of $35,000. In addition, the chairperson of the Audit
Committee, Compensation Committee and Nominating and Governance Committee shall receive an annual compensation of $20,000, $15,000
and $10,000, respectively; and the lead independent director shall receive an annual cash compensation of $15,000. There shall
also be (i) an initial award of $270,000 in restricted stock units of the Company to each new independent director which shall
be awarded on May&#160;1<sup>st</sup> of each fiscal year commencing in 2022 and which will vest monthly over three (3) years,
and (ii) an annual award of $180,000 in restricted stock units of the Company, which shall be granted on May&#160;1<sup>st</sup>
of each fiscal year starting in 2022 and which will vest in its entirety one (1) year from the grant date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the summary compensation information (described above) for each of our non-employee directors:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="29" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">DIRECTOR COMPENSATION</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fees Earned<br/>
or<br/> Paid
    in Cash<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock<br/> Awards<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Awards<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-Equity<br/> Incentive<br/> Plan<br/> Compensation<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nonqualified<br/> Deferred<br/> Compensation Earnings<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other<br/> Compensation<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/>
($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left">Karen Macleod</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">61,019</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">61,019</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Colleen Cunningham</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,508</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">James McDonnell</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,508</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to the beneficial ownership of our voting securities as of May&#160;11,
2022 by (i) any person or group beneficially owning more than 5% of any class of voting securities; (ii) our directors, and; (iii)
each of our named executive officers; and (iv) all executive officers and directors as a group as of the date of May&#160;11,
2022. The information presented below regarding beneficial ownership of our voting securities has been presented in accordance
with the rules of the Securities and Exchange Commission and is not necessarily indicative of ownership for any other purpose.
Under these rules, a person is deemed to be a &#8220;beneficial owner&#8221; of a security if that person has or shares the power
to vote or direct the voting of the security or the power to dispose or direct the disposition of the security. A person is deemed
to own beneficially any security as to which such person has the right to acquire sole or shared voting or investment power within
60 days through the conversion or exercise of any convertible security, warrant, option or other right. More than one person may
be deemed to be a beneficial owner of the same securities. Unless otherwise indicated, the address of all listed stockholders
is c/o Cyngn Inc., 1015 O&#8217;Brien Drive, Menlo Park, CA 94025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif;  width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common<br/> Stock Beneficially<br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/> Common Stock<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-align: left">Directors and Officers:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior Tal<sup>(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,365,004</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald Alvarez<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.34</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ben Landen<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.34</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitch Lasky<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,238,787</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karen Macleod<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.06</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen Cunningham<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,868</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.03</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James McDonnell<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,868</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.03</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">All Executive Officers and Directors as a Group (7 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,857,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.70</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Beneficial owners of more than 5%:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities affiliated with Benchmark<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,238,787</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andreessen Horowitz Fund III, L.P<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,234,828</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.94</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities affiliated with Redpoint<sup>(10)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,463,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.97</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">represents
less than 1%</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have based our calculation of the percentage of beneficial ownership on 30,894,752 shares of common stock outstanding on May&#160;11,
2022. We have deemed shares of common stock subject to stock options that are currently exercisable or exercisable within 60 days of
this prospectus to be outstanding and to be beneficially owned by the person holding the stock option for the purpose of computing the
percentage ownership of that person. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership
of any other person.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
500,000 shares of common stock held directly and 4,865,004 shares of common stock issuable upon the exercise of stock options that are
currently exercisable or exercisable within 60 days of this prospectus.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
shares of common stock underlying 108,333 options to purchase shares of common stock of the Company which are vested and currently exercisable
and shares underlying options which will become exercisable within 60 days of this prospectus.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
shares of common stock underlying 106,250 options to purchase shares of common stock of the Company which are vested and currently exercisable
and shares underlying options which will become exercisable within 60 days of this prospectus.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
shares of common stock underlying 19,737 options to purchase shares of common stock of the Company which are vested and currently exercisable
and shares underlying options which will become exercisable within 60 days of this prospectus.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
shares of common stock underlying 9,868 options to purchase shares of common stock of the Company which are vested and currently exercisable
and shares underlying options which will become exercisable with 60 days of this prospectus.</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="text-align: left; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
shares of common stock underlying 9,868 options to purchase shares of common stock of the Company which are vested and currently exercisable
and shares underlying options which will become exercisable within 60 days of this prospectus.</span></td>
</tr>
</table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely on a Schedule&#160;13G filed with the SEC on February&#160;14, 2022 by entities and individuals affiliated with Benchmark. Represents
9,238,787 shares, of which 239,529 are directly owned by Benchmark Capital Partners VI, L.P. (&#8220;BCP VI&#8221;), 14,980 are directly
owned by Benchmark Founders&#8217; Fund VI, L.P. (&#8220;BFF VI&#8221;), 9,832 are directly owned by Benchmark Founders&#8217; Fund VI-B,
L.P. (&#8220;BFF VI-B&#8221;), 25,821 are held in nominee form for the benefit of persons associated with Benchmark Capital Management
Co. VI, L.L.C. (&#8220;BCMC VI&#8221;), 7,111,971 are directly owned by Benchmark Capital Partners VII, L.P. (&#8220;BCP VII&#8221;),
789,847 are directly owned by Benchmark Founders&#8217; Fund VII, L.P. (&#8220;BFF VII&#8221;) and 1,046,807 are directly owned by Benchmark
Founders&#8217; Fund VII-B, L.P. (&#8220;BFF VII-B&#8221;). BCMC VI is the general partner of BCP VI, BFF VI and BFF VI-B, and BCMC VII
is the general partner of BCP VII, BFF VII and BFF VII-B. Matthew R. Cohler (&#8220;Cohler&#8221;), a member of BCMC VI and BCMC VII,
may be deemed to have shared power to dispose of the shares held directly by these entities. BCMC VI, the general partner of BCP VI,
BFF VI and BFF VI-B, may be deemed to have sole power to vote and sole power to dispose of shares of the Company directly owned by BCP
VI, BFF VI and BFF VI-B. BCMC VII, the general partner of BCP VII, BFF VII and BFF VII-B, may be deemed to have sole power to vote and
sole power to dispose of shares of the Company directly owned by BCP VII, BFF VII and BFF VII-B. Alexandre Balkanski (&#8220;Balkanski&#8221;),
Matthew R. Cohler (&#8220;Cohler&#8221;), Bruce W. Dunlevie (&#8220;Dunlevie&#8221;), Peter Fenton (&#8220;Fenton&#8221;), J. William
Gurley (&#8220;Gurley&#8221;), Keven R. Harvey (&#8220;Harvey&#8221;), Robert C. Kagle (&#8220;Kagle&#8221;) and Mitchell H. Lasky (&#8220;Lasky&#8221;)
are members of BCMC VI and may be deemed to have shared power to vote and shared power to dispose of shares of the Company directly owned
by BCP VI, BFF VI and BFF VI-B. Cohler, Dunlevie, Fenton, Gurley, Harvey and Lasky are members of BCMC VII and may be deemed to have
shared power to vote and shared power to dispose of shares of the Company directly owned by BCP VII, BFF VII and BFF VII-B. The principal
business address for each of these entities and individuals is 2965 Woodside Road, Woodside, California 94062.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely on a Schedule&#160;13G filed with the SEC on February&#160;14, 2022 by entities and individuals affiliated with Andreessen Horowitz
Fund III, L.P. (&#8220;AH III&#8221;). Represents 5,234,828 shares of common stock, all of which are held of record by AH III. The address
of the stockholder is Andreessen Horowitz Fund III, L.P. 2865 Sand Hill Road, Suite 101 Menlo Park, CA 94025 Attn: Robin Casey. Marc
Andreessen and Ben Horowitz share voting and dispositive power over the securities held by the stockholder.</span></td>
</tr></table><div>
</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely on a Schedule&#160;13G filed with the SEC on February&#160;11, 2022 by entities affiliated with Redpoint. Represents (i) 2,402,255
shares of common stock, held of record by Redpoint Ventures IV, L.P. (&#8220;RV IV&#8221;) and (ii) 61,596 shares of common stock held
of record by Redpoint Associates IV, L.L.C. (&#8220;RA IV,&#8221; and together with RV IV, the &#8220;Redpoint Entities&#8221;). Redpoint
Ventures IV, LLC (&#8220;RV IV LLC&#8221;) is the sole general partner of RV IV and the managers of RV IV LLC commonly control RA IV.
Voting and dispositive decisions with respect to the shares held by RV IV and RA IV are made by the managers of RV IV LLC and RA IV:
W. Allen Beasley, Jeffrey D. Brody, Satish Dharmaraj, R. Thomas Dyal, Timothy M. Haley, Christopher B. Moore, Scott C. Raney, John L.
Walecka and Geoffrey Y. Yang. The address for each of the Redpoint Entities is 2969 Woodside Road, Woodside, CA 94062.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><b>Securities
Authorized for Issuance under Equity Compensation Plans</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2013
Equity Incentive Plan</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif"><i>General</i>. In
February&#160;2013, our Board of Directors adopted the 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;). Our 2013 Plan
became effective immediately on adoption.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font: 10pt Times New Roman, Times, Serif"><i>Share
Reserve</i>. The number of shares of our common stock available for issuance under our 2013 Plan is 17,158,579,
subject to adjustment as described in the 2013 plan.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021
Equity Incentive Plan</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i>. In
October&#160;2021, our Board of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) and
the 2021 Plan was submitted to our stockholders for approval. Our 2021 Plan became effective immediately on adoption. Our 2021
Plan replaces our 2013 Plan. However, awards outstanding under our 2013 Plan will continue to be governed by their existing terms.
Our 2021 Plan has the features described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Reserve</i>. The number of shares of our common stock available for issuance under our 2021 Plan is 1,500,000
plus up to 8,500,000 shares common stock that are reserved and not yet issued or subject to awards granted under the 2013 Plan
or that have subsequently forfeited, expire or lapse unexercised or unsettled. There will also be an annual increase to be added
as of the first day of the Company&#8217;s fiscal year beginning in 2022 equal to the least of (i) 5% of the outstanding common
stock on a fully diluted basis as of the end of the Company&#8217;s immediately preceding fiscal year, (ii) 1,000,000 shares,
and (iii) a lesser amount determined by the board; provided, however, that any shares from any such increases in previous years
that are not actually issued shall continue to be available for issuance under the 2021 Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Plan Category</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of securities to be issued upon exercise of outstanding options, warrants and rights<br/> (a)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-average exercise price of outstanding options, warrants and rights<br/> (b)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 55%; text-align: left">Equity compensation plans approved by security holders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">8,535,221</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.75</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,473</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6.88</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,490,196</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,769,694</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,490,196</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>




</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as set forth below and compensation arrangements, including employment, and indemnification arrangements, discussed, there
have been no transactions since January&#160;1, 2020, in which the amount involved in the transaction exceeded or will exceed
the lesser of $120,000 or one percent of the average of our total assets as at the year-end for the last two completed fiscal
years, and to which any of our directors, executive officers or beneficial holders of more than 5% of our capital stock, or any
immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect
material interest.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amended
and Restated Investor Rights Agreement</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are parties to that certain second amended and restated investor rights agreement dated December&#160;24, 2014, entered into with
our certain of our stockholders, including an entity with which one of our directors is affiliated. These stockholders are entitled
to rights with respect to the registration of their shares following our initial public offering. In connection with the filing
of the registration statement, we have obtained waivers from the stockholders who are entitled to piggy-back registration rights.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
Agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October&#160;29, 2021, we entered into indemnification agreements with each of our directors and executive officers (the &#8220;D&amp;O
Indemnification Agreements&#8221;). The D&amp;O Indemnification Agreements provide that the Company will indemnify each of its
directors, executive officers, and such other key employees against any and all expenses incurred by that director or executive
officer because of his or her status as one of the Company&#8217;s directors or executive officers, to the fullest extent permitted
by Delaware law and the Company&#8217;s amended and restated certificate of incorporation. In addition, the D&amp;O Indemnification
Agreements provide that, to the fullest extent permitted by Delaware law, the Company will advance all expenses incurred by its
directors, executive officers, and other key employees in connection with a legal proceeding involving his or her status as a
director, executive officer, or key employee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
of Liability and Indemnification of Officers and Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, as amended and restated, limits the liability of directors to the maximum extent permitted by Delaware
General Corporation Law (the &#8220;DGCL&#8221;). The DGCL provides that directors of a corporation will not be personally liable
for monetary damages for breach of their fiduciary duties as directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we will indemnify our directors and officers to the fullest extent permitted by law, and may indemnify employees
and other agents. Our bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance
of the final disposition of any action or proceeding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, subject to the provisions of the DGCL contain provisions which allow the corporation to indemnify any person against liabilities
and other expenses incurred as the result of defending or administering any pending or anticipated legal issue in connection with
service to us if it is determined that person acted in good faith and in a manner which he or she reasonably believed was in the
best interest of the corporation. Insofar as indemnification for liabilities arising under the Securities Act of 1933 as amended,
or the Securities Act, may be permitted to our directors, officers and controlling persons, we have been advised that in the opinion
of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability and indemnification provisions in our bylaws may discourage stockholders from bringing a lawsuit against
directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors
and officers, even though an action, if successful, might provide a benefit to us and our stockholders. Our results of operations
and financial condition may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers
pursuant to these indemnification provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is
required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>



</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Related Party Transactions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a formal, written related party transactions policy that provides that transactions with directors, officers and
holders of five percent or more of our voting securities and their affiliates, each a related party must be approved by our audit
committee. Pursuant to this policy, the audit committee will have the primary responsibility for reviewing and approving or disapproving
&#8220;related party transactions,&#8221; which are transactions between us and related persons in which the aggregate amount
involved exceeds or may be expected to exceed the lesser of (i) $120,000 or (ii) one percent of the average of our total assets
for the last two completed fiscal years, and in which a related person has or will have a direct or indirect material interest.
For purposes of this policy, a related person will be defined as a director, executive officer, nominee for director, or greater
than 5% beneficial owner of our common stock, in each case since the beginning of the most recently completed year, and their
immediate family members.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board evaluates the independence of each nominee for election as a director of our Company in accordance with the Nasdaq Listing
Rules. Pursuant to these rules, a majority of our Board must be &#8220;independent directors&#8221; within the meaning of the
Nasdaq Listing Rules, and all directors who sit on our Audit Committee, Nominating and Corporate Governance Committee and Compensation
Committee must also be independent directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board currently consists of five directors, Lior Tal, Mitch Lasky, Karen Macleod, Colleen Cunningham and James McDonnell. Ms.
Macleod, Ms. Cunningham and Mr. McDonnell are <i>&#8220;independent directors&#8221;</i> within the meaning of the Listing Rules
(the &#8220;Nasdaq Listing Rules&#8221;) of the Nasdaq Stock Market (&#8220;Nasdaq&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DESCRIPTION
OF CAPITAL STOCK</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, as amended and restated (&#8220;Certificate of Incorporation&#8221;) authorize us to issue up to
100,000,000 shares of common stock, $0.00001 par value. Each holder of our common stock is entitled to one (1) vote for each share
held of record on all voting matters we present for a vote of stockholders, including the election of directors. Holders of common
stock have no cumulative voting rights or preemptive rights to purchase or subscribe for any stock or other securities, and there
are no conversion rights or redemption or sinking fund provisions with respect to our common stock. All shares of our common stock
are entitled to share equally in dividends from sources legally available when, and if, declared by our Board of Directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is authorized to issue additional shares of common stock not to exceed the amount authorized by the Certificate
of Incorporation, on such terms and conditions and for such consideration as the Board may deem appropriate without further stockholder
action.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of our liquidation or dissolution, all shares of our common stock are entitled to share equally in our assets available
for distribution to stockholders. However, the rights, preferences and privileges of the holders of our common stock are subject
to, and may be adversely affected by, the rights of the holders of shares of preferred stock that have been issued or shares of
preferred stock that our Board of Directors may decide to issue in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation authorize us to issue up to 10,000,000 shares of preferred stock, $0.00001 par value. Our Board of
Directors is authorized, without further action by the stockholders, to issue shares of preferred stock and to fix the designations,
number, rights, preferences, privileges, and restrictions thereof, including dividend rights, conversion rights, voting rights,
terms of redemption, liquidation preferences and sinking fund terms. We believe that the Board of Directors&#8217; power to set
the terms of, and our ability to issue preferred stock, will provide flexibility in connection with possible financing or acquisition
transactions in the future. The issuance of preferred stock, however, could adversely affect the voting power of holders of common
stock and decrease the amount of any liquidation distribution to such holders. The presence of outstanding preferred stock could
also have the effect of delaying, deterring, or preventing a change in control of our Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are parties to that certain registration rights agreement dated as of April&#160;28, 2022 - See &#8220;Private Placement of Shares
of Common Stock, Warrants and Pre-Funded Warrants&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also parties to that certain second amended and restated investors&#8217; rights agreement dated December&#160;24, 2014. At
any time after the 180 days following the effectiveness of the registration statement in connection with our initial public offering,
the holders of registrable securities, as described in the second amended and restated investors&#8217; rights agreement are entitled
to rights with respect to the registration of their shares under the Securities Act. These rights are provided under the terms
of the second amended and restated investors&#8217; rights agreement, and include demand registration rights, short-form registration
rights and piggyback registration rights. All fees, costs and expenses of underwritten registrations will be borne by us and all
selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares being registered,
except for certain expense of counsel which shall be borne by the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time after the 180 days following the effectiveness of the registration statement in connection with our initial public offering,
the holders of at least a majority of the registrable securities then outstanding, may make a written request that we register
all or a portion of such registrable securities, subject to certain specified conditions and exceptions. Such request for registration
must cover at least 40% of the registrable securities then outstanding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time we are eligible to file a registration statement on Form S-3 the holders of at least 30% of the registrable securities
then outstanding may make a written request that we that we prepare and file a registration statement on Form S-3 under the Securities
Act with respect to registrable securities of such holders having an anticipated aggregate offering price, net of selling expenses,
of at least $10 million, the Company, subject to certain specified conditions and exceptions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we propose to register any of our securities under the Securities Act in connection with the public offering of such securities
solely for cash, the holders of our registrable securities, subject to certain exceptions, be entitled to include their shares
in our registration statement. These registration rights are subject to specified conditions and limitations, including, but not
limited to, the right of the underwriters to limit the number of shares included in any such offering under certain circumstances,
but not below 30% of the total amount of securities included in such offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
piggy-back registration rights with respect to this offering have been waived.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Indemnification</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
second amended and restated investors&#8217; rights agreement contains customary cross-indemnification provisions, under which
we are obligated to indemnify holders of registrable securities in the event of material misstatements or omissions in the registration
statement attributable to us, and they are obligated to indemnify us for material misstatements or omissions attributable to them.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expiration
of Registration Rights</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration rights granted under the second amended and restated investor rights agreement will terminate on the earlier of the
closing of a deemed liquidation event as defined in our second amended and restated certificate of incorporation, such time as
Rule&#160;144 is available for the sale of all of the holders&#8217; shares without limitation during a three-month period and
the fifth anniversary of the completion of this offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Provisions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certificate
of Incorporation and Bylaw Provisions</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated certificate of incorporation and our amended and restated bylaws will include a number of provisions that
may have the effect of deterring hostile takeovers or delaying or preventing changes in control of our management team, including
the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Classified
Board.</i></b> Our fifth amended and restated certificate of incorporation and amended and restated bylaws
provide that our board of directors will be classified into three classes of directors, each of which will hold office for a three-year
term. In addition, directors may only be removed from the board of directors for cause and only by the approval of two-thirds
of the combined vote of our then outstanding shares of common stock. A third party may be discouraged from making a tender offer
or otherwise attempting to obtain control of us as it is more difficult and time consuming for stockholders to replace a majority
of the directors on a classified board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Supermajority
Approvals.</i></b> Our amended and restated bylaws require the approval of two-thirds of the combined vote
of our then-outstanding shares of our common stock to amend our bylaws. This will have the effect of making it more difficult
to amend our amended and restated bylaws to remove or modify certain provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
Notice Requirements for Stockholder Proposals and Director Nominations.</i></b> Our amended and restated
bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders,
or to nominate candidates for election as directors at any meeting of stockholders. Our amended and restated bylaws will also
specify certain requirements regarding the form and content of a stockholder&#8217;s notice. These provisions may preclude our
stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our meetings
of stockholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issuance
of Undesignated Preferred Stock.</i></b> Our board of directors have the authority, without further action
by the holders of our common stock, to issue up to 10,000,000 shares of undesignated preferred stock with rights and preferences,
including voting rights, designated from time to time by the board of directors. The existence of authorized but unissued shares
of preferred stock will enable our board of directors to render more difficult or discourage an attempt to obtain control of us
by means of a merger, tender offer, proxy contest, or otherwise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>



</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issuance
of Unissued Stock.</i></b> Our shares of unissued common stock are available for future issuance without stockholder
approval, subject to certain protections afforded to our preferred stock pursuant to our certificate of incorporation, as
amended and restated. We may utilize these additional shares for a variety of corporate purposes, including future public
offerings to raise additional capital, to facilitate corporate acquisitions, payment as a dividend on the capital stock or as
equity compensation to our service providers under our equity compensation plans. The existence of unissued and unreserved
common stock may enable our board of directors to issue shares to persons friendly to current management thereby protecting
the continuity of our management. Also, if we issue additional shares of our authorized, but unissued, common stock, these
issuances will dilute the voting power and distribution rights of our existing common stockholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Delaware
Law</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are governed by the provisions of Section&#160;203 of the DGCL. In general, Section&#160;203 prohibits a public Delaware corporation
from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years
after the date of the transaction in which the person became an interested stockholder, unless:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
business combination or transaction which resulted in the stockholder becoming an interested stockholder was approved by the board of
directors prior to the time that the stockholder became an interested stockholder;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned
at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by directors
who are also officers of the corporation and shares owned by employee stock plans in which employee participants do not have the right
to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
or subsequent to the time the stockholder became an interested stockholder, the business combination was approved by the board of directors
and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least two-thirds
of the outstanding voting stock which is not owned by the interested stockholder.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section&#160;203 defines a &#8220;business combination&#8221; to include mergers, asset sales and other transactions
resulting in financial benefit to a stockholder and an &#8220;interested stockholder&#8221; as a person who, together with affiliates
and associates, owns, or within three years did own, 15% or more of the corporation&#8217;s outstanding voting stock. These provisions
may have the effect of delaying, deferring or preventing changes in control of our company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Choice
of Forum</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated certificate of incorporation provide that unless the Company consents in writing to the selection of an alternative
forum, the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action or proceeding brought
on our behalf; any action asserting a breach of fiduciary duty by any of our directors, officers or other employees to us or our
stockholders; any action asserting a claim against the Company, our directors or officer or employees directors arising pursuant
to any provision of the DGCL, our amended and restated certificate of incorporation or amended and restated bylaws or any other
action asserting a claim against us our directors or officers or employees that is governed by the internal affairs doctrine.
This choice of forum provision does not apply to actions brought to enforce a duty or liability created by the Exchange Act or
any other claim for which federal courts have exclusive jurisdiction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall
be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. We intend
for this provision to apply to any complaints asserting a cause of action under the Securities Act despite the fact that Section&#160;22
of the Securities Act creates concurrent jurisdiction for the federal and state courts over all actions brought to enforce any
duty or liability created by the Securities Act or the rules and regulations promulgated thereunder. The enforceability of similar
choice of forum provisions in other companies&#8217; certificates of incorporation has been challenged in legal proceedings, and
it is possible that a court could find these types of provisions in our certificate of incorporation to be inapplicable or unenforceable</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitations
of Liability and Indemnification</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation limits the liability of directors to the maximum extent permitted by the DGCL. The DGCL provides
that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, as amended, provide that we will indemnify our directors and officers to the fullest extent permitted by law, and may
indemnify employees and other agents. Our bylaws also provide that we are obligated to advance expenses incurred by a director
or officer in advance of the final disposition of any action or proceeding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, as amended, subject to the provisions of the DGCL, contain provisions which allow the corporation to indemnify any person
against liabilities and other expenses incurred as the result of defending or administering any pending or anticipated legal issue
in connection with service to us if it is determined that person acted in good faith and in a manner which he or she reasonably
believed was in the best interest of the corporation. Insofar as indemnification for liabilities arising under the Securities
Act of 1933 as amended, or the Securities Act, may be permitted to our directors, officers and controlling persons, we have been
advised that in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability and indemnification provisions in our bylaws may discourage stockholders from bringing a lawsuit against
directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors
and officers, even though an action, if successful, might provide a benefit to us and our stockholders. Our results of operations
and financial condition may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers
pursuant to these indemnification provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is
required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is Continental Stock Transfer &amp; Trust Company. Its fax number is (801) 274-1099.
Investors may reach our transfer agent at info@actionstocktransfer.com.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &#8220;CYN.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLAN
OF DISTRIBUTION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &#8220;<span style="text-decoration:underline">Selling Stockholders</span>&#8221;) of the securities and any of their pledgees, assignees and
successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market
or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales
may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the
    block as principal to facilitate the transaction;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities
    at a stipulated price per security;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="vertical-align: top; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule&#160;144 or any other exemption from registration under the Securities
Act of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;), if available, rather than under this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities,
from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an
agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule&#160;2440; and in the case
of a principal transaction a markup or markdown in compliance with FINRA IM-2440.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of
hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close
out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling
Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one
or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered
by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The
Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities
under the Securities Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling
Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule&#160;144, without
the requirement for the Company to be in compliance with the current public information under Rule&#160;144 under the Securities
Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule&#160;144
under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed
brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered
hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the
registration or qualification requirement is available and is complied with.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable
provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of
purchases and sales of the common stock by the Selling Stockholders or any other person. We will make copies of this prospectus
available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser
at or prior to the time of the sale (including by compliance with Rule&#160;172 under the Securities Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities being offered by this prospectus has been passed upon for us by Sichenzia Ross Ference LLP, New York,
New York.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPERTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Cyngn Inc. appearing in this prospectus, have been audited by Marcum LLP, as set forth in its report thereon,
included herein. Such financial statements are included herein in reliance upon such report given on the authority of such firm
as experts in accounting and auditing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
securities laws require us to file information with the SEC concerning our business and operations. Accordingly, we file annual,
quarterly, and special reports, and other information with the Commission. The SEC maintains a web site (http://www.sec.gov) at
which you can read or download our reports and other information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities being offered
hereby. As permitted by the rules and regulations of the SEC, this prospectus does not contain all the information set forth in
the registration statement and the exhibits and schedules thereto. For further information with respect to the Company and the
securities offered hereby, reference is made to the registration statement, and such exhibits and schedules. The registration
statement may be accessed at the SEC&#8217;s web site.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Page</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; width: 90%"><span style="font-size: 10pt; color: Black"><a href="#new_id">Consolidated Balance Sheets as of March 31, 2022 (unaudited) and December 31, 2021</a></span></td>
    <td style="width: 1%"><span style="color: Black">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center; width: 9%">F-2</td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt; color: Black"><a href="#new_id-0">Consolidated Statements of Operations for the Three Months ended March 31, 2022 and 2021 (unaudited)</a></span></td>
    <td><span style="color: Black">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="color: Black">F-3</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"><span style="font-size: 10pt; color: Black"><a href="#new_id-1">Consolidated Statements of Stockholders&#8217; Equity for the Three Months ended March 31, 2022 and 2021 (unaudited)</a></span></td>
    <td><span style="color: Black">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="color: Black">F-4</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt; color: Black"><a href="#new_id-2">Consolidated Statements of Cash Flows for the Three Months ended March 31, 2022 and 2021 (unaudited)</a></span></td>
    <td><span style="color: Black">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="color: Black">F-5</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt; color: Black"><a href="#new_id-3">Notes to Condensed Financial Statements (unaudited)</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">F-6</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 90%; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-18</span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">Consolidated Balance Sheets as of December&#160;31, 2021 and December&#160;31, 2020</a></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-19</span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">Consolidated Statements of Operations for the years ended December&#160;31, 2021 and December&#160;31, 2020</a></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-20</span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">Consolidated Statements of Stockholders&#8217; Equity for the years ended December&#160;31, 2021 and December&#160;31, 2020</a></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-21</span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2021 and December&#160;31, 2020</a></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-22</span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_006">Notes to Consolidated Financial Statements</a></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-23</span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>



</div><!-- Field: Page; Sequence: 73; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><div><a id="new_id"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center; "><b>CYNGN INC.
AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center; "><b>CONSOLIDATED
BALANCE SHEETS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>March 31,</b></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"><b>December&#160;31,</b></td><td style="font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>(U<span style="text-transform: lowercase">NAUDITED</span>)</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Assets</td><td>&#160;</td>
    <td colspan="2"><b>&#160;</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Current assets</td><td>&#160;</td>
    <td colspan="2"><b>&#160;</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><b>$</b></td><td style="width: 9%; text-align: right"><b>18,331,241</b></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><b>$</b></td><td style="width: 9%; text-align: right"><b>21,945,981</b></td><td style="width: 1%; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>126,489</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>50,000</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>509,360</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>525,304</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>18,967,090</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>22,521,285</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>308,618</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>102,787</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>777,181</b></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>&#160;</b></td><td style="font-weight: bold; text-align: right"><b>-</b></td><td style="font-weight: bold; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intangible assets, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>30,050</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>30,917</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total Assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b>20,082,939</b></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b>22,654,989</b></td><td style="padding-bottom: 4pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities and Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><b>94,688</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><b>112,271</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accrued expenses and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>172,977</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>295,156</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Operating lease liability, current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>548,982</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>816,647</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>407,427</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Operating lease liability, net of current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>228,742</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: right"><b>-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>1,045,389</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>407,427</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Commitments and contingencies (Note 12)</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Series A, B and C preferred stock, Par $0.00001; 10,000,000 shares authorized; none issued and outstanding as of March 31,
2022 and December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>-</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>-</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: 400; font-style: normal">Common stock, Par $0.00001; 100,000,000 shares authorized; 27,104,430 and 26,487,680 shares issued and outstanding as of March 31, 2022
and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>271</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>265</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Common stock warrants</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>170,397</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>170,397</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>139,179,451</b></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>138,570,430</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(120,312,569</b></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(116,493,530</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>19,037,550</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>22,247,562</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: right"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: right"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b>20,082,939</b></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b>22,654,989</b></td><td style="padding-bottom: 4pt; text-align: left"><b>&#160;</b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center; ">See accompanying
notes to consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center; "></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: center; "><b>&#160;</b></p><div>

</div><div><a id="new_id-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><b>CYNGN INC.
AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><b>CONSOLIDATED STATEMENTS
OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><b>(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-indent: 0.25in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Three Months Ended<br/>
    March 31,</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 76%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Research and development</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><b>&#160;</b></td><td style="width: 9%; text-align: right"><b>1,681,145</b></td><td style="width: 1%; text-align: left"><b>&#160;</b></td><td style="width: 1%"><b>&#160;</b></td>
    <td style="width: 1%; text-align: left"><b>&#160;</b></td><td style="width: 9%; text-align: right"><b>934,290</b></td><td style="width: 1%; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>2,137,516</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>615,391</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>3,818,661</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>1,549,681</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Loss from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(3,818,661</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(1,549,681</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Other income, net</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Interest expense, net</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>(379</b></td><td style="text-align: left"><b>)</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>(2,142</b></td><td style="text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>1</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total other (expense) income,
    net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(378</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b>(2,142</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Net loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b>(3,819,039</b></td><td style="padding-bottom: 2pt; text-align: left"><b>)</b></td><td style="padding-bottom: 4pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b>(1,551,823</b></td><td style="padding-bottom: 2pt; text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net loss per share attributable to ordinary stockholders&#8217;, basic and
diluted</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><b>(0.14</b></td><td style="text-align: left"><b>)</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><b>(1.63</b></td><td style="text-align: left"><b>)</b></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>&#160;</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted-average shares used in computing net loss per share attributable to ordinary
stockholders&#8217;, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>26,862,227</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b>951,794</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">See accompanying notes
to consolidated financial statements.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="new_id-1"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>CONSOLIDATED STATEMENTS
OF STOCKHOLDERS&#8217; EQUITY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Convertible Preferred Stock</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Common Stock</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Common Stock</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Additional Paid in</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Accumulated</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Total Stockholders&#8217;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Shares</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Shares</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Warrants</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Capital</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Deficit</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Equity</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 12%">Balance as of December&#160;31,<br/>
 2020</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 8%; font-weight: bold; text-align: right">21,982,491</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">220</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 8%; font-weight: bold; text-align: right">951,794</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">10</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">114,291,505</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">&#160;(108,694,001</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">5,597,734</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Stock-based compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,860</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,860</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,551,823</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,551,823</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Balance as of March 31, 2021 (unaudited)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21,982,491</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">220</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">951,794</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">10</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">114,299,365</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(110,245,824</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">4,053,771</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Convertible Preferred Stock</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Common Stock</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Common Stock</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Additional Paid in</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Accumulated</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>Total Stockholders&#8217;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Shares</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Shares</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Warrants</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Capital</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Deficit</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Equity</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 12%">Balance as of December&#160;31,<br/>
 2021</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 8%; font-weight: bold; text-align: right">&#160;&#160;-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">&#160;&#160;-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 8%; font-weight: bold; text-align: right">26,487,680</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">265</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">170,397</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">138,570,430</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">&#160;(116,493,530</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">22,247,562</td><td style="width: 1%; font-weight: bold; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Exercise of stock options</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">616,750</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">6</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">88,879</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">88,885</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">520,142</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">520,142</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,819,039</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,819,039</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">Balance as of March 31, 2022 (unaudited)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; padding-bottom: 4pt; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; padding-bottom: 4pt; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">27,104,430</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">271</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">170,397</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">139,179,451</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(120,312,569</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,037,550</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">See accompanying notes
to consolidated financial statements.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="new_id-2"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>CONSOLIDATED STATEMENTS
OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>(UNAUDITED)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended<br/>
 March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Cash flows from operating activities</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(3,819,039</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,551,823</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,054</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,909</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">520,142</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,860</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Prepaid expense, operating lease right-of-use assets, and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(808,350</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,897</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,583</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(72,436</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued expenses, lease liabilities, and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">655,546</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(116,049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,400,230</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,711,436</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Purchase of property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(226,906</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,703</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(226,906</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,703</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Proceeds from note payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">899,790</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Proceeds from exercise of stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,885</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,885</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">899,790</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net decrease in cash and cash equivalents and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,538,251</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(813,349</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents and restricted cash, beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,995,981</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,456,190</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Cash and cash equivalents and restricted cash, end of period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">18,457,730</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,642,841</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Supplemental disclosure of cash flow:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Cash paid during the period for interest and taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Supplemental disclosure of non-cash activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition of operating lease right-of-use
    assets and operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">824,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in deferred rent associated with ASC 842</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,676</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">See accompanying notes
to consolidated financial statements.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="new_id-3"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Notes to Consolidated
Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>(Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Description of Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">CYNGN Inc., together with
its subsidiaries (collectively, &#8220;Cyngn&#8221; or the &#8220;Company&#8221;) was incorporated in Delaware in 2013. Cyngn Singapore
PTE. LTD., a Singaporean limited company organized in 2015 and Cyngn Philippines, Inc., a Philippines corporation incorporated in 2018
are wholly owned subsidiaries. The Company is headquartered in Menlo Park, CA. Cyngn develops autonomous driving software that can be
deployed on multiple vehicle types in various environments. The Company has been operating autonomous vehicles (&#8220;AV&#8221;) in production
environments. Built and tested in difficult and diverse real-world environments, the self-driving system (DriveMod), fleet management
system, and Software Development Kit combine to create a full-stack advanced autonomy solution designed to be modular, extendable, and
safe.&#160;The Company operates one business segment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Initial Public Offering</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October&#160;22, 2021,
the Company closed its initial public offering (the &#8220;IPO&#8221;) of 3,500,000 shares of its authorized common stock at an offering
price of $7.50 per share. Simultaneously with the closing of the IPO, the common stock began trading on the NASDAQ Capital Market under
the symbol &#8220;CYN.&#8221; The IPO generated net proceeds of $23.3 million after deducting underwriting discounts, commissions and
offering expenses. The Company also granted its underwriters the election to exercise a 45-day over-allotment option to purchase an additional
525,000 shares of common stock at the IPO offering price, less underwriting discounts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Simultaneous with the closing
of its IPO, the Company also issued 140,000 warrants (the &#8220;Purchase Warrant&#8221;) to the underwriters. Each Purchase Warrant entitles
its holder the option to purchase at a future exercise date, one share of common stock at an initial exercise price of $9.375 per share,
subject to certain adjustments and restrictions relating to subsequent resale and transfers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">At the completion of the
IPO, all shares of the Company&#8217;s outstanding redeemable convertible preferred stock automatically converted to shares of common
stock (see Note 7. Capital Structure).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Immediately after the IPO,
the Company filed an amended and restated certificate of incorporation, which became effective on October 22, 2021. The amended and restated
certificate of incorporation authorized 110,000,000 shares consisting of 100,000,000 shares of common stock, at a par value of $0.00001,
and 10,000,000 shares of preferred stock at a par value of $0.00001. The rights of the holders of common stock are subject to and qualified
by rights of the holders of the preferred stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has incurred
losses from operations since inception. The Company incurred net losses of $3.8 million and $1.6 million for the three months ended March
31, 2022 and 2021, respectively. Accumulated deficit amounted to $120.3 million and $116.5 million as of March 31, 2022 and December 31,
2021, respectively. Net cash used in operating activities was $3.4 million and $1.7 million for the three months ended March 31, 2022
and 2021, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&#8217;s liquidity
is based on its ability to enhance its operating cash flow position, obtain capital financing from equity interest investors and borrow
funds to fund its general operations, research and development activities and capital expenditures. The Company&#8217;s ability to continue
as a going concern is dependent on management&#8217;s ability to successfully execute its business plan, which includes increasing revenue
while controlling operating costs and expenses to generate positive operating cash flows and obtaining funds from outside sources of financing
to generate positive financing cash flows. As of March 31, 2022 and December 31, 2021, the Company&#8217;s unrestricted balance of cash
and cash equivalents was $18.3 million and $21.9 million, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based on cash flow projections
from operating and financing activities and existing balance of cash and cash equivalents, management is of the opinion that the Company
has sufficient funds for sustainable operations and it will be able to meet its payment obligations from operations and debt related commitments
for at least one year from the issuance date of these financial statements. Based on the above considerations, the Company&#8217;s consolidated
financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation of liabilities
during the normal course of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. Summary of Significant Accounting Policies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The accompanying unaudited
consolidated financial statements as of and for the three months ended March 31, 2022 and 2021 have been prepared in accordance with accounting
principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities
and Exchange Commission (&#8220;SEC&#8221;). These financial statements should be read in conjunction with the audited consolidated financial
statements and the notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal years ended December 31, 2021,
and 2020, which was filed with the SEC on March 24, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">T<span style="font-size: 10pt">he
accompanying unaudited consolidated financial statements have been prepared on a consistent basis with the audited consolidated financial
statements for the fiscal years ended December 31, 2021, and 2020, and include all adjustments, consisting of only normal recurring adjustments,
necessary to fairly state the information set forth herein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The results reported for
the interim period presented are not necessarily indicative of results that may be expected for any subsequent quarter or for the full
year December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Principles of Consolidation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The unaudited consolidated
financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions have
been eliminated upon consolidation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial
statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well
as reported amounts of revenue and expenses during the reporting period. The Company&#8217;s significant estimates and judgments include
but are not limited to share-based compensation. Management bases its estimates on historical experience and on various other assumptions
believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Actual results could differ from those estimates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents. The Company&#8217;s cash is placed
with high-credit-quality financial institutions and at times exceeds federally insured limits. The Company has not experienced any credit
loss relating to its cash equivalents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Supplier Risk</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company is not currently
in the production stage and generally utilizes suppliers for outside development and engineering support. The Company does not believe
that there is any significant supplier concentration risk as of March 31, 2022 and December&#160;31, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Cash Equivalents and Restricted
Cash</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company considers all
highly liquid investments purchased with a remaining maturity of three months or less to be cash equivalents. Additionally, the Company
considers investments in money market funds with a floating net asset value to be cash equivalents. As of March 31, 2022 and December&#160;31,
2021, the Company had $18.3 million and $21.9 million of unrestricted cash and cash equivalents.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the Company
had $126,489 and $50,000 in restricted cash as of March 31, 2022 and December 31, 2021, respectively, which is reported separately as
current assets on the consolidated balance sheet. The Company&#8217;s restricted cash consists of cash not available for immediate use
that the Company is obligated to maintain in accordance with the terms of its credit card spending arrangement and a letter of credit
for its lease agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table provides
a reconciliation of cash and cash equivalents and restricted cash to amounts shown in the consolidated statements of cash flows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18,331,241</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,242,841</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Cash and cash equivalents and Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,457,730</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,642,841</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value of Financial Instruments</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The accounting guidance defines
fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability category
measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing the amount that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair
value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset
or liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The carrying amounts of cash equivalents, and
accounts payable are reasonable estimates of their fair values due to the short-term nature of these accounts. The fair values of the
Company&#8217;s share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes
valuation models derived from independent external valuations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Property and equipment is
stated at cost less accumulated depreciation. Repair and maintenance costs are expensed as incurred. Depreciation is recorded on a straight-line
basis over each asset&#8217;s estimated useful life.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 59%; font-weight: bold; text-align: left; padding-left: 1pt">Property and Equipment</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 40%; font-weight: bold; text-align: center; padding-left: 5.4pt">Useful life</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">5 years</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 1pt">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">7 years</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">Shorter of 3 years or lease term</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 1pt">Automobile</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">5 years</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Costs related to construction
activities include additions or betterments to existing property and equipment and leased facilities are accumulated during the acquisition
and construction period. Costs are transferred to completed property and equipment no later than six months from the date the asset is
placed in service. Depreciation commences from the date the asset is placed in service. The placed in service date is determined at the
discretion of the department head with responsibility for construction activities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Leases</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company accounts for
leases in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 842 (&#8220;ASC 842&#8221;). All contracts are evaluated
to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified asset for a period of
time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company
does not hold any finance leases. The Company recognized a &#8220;right-of-use&#8221; asset and lease liability in the consolidated balance
sheets as of March 31, 2022 under ASC 842 on the office space lease that was amended and renewed in February 2022. On a prospective basis,
lease expense will be recognized on a straight-line basis over the remaining term of the lease. Operating leases are recognized on the
balance sheet as right-of-use assets, and operating lease liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon adoption of ASC 842,
the Company elected the &#8220;package of practical expedients&#8221; which allowed it to not reassess: (a) whether expired or existing
other contracts are or contain leases, (b) the lease classification for any expired or existing leases, and (c) the treatment of initial
direct costs relating to any existing leases as of March 31, 2022. The package of practical expedients was made as a single election and
was applied to the lease renewed in February 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">Upon
adoption of ASC 842, the Company also elected the practical expedient to not separate non-lease components, such as common area maintenance,
from associated lease components for our ground and office space leases (see Note 4. Leases).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Long-Lived Assets and Finite Lived Intangibles</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has finite lived
intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining
economic lives. The patents and trademarks are amortized over 15 years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company reviews its long-lived
assets and finite lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not
be recoverable. The events and circumstances the Company monitors and considers include significant decreases in the market price of similar
assets, significant adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business
climate, an accumulation of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed
forecasted costs. The Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group
to the future undiscounted cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the
sum of the expected long-term undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount
of the long-lived asset being evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount
exceeds the fair value of the asset.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income Taxes</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company accounts for
income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future
tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their
respective tax basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A valuation allowance is
provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company&#8217;s
lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance as of and March 31, 2022 and December&#160;31,
2021 (see Note 11. Income Taxes).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are no uncertain tax
positions that would require recognition in the financial statements. If the Company were to incur an income tax liability in the future,
interest on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income
taxes. Management&#8217;s conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based
upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof as well as other factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net Loss Per Share Attributable to Ordinary Stockholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company computes loss
per share attributable to ordinary stockholders by dividing net loss attributable to ordinary stockholders by the weighted-average number
of ordinary shares outstanding. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts
to issue shares were exercised into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the
fair value of the shares (only if dilutive) and the denominator is increased to include the number of potentially dilutive common shares
assumed to be outstanding (see Note 8. Net Loss per Share Attributable to Common Stockholders).</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue Recognition</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has not generated
any revenues for the three months ended March 31, 2022 and 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Accounting Standards</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There were no significant
updates to the recently issued accounting standards. Although there are several other new accounting standards issued or proposed by the
Financial Accounting Standards Board (&#8220;FASB&#8221;), the Company does not believe any of those accounting standards have had or
will have a material impact on its financial position or operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. Balance Sheet Components</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment, Net</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Property and equipment is
comprised of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<b>Unaudited)<br/>
March 31,</b></span></td><td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">December&#160;31,</td><td style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Automobiles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">288,430</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">279,617</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,483</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133,102</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,048</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Construction work in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,279</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">715,674</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,767</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(407,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(385,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">308,618</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">102,787</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Depreciation expense for
the three months ended March 31, 2022 and 2021 was $21,075 and $22,042, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accrued Expenses and Other Current Liabilities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accrued expenses and other
current liabilities are comprised of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited)<br/> March 31,</b></span></td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,829</p></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,678</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,478</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46,934</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">172,977</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">295,156</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March 27, 2020, the United
States Congress passed the Coronavirus, Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) in response to the economic
impact of the coronavirus (&#8220;COVID-19&#8221;) pandemic in the United States (see Note 13. Risks and Uncertainties). Section 2302
of the CARES Act allowed employers to defer the deposit and payment of the employer&#8217;s share of social security taxes that were otherwise
required to be deposited between March 27 and December 31, 2020, and to pay the deferred taxes in two installments &#8212; with the first
half due on December 31, 2021, and the remainder by December 31, 2022. As of December 31, 2021, the Company remitted $67,958 in social
security taxes due that were deferred between May 1 and December 31, 2020. The remaining $67,958 is expected to be paid prior to December
31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section 2301 of the CARES
Act also provided refundable employee retention credits (the &#8220;ERC&#8221;) against certain employment taxes.&#160;The Company is
currently evaluating its eligibility to claim the ERC and the impact of the credits on its consolidated statement of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. Leases</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company leases its office space in Menlo Park,
California, under a lease agreement which expired in February 2022 and was subsequently renewed and amended for an 18 month term that
expires in August 2023. Monthly payments are approximately $47,000. The lease includes non-lease components (i.e. common area maintenance
costs) that are paid separately from rent based on actual costs incurred.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&#8217;s future
lease payments under non-cancellable leases as of March 31, 2022 are as follows, which are presented as lease liabilities on the Company&#8217;s
consolidated balance sheet:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Period</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating Lease</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; padding-left: 1pt">Remainder of 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">419,115</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">382,326</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">801,441</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Less: imputed interest</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,717</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Present value of lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">777,724</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 1pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Operating lease liability, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">548,982</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">Operating lease liability, net of current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">228,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">777,724</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 1pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 1pt">Weighted-average remaining lease term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.42</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 1pt">Weighted-average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.96</td><td style="text-align: left">%</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Lease expense under the Company&#8217;s
operating lease was $78,099 and $39,595 for the three-month periods ended March 31, 2022 and 2021, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The amortization of the operating
lease right-of-use assets for the three-month period ended March 31, 2022 was $47,112.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. Intangible Assets, Net</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The gross carrying amount
and accumulated amortization of separately identifiable intangible assets are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross<br/> Carrying <br/> Amount</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accumulated <br/> Amortization</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Net Carrying <br/> Amount</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Patent</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,200</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">27,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,950</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,050</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gross<br/>
 Carrying <br/> Amount</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Accumulated <br/> Amortization</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying <br/> Amount</b> &#160;</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 1pt">Patent</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,083</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,917</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 1pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 10pt; padding-left: -0.625in">Total intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,083</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,917</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Amortization expense for
each of the three months ended March 31, 2022, and 2021 was $867.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Estimated amortization expense
for all intangible assets subject to amortization in future years as of March 31, 2022 is expected to be:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Years Ending December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Remainder of 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,582</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,050</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. Debt</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Payroll Protection Program Note</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In April 2020, the Company
entered into a Note with JPMorgan Chase (the &#8220;Lender&#8221;) under the U.S. Small Business Administration (&#8220;SBA&#8221;) Paycheck
Protection Program (&#8220;PPP&#8221;) established under Section 1102 of the CARES Act, pursuant to which the Company borrowed $695,078
(the &#8220;Note&#8221;). The Note accrues interest at a rate of 0.98% per annum and matures in 24 months from the date of the Note. The
Note may be repaid at any time with no prepayment penalty. All of the funds received under the PPP had been used for qualified purposes.
The Company applied for forgiveness of the Note in accordance with PPP guidelines, and in October, 2021, received approval of the forgiveness
application. As of March 31, 2022 and December 31, 2021, there was no outstanding balance for the Note.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In February 2021, the Company
entered into a second Note (the &#8220;PPP2 Note&#8221;) with the Lender, pursuant to which the Lender agreed to make a loan to the Company
under the PPP offered by the SBA in a principal amount of $892,115 pursuant to Title 1 of the CARES Act. The PPP2 Note matures in five
years with interest accruing at 0.98% per annum. Proceeds of the PPP2 Note are available to be used to pay for payroll costs, including
salaries, commissions, and similar compensation, group health care benefits, and paid leaves; rent; utilities; and interest on certain
other outstanding debt. All of the funds received under the PPP2 Note were used for qualified purposes during 2021. The Company applied
for forgiveness of the loan in accordance with PPP guidelines, and in November, 2021, received approval of the forgiveness application.
As of March 31, 2022 and December 31, 2021, there was no outstanding balance for the PPP2 Note.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. Capital Structure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Common Stock</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of March 31, 2022 and
December 31, 2021, the Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.00001 per share. As of
March 31, 2022 and December 31, 2021, the Company had 27,094,430 and 26,487,680 shares of common stock issued and outstanding, respectively.
Holders of common stock have no preemptive, conversion or subscription rights and there is no redemption or sinking fund provisions applicable
to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected
by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Convertible Preferred Stock</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In October 2021, the Company
amended its Certificate of Incorporation and revised the number of preferred stock shares authorized for issuance to 10,000,000 shares
at a par value of $0.00001. As of March 31, 2022, there were no shares issued and outstanding against these shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Conversion</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company&#8217;s convertible
preferred stock shares that were outstanding at the completion of the IPO on October 20, 2021 automatically converted to shares of common
stock on a 1:1 basis. As of March 31, 2021 and prior to the completion of the IPO, the Company was authorized to issue up to 21,982,491
shares of preferred stock at a par value of $0.00001.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The authorized, issued and
outstanding shares of the convertible preferred stock and liquidation preferences prior to the IPO were as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Series</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/>
 Authorized</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares <br/>
Issued and<br/>
 Outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Per Share <br/>
Liquidation<br/>
 Preference</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/>
 Liquidation<br/>
 Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross<br/>
 Proceeds</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; text-align: left">Series A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">10,157,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">10,157,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">0.6842</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">6,949,996</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">6,949,996</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Series B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,567,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,567,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.3939</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,290,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,290,015</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Series C</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,256,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,256,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">15.7933</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83,025,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83,025,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,265,042</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,265,042</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dividends</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The holders of preferred
stock are entitled to receive dividends, when and if declared by the Company&#8217;s Board of Directors, out of any legally available
funds. The holders of preferred stock are entitled to receive dividends, prior and in preference to dividends declared on common stock,
at the rate of: Series A -&#160;$0.0411 per share per annum; Series B -&#160;$0.2036 per share per annum; and Series C -&#160;$0.9476
per share per annum. Dividends are non-cumulative and will be paid pro rata, on an equal priority, pari passu basis. After payment of
preferred stock dividends, any additional dividends will be paid ratably among holders of common stock and preferred stock on an as converted
to Common Stock basis. As of March 31, 2022 and December 31, 2021, no dividends have been declared.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Voting</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The holder of each share
of Preferred Stock is entitled to voting rights equal to the number of shares of common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Preferred stockholders shall
cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred Stock held by such holder
are convertible. So long as any shares of Series A Preferred Stock remain outstanding, the holders of the Series A Preferred Stock, voting
as a separate class, are entitled to elect one director of the Company. So long as any shares of Series B Preferred Stock remain outstanding,
the holders of the Series B Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. So long as
any shares of Series C Preferred Stock remain outstanding, the holders of the Series C Preferred Stock, voting as a separate class, are
entitled to elect one director of the Company. The holders of Common Stock, voting as a separate class, are entitled to elect two directors
of the Company. The holders of Preferred Stock and Common Stock, on an as converted to basis, are entitled to elect any remaining members
to the Board of Directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of any liquidation,
dissolution or winding up of the Company, either voluntary or involuntary, the holders of preferred stock on a pari passu basis, are entitled
to receive, prior to and in preference over holders of common stock, an amount equal to the original issuance price&#8212;Series A -&#160;$0.6842
per share; Series B -&#160;$3.3939 per share; and Series C -&#160;$15.7933 per share. 2) If the assets of the Company available for distribution
to its stockholders shall be insufficient to pay the holders of the shares of Preferred Stock the full amount to which they are entitled,
the holders of shares of Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion
to the respective amount which would otherwise be payable in respect to the share of Preferred Stock held by them upon such distribution
if all amounts payable on or with respect to such shares were paid in full.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>8. Net Loss Per Share Attributable to Common
Stockholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table summarizes
the computation of basic and diluted loss per share:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Three&#160;months&#160;Ended<br/> March 31,</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(3,819,039</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,551,823</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Basic and diluted weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,862,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">951,794</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.14</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.63</td><td style="text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Basic loss per share is based
upon the weighted average number of shares of common stock outstanding during the period. Diluted loss per share would include the effect
of unvested restricted stock awards and the convertible preferred Stock; however, such items were not considered in the calculation of
the diluted weighted average common shares outstanding since they would be anti-dilutive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Common stock reserved for
future issuance, on an as-if converted basis, are shown below as of:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Issuance of options under stock option plan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,250,569</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,973,366</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Shares available for future stock option grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">9,392,571</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">10,827,940</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Common shares issuable upon conversion of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,643,140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,783,797</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9. Stock-based Compensation Expense</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-Based Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company measures employee
and director stock-based compensation awards based on the award&#8217;s estimated fair value on the date of grant. Expense associated
with these awards is recognized using the straight-line attribution method over the requisite service period for stock options, RSUs and
restricted stock, and is reported in our consolidated statements of comprehensive loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The fair value of our stock
options is estimated, using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over
the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures
as they occur. Stock options generally vest over four years and have a contractual term of ten years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Determining the grant date
fair value of options requires management to make assumptions and judgments. These estimates involve inherent uncertainties and if different
assumptions had been used, stock-based compensation expense could have been materially different from the amounts recorded.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The assumptions and estimates
for valuing stock options are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
value per share of Company&#8217;s common stock.</i> Because there was no public market for Cyngn&#8217;s common stock prior to the IPO,
our Board of Directors, with the assistance of a third-party valuation specialist, determined the common stock fair value at the time
of the grant of stock options by considering a number of objective and subjective factors, including our actual operating and financial
performance, market conditions and performance of comparable publicly traded companies, developments and milestones in the company, and
the likelihood of achieving a liquidity event among other factors. Since our common stock began publicly trading on the NASDAQ, the value
of our common stock underlying stock options has been valued based on prevailing market prices.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
volatility. </i>Because our common stock had no publicly traded history prior to the IPO, we estimated the expected volatility using
our own stock price volatility to the extent applicable or a combination of our stock price volatility and the stock price volatility
of peer companies, for a period equal to the expected term of the options.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
term. </i>The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain
outstanding. We estimate the expected term of options granted based upon the &#8220;simplified method&#8221; provided under <i>Staff
Accounting Bulletin, Topic 14</i>, or SAB Topic 14.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk-free
interest rate.</i> The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were
granted corresponding to the expected term of the awards.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Estimated
dividend yield.</i> The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in the foreseeable
future.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Equity Incentive Plans</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In February 2013, the Board
of Directors adopted the 2013 Equity Incentive Plan (&#8220;2013 Plan&#8221;). The 2013 Plan authorizes the award of stock options, stock
appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards, and other stock or cash awards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In October 2021, our Board
of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). Our 2021 Plan replaces our 2013 Plan. However,
awards outstanding under our 2013 Plan will continue to be governed by their existing terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of March 31, 2022 and
December 31, 2021, approximately 9,392,571 and 10,502,696 shares of common stock were reserved and available for issuance under the 2021
Plan and 2013 Plan, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Options issued under the
Plan generally vest based on continuous service provided by the option holder over a four-year period.&#160; Compensation expense related
to these options is recognized on a straight-line basis over the four-year period based upon the fair value at the grant date.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table summarizes
information about the Company&#8217;s stock options outstanding as well as stock options vested and exercisable as of March 31, 2022,
and activity during the three months then ended:&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>Shares</b> &#160; &#160;</span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> average <br/> remaining <br/> contractual term <br/> (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate intrinsic <br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%">Outstanding as of December 31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,769,694</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7.15</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,746,916</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,139,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(616,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">880,550</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in">Cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(41,875</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.88</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Outstanding as of March 31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,250,569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.29</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.38</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,703,990</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Vested and expected to vest at March 31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,250,569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.29</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.38</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,703,990</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Vested and exercisable at March 31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,187,221</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.30</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.79</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,493,460</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The fair value of a stock
option is estimated using an option-pricing model that takes into account as of the grant date the exercise price and expected life of
the option, the current price of the underlying stock and its expected volatility, expected dividends on the stock, and the risk-free
interest rate for the expected term of the option. The Company has used the simplified method in calculating the expected term of all
option grants based on the vesting period and contractual term. Compensation costs related to share-based payment transactions are recognized
in the financial statements upon satisfaction of the requisite service or vesting requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The weighted average per
share grant-date fair value of options granted during the three months ended March&#160;31, 2022 and 2021 was $0.57 and $0, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following weighted average
assumptions were used in estimating the grant date fair values during the:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Three Months Ended <br/>
March 31,</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of common stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.45</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.39</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During the three months ended
March 31, 2022 and 2021, we recorded stock-based compensation expense from stock options of approximately $520,142 and $7,860, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of March 31, 2022, total
unrecognized stock-based compensation cost related to outstanding unvested stock options that are expected to vest was $7,053,547. This
unrecognized stock-based compensation cost is expected to be recognized over a weighted-average period of approximately 4.3 years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. Retirement Savings Plan</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Effective November 17, 2017,
the Company established the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees and their beneficiaries with the
intention to provide a measure of retirement security for the future. This plan is subject to the provisions of the Employee Retirement
Income Security Act of 1974 (ERISA) and qualifies under Section 401(k) of the Internal Revenue Code. Cyngn, Inc. did not offer and has
not provided a company match for its 401(k) Plan.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. Income Taxes</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the three months ended
March 31, 2022 and 2021, the Company recorded income tax expense of $0. The effective tax rate is 0% for the three months ended March
31, 2022 and 2021.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.25pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For financial reporting purposes,
the Company&#8217;s effective tax rate used for the interim periods is based on the estimated full-year income tax rate. For the three
months ended March 31, 2022, the Company&#8217;s effective tax rate differs from the statutory rate, primarily due to a valuation allowance
recorded against the net deferred tax asset balance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March 27, 2020, the CARES
Act was enacted in response to market conditions related to the COVID-19 pandemic. The CARES Act includes many measures to help companies,
including changes that are temporary and non-income based tax laws, some of which were part of the Tax Cuts and Jobs Act. One provision
of the CARES Act increases the tax deduction for net operating losses from 80% to 100% for 2018 through 2020 and allows net operating
losses generated in 2018 through 2020 to be carried back up to five years. The Company has made reasonable assessments in accounting
for certain effects of the CARES Act that was passed. However, the provisional impacts may be refined over the prescribed measurement
period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Currently, the Company is
not under examination by any taxing authority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>12. Commitments and Contingencies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legal Proceedings</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company is subject to
legal and regulatory actions that arise from time to time. The assessment as to whether a loss is probable or reasonably possible, and
as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome
of litigation is inherently uncertain. There is no material pending or threatened litigation against the Company that remains outstanding
as of March 31, 2022 and December&#160;31, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>13. Risks and Uncertainties</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b><i>COVID-19.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A novel strain
of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a pandemic by the World Health Organization.
While Cyngn&#8217;s business has experienced limited disruption due to this pandemic, our leadership team continues to focus on the highest
level of safety measures to protect our employees. The Company is aware COVID-19 continues to present significant uncertainty in the future
economic outlook for our customers and the markets we serve.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14. Subsequent Events</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company evaluated subsequent
events and transactions that occurred after the balance sheet date up to the date of the financial statements were issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 28, 2022, the Company
entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain accredited and institutional investors
for a private placement offering (&#8220;Private Placement&#8221;) of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;)
or pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) and warrants exercisable for Common Stock (the &#8220;Common Warrants&#8221;).
Pursuant to the Purchase Agreement, the Company sold (i) 3,790,322 shares of its Common Stock together with Common Warrants to purchase
up to 3,790,322 shares of Common Stock, and (ii) 2,661,291 Pre-Funded Warrants with each Pre-Funded Warrant exercisable for one share
of Common Stock, together with Common Warrants to purchase up to 2,661,291 shares of Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Pre-Funded Warrants are
immediately exercisable, at a nominal exercise price of $0.001, and may be exercised at any time until all of the Pre-Funded Warrants
are exercised in full.&#160;Each share of Common Stock and accompanying Common Warrant were sold together at a combined offering price
of $3.10, and each Pre-Funded Warrant and accompanying Common Warrant were sold together at a combined offering price of $3.09.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Common Warrants have
an exercise price of $2.98 per share (subject to adjustment as set forth in the warrant), are exercisable upon issuance and will expire
five years from the date of issuance. The Common Warrants contain standard adjustments to the exercise price including for stock splits,
stock dividend, rights offerings and pro rata distributions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Private Placement closed
on April 29, 2022. The Company received gross proceeds of approximately $20 million before deducting transaction related expenses payable
by the Company. All qualified legal, accounting, registration and other direct costs related to the Private Placement will be offset against
the gross proceeds. The Company intends to use the net proceeds to fund its cash needs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><div><a id="b_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cyngn
Inc.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Cyngn Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2021
and 2020, the related consolidated statements of operations, changes in stockholders&#8217; equity and cash flows for each of
the two years in the period ended December&#160;31, 2021, and the related notes to the consolidated financial statements (collectively
referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its
cash flows for each of the two years in the period ended December&#160;31, 2021, in conformity with accounting principles generally
accepted in the United States of America.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on
the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
Accordingly, we express no such opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide<b>s</b> a reasonable basis for our opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum LLP</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2021<b>.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Jose, California<br/>
March&#160;24, 2022</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID Number 688</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;  text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYNGN
INC. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif;  width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">21,945,981</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">6,056,190</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Restricted cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd">50,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="0" unitRef="usd">400,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">525,304</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">48,852</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">22,521,285</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">6,505,042</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Property and equipment, net</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">102,787</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">133,805</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intangible assets, net</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" unitRef="usd">30,917</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" unitRef="usd">34,383</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">22,654,989</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">6,673,230</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities and Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd">112,271</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd">73,016</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued expenses and other current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="0" unitRef="usd">295,156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="0" unitRef="usd">307,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">407,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">380,418</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Note payable, Paycheck Protection Program</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LongTermNotesPayable" scale="0" unitRef="usd">695,078</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">407,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">1,075,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Commitments and contingencies (Note 12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
    <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-9; -sec-ix-hidden: hidden-fact-8; -sec-ix-hidden: hidden-fact-7; -sec-ix-hidden: hidden-fact-6; -sec-ix-hidden: hidden-fact-5; -sec-ix-hidden: hidden-fact-4">Convertible Series A, B and C preferred stock, Par $<ix:nonFraction contextRef="c3" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c5" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c6" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c7" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c8" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>; <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">10,000,000</ix:nonFraction></ix:nonFraction></ix:nonFraction> authorized as of December&#160;31, 2021 and <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">21,982,491</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized, issued and outstanding as of December&#160;31, 2020</div></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockValue" scale="0" unitRef="usd">220</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Common stock, Par $<ix:nonFraction contextRef="c1" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c2" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">100,000,000</ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">26,487,680</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2021 and <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">42,000,000</ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">951,794</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">265</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">10</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Common stock warrants</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd">170,397</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additional paid-in capital</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">138,570,430</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">114,291,505</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">116,493,530</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">108,694,001</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">22,247,562</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">5,597,734</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">22,654,989</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">6,673,230</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><div><a id="b_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYNGN
INC. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Years ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Research and development</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">4,990,407</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">5,120,979</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">4,409,651</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">3,252,649</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">9,400,058</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">8,373,628</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">9,400,058</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">8,373,628</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other income, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest (expense) income</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="0" sign="-" unitRef="usd">9,580</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="0" unitRef="usd">39,841</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other (expense) income</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="usd">7,173</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" sign="-" unitRef="usd">5,020</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Paycheck Protection Program Note forgiveness</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PPPLoanForgiveness" scale="0" unitRef="usd">1,602,936</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total other income, net</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" unitRef="usd">1,600,529</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" unitRef="usd">34,821</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">7,799,529</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">8,338,807</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss per share attributable to common stockholders, basic and diluted</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">1.33</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">8.78</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares">5,861,730</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares">949,544</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><div><a id="b_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYNGN
INC. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Convertible<br/>
    Preferred Stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Common
    Stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt">Common<br/> Stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional<br/> Paid in</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt">Total Stockholders&#8217;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 20%; text-align: left"><span style="font-size: 8pt">Balance
    as of December&#160;31, 2019</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">21,982,491</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">220</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">949,086</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">10</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-14"><span style="font-size: 8pt">-</span></div></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">114,159,150</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">100,355,194</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">13,804,186</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Exercise of stock
    options</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">2,708</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-16"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-17"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">623</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-18"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">623</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Stock-based compensation</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-19"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" unitRef="usd">131,732</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-22"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" unitRef="usd">131,732</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Net
    loss</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-23"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-26"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd">8,338,807</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd">8,338,807</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Balance as of December&#160;31,
    2020</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c21" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">21,982,491</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">220</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">951,794</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">10</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-27"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">114,291,505</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">108,694,001</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">5,597,734</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Exercise of stock
    options</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">53,395</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">14,220</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">14,220</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Issuance of common stock in connection with initial public offering, net of closing costs of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">2,954,110</ix:nonFraction></span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares">3,500,000</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">35</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">23,295,855</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-34"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">23,295,890</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Conversion of convertible
    preferred stock to common stock in connection with initial public offering</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" sign="-" unitRef="shares">21,982,491</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="0" sign="-" unitRef="usd">220</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" unitRef="shares">21,982,491</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="0" unitRef="usd">220</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Stock-based compensation</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" unitRef="usd">1,139,247</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" unitRef="usd">1,139,247</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Issuance of warrants</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="0" unitRef="usd">170,397</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="0" sign="-" unitRef="usd">170,397</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43"><span style="font-size: 8pt">-</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Net
    loss</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd">7,799,529</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="0" sign="-" unitRef="usd">7,799,529</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Balance
    as of December&#160;30, 2021</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48"><span style="font-size: 8pt">-</span></div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c32" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">26,487,680</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">265</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">170,397</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">138,570,430</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">116,493,530</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">22,247,562</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><div><a id="b_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYNGN
INC. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif;  width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Years ended<br/>
December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">7,799,529</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">8,338,807</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">85,855</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">159,040</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="0" unitRef="usd">1,139,247</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="0" unitRef="usd">131,732</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain on disposal of asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="0" unitRef="usd">31,356</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain on forgiveness of Paycheck Protection Program Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:GainOnForgivenessOfPaycheckProtectionProgramLoans" scale="0" unitRef="usd">1,602,936</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd">476,452</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd">33,774</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd">39,255</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" sign="-" unitRef="usd">43,335</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" unitRef="usd">3,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" unitRef="usd">137,535</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">8,642,419</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">7,920,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="0" unitRef="usd">62,204</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Disposal of assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" scale="0" unitRef="usd">42,189</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">20,015</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Proceeds from issuance of common stock upon initial public offering, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd">23,295,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Proceeds from Paycheck Protection Program Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="usd">892,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="usd">695,078</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Proceeds from exercise of stock options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">14,220</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">623</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">24,202,225</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">695,701</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net increase/(decrease) in cash and cash equivalents and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" unitRef="usd">15,539,791</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">7,224,360</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents and restricted cash, beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">6,456,190</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">13,680,550</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents and restricted cash, end of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">21,995,981</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">6,456,190</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Supplemental disclosure of cash flow:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Cash paid during the year for taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="0" unitRef="usd">16,719</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="0" unitRef="usd">10,813</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Supplemental disclosure of non-cash financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">The Company&#8217;s Paycheck Protection Program Note was forgiven by the SBA in the amount of $<ix:nonFraction contextRef="c0" decimals="-9" format="ixt:num-dot-decimal" name="cyngn:PPPLoanWasForgivenByTheSBAInTheAmount" scale="9" unitRef="usd"><ix:nonFraction contextRef="c9" decimals="-9" format="ixt:num-dot-decimal" name="cyngn:PPPLoanWasForgivenByTheSBAInTheAmount" scale="9" unitRef="usd">1,602,936</ix:nonFraction></ix:nonFraction>.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="b_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYNGN
INC. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to Consolidated Financial Statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_1" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>1.
Description of Business</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_2" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Headquartered
in Menlo Park, California, CYNGN Inc., together with its subsidiaries (collectively, &#8220;Cyngn&#8221; or the &#8220;Company&#8221;),
was incorporated in Delaware in 2013. Cyngn Singapore PTE. LTD., a Singaporean limited company organized in 2015 and Cyngn Philippines,
Inc., a Philippine corporation incorporated in 2018 are wholly owned subsidiaries. The Company is in the process of dissolving
these subsidiaries.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_3" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Cyngn
develops autonomous driving software that can be deployed on multiple vehicle types in various environments. The Company has been
operating autonomous vehicles (&#8220;AV&#8221;) in production environments since 16 Built and tested in difficult and diverse
real-world environments, the self-driving system (DriveMod), fleet management system, and Software Development Kit combine to
create a full-stack advanced autonomy solution designed to be modular, extendable, and safe. The Company operates one business
segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_4" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Initial
Public Offering</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_5" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
October&#160;22, 2021, the Company closed the initial public offering (the &#8220;IPO&#8221;) of <ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">3,500,000</ix:nonFraction> shares of its authorized
common stock at an offering price of $<ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">7.50</ix:nonFraction> per share. Simultaneous with the closing of the IPO, the common stock began trading
on the NASDAQ Capital Market under the symbol &#8220;CYN.&#8221; The IPO generated net proceeds of $<ix:nonFraction contextRef="c37" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:NetProceeds" scale="6" unitRef="usd">23.3</ix:nonFraction> million after deducting
underwriting discounts, commissions and offering expenses. The Company also granted its underwriters the election to exercise
a 45-day over-allotment option to purchase an additional <ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PurchaseAnAdditionalSharesOfCommonStock" scale="0" unitRef="shares">525,000</ix:nonFraction> shares of common stock at the IPO offering price, less underwriting
discounts. The underwriters elected not to exercise the over-allotment option in whole or in part. No price stabilization activities
have been carried out since the IPO, and due to the stock&#8217;s share price performance, the underwriters have, as stabilizing
manager on behalf of the Company, decided to end the stock trading stabilization period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_6" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Simultaneous
with the closing of its IPO, the Company also issued <ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="cyngn:RedeemableWarrants" scale="0" unitRef="shares">140,000</ix:nonFraction> warrants (the &#8220;Warrant&#8221;) to its underwriters. Each Warrant
entitles its holder the option to purchase at a future exercise date, one share of common stock at an initial exercise price of
$<ix:nonFraction contextRef="c39" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">9.375</ix:nonFraction> per share, subject to certain adjustments and restrictions relating to subsequent resale and transfers. <ix:nonNumeric contextRef="c38" name="cyngn:PurchaseWarrantsDescription">The Purchase Warrants
are exercisable six (6) months after the IPO and expire five (5) years thereafter.</ix:nonNumeric></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_7" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">At
the completion of the IPO, all shares of the Company&#8217;s outstanding convertible preferred stock shares automatically converted
to shares of common stock (see Note 7. Capital Structure).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_8" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Immediately
after the IPO, the Company filed an amended and restated certificate of incorporation, which became effective on October&#160;22,
2021. The amended and restated certificate of incorporation authorized <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesAuthorized" scale="0" unitRef="shares">110,000,000</ix:nonFraction> shares consisting of <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CommonStockShares" scale="0" unitRef="shares">100,000,000</ix:nonFraction> shares of
common stock, at a par value of $<ix:nonFraction contextRef="c40" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreference" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction>, and <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PreferredStockShareIssued" scale="0" unitRef="shares">10,000,000</ix:nonFraction> shares of preferred stock at a par value of $<ix:nonFraction contextRef="c1" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockRedemptionPricePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction>. The rights of the
holders of common stock are subject to and qualified by rights of the holders of the preferred stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_9" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Additionally,
the Company recognized $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" unitRef="usd">1.1</ix:nonFraction> million of stock-based compensation expense related to stock options granted to employees with time-based
vesting conditions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_10" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Liquidity</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_11" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company has incurred losses from operations since inception. The Company incurred net losses of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" unitRef="usd">7.8</ix:nonFraction> million and $<ix:nonFraction contextRef="c9" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" unitRef="usd">8.3</ix:nonFraction> million
for the year ended December&#160;31, 2021 and 2020, respectively. Accumulated deficit amounted to $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAppropriated" scale="6" unitRef="usd">116.5</ix:nonFraction> million and $<ix:nonFraction contextRef="c2" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAppropriated" scale="6" unitRef="usd">108.7</ix:nonFraction> million
as of December&#160;31, 2021 and 2020, respectively. Net cash used in operating activities was $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="6" unitRef="usd">8.6</ix:nonFraction> million and $<ix:nonFraction contextRef="c9" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="6" unitRef="usd">7.9</ix:nonFraction> million for
the year ended December&#160;31, 2021 and 2020, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_12" id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company&#8217;s liquidity is based on its ability to enhance its operating cash flow position, obtain capital financing from equity
interest investors and obtain funds from outside sources of financing to fund its general operations, research and development
activities and capital expenditures. The Company&#8217;s ability to continue as a going concern is dependent on management&#8217;s
ability to successfully execute its business plan, which includes generating progressive revenue streams while controlling operating
costs and expenses, to then result in positive operating cash flows. The Company&#8217;s unrestricted balance of cash and cash
equivalents was $<ix:nonFraction contextRef="c41" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:UnrestrictedCashAndCashEquivalents" scale="6" unitRef="usd">21.9</ix:nonFraction> million and $<ix:nonFraction contextRef="c42" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:UnrestrictedCashAndCashEquivalents" scale="6" unitRef="usd">6.1</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Based
on cash flow projections from operating and financing activities and existing balances of cash and cash equivalents, management
is of the opinion that the Company has sufficient funds for sustainable operations and it will be able to meet its payment obligations
and commitments from operations for at least one year from the issuance date of this prospectus. Based on the above considerations,
the Company&#8217;s consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and liquidation of liabilities during the normal course of operations.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>2.
Summary of Significant Accounting Policies</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Basis
of Presentation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_2" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
accompanying consolidated financial statements as of and for the years ended December&#160;31, 2021 and 2020 have been prepared
in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to applicable
rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include
all normal adjustments necessary for a fair presentation of the Company&#8217;s financial position at December&#160;31, 2021 and
2020, and operating results and cash flows for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">These
consolidated financial statements should be read in conjunction with the following: i) audited consolidated financial statements
as of and for the years ended December&#160;31, 2020 and 2019; ii) the discussion under &#8220;Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations&#8221; and&#8217; iii) our final prospectus (the &#8220;Prospectus&#8221;),
filed with the Securities and Exchange Commission or the SEC, pursuant to Rule&#160;424(b) under the Securities Act of 1933, as
amended or the Securities Act), on October&#160;21, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Principles
of Consolidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
consolidated financial statements include the accounts of CYNGN Inc. and its wholly owned subsidiaries. Intercompany accounts
and transactions have been eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Foreign
Currency Translation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other
than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average
exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments
and transactional gains and losses are immaterial to the consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Use
of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These
estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company&#8217;s
significant estimates and judgments include but are not limited to underwriter&#8217;s warrants and share-based compensation.
Estimates are based on historical experience and on various other assumptions believed to be reasonable, the results of which
form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those
estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Concentration
of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents. The Company&#8217;s
cash is placed with high-credit-quality financial institutions and at times exceeds federally insured limits. The Company has
not experienced any credit loss relating to its cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationOfSupplierRiskPolicyTextBlock-c0_cont_1" escape="true" name="cyngn:ConcentrationOfSupplierRiskPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Concentration
of Supplier Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:continuation id="_ConcentrationOfSupplierRiskPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there
is any significant supplier concentration risk as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Cash
and Cash Equivalents and Restricted Cash</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:continuation continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_2" id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company considers all highly liquid money market placements with a remaining maturity of three months or less to be cash equivalents.
The Company had $<ix:nonFraction contextRef="c1" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:UnrestrictedCashAndCashEquivalents" scale="6" unitRef="usd">21.9</ix:nonFraction> million and $<ix:nonFraction contextRef="c2" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:UnrestrictedCashAndCashEquivalents" scale="6" unitRef="usd">6.1</ix:nonFraction> million of unrestricted cash and cash equivalents as of December&#160;31, 2021 and 2020,
respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:continuation continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_3" id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
addition, the Company had $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCash" scale="0" unitRef="usd">50,000</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCash" scale="0" unitRef="usd">400,000</ix:nonFraction> in restricted cash as of December&#160;31, 2021 and 2020, respectively, which is
reported separately as current assets on the consolidated balance sheet. The Company&#8217;s restricted cash consists of cash
not available for immediate use that the Company is obligated to maintain in accordance with the terms of its credit card spending
arrangement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:continuation continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_4" id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table provides a reconciliation of cash and cash equivalents and restricted cash to amounts shown in the consolidated
statements of cash flows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"><ix:continuation id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_4"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedInvestmentsCurrent" scale="0" unitRef="usd">21,945,981</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedInvestmentsCurrent" scale="0" unitRef="usd">6,056,190</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherRestrictedAssetsCurrent" scale="0" unitRef="usd">50,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherRestrictedAssetsCurrent" scale="0" unitRef="usd">400,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total Cash and cash equivalents and Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="0" unitRef="usd">21,995,981</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="0" unitRef="usd">6,456,190</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Fair
Value Measurements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
accounting guidance under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, <i>Fair Value Measurements</i>, defines
fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability
category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing
the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value
as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
1</i>&#8212;Unadjusted quoted prices in active markets for identical assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
2</i>&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially
the full term of the assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
3</i>&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value
of the assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Assets
and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair
value measurement of an instrument does not necessarily result in a change in the amount recorded on the consolidated balance
sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting
guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets
and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived
assets, intangible assets, share-based compensation and underwriter warrants measured at fair value upon initial recognition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
carrying amounts of the Company&#8217;s cash and cash equivalents, accounts payable and notes payable are reasonable estimates
of their fair values due to the short-term nature of these accounts. The fair values of the Company&#8217;s share-based compensation
and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent
external valuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Property
and Equipment</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Property
and equipment is stated at cost less accumulated depreciation. Repair and maintenance costs are expensed as incurred. Depreciation
is recorded on a straight-line basis over each asset&#8217;s estimated useful life.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:nonNumeric contextRef="c0" escape="true" name="cyngn:ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 77%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
    and Equipment</b></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="width: 22%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    life</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c44" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric> years</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c45" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric> years</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c46" name="cyngn:PropertyAndEquipmentUsefulLifeLeaseholdImprovements"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of 3 years or lease term</span></ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automobile</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c47" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric> years</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Leases</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company accounts for leases in accordance with ASC 842, <i>Leases</i>. All contracts are evaluated to determine whether or not
they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for
consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not
hold any finance leases. The Company has elected to adopt the short-term lease exemption in ASC 842 and as such has not recognized
a &#8220;right of use&#8221; asset or lease liability in the consolidated balance sheets as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Long-Lived
Assets and Finite Lived Intangibles</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company has finite lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line
basis over their estimated remaining economic lives. The patents and trademarks are amortized over <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric> years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company reviews its long-lived assets and finite lived intangibles for impairment whenever events or changes in circumstances
indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include
significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the
asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost
to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability
of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects
the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted
cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated.
An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Income
Taxes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized
for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_3" id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">A
valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
Due to the Company&#8217;s lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance
as of December&#160;31, 2021 and 2020 (see Note 11. Income Taxes).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There
are no uncertain tax positions that would require recognition in the financial statements. If the Company were to incur an income
tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income
tax would be reported as income taxes. Management&#8217;s conclusions regarding uncertain tax positions may be subject to review
and adjustment at a later date based upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof
as well as other factors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_40" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:nonNumeric contextRef="c0" continuedAt="_ConvertiblePreferredStockPolicyTextBlock-c0_cont_1" escape="true" name="cyngn:ConvertiblePreferredStockPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; "><b><i>Convertible
Preferred Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_41" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:continuation id="_ConvertiblePreferredStockPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; ">The
Company has applied the guidance in ASC 480-10-S99-3A, <i>SEC Staff Announcement: Classification and Measurement of Redeemable
Securities</i> and has classified all of its outstanding convertible preferred shares as permanent equity. The Company records
shares of convertible preferred stock at their respective issuance price, net of issuance costs. The Company&#8217;s convertible
preferred stock share&#8217;s redemption and conversion provisions are not exclusively at the option of the holder and are contingent
on certain deemed liquidation events within the Company&#8217;s control (see Note 7. Capital Structure).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_42" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:nonNumeric contextRef="c0" continuedAt="_DerivativesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Warrants</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_43" id="_SignificantAccountingPoliciesTextBlock-c0_cont_42"><ix:continuation continuedAt="_DerivativesPolicyTextBlock-c0_cont_2" id="_DerivativesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company issued to its lead underwriter in the Company&#8217;s IPO warrants to purchase up to <ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">140,000</ix:nonFraction> shares of the Company&#8217;s
common stock. The Company accounts for warrants in accordance with ASC 480, <i>Distinguishing Liabilities from Equity</i>. The
Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments
in consideration of the cashless settlement provisions in the warrant agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_44" id="_SignificantAccountingPoliciesTextBlock-c0_cont_43"><ix:continuation id="_DerivativesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company also applied the guidance in ASC 340-10-S99-1, <i>Other Assets and Deferred Costs</i>, that states specific incremental
costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against
the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance
of an equity contract and accordingly, classified the warrants as additional paid-in capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_45" id="_SignificantAccountingPoliciesTextBlock-c0_cont_44"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Stock-based
Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_46" id="_SignificantAccountingPoliciesTextBlock-c0_cont_45"><ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value
of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the
award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the
period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model,
which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest
rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense<b>)</b>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_47" id="_SignificantAccountingPoliciesTextBlock-c0_cont_46"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Net
Loss Per Share Attributable to Ordinary Shareholders</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_48" id="_SignificantAccountingPoliciesTextBlock-c0_cont_47"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company computes loss per share attributable to ordinary shareholders by dividing net loss attributable to ordinary shareholders
by the weighted-average number of ordinary shares outstanding. Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share,
the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to
include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable
to Common Stockholders).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_49" id="_SignificantAccountingPoliciesTextBlock-c0_cont_48"><ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Research
and Development Expense</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_50" id="_SignificantAccountingPoliciesTextBlock-c0_cont_49"><ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Research
and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials,
labor and stock-based compensation related to development of the Company&#8217;s products and services. Research and development
costs are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_51" id="_SignificantAccountingPoliciesTextBlock-c0_cont_50"><ix:nonNumeric contextRef="c0" continuedAt="_SellingGeneralAndAdministrativeExpensesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Selling,
General, and Administrative Expense</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_52" id="_SignificantAccountingPoliciesTextBlock-c0_cont_51"><ix:continuation id="_SellingGeneralAndAdministrativeExpensesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Selling,
general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization,
travel, and advertising costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_53" id="_SignificantAccountingPoliciesTextBlock-c0_cont_52"><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Commitments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_54" id="_SignificantAccountingPoliciesTextBlock-c0_cont_53"><ix:continuation id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and
the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than
any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than
any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company
as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_55" id="_SignificantAccountingPoliciesTextBlock-c0_cont_54"><ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; "><b><i>Segment
Reporting</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_56" id="_SignificantAccountingPoliciesTextBlock-c0_cont_55"><ix:continuation id="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; ">The
Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages operations and business as one operating
segment for the purposes of allocating resources, makes operating decisions and evaluates financial performance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_57" id="_SignificantAccountingPoliciesTextBlock-c0_cont_56"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Revenue
Recognition</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_58" id="_SignificantAccountingPoliciesTextBlock-c0_cont_57"><ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
January&#160;1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts
with Customers </i>(&#8220;Topic 606&#8221;) and recognizes revenue upon the transfer of goods or services in an amount that reflects
the expected consideration received in exchange for those goods or services. The Company has not generated any revenue for the
years ended December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_59" id="_SignificantAccountingPoliciesTextBlock-c0_cont_58"><ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Recent
Accounting Pronouncements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_59"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There
were no significant updates to the recently issued accounting standards. Although there are several other new accounting standards
issued or proposed by the Financial Accounting Standards Board (&#8220;FASB&#8221;), the Company does not believe any of those
accounting standards have had or will have a material impact on its financial position or operating results.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_1" escape="true" name="cyngn:BalanceSheetComponentsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>3.
Balance Sheet Components</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_2" id="_BalanceSheetComponentsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Property
and Equipment, Net</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_3" id="_BalanceSheetComponentsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Property
and equipment is comprised of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_4" id="_BalanceSheetComponentsTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Automobiles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:Automobiles" scale="0" unitRef="usd">279,617</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cyngn:Automobiles" scale="0" unitRef="usd">325,406</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FurnitureAndFixturesGross" scale="0" unitRef="usd">133,102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FurnitureAndFixturesGross" scale="0" unitRef="usd">125,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Computer and Equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentOther" scale="0" unitRef="usd">76,048</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentOther" scale="0" unitRef="usd">26,157</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd">488,767</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd">476,563</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd">385,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd">342,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">102,787</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">133,805</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_5" id="_BalanceSheetComponentsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Depreciation
expense for the year ended December&#160;31, 2021 and 2020 was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="0" unitRef="usd">82,389</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="0" unitRef="usd">88,170</ix:nonFraction>, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_6" id="_BalanceSheetComponentsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Accrued
Expenses and Other Current Liabilities</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_7" id="_BalanceSheetComponentsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Accrued
expenses and other current liabilities are comprised of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_8" id="_BalanceSheetComponentsTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CreditCardPayable" scale="0" unitRef="usd">11,678</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CreditCardPayable" scale="0" unitRef="usd">37,455</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" unitRef="usd">82,478</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" unitRef="usd">175,761</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedPayrollTaxesCurrent" scale="0" unitRef="usd">201,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedPayrollTaxesCurrent" scale="0" unitRef="usd">94,186</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="0" unitRef="usd">295,156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" scale="0" unitRef="usd">307,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BalanceSheetComponentsTextBlock-c0_cont_9" id="_BalanceSheetComponentsTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
March&#160;27, 2020, the United States Congress passed the Coronavirus, Aid, Relief and Economic Security Act (the &#8220;CARES
Act&#8221;) in response to the economic impact of the coronavirus (&#8220;COVID-19&#8221;) pandemic in the United States (see
Note 13. Risks and Uncertainties). Section&#160;2302 of the CARES Act allowed employers to defer the remittance and payment of
the employer&#8217;s share of social security taxes that were otherwise required to be remitted between March&#160;27 and December&#160;31,
2020, and to pay the deferred taxes in two installments &#8212; with the first half due on December&#160;31, 2021, and the remainder
by December&#160;31, 2022. As of December&#160;31, 2021, the Company remitted $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd">67,958</ix:nonFraction> in social security taxes due that were deferred
between May&#160;1 and December&#160;31, 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_BalanceSheetComponentsTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Section&#160;2301
of the CARES Act also provided refundable employee retention credits (the &#8220;ERC&#8221;) against certain employment taxes.
The Company is currently evaluating its eligibility to claim the ERC and the impact of the credits on its consolidated statement
of operations.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>4.
Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_2" id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company leases its office space under a recurring lease agreement which expired in February&#160;2022 and was subsequently renewed
and amended (see Note 14. Subsequent Events). Monthly payments are approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd">15,500</ix:nonFraction> while future minimum payments under the
primary terms of the lease in effect at December&#160;31, 2021 are approximately $<ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd">31,000</ix:nonFraction> in 2022 until the expiration of the lease
in February&#160;2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Rent
expense for the year ended December&#160;31, 2021 and 2020 was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:RentExpense" scale="0" unitRef="usd">236,476</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cyngn:RentExpense" scale="0" unitRef="usd">229,019</ix:nonFraction>, respectively.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>5.
Intangible Assets, Net</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_2" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_3" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of December&#160;31, 2021</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated<br/>
    Amortization</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd">7,000</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" sign="-" unitRef="usd">4,083</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd">2,917</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd">45,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" sign="-" unitRef="usd">17,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd">28,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible
    assets</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd">52,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" sign="-" unitRef="usd">21,083</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd">30,917</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_4" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_3"><ix:continuation id="_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of December&#160;31, 2020</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated<br/>
    Amortization</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/>
Carrying<br/>
Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd">7,000</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" sign="-" unitRef="usd">3,617</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd">3,383</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd">45,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" sign="-" unitRef="usd">14,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd">31,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible
    assets</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd">52,000</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" sign="-" unitRef="usd">17,617</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd">34,383</ix:nonFraction></span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_5" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Amortization
expense for each of the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentForAmortization" scale="0" unitRef="usd"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentForAmortization" scale="0" unitRef="usd">3,466</ix:nonFraction></ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_6" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Estimated
amortization expense for all intangible assets subject to amortization in future years is expected to be:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IntangibleAssetsDisclosureTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Years ended December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" scale="0" unitRef="usd">3,467</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="0" unitRef="usd">3,467</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="0" unitRef="usd">3,467</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="0" unitRef="usd">3,467</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" scale="0" unitRef="usd">17,049</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="0" unitRef="usd">30,917</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DebtDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>6.
Debt</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_2" id="_DebtDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Paycheck
Protection Program Notes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_3" id="_DebtDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
April&#160;2020, the Company entered into a Note with JPMorgan Chase (the &#8220;Lender&#8221;) under the U.S. Small Business
Administration (&#8220;SBA&#8221;) Paycheck Protection Program (&#8220;PPP&#8221;) established under Section&#160;1102 of the
CARES Act, pursuant to which the Company borrowed $<ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherBorrowings" scale="0" unitRef="usd">695,078</ix:nonFraction> (the &#8220;Note&#8221;). The Note accrues interest at a rate of <ix:nonFraction contextRef="c54" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">0.98</ix:nonFraction>%
per annum and matures in <ix:nonNumeric contextRef="c55" format="ixt-sec:durmonth" name="cyngn:MaturityDate">24</ix:nonNumeric> months from the date of the Note. The Note may be repaid at any time with no prepayment penalty. All
of the funds received under the PPP had been used for qualified purposes. The Company applied for forgiveness of the Note in accordance
with PPP guidelines, and in October, 2021, received approval of the forgiveness application.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_4" id="_DebtDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
February&#160;2021, the Company entered into a second Note (the &#8220;PPP2 Note&#8221;) with the Lender, pursuant to which the
Lender agreed to make a loan to the Company under the PPP offered by the SBA in a principal amount of $<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd">892,115</ix:nonFraction> pursuant to Title
1 of the CARES Act. The PPP2 Note matures in <ix:nonNumeric contextRef="c57" format="ixt-sec:durwordsen" name="cyngn:MaturityDate">five years</ix:nonNumeric> with interest accruing at <ix:nonFraction contextRef="c57" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" unitRef="pure">0.98</ix:nonFraction>% per annum. Proceeds of the PPP2 Note are
available to be used to pay for payroll costs, including salaries, commissions, and similar compensation, group health care benefits,
and paid leaves; rent; utilities; and interest on certain other outstanding debt. All of the funds received under the PPP2 Note
were used for qualified purposes during 2021. The Company applied for forgiveness of the PPP2 Note in accordance with PPP guidelines,
and in November, 2021, received approval of the forgiveness application.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DebtDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
PPP and PPP2 Notes that were forgiven by the SBA were recognized as gains and included in &#8216;Other income&#8217; or the non-operating
section of the Company&#8217;s consolidated statements of operations.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:PartnersCapitalNotesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>7.
Capital Structure</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_2" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Common
Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_3" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the Company is authorized to issue <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CommonStockShareAuthorized" scale="0" unitRef="shares">100,000,000</ix:nonFraction> shares with a par value of $<ix:nonFraction contextRef="c1" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction> per share. As of
December&#160;31, 2020, the Company was authorized to issue <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CommonStockShareAuthorized" scale="0" unitRef="shares">42,000,000</ix:nonFraction> shares of Common Stock with a par value of $<ix:nonFraction contextRef="c2" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction> per
share. As of December&#160;31, 2021 and December&#160;31, 2020, the Company had <ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares">26,487,680</ix:nonFraction> and <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">951,794</ix:nonFraction> shares of Common Stock
issued and outstanding, respectively. Holders of common stock have no preemptive, conversion or subscription rights and there
is no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders
of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred
stock that the Company may designate in the future.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_4" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Convertible
Preferred Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_5" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
October&#160;2021, the Company amended its Certificate of Incorporation and revised the number of preferred stock shares authorized
for issuance to <ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">10,000,000</ix:nonFraction> shares at a par value of $<ix:nonFraction contextRef="c58" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction>. As of December&#160;31, 2021, there were no shares issued and outstanding
against these shares. As of December&#160;31, 2020 and prior to the completion of the IPO, the Company was authorized to issue
up to <ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">21,982,491</ix:nonFraction> shares of preferred stock at a par value of $<ix:nonFraction contextRef="c59" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.00001</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_6" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Conversion</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_7" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company&#8217;s convertible preferred stock shares that were outstanding at the completion of the IPO on October&#160;20, 2021
automatically converted to shares of common stock on a 1:1 basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_8" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences prior to the IPO were
as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_9" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_8"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfConversionsOfStockTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Series</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Issued and<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share<br/> Liquidation<br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Liquidation<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Proceeds</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Series A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" unitRef="shares">10,157,843</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:SeriesASharesIssuedAndOutstanding" scale="0" unitRef="shares">10,157,843</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreference" scale="0" unitRef="usdPershares">0.6842</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" scale="0" unitRef="usd">6,949,996</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="0" unitRef="usd">6,949,996</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Series B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" unitRef="shares">6,567,670</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:SeriesASharesIssuedAndOutstanding" scale="0" unitRef="shares">6,567,670</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreference" scale="0" unitRef="usdPershares">3.3939</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" scale="0" unitRef="usd">22,290,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="0" unitRef="usd">22,290,015</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Series C</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" unitRef="shares">5,256,978</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:SeriesASharesIssuedAndOutstanding" scale="0" unitRef="shares">5,256,978</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreference" scale="0" unitRef="usdPershares">15.7933</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c62" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" scale="0" unitRef="usd">83,025,031</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="0" unitRef="usd">83,025,031</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" unitRef="shares">21,982,491</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:SeriesASharesIssuedAndOutstanding" scale="0" unitRef="shares">21,982,491</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockAmountOfPreferredDividendsInArrears" scale="0" unitRef="usd">112,265,042</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="0" unitRef="usd">112,265,042</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_10" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Warrants</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_11" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the fair value of the warrants was estimated using the Black-Scholes option-pricing model. The Company
used the following assumptions in the model:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_12" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c63" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">2.88</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c64" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">51.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c64" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.0</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c64" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">1.13</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_13" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Dividends</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_14" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
holders of preferred stock are entitled to receive dividends, when and if declared by the Company&#8217;s Board of Directors,
out of any legally available funds. The holders of preferred stock are entitled to receive dividends, prior and in preference
to dividends declared on common stock, at the rate of: Series A - $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableAmountPerShare" scale="0" unitRef="usdPershares">0.0411</ix:nonFraction> per share per annum; Series B - $<ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableAmountPerShare" scale="0" unitRef="usdPershares">0.2036</ix:nonFraction> per share per
annum; and Series C - $<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableAmountPerShare" scale="0" unitRef="usdPershares">0.9476</ix:nonFraction> per share per annum. Dividends are non-cumulative and will be paid pro rata, on an equal priority,
pari passu basis. After payment of preferred stock dividends, any additional dividends will be paid ratably among holders of common
stock and preferred stock on an as converted to Common Stock basis. As of December&#160;31, 2021 and 2020, respectively, no dividends
have been declared.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_15" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Voting</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_16" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
holder of each share of Preferred Stock is entitled to voting rights equal to the number of shares of common stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_17" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Preferred
stockholders shall cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred
Stock held by such holder are convertible. So long as any shares of Series A Preferred Stock remain outstanding, the holders of
the Series A Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. So long as any shares
of Series B Preferred Stock remain outstanding, the holders of the Series B Preferred Stock, voting as a separate class, are entitled
to elect one director of the Company. So long as any shares of Series C Preferred Stock remain outstanding, the holders of the
Series C Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. The holders of Common
Stock, voting as a separate class, are entitled to elect two directors of the Company. The holders of Preferred Stock and Common
Stock, on an as converted to basis, are entitled to elect any remaining members to the Board of Directors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_18" id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Liquidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_PartnersCapitalNotesDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of preferred
stock on a pari passu basis, are entitled to receive, prior to and in preference over holders of common stock, an amount equal
to the original issuance price&#8212;Series A - $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">0.6842</ix:nonFraction> per share; Series B - $<ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">3.3939</ix:nonFraction> per share; and Series C - $<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">15.7933</ix:nonFraction> per share.
2) If the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of the
shares of Preferred Stock the full amount to which they are entitled, the holders of shares of Preferred Stock shall share ratably
in any distribution of the assets available for distribution in proportion to the respective amount which would otherwise be payable
in respect to the share of Preferred Stock held by them upon such distribution if all amounts payable on or with respect to such
shares were paid in full.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerShareTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>8.
Net Loss Per Share Attributable to Common Stockholders</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_2" id="_EarningsPerShareTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table summarizes the computation of basic and diluted loss per share:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_3" id="_EarningsPerShareTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" sign="-" unitRef="usd">7,799,529</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" sign="-" unitRef="usd">8,338,807</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Basic and diluted weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">5,861,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">949,544</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">1.33</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">8.78</ix:nonFraction></td><td style="text-align: left">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_4" id="_EarningsPerShareTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Basic
loss per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted loss
per share would include the effect of unvested restricted stock awards and the convertible preferred Stock; however, such items
were not considered in the calculation of the diluted weighted average common shares outstanding since they would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_5" id="_EarningsPerShareTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Potentially
dilutive securities excluded from the calculation of diluted shares outstanding are shown below:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_EarningsPerShareTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="cyngn:ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year ended<br/> December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Unvested restricted shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" unitRef="shares">3,123,931</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" unitRef="shares">10,652,680</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Common shares issuable upon conversion of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" scale="0" unitRef="shares">21,982,491</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:EarningsPerShareTotal" scale="0" unitRef="shares">3,123,931</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:EarningsPerShareTotal" scale="0" unitRef="shares">32,635,171</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>9.
Stock-based Compensation Expense</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Stock-Based
Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company measures employee and director stock-based compensation awards based on the award&#8217;s estimated fair value on the
date of grant. Expense associated with these awards is recognized using the straight-line attribution method over the requisite
service period for stock options, and is reported in our consolidated statements of comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_4" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
fair value of our stock options is estimated, using the Black-Scholes option-pricing model. The resulting fair value is recognized
on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The
Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual
term of ten years. Vesting terminates at the end of the employment relationship.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_5" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Determining
the grant date fair value of options requires management to make assumptions and judgments. These estimates involve inherent uncertainties
and if different assumptions had been used, stock-based compensation expense could have been materially different from the amounts
recorded.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_6" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
assumptions and estimates for valuing stock options are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_7" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
    value per share of Company&#8217;s common stock.</i> The fair value of the Company&#8217;s stock options with service conditions
    is measured on the following basis according to when the stock options were granted: i) stock options granted prior to the
    IPO: due to the absence of a public market for Cyngn&#8217;s common stock prior to the IPO, our Board of Directors, with the
    assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock
    options by considering a number of objective and subjective factors, including our actual operating and financial performance,
    market conditions and performance of comparable publicly traded companies, developments and milestones in the company, and
    the likelihood of achieving a liquidity event among other factors; ii) stock options granted after the IPO: the closing fair
    market value of its common stock at the time of the grant.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>
</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_8" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
    volatility. </i>The Company determines the expected volatility based on historical average volatilities of similar publicly
    traded companies corresponding to the expected term of the stock options.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_9" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
    term. </i>The Company does not have sufficient historical data relating to its common stock nor to its stock-option exercises.
    As such, the Company determines the expected term of awards which contain only service conditions using the simplified approach,
    wherein the expected term of an award is presumed to be the mid-point between the vesting date and the expiration date of
    the award.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_10" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk-free
    interest rate.</i> The risk-free interest rate is based on the U.S. Treasury yield curve with maturities that approximate
    the expected term of the stock options.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_11" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Estimated
    dividend yield.</i> The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in
    the foreseeable future.</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_12" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Equity
Incentive Plans</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_13" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
February&#160;2013, the Board of Directors adopted the 2013 Equity Incentive Plan (&#8220;2013 Plan&#8221;). The 2013 Plan authorizes
the award of stock options, stock appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards,
and other stock or cash awards.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_14" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
October&#160;2021, our Board of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). Our
2021 Plan replaces our 2013 Plan. However, awards outstanding under our 2013 Plan will continue to be governed by their existing
terms.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_15" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021 and 2020, approximately <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CommonStockSharesIssurance" scale="0" unitRef="shares">10,502,696</ix:nonFraction> and <ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CommonStockSharesIssurance" scale="0" unitRef="shares">9,830,005</ix:nonFraction> shares of common stock were reserved and available
for issuance under the 2021 Plan and 2013 Plan, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_16" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Options
issued under the Plan generally vest based on continuous service provided by the option holder over a four-year period. Compensation
expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at
the grant date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_17" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table sets forth the summary of options activity for the year ended December&#160;31, 2021 and 2020:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_18" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_17"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/>
average<br/>
exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/>
    average<br/> remaining<br/> contractual<br/> term (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> intrinsic<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Outstanding as of December&#160;31, 2020</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">6,971,301</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.20</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.0</ix:nonNumeric></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" scale="0" unitRef="usd">1,399,827</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and expected to vest at December&#160;31, 2020</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" unitRef="shares">10,892,738</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="cyngn:ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" scale="0" unitRef="usdPershares">0.54</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">7.0</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="0" unitRef="usd">5,860,120</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and exercisable at December&#160;31, 2020</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">5,978,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.20</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.03</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" unitRef="usd">406,094</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">2,926,473</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cyngn:WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" scale="0" unitRef="usdPershares">3.20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:StocksIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">41,416</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" scale="0" unitRef="usdPershares">0.23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">109,902</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares">1,086,664</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" scale="0" unitRef="usdPershares">0.20</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Outstanding as of December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">8,769,694</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.20</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="cyngn:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">7.15</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" scale="0" unitRef="usd">15,746,916</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and expected to vest at December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" unitRef="shares">8,769,694</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="cyngn:ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" scale="0" unitRef="usdPershares">1.20</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares">7.15</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="0" unitRef="usd">15,746,916</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and exercisable at December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">5,645,763</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.27</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt">5.94</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" unitRef="usd">14,967,973</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_19" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
fair value of a stock option is estimated using an option-pricing model that takes into account as of the grant date the exercise
price and expected life of the option, the current price of the underlying stock and its expected volatility, expected dividends
on the stock, and the risk-free interest rate for the expected term of the option. The Company has used the simplified method
in calculating the expected term of all option grants based on the vesting period and contractual term. Compensation costs related
to share-based payment transactions are recognized in the financial statements upon satisfaction of the requisite service or vesting
requirements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_20" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
weighted average per share grant-date fair value of options granted during the years ended December&#160;31, 2021 and 2020 was
$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cyngn:FairValueOfOptionsGranted" scale="0" unitRef="usd">2.78</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="cyngn:FairValueOfOptionsGranted" scale="0" unitRef="usd">0.07</ix:nonFraction> respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_21" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following weighted average assumptions were used in estimating the grant date fair values in December&#160;31, 2021 and 2020:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_22" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_21"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Fair value of common stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd">2.78</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd">0.23</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.15</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c9" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.00</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">0.95</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">0.68</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">51.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">29.34</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_23" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For
the year ended December&#160;31, 2021 and 2020, the Company recorded stock-based compensation expense from stock options of approximately
$<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockbasedCompensationExpenseOfStockOptions" scale="0" unitRef="usd">1,139,247</ix:nonFraction> and $<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockbasedCompensationExpenseOfStockOptions" scale="0" unitRef="usd">131,732</ix:nonFraction>, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, total unrecognized stock-based compensation cost related to outstanding unvested stock options that
are expected to vest was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockOptionsExpectedVest" scale="0" unitRef="usd">7,031,949</ix:nonFraction>. This unrecognized stock-based compensation cost is expected to be recognized over a weighted-average
period of approximately <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod">4.6</ix:nonNumeric> years. Income tax benefits recognized from stock-based compensation expense recognized for the year
ended December&#160;31, 2021 were immaterial due to cumulative losses and valuation allowances.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RetirementSavingsPlanTextBlock-c0_cont_1" escape="true" name="cyngn:RetirementSavingsPlanTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>10.
Retirement Savings Plan</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_RetirementSavingsPlanTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Effective
November&#160;17, 2017, the Company established the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees
and their beneficiaries with the intention to provide a measure of retirement security for the future. This plan is subject to
the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and qualifies under Section&#160;401(k) of the Internal
Revenue Code. Cyngn Inc. did not offer and has not provided a company match for its 401(k) Plan.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>11.
Income Taxes</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For
the years ended December&#160;31, 2021 and 2020, the Company recorded income tax expense of $<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">800</ix:nonFraction></ix:nonFraction>. The effective tax rate is <ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="pure">0</ix:nonFraction></ix:nonFraction>%
for the years ended December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_3" id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For
financial reporting purposes, the Company&#8217;s effective tax rate used for the interim periods is based on the estimated full-year
income tax rate. Income tax expense differed from the amount computed by applying the federal statutory income tax rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">21</ix:nonFraction>%
to pretax income for the year ended December&#160;31, 2021 as a result of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_4" id="_IncomeTaxDisclosureTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Federal tax at statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="0" sign="-" unitRef="usd">1,635,786</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" sign="-" unitRef="usd">543,984</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Nondeductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="0" sign="-" unitRef="usd">308,449</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Research and development credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="0" unitRef="usd">897,331</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">FIN 48 reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Foreign Tax Rate Difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="0" unitRef="usd">1,779</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" unitRef="usd">150,330</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">True-up and Rate Change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsTrueup" scale="0" unitRef="usd">26,751</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">3,207,490</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:FederalStatutoryIncomeTaxRateTotal" scale="0" unitRef="usd">800</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_5" id="_IncomeTaxDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
tax effects of temporary differences that give rise to significant portions of the Company&#8217;s deferred tax assets and liabilities
as of December&#160;31, 2021 and 2020 related to the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_6" id="_IncomeTaxDisclosureTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Intangibles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="0" unitRef="usd">1,772,704</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="0" unitRef="usd">2,299,275</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net operating losses and Credit carryover</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd">32,425,152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd">28,834,590</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" unitRef="usd">168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" unitRef="usd">168</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="0" unitRef="usd">89,979</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="0" unitRef="usd">101,694</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">SBC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsSBC" scale="0" unitRef="usd">243,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsSBC" scale="0" unitRef="usd">90,726</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Accruals And Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="0" unitRef="usd">40,005</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="0" unitRef="usd">38,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Gross deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="usd">34,571,977</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="usd">31,364,488</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">34,571,977</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">31,364,488</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in">Total deferred tax assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Deferred Commissions</td><td>&#160;</td>
    <td style="text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="text-align: right; border-bottom: Black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="text-align: right; border-bottom: Black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in">Total deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.375in; text-indent: -0.125in">Net deferred tax assets:</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_7" id="_IncomeTaxDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Management
regularly assesses the ability to realize deferred tax assets recorded based upon the weight of available evidence, including
such factors as recent earnings history and expected future taxable income on a jurisdiction by jurisdiction basis. In the event
that the Company changes its determination as to the amount of realizable deferred tax assets, the Company will adjust its valuation
allowance with a corresponding charge to the provision for income taxes in the period in which such determination is made. The
Company&#8217;s management believes that, based on a number of factors, it is more likely than not, that all or some portion of
the deferred tax assets will not be realized; and accordingly, for the years ending December&#160;31, 2021 and December&#160;31,
2020, the Company has provided a valuation allowance against the Company&#8217;s U.S. net deferred tax assets. The net change
in the valuation allowance for the year ended December&#160;31, 2021 was an increase of $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetNetCurrent" scale="0" unitRef="usd">3,207,490</ix:nonFraction>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_8" id="_IncomeTaxDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the Company had net operating loss carryforwards for federal and state income tax purposes of approximately
$<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="0" unitRef="usd">100,697,360</ix:nonFraction> and $<ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" unitRef="usd">101,454,126</ix:nonFraction>, respectively, which will both begin to expire in <span style="-sec-ix-hidden: hidden-fact-68">2034</span> with $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="0" unitRef="usd">65,360,163</ix:nonFraction> of our federal net operating
loss carryforward lasting indefinitely.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_9" id="_IncomeTaxDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the Company had federal and state research credit carryforwards of approximately $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="0" unitRef="usd">4,258,776</ix:nonFraction> and $<ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="0" unitRef="usd">2,192,429</ix:nonFraction>,
respectively. The federal research credit carryforwards will begin to expire in <span style="-sec-ix-hidden: hidden-fact-69">2023</span> while the California research credits carry
forward have an indefinite life.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_10" id="_IncomeTaxDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of net operating losses in the event of an
&#8220;ownership change&#8221; of a corporation. Accordingly, a company&#8217;s ability to use net operating losses may be limited
as prescribed under Internal Revenue Code Section&#160;382 (&#8220;IRC Section&#160;382&#8221;). Events which may cause limitations
in the amount of the net operating losses that the Company may use in any <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="cyngn:NetOperatingLosses">one year</ix:nonNumeric> include, but are not limited to, a cumulative
ownership change of more than <ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">50</ix:nonFraction>% over a three-year period. Utilization of the federal and state net operating losses may be subject
to substantial annual limitation due to the ownership change limitations provided by the IRC Section&#160;382 and similar state
provisions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_11" id="_IncomeTaxDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, and 2020, the total amount of gross unrecognized tax benefits was $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" unitRef="usd">1,797,238</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="0" unitRef="usd">1,412,668</ix:nonFraction>, respectively,
including no interest and penalties. As of December&#160;31, 2021, $<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="cyngn:TotalUnrecognizedTaxBenefit" scale="0" unitRef="shares">1,797,238</ix:nonFraction> of the total unrecognized tax benefits, if recognized,
would have an impact on the Company&#8217;s effective tax rate. The Company estimates that there will be no material changes in
its uncertain tax positions in the next <ix:nonNumeric contextRef="c0" format="ixt-sec:durmonth" name="cyngn:TaxPositionTerm">12</ix:nonNumeric> months. In accordance with FASB ASC 740, the Company has adopted the accounting policy
that interest and penalties recognized are classified as part of its income taxes. Total interest and penalties recognized in
the consolidated statement of operations was zero for 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company files income tax returns in the US federal and various state jurisdictions. The Company&#8217;s tax years for 2018 and
forward are subject to examination by the US tax authorities. The Company&#8217;s tax years for 2017 and forward are subject to
examination by various state tax authorities. However, due to the fact that the Company had loss and credits carried forward in
some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant taxing
authority through an adjustment to tax attributes carried forward to open years. The Company files U.S. and foreign income tax
returns with varying statutes of limitations. Due to the Company&#8217;s net carryover of unused operating losses, all years remain
subject to future examination by tax authorities.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>12.
Commitments and Contingencies</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Legal
Proceedings</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company is subject to legal and regulatory actions that arise from time to time. The assessment as to whether a loss is probable
or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment
about future events, and the outcome of litigation is inherently uncertain. There is no material pending or threatened litigation
against the Company that remains outstanding as of December&#160;31, 2021 and 2020.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>13.
Risks and Uncertainties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_ConcentrationRiskDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">COVID-19.
A novel strain of coronavirus (COVID-19) was first identified in December&#160;2019, and subsequently declared a pandemic by the
World Health Organization. While Cyngn&#8217;s business has experienced limited disruption due to this pandemic, our leadership
team continues to focus on the highest level of safety measures to protect our employees. The Company is aware COVID-19 continues
to present significant uncertainty in the future economic outlook for our customers and the markets we serve.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>14.
Subsequent Events</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
February&#160;17, 2022, the Company amended the lease agreement (the &#8220;Lease Amendment&#8221;). <ix:nonNumeric contextRef="c68" name="us-gaap:SubsequentEventDescription">The Lease Amendment extended
the current lease for an additional 18 months, which commenced on March&#160;1, 2022, and expanded the leased space to a total
of 23,311 square feet from the previous 6,886 square feet.</ix:nonNumeric></span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&#160;</div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II &#8212; INFORMATION NOT REQUIRED IN PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;13.
<i>Other Expenses of Issuance and Distribution.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all expenses to be paid by the registrant in connection with the issuance and distribution of the securities
to be registered, other than underwriting discounts and commissions. All amounts shown are estimates except for the SEC registration
fee:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: -9pt; padding-left: 9pt">SEC registration fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5.011.78</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Legal fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -9pt; padding-left: 9pt">Accounting fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Miscellaneous fees and expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">135,011.78</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;14.
<i>Indemnification of Directors and Officers.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
Agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October&#160;29, 2021, the Board of Directors entered into indemnification agreements with each of its directors and executive
officers (the &#8220;D&amp;O Indemnification Agreements&#8221;). The D&amp;O Indemnification Agreements provide that the Corporation
will indemnify each of its directors, executive officers, and such other key employees against any and all expenses incurred by
that director or executive officer because of his or her status as one of the Corporation&#8217;s directors or executive officers,
to the fullest extent permitted by Delaware law and the Corporation&#8217;s amended and restated certificate of incorporation.
In addition, the D&amp;O Indemnification Agreements provide that, to the fullest extent permitted by Delaware law, the Corporation
will advance all expenses incurred by its directors, executive officers, and other key employees in connection with a legal proceeding
involving his or her status as a director, executive officer, or key employee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
of Liability and Indemnification of Officers and Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, as amended and restated, limits the liability of directors to the maximum extent permitted by Delaware
General Corporation Law (the &#8220;DGCL&#8221;). The DGCL provides that directors of a corporation will not be personally liable
for monetary damages for breach of their fiduciary duties as directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we will indemnify our directors and officers to the fullest extent permitted by law, and may indemnify employees
and other agents. Our bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance
of the final disposition of any action or proceeding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws, subject to the provisions of the DGCL contain provisions which allow the corporation to indemnify any person against liabilities
and other expenses incurred as the result of defending or administering any pending or anticipated legal issue in connection with
service to us if it is determined that person acted in good faith and in a manner which he or she reasonably believed was in the
best interest of the corporation. Insofar as indemnification for liabilities arising under the Securities Act of 1933 as amended,
or the Securities Act, may be permitted to our directors, officers and controlling persons, we have been advised that in the opinion
of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of liability and indemnification provisions in our bylaws may discourage stockholders from bringing a lawsuit against
directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors
and officers, even though an action, if successful, might provide a benefit to us and our stockholders. Our results of operations
and financial condition may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers
pursuant to these indemnification provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is
required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>



</div><!-- Field: Page; Sequence: 109; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;15.
<i>Recent Sales of Unregistered Securities.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span>On
April&#160;28, 2022 pursuant to a securities purchase agreement with several institutional and accredited investors pursuant to which
we sold an aggregate of (i) 3,790,322 shares of common stock, (ii) pre-funded warrants to purchase up to an aggregate of 2,661,291 shares
of common stock, and (iii) warrants to purchase up to an aggregate of 6,451,613 shares of common stock for gross proceeds to the Company
of approximately $20,000,000. The combined purchase price for one share of common stock and a warrant to purchase one share of common
stock is $3.10 and the combined purchase price for one pre-funded warrant to purchase one share of common stock and a warrant to purchase
one share of common stock is $3.099 (see Private Placement of Shares of Common Stock, Warrants and Pre-Funded Warrants).</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;16.
Exhibits and Financial Statement Schedules.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 9%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-1_cyngninc.htm">Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.1 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-2_cyngninc.htm">Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.2 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-3_cyngninc.htm">Second Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.3 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-4_cyngninc.htm">Third Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.4 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-5_cyngninc.htm">Fourth Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.5 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021060692/f10q0921ex3-6_cyngninc.htm">Fifth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.6 to the Company&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on November&#160;19, 2021.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021050661/fs12021a1ex3-8_cyngninc.htm">Amended and Restated Bylaws of Registrant, incorporated by reference to Exhibit 3.8 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022014911/f10k2021ex4-1_cyngninc.htm">Description of Registrant&#8217;s Securities incorporated by reference to Exhibit 4.1 to the Company&#8217;s Annual Report on Form&#160;10-K filed with the SEC on March&#160;24, 2022</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><a href="ea159355ex5-1_cyngninc.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Sichenzia Ross Ference LLP</span></a></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-1_cyngninc.htm">Offer Letter between the Company and Lior Tal dated April&#160;17, 2016 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-2_cyngninc.htm">Offer Letter between the Company and Ben Landen dated as of September&#160;18, 2019 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-3_cyngninc.htm">Offer Letter between the Company and Donald Alvarez dated as of May&#160;28, 2021 incorporated by reference to Exhibit 10.3 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-4_cyngninc.htm">2013 Equity Incentive Plan incorporated by reference to Exhibit 10.4 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-5_cyngninc.htm">2021 Incentive Plan incorporated by reference to Exhibit 10.5 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-6_cyngninc.htm">Second Amended and Restated Investors&#8217; Rights Agreement dated as of December&#160;24, 2014 incorporated by reference to Exhibit 10.6 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-7_cyngninc.htm">Form of Indemnification Agreement to be entered into with the Registrant and each of its officers and directors incorporated by reference to Exhibit 10.7 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October&#160;15, 2021.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022000964/ea153553ex10-1_cyngn.htm">Employment Agreement by and between Cyngn Inc. and Lior Tal dated as of January&#160;1, 2022 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K filed with the SEC on January&#160;6, 2022.</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-2_cyngninc.htm">Form of Securities Purchase Agreement incorporated by reference to the Registrant&#8217;s current report on Form&#160;8-K filed with the SEC on April&#160;29, 2022</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-3_cyngninc.htm">Form of Warrant incorporated by reference to the Registrant&#8217;s current report on Form&#160;8-K filed with the SEC on April&#160;29, 2022</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-5_cyngninc.htm">Form of Pre-Funded Warrant incorporated by reference to the Registrant&#8217;s current report on Form&#160;8-K filed with the SEC on April&#160;29, 2022</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-4_cyngninc.htm">Form of Registration Rights Agreement incorporated by reference to the Registrant&#8217;s current report on Form&#160;8-K filed with the SEC on April&#160;29, 2022</a></span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-1_cyngninc.htm">Engagement Letter dated April&#160;27, 2022 incorporated by reference to the Registrant&#8217;s current report on Form&#160;8-K filed with the SEC on April&#160;29, 2022</a></span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022014911/f10k2021ex21-1_cyngninc.htm">List of Subsidiaries of the Registrant incorporated by reference to Exhibit 21.1 to the Company&#8217;s Annual Report on Form&#160;10-K filed with the SEC on March&#160;24, 2022</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea159355ex23-1_cyngninc.htm">Consent of Marcum LLP</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><a href="ea159355ex5-1_cyngninc.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Sichenzia Ross Ference LLP (included in Exhibit 5.1)</span></a></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#poa">Power of Attorney (Included in the signature page hereto)</a></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance
    Document.</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Schema Document.</span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Calculation Linkbase Document.</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Definition Linkbase Document.</span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Label Linkbase Document.</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Presentation Linkbase Document.</span></td></tr>
<tr style="vertical-align: top;  font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">104</td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (formatted as Inline XBRL and contained
in Exhibit 101).</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">107*</td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><a href="ea159355ex-fee_cyngninc.htm">Filing Fee Table</a></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
herewith</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;17.
Undertakings.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrant hereby undertakes:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by section&#160;10(a)(3) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;);</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b)
if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price
set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of the securities at that time
shall be deemed to be the initial bona fide offering thereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule&#160;424(b)
as part of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other
than prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement
as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or
prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract
of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that
was part of the registration statement or made in any such document immediately prior to such date of first use.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
For the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
of the securities in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless
of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser
by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered
to offer or sell such securities to such purchaser:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule&#160;424;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
to by the undersigned registrant;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the undersigned registrant; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by
the registrant of expenses incurred and paid by a director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding, is asserted by such director, officer or controlling person in connection with the
securities being registered hereby, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy
as expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The undersigned Registrant hereby undertakes that it will:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
for determining any liability under the Securities Act, treat the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule&#160;430A and contained in a form of prospectus filed by the registrant under
Rule&#160;424(b)(1), or (4) or 497(h) under the Securities Act as part of this registration statement as of the time the Commission
declared it effective.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
for determining any liability under the Securities Act, treat each post-effective amendment that contains a form of prospectus
as a new registration statement for the securities offered in the registration statement, and that offering of the securities
at that time as the initial bona fide offering of those securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement on Form S-1 to be signed
on its behalf by the undersigned, thereunto duly authorized, in Menlo Park, California, on the 12<sup>th</sup> day of May, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CYNGN
    INC.</span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 60%; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 36%; text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Lior Tal</i></span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior Tal</span></td></tr>
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief Executive
    Officer, Chairman of the Board of Directors and Director</i></span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><div><a id="poa"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Lior Tal and Donald Alvarez,
and each one of them, as their true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution,
for them and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective
amendments) to this registration statement, and to sign any registration statement for the same offering covered by this registration
statement that is to be effective on filing pursuant to Rule&#160;462(b) under the Securities Act of 1933, as amended, and all
post-effective amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully
to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact
and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement on Form S-1 has been signed by the following persons
in the capacities and on the dates indicated below:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 40%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Lior Tal</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Chairman of the Board of Directors and Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May &#160;12, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior Tal</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal Executive Officer)</i></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Donald Alvarez</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald Alvarez</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal Financial and Accounting Officer)</i></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mitch Lasky</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitch Lasky</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Karen Macleod</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karen Macleod</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Colleen Cunningham</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen Cunningham</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James McDonnell</span></td>
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 12, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James McDonnell</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p><div>



</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>






</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c1" id="hidden-fact-0" name="us-gaap:LongTermNotesPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-1" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-2" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-3" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-5" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-6" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-7" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-8" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-9" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-10" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-11" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-12" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-13" name="cyngn:PPPLoanForgiveness" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-14" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-16" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-17" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-18" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-19" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-21" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-23" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-24" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-25" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-26" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-27" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-28" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-29" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-30" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-31" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-32" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-33" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-34" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-35" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-36" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-37" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-38" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-39" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-40" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-41" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-42" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-43" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-44" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-45" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-46" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-47" name="us-gaap:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-48" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-49" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-50" name="cyngn:GainOnForgivenessOfPaycheckProtectionProgramLoans" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-51" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-52" name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-53" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-54" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-55" name="cyngn:TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-56" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-57" name="us-gaap:InventoryValuationReserves" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-58" name="us-gaap:DeferredTaxAssetsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-59" name="us-gaap:DeferredTaxAssetsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-60" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-61" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-62" name="us-gaap:DeferredTaxLiabilitiesOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-63" name="us-gaap:DeferredTaxLiabilitiesOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-64" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-65" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1" id="hidden-fact-66" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-67" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-68" name="us-gaap:IncomeTaxExaminationYearUnderExamination">2034</ix:nonNumeric>
<ix:nonNumeric contextRef="c67" id="hidden-fact-69" name="us-gaap:IncomeTaxExaminationYearUnderExamination">2023</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001874097</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="cyngn-20211231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYs2oFZtOTTU4jS6iJhwAty6PIH4pPzDs97dkXlMe6U6IN1M+lk5vzKEXByUg/z1wUlxyqJGPe6Zz0mQ0VgkjxWaC3zpaLfOpSLlryildOmpaRwqomOPGOgMsNG3+0+fSRb8e5SoWpWZRilaPT9QB0JTgSPhjL6nUNOarL1cFfr8c9Mznp4GNeo] CSR-->
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-10-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cyngn:CYNMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-01</xbrli:startDate>
    <xbrli:endDate>2021-10-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-01</xbrli:startDate>
    <xbrli:endDate>2021-10-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:PurchaseWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-10-01</xbrli:startDate>
    <xbrli:endDate>2021-10-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cyngn:LiquidityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cyngn:LiquidityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-28</xbrli:startDate>
    <xbrli:endDate>2022-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cyngn:AmortizationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-04-29</xbrli:startDate>
    <xbrli:endDate>2020-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-21</xbrli:startDate>
    <xbrli:endDate>2021-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-01</xbrli:startDate>
    <xbrli:endDate>2022-02-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea159355ex5-1_cyngninc.htm
<DESCRIPTION>OPINION OF SICHENZIAROSS FERENCE LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">May 12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<IMG SRC="ex5-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>VIA ELECTRONIC TRANSMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:</FONT></TD>
    <TD STYLE="width: 97%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cyngn Inc.</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration Statement on Form S-1</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel for
Cyngn Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), in connection with the registration for resale from time
to time by certain of the Company's stockholders of (1) 3,790,322 shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s
common stock, par value $0.00001 per share (&ldquo;<B><I>Common Stock</I></B>&rdquo;), issued as part of a private placement completed
by the Company on April 29, 2022, (the &ldquo;Private Placement&rdquo;); (2) up to 2,661,291 shares of Common Stock (the &ldquo;<B><I>Pre-Funded
Warrant Shares</I></B>&rdquo;) issuable upon the exercise of the Company&rsquo;s pre-funded warrants (the &ldquo;<B><I>Pre-Funded Warrants</I></B>&rdquo;)
issued in the Private Placement and (3) up to 6,451,613 shares of Common Stock issuable upon the exercise of the Company&rsquo;s Common
Warrants issued in the Private Placement (the Pre-Funded Warrants and the Common Warrants hereinafter jointly referred to as the &ldquo;Warrant
Shares&rdquo;), in each case as contemplated by the Company&rsquo;s Registration Statement on Form S-1 to which this opinion is filed
as an exhibit (as the same may be amended from time to time, the &ldquo;<B><I>Registration Statement</I></B>&rdquo;). The Shares and the
Warrant Shares may be offered and sold from time to time pursuant to Rule 415 under the Securities Act of 1933 (the &ldquo;<B><I>Securities
Act</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the opinions
expressed herein, we have examined such documents, records and matters of law as we have deemed relevant or necessary for purposes of
such opinions. Based on the foregoing, and subject to the further assumptions, qualifications and limitations set forth herein, we are
of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Shares are validly issued, fully paid and
non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The Warrant Shares, when issued upon exercise
of the Warrants pursuant to the terms and conditions of the Warrants will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The opinions set forth above
are subject to the following limitations, qualifications and assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In rendering the foregoing
opinions, we have assumed that the resolutions authorizing the Company to issue and deliver the Warrant Shares pursuant to the Warrants
by the Company&rsquo;s Board of Directors (or an authorized committee thereof) will be in full force and effect at all times at which
such Warrant Shares are issued and delivered by the Company, and the Company will take no action inconsistent with such resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As to facts material to the
opinions and assumptions expressed herein, we have relied upon oral or written statements and representations of officers and other representatives
of the Company and others. The opinions expressed herein are limited to the laws of the State of Nevada, as currently in effect, and we
express no opinion as to the effect of the laws of any other jurisdiction on the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to our firm under &ldquo;Legal Matters&rdquo; in the
related Prospectus. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required
under Section 7 of the Act, or the rules and regulations of the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%">&nbsp;</TD>
    <TD STYLE="width: 51%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Sichenzia Ross Ference LLP</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia Ross Ference LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1185 Avenue of the Americas | 31st Floor | New
York, NY | 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">T (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea159355ex23-1_cyngninc.htm
<DESCRIPTION>CONSENT OF MARCUM LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the inclusion in this Registration
Statement of Cyngn Inc. on Form S-1 of our report dated March 24, 2022 with respect to our audits of the consolidated financial statements
of Cyngn Inc. as of December 31, 2021 and 2020 and for the years then ended which report appears in the Prospectus, which is part of this
Registration Statement. We also consent to the reference to our Firm under the heading &ldquo;Experts&rdquo; in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Jose, CA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea159355ex-fee_cyngninc.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYNGN,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant As Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Table
1: Newly Registered Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
    Type</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
    Class Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
    Calculation Rule</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    Registered<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed
    Maximum Offering Price Per Unit<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Aggregate Offering Price<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    of Registration Fee</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="9" STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Newly
    Registered Securities</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
    to Be Paid</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock, par value $0.00001, held by selling stockholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,790,322</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.69</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$17,776,610.18</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0000927</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,647.89</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
    to Be Paid</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock, par value $0.00001, issuable upon exercise of pre-funded warrants held by selling stockholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,661,291</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.69</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12,481,454.79</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0000927</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,157.03</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
    to Be Paid</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of common stock, par value $0.00001, issuable upon exercise of warrants held by selling stockholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,451,613</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4.69</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$30,258,064.97</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0000927</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,804.92</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
    Previously Paid</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Offering Amounts</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$60,516,129.94</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5,609.84</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Fees Previously Paid</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Fee Offsets</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
    Fees Due</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5,609.84<SUP>(3)</SUP></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act, the shares of common stock being registered hereunder include such indeterminate number of
    shares as may be issuable with respect to the shares of common stock being registered hereunder as a result of stock splits, stock
    dividends or similar transactions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee and is based on the average of the high ($5.18) and low ($4.20) sales
    prices of the registrant&rsquo;s common stock of $4.69 per share on May 10, 2022 as reported on The Nasdaq Capital Market, pursuant
    to Rule 457(c) under the Securities Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    filing fee of $5,609.84&nbsp;is being paid concurrently with the filing of this registration statement on Form S-1.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %C MX# 2(  A$! Q$!_\0
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MMT<J Y4]..:Z4J#U%+10!S)^'?@\ZG_:)\.:>;K=NW>4,;O7;]W/X5TH50,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M21@'GGBO1O#6CC0],^QK>WEV@8L'NY-[C/;/I6$HV&C:HHHJ!A1110 4444
M<MXV95L(<.ZR9. I[=\UYI#<SQ7$Q25U)QT:O0?%&K6D5[M:+[0\493;Q@$\
MGG\JX4/82SREHI8"<8*-N'ZU]!EZ<:5I1/F\RDI5O=EJ2?VB\B[;F&&X'_35
M :J7%GHETI\W3!"Q_CMVVD?ATJU]B5SF"YAD]B=A_(U7N+6XA'SQ.H]<<?G7
M8Z5&>Z.&-;$4]FS,D\-6LBG['JDB'LEPO]16)>6>H:7(5FRK?PD'(8>H-=.@
M]:=*B7,#6\XW1GIZJ?45S5<O@U>&C.VCFDT[5%='"QWRK?NUR[DLBDL&X_$=
M*]H^$^N)=Z?=:5O9C;MYT98]4;J/P/\ .O#M9@DT_7#"X!!C&".C+S5G3K^]
ML+I9+"[FM2R>6WE.5R,Y[?2O$J0:O%[H]^$DTI+9FUXWT.&^^+%ZFFS0V\<C
M!ED8_NS<8&4+#[NYLC)XSG\/0OA5J!M;R\T:X.V4 X!/\2'!'Y'/X5XC/IJ2
M;D>61E+ERI;.6/?GO6EIMS-;$QQ,S29&W]X4.#P>1SCUQV%1RNUF7?4].^+.
M=4\3Z;HUW(+:R\DRI.2%RQR&&6XX ''O[UYO-8K;:<DD3N\2_NR60C&.!ST/
M'-;OQ%UB*TT[0Q:7%E<:C)%)]I?R!(\3!5Z-("W4MS[<8KBHI[R>T7?.2DH5
MW7U(&,_6E'0IG3:5X2OM*TO2->>:&2TOYD\M1]Y3GH0?H>AKZ<'2OGFP\1_V
MAX!TJQFMO(CTN\@"W&[*RJPD)(X[%<=_PKZ&4Y&:F3!"T445(PHHHH ****
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M10 4AI:0T >1>()X+34[V*XN8D83N?G< X)R.OM7,MJVE"1L:E9\_P#3=?\
M&F_'&!;;Q1;2?\]HQ)M'\1'R\_E7F*Z?Y@ZA6)X &!GCCZ\CIZU["S%TXQC%
M7T/&>5QJ2<I2MJSUV,I*@>-PZGHRG(-689;B#_52NH],\?E7CFF:M>^'[T/
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MUF*C_9 %=RQU9_97XGFO"X=;2;^2.%;3]37KI]T/K W^%0O9:A)&Z+:2[BI
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MHIV** &X-+BEHH 3%+BC-&: "BC(]:,B@ HHHS0 449'K1D>M !11D>M&10
M449'K1D4 %%&:* "BC(]:,B@ HHHH **** "BBB@ J&Y.+6;_<;^5357O3ML
MK@^D;?RIK= CS^*52N RD9ZYKC_'Y4/I[]>)!^@K<MKF5KH.614"8Y[G/UK"
M\<NT_P#9$2W A>>=K?>>F'&T_H:^FPE>E3Q,>:26^[\F=%6+E!V1Y3]LN+NP
MBMF8NL*E8P3]T<DUF;A%N"'+GJ<_RKU2/X+>*UMGC2^TQ;>3_6.)6RP'3^#/
MX=*\YUK01H^LW%B97E:W;:SK\H/\Z^GHYA1Q:7U)J?71]^NUCRO9."]Y61=T
MV:1)865EV[AE1V&>E;6@7.-7O;>TM(9VFG;RO.R-N#Q@#J3TQZXK!L="U^_
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MS>O7I[5[>79/6G6;K0:BUUT_X)Q5L=2A%<LKL\3N/&]]J&HVUW.2CVJ;+?:
M!&,YSTY.>>37H/A7XPZQ87D4>M2B_L7(#/L"R)[C'7Z']*[74/#^CZHBI=Z;
M;2(OW1LQM^F.E/L]$TO3P/LFG6L..A2)0?SQFOL*>%4%:.B/*GCE)WL=^FI6
M<EO'.ES$8I%#HVX<@\@US6@W*:/J>OQR FTGOOM5LZX.[>BEQCMAPW7UJI4D
M=O-*?W<3M_NJ36GL8K=F+QDWI%&W)XB3I';L?=FQ_C7$:IX9TS6;"6ROH3)
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MXA7ECXRU%[+2H;**338WNVMH96)/F.6#+EP< #/3M7IT=O%$[O'&B-(=SE5
M+'U/K3+JQM+Y EW;0W" Y"RH' /KS2 Y/X97=Y>>%'>XGGN;9+R:.PN;C/F3
M6H;$;L3R>,\GJ *[2FJH50 , = *=3 **** "BBB@ JM?D+I]R3VB8_H:LU4
MU,XTJ\_ZXO\ ^@FFE=H#Q3^U[82QD1SJH!! !)_G65XBO8]1N='^SP3R&&]5
MVW1D;1D<\U061BP)8U*974I@C[W>OHXY5"5;VE.3YM=TFMFOU-?;RM9['O\
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M_M-_A6C14.I)]3:-"G'9$$=G;Q?<AC7W"U/114&B26P4444#"BBB@ HHHQ0
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M<BNJU#4;32K":^OIU@M85W22MT4>IJ"/7--EU"'3X[J-[N:'[0D*\MY?9CZ
M^IQFGN[B6B,/P?H6H:=-J^JZOY"7^K7(GDM[=BT<*JH55W$#<<#DXY-5/ G@
MQO#Z3W=ZUP+^6XN&*+=NT.QY"RD1YV@XQSC/6NLM]3LKJ^N[*"=7N;,H+B,=
M8]PW+GZCFL ?$GP<;L6@UZV^T%_+$?S9W9QCIZT(9U=% Y%% !1110 4444
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M:MI#%'_JXT3_ '5 I]%1=O<U4(K9!1BBBD4%%%% !1110 44N*,4 )12XI:
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M,T8#(\"-*@20J"RAL@''(SWJ6C&**8!1110 4444 %-IU)B@!**7%-<80]Z
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M5]9V+VB7F5^8^6_(*GC(X/YDG<.QTUMXP\,WEXEG:^(=*GNG;8D,5W&SL?0
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MG+$*!@<DDG\:L4 )M%&T4M% "!0.E&!2T4 )M%&T4M% !1110 4444 %%%%
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M "Q$ZF.-U= 20"'4X^\W3'7Z8G_L:V^V?:_,EW_:OM6,C&_R?)QTZ;>?K^5
M#/[?LEM[221WW7,7G(D43R';Q\QV@X'S#DX'-/;6K>)[L3;T%O<+;_*A=I&*
M*XVJH)/#^G8U"F@1VZ6@M+Z[MVMX%MPR>6Q=!C ;<I&>.HQU-)?>'+*_6;S7
MD#R7(NMV%;:XC$? 92"-H[@]2>., &BE[;R:>M]',K6S1^:).Q7&<_E5'3]8
MFO&#36?V>.2+S8RTJE]O^THY4XYXR/<'BKL%E;V^G)8HB^0L?E[=J@$8QT
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M7.>=P(_+BNBM[B"[@6:WFCFB;H\;!E/XBI< C!Y%/H,P/#FK2ZG+?(]TES'
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MM+>2WC*RW<UR2<AI0@(]AM51BF!8HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D([TM-<$J0IP>QH
M3?@=*4G(S7*67A2X2PN+:ZEMF6>>WE:-(U"'RV4O\JJH^;;TQ[$FK4OAQQ91
M6\:VLL$-U),MK,I$11MV%P <;2V1P1QVX(0&S_:%JFE_VAYJ_8Q%YWFCILQG
M=],<TVTO[>^#M!YGRXSOB=/_ $(#-4?[$D/@O^PO.42?8/LGF+D#/E[<COBI
M;S27.FBWLY7WI-',OVB9Y-Q217VEF)(!VX[XSTH O&XC29("P\QU9U7N0" 3
M_P"/#\Z@M-3M+V&.>V??'*Q5'VD!\=<9'(X//0]JHV.B31/$]V\,F$NED0 E
M3YTJOCGJ !BHM&\-'2=,T>SC>%?L+,TGEIM$A*,O3ZL#^%&H&O;W]M>;3!*L
MF8TF&.Z-G:WT.#^56,\]*YQ?#4@TP6;S1L#96MJV5.#Y3,6_ AL5)8^&8[#5
M&N[80P*7D^6)-I",J@+] P+8Z9-/J!O9 SQ3))HX@I=E7<P4;CC)/0?6N8T_
MPC/;Z5-9SW"2F1X-['&V41N&9F4*/F89!SN)XR35JX\,HUG]GCAM7CCOENH8
M73$: 8RHX.,_,>!WI ;L<T<QD",#Y;[''H< X_455U>VL[BS$=\SB!G"$+*R
M!BQVA3M(R"3C!XYJKX@T>75;2..W,2R))O!D *@[2,E2K!L9Z$?0CK5G5;&>
M]TP01/'YRRQ2@OD*2CJ^.,XSMQWZT6 O  +MXQB@UBZKIM_JNGPQ3)9JZR[G
MC.)%9=I P7C.#D@_=[8SS5:'P[=PRZ.YGADDLK>*&65P&+;1R0"IQGGD%3Z[
ML 4P.E"\48YS2T4 %%%% !1110 4444 07-S!90//<RI%"@RTDC!57ZDU'9Z
ME:Z@KFVDW[#AE*E6&>F00#S4>K6$FH6:QQ2K'+'*DT;.NY=R,&&1D9'%9VJ1
M:M/HEP6BA-ZC(]HEN2P$BD%2Q;'RD@9Z87/)I ;N[':CC '&*Y?4_")O]+CM
M1.AFBL)X$FD7+">381,/0AE)R.>>*CUC2;R75[.1+5;HE[4F=QS;B.4,^TYX
MW#J.,^_0'4#JR_&<=*;!/'<01S1,&CD4,K#N#R#63I^@?8=4-\&B\QS<>8RK
MAG\R573)[[0"/QXI;O1I9M?M-0B,*K$H5BP#$ ;N%!4XSNZJR^^[@4P+]_J-
MII=M]HO9XX(=P7>YP,GI4ANX1<& N!+L\S83R5SC-9^K:*^KW-N7NWAMXE<E
M(U4EV8;<G<I&-I<=/XJJ7/AV[N-,L;?[<!<6ZFWEN"#NE@8;6'LQ 5L_WE':
MEJ!N17,,]K'=1R*T+H)%?/!4C.:>DBR(KHP96&58'((J*ZLXKG3Y+-D3RGC,
M>TKE<8QTKF[CPI<3VNE1+)#"EI"87BBP%4Y7]XA*'##:>@!YZCN[ =43STJ.
M&XBN81+"P>,DX(]C@UFQ:1)'K\U^R6LHD(99G!\V(; NQ?\ 9R"W4<L>.]9Z
M>$3%97<$4D,9NK:2*4JF-[LY8,WK@,1ZTA'3YXSBHGGB%PD#,/,=6=5[D*0"
M?PW#\ZP[CPVWV3[/;BV:W6\^T+:2*1"R%,%"!P!N);H1G'%26V@3Q6\*?:A&
MR6US"#$"/+,KJRA,]D"X'L!THU*-SKS1D 8[5RY\-W*:/J$"216K3)&%ALP=
MA*<DD$CF3[K<CC SWJE'I6I'29?LEI_9]W+J(>V6(#; AC6-V(XXV[SCUQQ0
M2=L.12[:@M;?[+&EO&JK;Q1JD8R<C'&#[8Q^M6*=AB8I:** "BBB@#GM:AU3
M^U[2>PCGE16C$B&79$%W_,>)%);:2<%7!P ,<TU8M2CEU.0V]U+<E93;NUSB
MW<?\LU"A\J>@)VCH3GFNCHQ0!RVEV.J![8W:2[(=1:1/-?++$;=E[R.?]8Q&
M-Q//85+I5MJ\.L7MQ>O.\8:;9&""DBE\Q[<R'!"\?=7.3DG@UT>*7% "(VY0
M2I4GL>U+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG6OAK3;?3Q9/:PW$(D:7$T2$;FSDX"A1UQP!Q5T:98B:&;[';^;"H6)_*&4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %G -P# 2(  A$! Q$!_\0
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MM^[!^7([UT1.*S=5MI;X6\4*J<%P^YL#!&*)*Z&CQJ_ANDUDW,$\FV*'R<N
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M=VQ.K?2@ EGA@V^=-'%O.%\QL;CZ"I0I*[E^93W4YKCM0U*XU:^TJWEL[6*
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M>15.E&DN6.Q[?\/N?"2_]=WKJ*Y;X><^$4_Z^'KJ:1H%6;8?NV_WJK5:M?\
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M<I;2"\<!XD>#+IEE7!#89<L,*,@Y'4XR2:- NSJ)+RVB4M)<1(J@,2S@  \
M_0TU+VUDC#K/'MV[N6QQG&>>V:YP>&-" D)NMRB *VZ1"%!QACQ_LC /RCL*
M:OAW0Y].F=+TFUN80&D9DZ @A@2N1VXZ=\9HL%V='>ZE::=")KN=8T.<$@G.
M 2>GL"?PIT-[;7%I'=QS+Y$@!1V^4$'IUK)==.NH4AGU)9?LYEPZNH"@@QD,
M>F0' YYSS3KK0]+U* V?F?O(_*+E'!<;/NYSG'3KB@#6EO+:%"\MQ$BA=Q+.
M  /7Z4INK=02T\0 ..7'7KBN<C\$6'E*L[N[[9E8J!@K)_#R#PHP /\ 9%./
M@;2&DE>19',CLYW%3R01Z>YQZ?2C0-3HUFB<@)(C$KN #9X]?I3ZQ;;PY!8W
MZWEG/)"XC6)EPI5HPQ;;T]\#T'2MJD-!5&U_Y"U_](_Y&KU4;7_D+7_TC_D:
M +K?=/TK''05L-]T_2L@#@4T E!Z4N*".*8SP?XI GXC:J516'V&+)8\CIT]
MZ\W(YKT?XIIGXC:H?*+XL8CN!^YTYKSGN*E@B!_M'9K4CMG&?QKK-"/_ !+4
M_P!XUR,D7.3IVX'^(-][WKJ]'D6+3D+L!R<"@1[G\.N?!Z?]?#UU-<I\-F$G
M@J)\$9N'X/6NMQ3 2K-M]P_[U5\58MO]6?\ >H I0^%K."+48DN+SR[\,)4,
MO"[B2=O'!.3D]:C_ .$-TSRQ$&N?(PP,1DW*0V[KD$\;V(Y[UT%%%V*R.=;P
M7I3ES)YSAL<,5QT/MSUSST[8'%*W@S27D5MLH4 CRP5VG(8>G'#MP,"NAHHN
MPLCG6\%Z69)I-TXDE"9;*G&T < C'( XQCT HN/!]C<W$)EEE\B&T2U2,8SA
M<X);&>_;'OGI71447861S[^#],:1G'FH2%"A2N$V[<8&.?N+P<CT S3!X+TT
M1J@EN@J !%WJ0I&WYL%<$G8O7(]JZ.BB["R,";PAIDQ8DS*69F&TK@$D$G&,
M'E>^>OTQ8LO#ECI]U]HM3+')T8A@=P^7@\9(^45KT4KA9!1110,**** "J-K
M_P A:_\ I'_(U>JC:_\ (6O_ *1_R- %UONGZ5D#I6NWW3]*R.<4T =*0L,<
MTTYJ*3?@X-,#P[XIE3\1M2)\PD64>-O0=/O>U><]^M>F_$C0/$-YXOO-0L[=
MWM984BW( VX#UKSFXTK5;4XFLYE [M$14L:,R0P!F^:Z1L\^GX5U.ENB6D'[
MO?+D[!7-/]N0X,G Z*>WYUU?A:UNM9C2WL4Y4D22,.(_6@1[=\-7;_A"XQ(0
M7^T/G'2NN!'K7+>&+!](TJ.RC+%%.XENI)ZFNCC)(YJ@)QBK%O\ </UJJ*M6
M_"'ZT@+]%%%( HHHH **** "BBB@ HHHH **** "BBB@ JC:_P#(6O\ Z1_R
M-7JHVO\ R%K_ .D?\C0!=;[I^E9..*UC]T_2LSL*: C*GTIC)FIJ6@"@]H&[
M5 ^E1OU0'ZC-,\0^)].\-0P->F1Y;A]D,$(S(_J0/04MIXJT2[NDM!>?9[N3
M[MO<H8W)].>* (V\/6$O^NLX9!Z,@-6;72;.RC\JTLX+>/.2L:  FM1E*]01
M24 5EA [?I4H3':I**!C ,"K$ ^0\]ZBJ> ?(>.] B[1112 **** "BBB@ H
MHHH **** "BBB@ HHHH *HVO_(6O_I'_ "-7JHVO_(6O_I'_ "- %T_=/TK,
M XK3;[I^E9M- )1R3QUI:H:W!>7.A7T&G/LO'B(B8G'-)Z(I*[L><^,9['Q!
M\3]-T=K2Z6XT=//-P#A&!YQ@CD9[BMJ]M+76HY+*<Q^6@!!906W=L'J!^M<U
MX)T[41JE_K&IP2KOC2"U#MDNH^\P]LTNHW<+Z[<0V)N6U!28X85_U<DN.%+#
MI7S&.<Z^,M#1Q7W/J;\L875[G76NEZII:1G0];R,#=8:CF2,GOM?JH_.KL?B
MZ.TF6V\06$^D3'@2O\]NQ]I!T_&HK'PYK-KI=MYVIQ3:@$!N%9,(7[A2.W:L
M3Q?XAU#POX:O[B[L?WHC'EAP)(G8G /IQZ5ZD,5C*34*]/FV5U^ICRQ>J9Z%
M&Z2Q++%(DL3#*R1L&4_B*6O$= %YI/A:WURV\07,-[<_OI$SOADSSM"_PUZ[
MH%W?7NC0SZDT1NW^9A&N JGD#ZXKT(5J<U[KZM?=O;N39HT:L0?</UJ"K$'W
M#]:T MT444A!1110 4444 %%%% !1110 4444 %%%% !5&U_Y"U_](_Y&KU4
M;7_D+7_TC_D: +K?=-9N#6DWW3]*SP*$ E R#D=:=BDQ3 YKQ!HUK;:;<7UD
MK6MT#N&QSM8D^G0?A7/^#?#%M;^(3J1&)06=N23(Q[FNQU_!TY(FZ22#Z<<U
M5T-$6Z^7'*DY%>)7G%8Z,(K>US5? ;N,U!>6-KJ-G)9WUO%<VL@P\4JY4U9
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M#!&9%)*OM&1GK@^],%E:A95%O%MEQYBE1AL  9'T JQ13$1"V@50HAC"A2H
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-@1%"J.  , 444@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %3 2(# 2(  A$! Q$!_\0
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M8:3?Z98L"-D4;>:X_P!I^WT'ZT'7?&GAKQ5>MIUI>7-BSJ3;2Q,\3?(N=O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA@?C0!)15>WOK2[0O;7,,RKU:*0,!^5'VZT_Y^8?^_@_QH L44=110 4444
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MT9=LP'3>C @D>M',N@N5WU.1\3)X?L_A[XUTW0[62W%G*BW,39\L.2A^0$D
M8],5EZQJ][HW@+5O"FO2F5I-/\S2[UNEQ'P3&?\ ;7]1^O>+\/=._P"$>U;2
MI;R^G;5F#WEW)(#*[#&".,#IZ5HZ_P"$=,\2>'TT>_5S%&JB.52!)&0,!@<=
M<4U)!RLS;+PW]JL(M5MY_*OY=#2R@<(!Y1*YW9ZDY(^F*X[3+;1O#-MIUKXL
M\&-9S02H/[8C EC>7/#M(#N&3ZUZH--C&BC2_,E$0M_LX=6VOMV[<@CH?>N9
M;X?_ &KR[?5/$6KZCIL;JZV=PZ;6*G(#L%#,,XX)I*7<;CV+'Q)Y^&^N\_\
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MHW,3W]C&N=LBN")4';.,-^?TW-134/"_CF]U^+3+G4=+U."..X%HN^6WDC&
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MAY%)PL"D;]%9\&IJV%F7:?[PZ5?!!&0<BI*%HHHH **** "BBHI)UCXZGT%
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M4 L.B#H*O1Q)&-L:!?8"K,=LS'+\#T[US5<1*9VT,)"GJ,BB,K>B]S5T*%
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M\V0W!8B[S$R-R>1E"/3''>H;WPYXCNQ%=S9,URLDD\$4_P#Q[3,1L926 .U
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M>]:Q,EO:S-"JL,M&57S.,$@\*".?2H[C4/#RA-^E%98L +*@784*IMR"<D
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MXCTJ5)2MVNZ+:73'S -C!QUQ\PJV=2LA;O<&\@$,;;7D\P;5/H3ZUE)X1TQ
M5_?LG&$,OR@X R/?"@5-%X9L+>R-K%YR+YJRJX?YT9?NX..PXYS3T#4GCU[2
MI8HY%OX ) A4,X!^?[O!]<U.=3L%MGN#>0"%&V/(9!A6Z8)]:RHO"&G0O&Z/
M=;HU18R9<[-I4C&1ZH/UIW_"+6R6DD$%Q<Q^9<QW+R%]S[DQC!/LHHT#4OKK
M6G-.(?ML D9@J R ;\@$;?7AEZ>M-DUW38Y4C^UQL7) *G(&" <D<#DBLW_A
M#=.%U&ZM,L*Q[&A#\2?<ZGKC]VO%/7P=I2QA LV!P/WG..,#IVV@"C0-35BU
M2PF$1BO;=Q,2L960'>1U ]:MUBKX8TU;R*Z5)/,B8,/FR#@* "/;8I^M;5(8
M4444 %0R6EM))YLD$;2<?,5!/&<<_B?S-344 <?=ZEX>COC:/IPWV,J^6\2+
M@.2=JC'JZ[<>I'K4!U_2+><1V6E6R/%-M8[% '*_,I'X_E7:>3%N9O+3<Q!)
MVC)(Z4@@A!)$48).3\HY-.XK,XV+Q+HPO8?)TN,1QLYWJ$W(^Y!E1WR'4\<U
M-9ZQI&H074BZ3%]J@@-W)F(;3(%!//7N,'OR:ZL6\ *D0Q@J<C"C@^M*(H@2
M1&@)&TD*.1Z47069R9\0Z,D$*7.EJCN"KP[$;80A('7D$,0#[D>M-N?$.E&\
M2*XTE%@*,]P\@0M&?D;. >GSJ2?RS77&"$D$Q(2.AVB@PPEBQBC)(P3M'(]*
M+H5F<J_B/0I!;2R:=G>[ ;HUW(^!O!'KN^4^XJQI-[HNIWLEK%I"PRB,2.'A
M7 RH."1[/^IKHC%"2"T<9()QD#J>M*L<:N75%#$8R!SCTHN.Q#96,&GPM% I
M =VD8DY+,QR23W-6:**0PHHHH 1T61&1U#*PP5(R"*@2PLXT"):0*HQ@+& .
M,_XG\S5BB@"M_9UC]F^S?8[?[/G=Y7E+MSZXQBD&FV()(LK<%B"2(EY(Z'IV
MJU10!673[)8?)6T@$6=VP1C;G&,XQZ<4K6%HS^8;6 OS\QC&>>35BB@#/M=%
MTZS,QBM8]TQ)D9_G+9&#R?:K"6-G'/YZ6L"RY)\Q8P&YZ\^]6** "BBB@ HH
MHH Y[7->GTJ]$2QH8V@9U(!9BP#'& 1@<#GD<]JKCQ;, S'2I#&.A67+-\SH
M/EQW*'\"*N7>L7%OXHMM/%NQM94^:01,3O.<<] O')_#N*K'Q1.+EH/[/)<S
M/#& Q.2HW9/'3:&.1T(QWIV)*TWC9(WGFCM_,M8H\@@G+MP3@XQT)&/4=:>O
MB^7EGL0@W2+AI>%"L &=L?+D'I@\D<\TVX\2ZMY&$TQ8Y3$6!)=@6Q&RJ/EY
MX<Y]"IZXIUUXJU&!IHDT=FFB1R26.QBI8$J=N2OR^F>1Q3L%R[8^(WO;J.)K
M%H$E9E1I9,'Y2H((QP?F&!WP:KR>+FB:,'2[AO,$K*$;)8(S+QQR?ESCL".M
M6-/UNYN-4:TEMPB;WV2,&&]03C;\N#@#DDCJ*JP^*KF52W]EN"J2-L&XF0KG
MY4.W!/ R3@<TK!<2?QB858_8#*1'O'DS;@W#'Y3CE1MP6[$@4RZ\836E_+"]
MA^[B4JP$GS!PX7+''RKR2#WX/%2Q>*;Q]LC:4P@V@LZLS$D^9@@!>1^[&>_S
M#BHD\4:C<6PFCTIPJ% RC):3+."%&.F$!S_M"G8+EW3?$$NHZX;+[+Y$:PN[
M!VS(&5E R.@!W$CKD<UT%<Y9>)I9[R"&XLC''(K?ODWLI(.!C*@@=LG'-='2
M8T%%%%(85@:SHU[?:E'=6=PD#+ T7F,2Q7(."HQP<D?,"/H>*WZYR3PL9+Z2
M[%]*LCRM(""W&75AQG'"AE_X$::$RC-IOB)]19FOD0NK.BQW#84[ONJIQNXX
MR>!NS1:Z3KHMH)I=85%7!<&X=Q&1MW-N/WLX8;3P,Y%2-X/N9E_?ZD)&2-8X
M_P!VPP%V8S\V>=G.",YJ,^#[R6YN0]^JP.I"D!BQW;]RD9P%RX]<[1TIW%8F
M.@:U'L,.J,S>7!O,EQ)@N@._CN#D'J.E3:CI&MW-Y=26NI>3#(4*)YC C P0
M"!A1GG@')Z\<5);^&Y8[*]MIM0EF%S*C[F)SM#;B#SU(X)&.U5'\(7 @6*#4
MWC 97)(9CN4L0P);@X*CZ+1<+$DNAZWEFAU9V9I-Y\R5@O#DC@#@;2 0,9(I
MD>C:M*9 =:9MC.#Y4[9+E2 3P=O+*=G(&!ZT\^%+E+=DMM4:-W5@Q968$L'!
M;&[KAUQ_N"F2>$)O.#6^I-;J7F=C&IW$R%B><_[0_P"^:+A8EFT#4;BVLR]]
MMO+>UFB\Q)'QO<KAN>20 1GKS23:%K$D\NW5I$@+D@+,^XK\VW_=QE1Q][&3
MS2?\(M<QL\EO>Q02,J<*CE 55UP 7Z8?/7J*5?"DR_9\:G-F.0NY!(WYVX/7
M@@+CTPQI7"QK:1975A!)%=73W&7#(SL6(&U002?]H,?QK1K#TC09=+N_-^UF
M6/[.D)5@22PQELDG&3DX'K6Y2&@HHHH&%%%% !1110 4444 %%%% !1110 4
M444 %1F*)I1(44R*,!R.0#VS4E<D_A[6497CU/<$DF>.)G90/,+9^8<G&1CT
MR>O% F=9QZT<>M<H-%UJ6&*._P!2W[6A+2I.R8"LI( QRQP?FSGG%+!H>O)-
MYKZH-X"GY7.'8>6/F&.?E5_SIV"YU7'K1QZUSD>EZVNFLD]XES<K=Q3)ND*J
M55@2,XR,X/'(%0W6E>)9OMC1:BD9E;=$HE8",<D8P.W ]&%%@N=3QZT9'K7-
MMHVMEA)_:C%LL2ID.PYESC&.GE\ >OYU6;1]?L[-2E_),54*\,<A&Y1LP%.!
MMX#Y(YY'X%@N=;U[TM4-%CNXM&M([]BUVL0\TLVX[OKWJ_2&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 55U.V>\TN[M8V"/-"\:L?X25(!_6H=0U5;"18Q;RSR-&\I6,J,(N-QY(]
M1Q5,^+=(58R;D@R#('EG(Z]1VX!/TYHLQ7*?_".7LEQ;O/J#RQ1S^<8VD<C(
M9RN!V #*,=/EILFA:X1$L6KD!+81N3*^YY,#+$G/?GUP<5I'Q+I_DPRJ\CB:
M58D18SO.7V!MO7;GO5>W\8:;);0RSF2W>4 B)T.<'^(>J\=13U%H5X] U:/S
M_P#B:L&?S'4K))C>P3'!/ !5N,_Q>M)-H6L74-TL^I?-.C;#'-(HA)8D 8ZC
MD#)Y&.*T;KQ)I]LP02K([(738<JV#@C([\'\J?\ \)!8_94N2\BQ.LC(3&02
M(P2QQ]!^-&H:% Z1K+WJ,VJ;;9)"^U9'W,"^[!^GW1Z@5H:%8WUA9M'?WINY
MBV=Y)/& ._3.,X[9JLWBS30&">>\GS[(Q"V9=I(8KQR 5.335\7::1"'\Y9)
M%1BHC+; RELDCL,')HU#0WZ*R;/Q%IU_/##;S%GE!*@H1TP>I]B#6M2*"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH K7=A:7RJMU;QS!3E0ZYQ4;Z3I\KM(]G"7:196;8,EE& <^H Q
M]*** )&T^T:V%L;>,P A@FW@$'((_'FHCH^FGR\V4/[O;L^3[NW.,?3)_.BB
M@0Z;2K"YG^T36<,DVW;O91G'^2:2;2M/N+=+::SA>!,E8V7('KC\S110,I6.
M@Z4UFX:PA;S)79BRY).]NY^I_.K2Z%I2DE=/MP20>$';I113$/BTG3X&A:*T
5B0P9\K"_<SUQZ5=HHI#"BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $^ /4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH9[J*W&9&P?0=
M: )J*R)M6=N(D"CU;DU3>YGD^_*Q]LXH Z$R(OWF ^II!-$>DB_G7-=>M% '
M3@@]*6N95W3[KLOT-68M1N(^K[QZ-0!NT50@U2*3 D!C/OTJ\"& (((/I0 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!GZY<W%GH=Y<6@4W$<1
M:/<,C=VR/2L.77M4,\P:V^QP!8E+R1EC'EF620CNH( '_?1XKJSTKF!XFDAN
MY3</:FW2YFA:.//FQK&&.\\G(^7'0?>% %*7Q!JHG41,TL2JQ25+;Y)_G"AF
M)/RKR02/0GI6GX;U2XU%[H74X:1'<"(!!M =@.!ST ZU6M_$.H745J +6"X:
MZ$$Z21/\H92ZL,D'H,'/<'TJ]HFO_P!JW5Q$Z! /WMMA6!>+)7)SU.1GCC#+
M0!PWQ#\=WEMJ,FBZ3,8/* %Q.GWBQYVJ>V.YKSB/5M2AG$\>HW:R@YWB=L_S
MJ[XMMY;7Q?JT<^=YN7?)[ACD'\B*QJ]:E3C&"LCQZM24IN[/7_!7CN\UBVDT
MZ^93?1+N68#!D3IR/[PKHR2Q))))[FO)_A[#))XI61,[(H'+GV/ _6O5ZX,3
M!1J6B>AAIN5.\@P<$XX'6IHK2>;E(SCU/ J[:R6D%OM>16=N3QD9JM/>SR,1
MYF%[;.!6!T$@TQQ_K)HT]B:1[!%1F%S&<#.*I$D]3GZT4 %%%% !4]O=2V[?
M(V5[J>E05>33O-A$L<P*D9Y% &G;74=RF5.&'53U%3US*.T4FZ-B"#P:W+.[
M6ZCYXD'WA0!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B%O &=A#&&
M?[QVC+?7UJ6B@!IC1FW,BD^I'^?4T!%&"% *C XZ"G5#=3BWMV?OT'UH XKQ
MSX6LO$4R21O]GOXEV^<!D,/[K#O]>U<&GPVU8S;7NK18O^>@+$G\,5Z>2222
M<D\DTI4@ E2,\C/>MH5YP5DS&>'IS=VC)T'0+3P_9F"WR\CG,LS#ES_0>U:M
M%210O/($C&3_ "K*4G)W9K&*BK(CJ>*SGFY6,X]3Q6K;:?%!AF&^3U/;Z5<I
M#,9=)F/5T%..D2_\]4_*M>B@##?3+A!D!6^AJJ\;QMM=2I]Q734R2))5VNH8
M>] '-58AO)8(]B'HV:GO-.:$&2++)W'<50H T)HDO(3<P+AQ]]*I0RM#*LB'
M!'ZU):W!MI@_\)X8>HI]] (I@Z?ZN0;EH VH)EGB61>A_2I*Q=,N#'/Y1^Z_
M3V-;5 !1110 4444 %%%% !1110 4444 %%%% !1110 5D:K-NE6(=%&3]:U
MZYNX?S+B1_5J "WB\Z=(_4\_2I]0E#S^6OW(_E&*?IPV"><_P+Q5$DDDGJ>:
M '(C2.$498G K?M;9+:(*.6/WCZU0TF#+-,1T^5?ZUK4 %%(S!023@#J34<5
MQ#-GRI4DQUVL#B@5T2T49HS0,**,TF: %K%U&S$+>:@^1CR/0UM4R6-98FC;
MHPQ0!S56&N0]BD#*2Z'AO:H'4H[(>JG!I* %!*D$=1R*Z."030I(/XAFN;K9
MTF3=;,A_A:@"_1110 4444 %%%% !1110 4444 %%%% !1110 R4[87;T4FN
M:KH[G_CUE_W37-@@Y&>1UH T+<$:9<<')..E4"""01@CM6C:WVRSD5C\Z#Y3
MZU01'ED"J"S,: -VP3R[.,>HR:LU7MIHV/DHP;RU&2.E6* ,K7,>5;^;G[+Y
MZ^?Z;??VSBDD2U9)1IKP)>"/*F+&< ]#CL:TG>/>(F9=S X0GDCOQ4+6<0A9
M+?\ T<MSNB4 _P JM2T2,90NVUU^_P"1DRZE/<V5W>P.T4<, "C'_+3J?RZ5
M(T][9W$:^>UTTUN\@1E PR@$8QVYK2AM8;2T\D#,8!+%^<]R33HS!=0K-$0R
MLOR..N#Z>E4YKHM"53EUEJ8EO?2-=6"KJ+3F9_WT>T#;\IXZ<<]J$N;U;(7Q
MO&8"Y,?E%1M*[\?6M!;*"WNX'GNI9'R1"LA'7'/0<G'K5XQQ!=I5 N<X(&,T
MY371$QI3>[_K0D%+2#I2UB=1A:DFR\8_W@#52K^K?\?"?[O]:BL+?SY_F&44
M9- %6M'2&Q+(OJ :IW$+6\S1MVZ'U%6M)_X^7_W: -FBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!DPW0N/537F.OWMQI>N0W$#8#Q ,IZ-@]Z]1KS7QO
M:E1#+C_5R,A^AY% &IIFJ0:I#OB.)!]^,]5_^M7,>-O%\NGVYT[2I-LLH*SW
M*GE1_=7W]36)'+)"^^*1D;&,J<'%9NKP&:Q8@9:,[O\ &@#UCX?7@N?#]@V<
MDP;#]5.*[*O(/A9JP6WGL6;YH)/-4>JMP?UKUY2&4$=#0!EW6/\ A(;#_KE+
M_2J-M-=):65XUY*YEF$;(V-I4DC\_>NBV@D$@9'>C8N -HP.0,5HIV5K?UJ8
MNDVV[_UI_D<_:W<HO@DUT9C(7 ,4H9.,XRN,K4<5W*T%E]INY8(&@W>8@^^^
M>A.#V[5T2PQ*S,L:!FZD*,FJ]S9+<%2)IH=HQ^Z; _*G[17V(=&:6YA1/->1
M:=ON'\PW4H$F/FP >W;BEO#(89H9KF5DMKN,"0M@A3@\GV]:Z"VM8K6%(HU^
M5>1GDY[G-2F-&# HI#=01UI^U5]$)8=N-F]?^ -@*F!-DGF+CA\YW>^:DI%4
M*H50 !T '2FRR"*)G;HHS6)TK8Q=2??>,/[H I=-+&[103MY)%57<R2,[=6.
M35S3AL$TYZ(N ?>@96N'+3ODD@,<9JYI"YED;T %9V<G)ZFMC24VV[/_ 'FH
M T**** "BBB@ HHHH **** "BBB@ HHHH **** "N7\6:?\ :K.95'+IN7_>
M%=156_@\^V; ^9>10!X=00""",@]16MX@T\V.I,5&(9OG3V]12Z08;J";3I@
MJM)\T;XYS0!R.G7LGAGQ'%= $Q X8#^*,]17OVBW\=W:ILD#HRAHV'\2FO$M
M6TQG#V\@VS1G@_Y[&M#P'XH?3+I=(OG*1EOW#M_ W]T^QH ]QHJO:72W,>>C
MC[R^E6* "BBB@ HHIKNL:EG8 #N: '5C:C>>:WDQGY%ZGU-%YJ)F!CARJ=SW
M-4*   DX'4U?N<6MDEL#\[?,]4*5F9SEB2?4T ( 20!U/ KI((A# D8["LG3
M+?S9_,(^5/YUM4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RO
MB;1%O+9T  R=T;?W6]*\Q99+:<JP*2QM^((KW2:%9XFC<<&O/_%/AZ21FN(4
M_?H/F _Y:+ZCWH QE:'7H CD1WZ#ANSBN:U70III3&8BETHRO^T!5@%E8$$J
MP/!Z$&N@T_6D\G_B8.C,GW#MRU %7P;XXDMY8]-U:0QS)\D4[]_]EO\ &O6[
M2\2Y3J _=?\ "O#-<L+&]F9K9CAN0=N"OM[BI-!\;7GA^1;#40\\*\13*<M'
M^/<4 >\4A8+U-<[H_B7[?:AW4-D966/[K?\ UZDGO))LC.U?04 :5QJ44.0G
MSOZ#I63/<2W#9D;([ =!6;?:G!8RQ0L&DGERRQ)C.P?><D\*H[DU<5E=%=&#
M(PRK \$=B* %JK?:E9:;$)+VZBMU/0R-C/T'4U-<SI:VLUQ)]R)&=OH!FO#-
M2U*YU:^DO;IRTCG@=D'91["MZ%'VCUV.>O7]DM-SV.R\1Z-J$PAM=1@>4]$)
M*D_3.,UKQ1/-*(T'S']*^>Z]N^&>M/JOAZ?[2=]W:/Y;2-R67&5)_4?A5U\/
M[-<R>A-#$^T?*UJ=M;PK;Q+&O0=3ZFI:Y"/QI*]M;R?V>5<VSRS@M@(X"E5!
M[@AMV>PQ2WGBJZLV,+"S9E<AIX][QX\LOC"\Y^7GV(-<IU'745@:1KESJ6IS
M020QPI&%RFTELF-&^]G'&[&,=JWZ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ J"ZMDN8]IX8?=;TJ>B@#S7Q)X:<2/<VT>)1S)&/X_<>]<:S! 2QQC
MKFO=KFVCN8]KC![-W%>;:[X3GN]2)8*DA.=ZCY&'^- '&*)KMQ'"IP>!@<FN
MKTGP;$46345!'41?XFM[2]%M=+C C4/+CF0CG\/2M!W6-&=V"JHRQ/0"@!L,
M,5O$L4,:QHO 51@"JUS>'SY;&U:,:B(1-''.&",N<9R.OOCID5D:UJDEPEO!
M8%KBUN4$S2V;YDDC5U$BH1WVMGCGK4%EH\.H7$[0B_M-/0H]HSL\<J28(DV;
MOF5&7 (/4Y(]:JW5DM]B"73IM=U6\CN[&6RG6.*>*611+$LJDJ0".'1EQE3C
MIR*ZFRM39V_EM/+.Y)9Y)#RQ/H.@'H!P*?;6\-I;1V]O&L<,8PJ+T J959V"
MJ"2>P%)NXTK%>]MA>6%S:DX$T31Y],C%>$W%O-9W,EM<(4FB8JZGL17TA:Z9
MGYIV'^X#_.JFN^#-$\0E6O;7;,HVK-"VQP/3/?\ &M\/75-M/9G/B*#J)-;H
M^=J]H^%FDS:;X:N;^XC*F]?S$1N"8U& ?QR?PQ5W3OAAX<T^X6=HI[ME.56X
MDRH/T  /XUV>Q=NW:-N,8[8JZ^(4X\L2,/AW"7-(Y-_$DD-I:/+IMN))XHY+
M=4<LJH[!2#A<@C<. #G\*7^WH[2^^Q+IMJ/+16V1$A@70L6"E1A1C!)P>>E;
MBZ'I20/ FGVRQ.0641C!QR/R[58BL;6!'2*WC174*P"_> & #Z\5R'88S7\:
M/:RVFF6QNI;/[4S.PCVQ@+\H;')Y [#CFH9O%SQP/+'ILLFQ(YBN<$Q2%0A'
M'+')X]5/M6N-#TH0+#_9]MY2MN5#&" <8JR]G;2,6>"-F(4$E1R%.5_(\B@#
MGYO%RO(ZV5N)8_.CBCF8MMDW([%@%4G *$=.N?2I#XH(U)M.-J%N#<+!&6<A
M),QAR0<9X) (ZX(-;$^E6%R")K.!P2#R@ZC('Y9/YFG#3[-2I%K#E'$BG8,A
MMNW</?'&?2@#$A\27?E6\MS900PRNRF;S6*+M?9@G9P2<D9P/?-=(*J/I=@Y
MC+V4#>424S&/E).3C\>:MT %%%% !1110 4444 %%%% !1110 4453OKP6Z;
M5YD/0>E "7E\L VKRY[5C/(TC%G.2:1F+,68Y)ZFJ&J:DNG0$!=]T\4CV\1!
M_>LB[MH/K[=3SB@&7)'\N)Y COL4ML099L=@.YKFM<EFOK33]7T^0W%B,,\0
MC+E"2,2A!R[(<C8>_.,BL^[BCUV338X+R/4[U(VN1.DNQ5^[NB<)@HIS\ISN
M##OS74:7I%MH\<T=HT^R:0RLLLIDPQZX)]>]5:Q-VRK8:/:O=Q:L]@UG>#<=
MBOC=D8W.J_+O(ZXZ>M;-210R3MMC7/J>PK'UKQ)!HTC6MI%Y]X!S+(OR)]!W
MJ6-*QJ7$EO8V_P!HOIUMXNV?O-]!7&:]XOU&9/*T%A9(IR7< R2?4]A[5C7=
MY<WUPT]U,\LIZLQ_EZ5!0,Z/0/B*%F6VU=?L=R>/-Q^[?Z^E>E6>J0W2*=P!
M89!!RK?0UX;<6T5U'LE0,.Q[BFZ=K&J^%I/W+FZT_/S0N>GT]* /H*BN3\->
M+K/6+4/!*74??C;[\9]QW%=4CK(@92"#T(H =1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%!X&: (;FX6VA+GD]AZFN?DD:60NYRQZU/>W)N9
MR0?D7A?\:IRQK-"\3YVNI4X.#@C% &)?^("=-NIM,MKNY5(W"7,$6Y5D .,
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MG3Y3]V1>5:J= &7+%<Z1=KJ.F2-$Z<D+V_Q'M7J7@OQE'K%O\V$N$QYT.?\
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M_P >LW^X:D^&H/\ PD$Y["V/\Q5?4'V:?.?]G%:OPNMB]]?SXX")&/J3G^E
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M^MQ6=N"Q9Q$F/U-?0'AZP2RL8XXQB.)!$GT% &S1110 4444 %%%% !1110
M4444 %%%% !1110 5%<0+<0-&>XX/H:EHH \F\7Z,8IS>",%2=LPQT/8URXC
M4#   ]A7MFL::EW Y*!@5VNO]X5Y1J^E2:7=;#DPMS&_J/3ZT 9I164JP!4C
M!![U0MS?>'M0%_IC$J/OQGD%?0CN*TA10!Z)X6\;6>K0A8FVS ?/;.?F7_=]
M178PW4,XRCC/H>M> 36$,D@E3=#,#D21G:0:V]/\3:W8!4EDBOXQT,F4D'_
MA0![517G5GX]7 $T-S"?J'%:'_"<VFW_ (^6_P"_7- ':U!/=PP#YW&?[HY-
M<)<^.8B"$^T2?^.BL&]\47UUE8B+=#UV<L?QH Z_7_%$5JA0D-)_#"I_5J\\
MO+R>^N&GG?<Y_(#T%0DEF+,22>I/4U!+=V\+;9)D5O3/--)O83DEN353U*[%
MK:G:?WC\+_C4K7ENL#3>:K(OH?TJ'0-$N/%>K&64,EC$?WC#T_NCW-#5M&"=
M]CH/AKX=>64ZO,AR^8[<$=OXG_I7LL4:Q1*B]%&*H:1IT=E;(%C" *%1!T5?
M2M*D,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"UK1(KVW=3'
MOC;EE'4'U%;M% 'BVJZ-<:7)E@7@)^60#]#Z&LVO:K[2HKI'PJY8?,K#Y6KA
M-6\'E'9[3]VW7RG/RGZ&@#D**GN;.YLWVW$+QGW'!_&H* "BBB@ HHIKR)$I
M9V"CU8XH J:G<M;6OR'#N=H/IZUSW4Y/6M>_9M0A+VD$TL<&7DE5#M4?6LBO
M3PBC[.ZW/,Q;?M+/8#C^(9'<>M>^Z+%IFCZ+ITJ1.MO.%^SQ1QEV8E2V2 .3
M@$_A7@UO;37ES%:VT9DGF8)&BCDDU[_>Z18V_A[2[&_NA"MF$"-M#;W"%<;2
M#G@D].U98VVCZFN";U70TIO$&GVYD$LK*\:EGC,;;U& <E<9QR.?7CK3EUVP
M9H$,Q1YIC J.C*P<#.T@CCC'7U'K6/=6&C7-W+%/JK?:I8/)<A@/W6W(3&,#
M'WQWY/:H)H?#,NR47\T8D 6%D>3E\A]V2,LQ*J><\**X3N-L^)-*^SM.+H-&
MID4[5)(,?WP1CJ/UI3XAL0ZQC[09F8IY(MW,@( )RN,C@@YK$DT;P_*NX:D4
M<VLC,Z./GCD8X<C&"020#^%/O=.TF61[RZU<O<6UQLEE94;#E0%0KMP, \8&
M>30!NPZU93W9MD>02>8T0+Q,JLZ_>4,1@D8/Y5H5S5K'I?\ :,.W59+C?,UW
M#  "H=RPW$A<]=V 3_*NEH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"FO&DB[74,/0TZB@#,N=&@G4@8P?X7&X5@7?@JUE8D6VT^L+8_2NRHH \WF\
M#J#\LTZ?[R U6;P3-GY;LCZPG_&O4:* /,8_ ,DA_>7MP1Z1Q!?U.:U++X>:
M;$XDDM/.<?Q7,A?].E=U10!F6VBVT$0C*KLQC8JA5_*N:U'X5^'[ZY::'[19
M%CDI XV?@"#C\*[BBJC.4=8NQ,H1G\2N<YX>\$Z-X;<S6D#27)&/M$S;G ]N
MP_"K^NVL5S9J9KJ*U6-MPFD'W#@C(.00>>H/YUJ5GZII\E[]FEADC6:VE\U!
M*FY&.TK@C\>#V-)R<G=CC%15D9/]BP/']G_M=7MI3]JVL%+NP !?=GE<X)X]
MLXXJ>UM=,&GZ>EMJ4;Q6DZ'S/.WAWVE0N23C.>E0W'ANZN;S[8U]$LP41JB0
M ($VE67KD [F/7J%]*BE\'>;;QP_VC*,1@2.8U)9E7:A Q@!<L1WR1SQ2&,&
MAZ;#J)_XFR":*X:=H6*Y$7WA$1G.P-AZ>/#EM'&'&L2A?,0S.64%I%?>""/N
MDEF]>"/2DG\+7ES<3R2WL?[TLY(5OO-!Y1^7./?/7M5N/0[M6:(SP&V-VET/
MD._*E3CKC^&@"EIUAI]M>)>6^MVLJQ1A92S9+89V+$AP,G><D@^O%=&FIV$A
MB"7MNQE.(P)!\Y]N>:Q;SPP]S:RQ)<(A<W)!V=/-;(_*I$T.]^UVMQ]KC26/
M ED7>S2(&+;3DX(Y/49&>* .@HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $P A\# 2(  A$! Q$!_\0
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M =J***8@HHI0&9@J#<[$!0.Y/04,#I]'\"ZAK7AN?6(;JVCV"5H;5\^9<",
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MMW>Z6AP/L:3H/_KUWFBVSV'A"TOK ::EW<2OYD]]MZ+P$7=Q[U.+?2[SQC9
M16<TC6+M>I;<PF4*3\N.!QCIWI6#ZSNK'GI/;K1D$=LUVFAW4/B;Q+8V,^GV
M=O8VX>1((8_O;5SAFZMT[U;NIXKG1]2.KOH9C\DM:+9!1(DN?E Q@X]<U02K
MV:31P%(:.WI1QZU+9T!2TF12Y%"8PHHS1^-%P"BBE52YPOZT7!Z$;#FDJ1XR
M&() Q38P#)@\\5+*3T&9HS5C ]*:<>@_*G87.0^@HJ4@>U,;ITH&G<;Z4\4P
M<XIX%"T!@**!UHJKD!2TE&:3 6BMC2="35+9Y6U:PLRC[=ES)M9N,Y'M5_\
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MOJTE_JEQ;2O<(SE$1PJQI@\-@YSUJ+Q+X8L[&PO8M,LWN)(?$#6:2(K.QBV
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M)NCR?3'..U5=1\(0:+%=7%_K4:1)*(;8Q0%VFD\L/M89^3 8 YZ&M:;PEI\
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MN1Z<UP_  X_^M717'A06VEW-TNIQ275M:P7<MLL3#$<F /FZ;AN'%<^" 02
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MX^T:/9-ZM$#$3^1Q^E(#H4O#)?VQ/\2LLBC^1IW#9:Q,\RC'0UZY9\V5L?\
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M3-=+X&'_ !/IO^O.?_T UV+<XZ_\.1S(I:!THI&JV"BDH)QQ0 IZ"DI>U%4
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M^]N.8[.9ACKL('YU)_95POS326\ _P"FDPS^0S5:6ZN9_P#77$T@_P!IR:B
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M]4VCIA+X0[VNL?\ ?U/\*/-\'9_X]=9_[^I_A7-9Q3@U O9?WG]YT9D\'_\
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M4!['^\_O.D#^#B/]3K/X,E&[P=_SQUC_ +[2N<HS0'LO[S^\Z+?X._YY:O\
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%4AH__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #? :8# 2(  A$! Q$!_\0
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MK>.UC$4W^M4C=OXQR3UJWFC- %"UT33K.9)H+1%E3(5R26 (QC)[5H4F:,T
M+129HS0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %5[JZ2TA,C@MR%55'+$] *L50U(<V?\
MU\I_6FM63-M1N@%SJ)&?L$8]C.,_RH^T:C_SX1_]_P#_ .M5_%%%_(7(^[*]
MO+=.Y%Q;I$N."LF[)_*L[Q%#,\%G<PPM/]CNDN'B499U&0<#N1G./:MFC&:$
M[.XW&\;7,:+7-.U&1;.!IIC,"KA(F&P8Y+$@;?3US6);&]N$N;69ILZ/;2Q,
MV3^^D*G8WO\ )@_5J[%T+(RJQ4D8##J/>J=G91Z9:R_O))79FEEED(W.W<G&
M!T 'X549)+1&<H2;5V8$%E)8RZ:]B)!<W-C)YK.S'?($4J6SWR35",V40T?R
M5O(]2-W"MV7\P$G/S>83P<GI^G%;J>)8I+-+J?3K^"RD0-]H9%*JI[G:Q('O
MCBIX-%026\LM_=W<4!\R!)74J#C@Y RQ /&2:TYFOB_K<SY%+X?ZV_R,&.U:
M.S740)S>KJYC5RS$B,SE2N/[NT_3O6AXJB@5+8O+'&H,C>3(C^7,V!U*<AO0
M^YKH+6<W-JDQAEA+C/ERC#+]12+.3>-;^3* J!_-(^0Y., ^O'ZU'.[W+5)<
MMNY274/LOAU;Z2VE1EMP_D'+.#CA?4G/%<ZUEK>FV-I?2VUJSV<K7,S12,TL
M@?\ U@QMQT/3/\(KMN*.*49VZ%2I\W4XK4KUH;+7[7S)_M-Q,);54#$E"B<J
M>PX;/I4DML+7Q!KAM$9-1FME>S)+?,VQMQ';K70ZCJ<=@\$*P37%Q.3Y<,0&
M6 Y)))  'O4UG<M=VPD>VFMVR08Y@ P(^A((]ZKG:5[?UI_D1[-.5K[?\'_,
MYG3Q9?VCIG]D"X\_)^V[]_W-ISYF[^+=C'?KVJ'3K1H+'1+\"?[9+?&.61F8
MDQDR#:0?X>!75:G?)IFG37CH7$8&%!P6). /S(IUK<^8P@N!''>",220H^[:
M"2 <X&1P:.=VO;^OZ8>S5[7_ *_I''';]ER/M'_"3?:/]O.=_P#WSY>W\,>]
M2W]B9+36;W-R;J*_"P.KL#&N8P=H'8Y.:[; HP/2CVOD/V-^IR%[:SZ=<:M:
M:2DT<;6<4H6,DG=O8.5S_%M'YXI;5;1M1C70!-Y1MY1=8W[<X^3.[^//X]<U
MUW [4=:7M/(?LM=SD+34!=/H4$<EQOAMY%N2$;Y&$6,-GJV<\>U/\)LD=W-;
MPA9U$2LUV@D7>V<8=6Z/W./\*ZS I<4.=U:PU2::=RM<2W:2 06R2KCDM)MY
M_*HOM&H_\^,?_?\ _P#K5>HJ+^13BWU,Z2^O+=3)/8@1+RS1RABH]<8J^C!T
M#J<J1D$=Q45V/]$F_P"N;?RI+#_D'VW_ %R7^0H>P*ZE:Y8HHHI%A1110 44
M44 %%%% !1110 4444 %%%% !1110 4449H **0D 9)P/>D\V/\ OK^= #J*
M;YL?]]?SH\R/^^OYT!<=13?-C_OK^='FQ_WU_.@+CJ*;YL?]]?SH\R/^^OYT
M!<=5#4NMG_U\I_6KOF)_?7\ZH:DZ$V>&7_CY3O\ 6G'<BI\+-&BF^;'_ 'U_
M.CS8_P"^OYTBQU%-\V/^^OYT>;'_ 'U_.@!U17'_ ![2_P"X?Y4_S8_[Z_G1
MYL?]]?SIB>IR.F:]9#PM;6,(DNKT6JQ?9HXF)+;<8/& /4GBGZ3I3IJT=I>/
M+(+&PMMBAV$?F#<"V.A/ KJO-C_OK^=+YL?]]?SJW/>RW,E2VN]CC([N]TW1
M]*U1//G:2W-M)&<L2Y),;$?[W!/HU+>PW=C#J-J+BX9XM)CQ(&8DR;WW,/?/
M]*[+S8_[Z_G2>;'_ 'U_.G[36]A>QTM<YBYL[C3KN\@TDS"673GD +EMTH8
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MABA&619"7/T&WFN+$57&:47H>AAZ,91]Y:FQDC^(GOP:,G^\WYT%#&=C##*
M"*2NU6L<$KIBY/\ >;\Z,G^\WYTE%%D*[%W-_>;\ZT=))/V_+'_CSD[_ $K-
MK1TC_E__ .O.3^E*25@NS.R?[S?G2Y/]X_G244[(+L7)_O'\Z3)_O'\Z**+(
M+L7)_O'\Z,M@G+8'4Y/%)70V=ZB+8%-0B@LHHPMS;-G+G)W_ "8^?<.A[>V*
MB;Y=D5%7ZG/Y/]X_G1D_WC^=;UM'H#&%Y"%,L9<Q,QQ$RC 1CD<,<MU]!D51
MU/\ LY%\NQC!S*Y+LY8A1C:/3'7GKTI*:;M8;BTKW,_YL@?/D]!SS0"Q. 6)
M/8$UT[7ZFP6)=3B&HB-U2Y\XG'S(?O8!3(# +VP?6JUO?0+K^HRV\D45O.2%
M<RF%@NX'*, <'C.,<CBI51N^A7)MJ8*[W8*N]B>@&231D_WC^=='9#2;?48K
MLWL;*LR89V(<_O&W,1C@%,'\:B2'1BD@D-K'*8#]R9VC1P3C'<D@#/)P3TYX
M?M%V#D?<P,G^\WYT9/\ >/YUT;VFBPR/'($0RV_GH9I&'E;QE4P""2!_/H:D
ME_X1^X>YFD6%"RIY:0N5 'E\D9/W]_!'/;CG-+VJ[![-]SF<G^\?SHRQ[M^=
M;;'1&!B$$:95U\X2OGB(,K8Z9+Y'T_.G!M,M/$&E3VTL20*R-,%8L$(/))[Y
MZ\8^@I^T787(^YA9/]X_G0=V 3NP>AR>:VU71'>%"L:;$0EC(^)',1)#>@#@
M#CIDT*MA<>1!+-:P^6V<"5O+4&0%@&ZGY<T>T78.1]S% =L[=YP,G&3BDR?[
MS?G72VLFDVJRF&:%%<*/,\UQ+GSE)&.@4*N0>OO5:./1YYH(B@SE"SJ[EI"=
M^X$=APG09 )H]HNP<C[F%D_WC^=&3_>;\ZU]7MK>WB@,4-M')+;QR.L<K-AB
MSYVYZC &<].,=:R*N#4E=(B2<7:XN3_>/YT9/]YOSI**JR%=D]D3]OMOF/\
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M+.C#/7H,9[&K T*X*%_,38,\A6.0.X &365N+<Y)SZFGK+(@(21E!&#@]O\
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M=>3ZE!J>HZHLEW:7"&1Q'%$5()]%7/6OI;XJVQTZUBUU(T,2XAN&;/R\_(>
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M08C$^"K^9@$'O^M1OILT;0*98MTB,X^<@*HYR3[CFII8-5O)0<2/O4$;&PN
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MI78]!DUZ> H13=2QYF88B;BJ;D_O.V^&FC)JNLWDDRYAAM]I/^TS#'Z*:*]
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MC_T&_P#R6_\ LJ]3HH^M5NX?5:78\L_X4\?^@W_Y+?\ V5'_  IX_P#0;_\
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M%7**+L.2/8I_V58?\^</_? H_LJP_P"?.'_O@5<HHNPY(]BG_95A_P ^</\
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M3I5M#?O<S3R$IN?<1VQU_P X/%;-95EI>E21Q75O%N5U!1BQ/RXP!S[<5J@
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MZ,7DEW:R[QKADVR[F4  9.2<<@D?SJ6"S\IKI7U@>7)$%C!ESL)R2P!/ QM
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #6 C # 2(  A$! Q$!_\0
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MG_G^G_\ 1C5FAL<=JD9V7_"T_&W_ $&V_P"_$?\ \32_\+4\:$<:VW_?B/\
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M_P#Q-)_PL_QF,?\ $Z;_ +\1_P#Q-<B >XP.]/;81R<>AS1=@=9_PM#QD/\
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MPV]B!685*LRMP1P0:&K FF:__"8>*/\ H9-7_P# V3_&C_A,?%'_ $,FK_\
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M+:DHVGU.*D;X>Z?DJVLZ'%NQM#Z@S$>O0<YKR^YA\F9D89YXJ+:O7 _*LMM
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M@A3PHZ?6KOAF0W'ARS).2J[2?I6BZA>>U=L(JQQMD,:!1@=!6+XW '@Z^/\
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M"(@A?IBI=+FU+3)&^Q/<1>;@/B'@X^M6G0%!(@.T\$%N5/I357!W!5)]V/\
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M6\?]!"?_ -&-7MOP_P##KZ!H"R7 !N[S$LG^RN/E7^M<]9Z6+B='?6"7UG-
MQQO0KN],BO-+3X3ZC!J,4@O+-H@X+$!@=N<]*]/NKJ"RM9;JZF6*WB4L\C\
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M2-(=K< O-$G CW2H-Z$=1CK6MX/GTS0O \]Y+;R-+M,LI:,;7/15!/!JG#*
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M8(]1MX3')OR4)SQBN7D^!&I/S_;5H#Z^2U%%4DD(B'P$U4-G^W;3'IY+4I^
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MO"C^SS_>%%%',QW$.G$_QBHGTAG_ .6B_E111=A=D)T%B?\ 6K^5-_X1]O\
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%BF!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Y ;,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#SO6=1U!-7
M:"WNI@,($1#W('3WJ"ZE\1642379U"")^%DD4JK?B13M4N/LGBF.YV[O)>*3
M:.^,''Z5JZKXQM;W[3)%IADENO*$R7C[X@(P<;5&#G)ZDUK5G)5&KF-*$'!:
M(R6?Q+&C.RZDJI&)6)C;"H>C'CI[U7EU/5X7\N:ZNHWP#M<D'!&1P:ZNY^(%
MM+:O%'8W:L'DGC)G&/-D0HP/',8!R!UR*Y+5]3;5]1-XX8.8HT8LVXL50*23
M[XS4>TGW_$T]G#LAO]LZG_S_ %Q_WU2_VSJ>/^/Z?_OJJ5%+VD^_XA[*'\J+
MO]L:G_S_ %Q_WW2?VSJ?_/\ W'_?=4Z3%'M)]_Q#V</Y2[_;.I_\_P#<?]]4
M?VSJ?_/]/_WU5/%%/VD^_P"(>SI]B[_;&I_\_P!/_P!]4?VQJ?\ S_3_ /?=
M4J*7M)]_Q#V<.R_ NG6-3'2^G_[ZI/[8U/\ Y_I_^^JIT4>TGW_$/90_E+G]
ML:E_S_7'_?5']LZE_P _UQ_WU5.BCVD^_P"(>SAV7X%S^V=2_P"?Z?\ [ZI5
MUC4A*O\ IT_4=6]ZI&A?OI_O#^=.-2=]R94X6>AU_C+5+^Q\336]K=R0PB&$
MA(^ "4!/%9D]SXHM+<7$YU&*#./,>,JN?KBK/CSCQ=,?2" _^0UJWJ7C2UO3
M=3IIKO<74 MWCN9-T&P2;P=HP2W0=:Q45U1<?A7R,I;KQ0ZJZG4V5HS*K"-L
M%!U8<=/>H[C4_$%FR+<W%[;LZ[U$H*EE]1D=*Z6W^(-K% (SIUR#YT=TWES@
M*LJ*%54STC('(ZUSWB76X=:NK=K>.XBAB0A8YW#D,3ECNZDD\Y-/ECV**O\
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MQ7S0SVZ_KQZUY7\2/A]J*ZW'J7AK3Y[BROEWO%;QY\B3N,=@>U<IWGEH@E]
M/QI?L\GH/SKZ:T/X;^&I](A34- C6Y\I1(QR"3CD]>#FLZ?X'>'FU,S)=WL=
MF5YM_,Y5O4-UQ[&BPCYV\B3T'YTY+2:3(0 D=MU?04WP%T.27=#JVHQ1_P!S
M*M^I%5+KX!6)MV%MK]XD_P#"TD:E?R%.PSPL:==,&*H#MY(SS^5,2"1)T#+@
MAAP?K7ND/P+GAR1XID<-]X/:@Y_\>KG_ !!\,=:T_4((H%FU2WDZ2PQ<QX(^
M_P"GMBE+8$<%XT!_X2N]_P!X?RK"KH/&ZE/%]^A&"K[3^%<_6=+X$;8C^++^
MNP4445H8A103BN^\'?"R_P#$UN+N]NAIMHZYA+*&>3WQG@>] ' T9KO=3^&;
MQ^);+1='U!M0>=V6:8Q;5A"XR>IJSXK\"6.GW>S1+6YN((K8AY7?<)9L@9'H
M.O%4HN3LB7)1W9YSFBNCT_PIJ4]UMGTV;R]C994(VM@[>?KBJ<6E&&Z1;U$6
M/.) '&Y<]^">G]*)1DMT)5(RV9D45TMGX3=?%%AIEVX>&:>-2R'&^-CU'X5[
M9#\%_!$T8=(+X@_]/1XI6*N?-U%?2_\ PI'P7C_CUO?_  *- ^"/@HY_T6\R
M/^GHT6"Y\T45] ^*?@UX;LO#-_<:5!,M]'$6B::Y.T$<\_AFO"QIPQ_Q]0?B
MU%@*5!'%73IW_3U!_P!]5*-)1MH2^@9F_AS@@_CQ04MT9.K@G5)L?[/_ *"*
M*=K *ZK.#U! _045DMCNJ-\[.D\4ZYJ-W+'IDUP396T:"*$* !QG\:YVM/Q
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M4K%MP-O'<58'P'\/X_Y"FI?^.?X5G2^!&^(_BR/ *ZWP=X1M?$UO=O/>2PO
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M]L#@?ES^->2^/M;O-9U:WL9)VF6T4(@/9F[?E@47$5$7^SOA^[GB74;@*/\
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MAH_B/2-0S+I-XD9PX+*,9'4=>XKLY<8)]ZSYV;=U/3UJ/K%3R'H>CZ1++;3
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MTK.-17?^02@]-2&U.48^]7(UXS34B@56\N7=G)^AI]NV_3[>5QMF=<LHZ?\
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M%8@[C^7/^"TD:[C&&'+;,@^[%C^E<R8-$$@1)-C9VK(H_!%R?UJG!\C+(?\
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M70Y:?Q&99/)#-Y6]@DG#+G@^E;,]U<02$13.B3PA9%4X# >M98@D:XB*0R$
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MKO(=?EEY,2C\:Z5"YC[2+>K.=;3KQ;>3_1Y,[#_#[4FF6T\MHKI$[ 87('?
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M573K<QO<,A&,-DX7/<5I]6E'J8\[:YK:'1W%]*MA<D@X\IOPX-4O!=U)'H@
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M8>71+E\$=?+)Z?Y[UPNJKHMQJ$S7<VR8OEB)"!&I[ 8QFIE*P4L*IWL]._\
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M?SK5@EV7EU<C[EK#L7ZXP*YBPU4RQP6\G$L;M*S-T<]OQK7M"[Z:D1R7O+@
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M,$)("H0<#KV%.V!,8^>0]:%)(VIP/7%.#!/E0<GJ?2IN%@* $%B2XZ 5*2
M6Y;L!46[8>.7/>HVDVD\[G/>@7*/D?!!/7L/2H=32(6EK+&,-DAZAFG" C.7
M]:CC$MSM0Y*YX6JC%W'S*";9#?Q_;)PZC@J,_6FVME(D@POR]>:ZG3]*BB*/
M-\S]=I' K5DL8;E5&U$P<DJ.HKJA2T.&IC[>ZC*T?1S=ON<8C!^9O7V%=W:Q
MQQ1)&B!448 %9UO&D:*B855& !6A"_'-=$8V1XU>K*H]2_'MR.*N1@ <UGH^
M,5;BDS6J.5.SU+:@'N:E">]0(U3*V#FE>YTQL<AXH9H=2DP>#&I_G6+XZL;&
M&2SO+*%(1<1 D1\!N!S70^)U5]04,!AHAU^IKAM9N[Y56U8B>T@XBRO,8],^
ME&,I2J4XRCK8]W+YQ4;,QUGE4?ZQOSJQ#>7J@^5<NN/>LWSP0?EI\=YY1)V9
M!&,&O)Y6>CS&S'KNJQM@7THQ]/\ "EM?$^MB[$8U*8*2>./\*REOHB23 1ZX
M;O4$-R$NPX7N>,T697.;5QK^K?;%?^T)MWE@ YY ]*K3Z[JLGW]1N#_P.LV>
M\WS!PF/EQUJN]P3V II!<NO?W4G#W,S#WD)KH_".7O\ 35!PSW* MW/S<UR]
MA9W&H2A4&$S\SXX%=SX5CB7Q+I5K" 5CF!)]:]/!4G!.;6ECDQ4KQL>Y@CH*
M=3$.>O6GU)QH2C%*>:,4 1L .:C:IF&:B(IDM#,9ZU&RC\:E/%1D&FC-HA9<
M]*@=<U:(J)QVIF<D4)8ZI3P@BM1UZU5D7M0<M2"9A3V_7 K'NK4-VKIYHN3Z
M5E7,(RQ J)1.>+<78X^\ML;JIS74GV:"T9<*C%LC^+TK?OH3C('>N;O24FVL
M, =#7+5I1=FUL>K@J\HRM?<BO9R+=4'5CC%8R7K*TK!R@VD;3S[5%JUQ(TR1
M1L<@?K5.X++9*''SD\^M9H]F-/0?I2>?J&X\]ZZZ<EA%;IWP36!H-OA?-(ZU
MTFBQ&\U@,5) /X<5QXB6K?8WBKLZ6]D&F^&!$N \@  ]S4?AJV,,$D[@8Q@&
MJGB*?[3J45I']V(<CW-:%_-_9/AXHI^=EVC\:\VS4$EO)F[5W8\Q\1W'VKQ#
M>S#=AGX_("BJNIJPU&8 ]Q_(45[$8VBD9,GE8FYE!X'F-_,U,KI%&2.M5YFQ
M<S8&3YC?SIZ#'+<FM&<TE=CPS2^P]:?A(Q]>WK4>[GY>3Z]J<O3)Y/J:DFP'
M+^P]*D4JHPHRWZ"F#D<9 _4TX$+T'/I2&/ &-[$GWIX!<<G:/[OM[TQ2!\S&
MEY8_-PH[?XTA6)MVXX4X4=_7Z4A;'R)^=1ERW3A?YTUI,C:O3UI#L/9@HVJ.
M>YZU6DFV [2=W<^E,EN  57Z$BH5!)R>M:) [)78Y$+MN:N@TV-$B5BHW^M9
M$28_&MNV 6-1FMH(\[$5'+0T(F(ZU=B?@5G*W.>U68F'Y5NCS9:&M"W(S5V-
MO:LN%NG-78V '6M4SFD:49JS%)@\]#5&)ACD\>E6%.[VJT825C11L"I5?%4D
M?H.]2-(!QF@N,CC/B#J#6E[8M$3N,; @'WX_K619S^8"90&W+SQ5'Q[?%O%4
MD;-E4C11[<9K(LM4:"4J263^$CM54<6H3<9['TE"D_J\>YT$FFV3N#Y:CU'2
MF_V+IS=<C_@55$UBV+9=B"?:I?M]H3GSEKM3P\M= ;FB0:)89/S'_OJA=#L-
MV<D_\"J$WML3Q.GYT@OK8'_7I^=+EP_D.\[$TNB:8C#()_X&:GN=/T.!5,42
MD@C/)-9MQ?6WEL!,I...:S;>_$< 65F+;L\UE.="+LDC2,)25VS<DN55?*@C
M$<8]!C-:?@.ZB?QQ8Q$C(+'/;.#Q7%7.HM(-J?+FM#0,6&H:9J/VE1+]K0"(
M'Y@N>2?2N6KBKVC$N5/W&?3:-Q4BFJX:GA\U-CSU(FR*,U&#06I%W',?>F,1
M2$TTG%,EL0TW-*3D4S--&;$-1GH*>QIC<"F2R)ZK2**L.:@?I08S*LB>M9\\
M(8$8K3D&15.1<DTF<E2)@W-L&)XQ7.:AIZ2@@@GW':NRG3'&.#6/=P#K2<58
MBG4<6>5:I9S6EWO<%ESPWI5"Z?SI54GVKT34;"*="KH".XK"A\*3:E=K:Z;;
MSW%PQ^6.-<G_ .L*Y9T[;'T.%QL9I*2U(K8"VL,=\5UGAF-;:QDNG_A4GFNA
MT_X.745C9#6M2$-S<3B)8H &" @GYB>IX[56\5^%]5\*Z2T30M/;LVT7,()7
M'OZ?C7E8BG-JRZGL4FNIB:)$=1U5YY.26W<TOBBZ\_48[1#E8NH]ZMZ(4L+)
M[IB,;<BL;3%?5-:,IYW/N/TKE7QN?1&MO=\V<EKELT6LW"$$$;>/^ BBM+Q<
M%'BF^&.C+_Z"**]&$[Q1AR&3,<7,W_71OYT ENN0/2EE %U,?^FC?SH&3]T<
M>M;LYWN/!P0 ,GTJ0+@Y8Y([=JC!"C_.:7J.?RJ6*Q(6W'Y>!ZT9 XZD]JCS
MN/R_GZ4Y?E'3.?UI!8>.S-VIV=PYX YQ4>23N8]*0MQGH!0,<S[N.W\ZJRSD
M<+TIDL^?E7O^M-1<G)JXQ!Z(?&A)R>M68TP>14<8JR@S5)')5J7)8EK2C./>
MJ,?45<C;C%:I'!-EM&/2K:-CK5%'P/QJP&R,UHCGDC3A?@8JY&^XX_&LV*3@
M8JW&V<5<=SFFC2B<GC'-6D;\:H1..*M*V&Y_2M4821<1O7K2EQ^E1!N.M(3G
MO3(L>3^/,_\ "4W!]54C'TKG(I) P&"17H?C#PW=:E>I>6:*[; KH6 .1TK#
MT[P9JDE]%]JA,4 .79F'3VKDG3DY/0^KPV*I+#QO):(PT;/!!S4F\5W]_P""
M[74;HW"3M;LRC<JJ",CO5<?#9F/RZHH^L?\ ]>CV$S..8X:23YK'#%A]*4-T
MYKN3\,YRV!J<>/7RS3Q\+9S_ ,Q2/_OT:?L)]A_7L-_,<$Q!:F3,=H(]:]#'
MPKD;_F++_P!^C_C5JW^%ELDR/<:D\JJV2@CP#[4E0FROK^'6O,>4-OSD@_C5
MS3=\NIVB+R3,O3ZBO0O&7@2]O-3^V:/!&Z2 !HE(7:1QQGM5;PK\/=937[2Z
MU&!(+>"02,"P);'. !0J4E*UC58NE.GS7/<48[5^@J16JLC9J9:ZFCRHLFW4
M;JCS1F@NX\GT-,R:3-!-*Q-PI#2%J86JA-BEJC+&@M49:BQ#8,14#MFGL:@9
MJ#&3&N>*JOBII#QUJL[4K7.>I(J7&"1S6;..HJ_*V35*4BF<R=V9R64E[=QV
MT0S)*VU0>YKU/PU8QZ19PV\$UO9-*HQ(UJ#YW_ \\GV/-<%X>'_%4:8?^GE:
M]9E^SV%U-;70C^P76Z1/,QM5^K+ST]1^-<M5ZGT&507*YLJZI::FUSII.J1\
M70P!:@<[6]ZGOC>6D.+W6+8I(=HC-F"9/8+G)K%U!M12XLO[%\Q[,7 V_:NQ
MP?\ 5YY(_P![BM&.[T^R@DN%$LVK_P"KV77^N9SP%]ES_=XQ6#5SV$]3R7XD
M:=)I</G0VZ6\$SB-T5=NUR"?NC(' Z=N*QO#,0MH7N2<8'6NZ^,%E]A\'Z-%
M(X>9K\O-(?XY"A)/YUYQ=WHL]',2?>88KS:]*RY(]3IA.[UZ'(:_>FZUV\GZ
M[GZY]L45G7N1>2=^?Z45V1II)(7.79E_TF8G_GHV!^-&[V_^M397/VJ8?]-&
M_G32P QFK9RM$@(]>?6G9!& >/U-0*<G'Z5,-H/'XFDT(>.@"@?X4I^49))-
M-!"C Z^E-+*!EC2L,<6XR3566<D[!^ ILLY)P/P'I21I@Y)R:I1"UA53G)Y-
M3J,TP5,H'XU1A4D2HHJ5*B6I5Z4T<<RPG:K*MBJBFIU/ %:HYY%M6P ?>K*,
M"M4E. !4\;<\8JT8R1?B<+Q5V-\@8-9BDY&>*M0OCIS5)V.>2L:D3@'WJVC_
M (5F(W0U;C<<<UI?J8-:V+P)QC-2/C@"J\3$\FID(;O5HSZCB@X/7![TT1[C
M@@X^M3 @]>12@C'O3);0)$#R*G2+/]*6(#C@U80<<U3$M6"H14H!/7-*H' J
M4 "I-8Q&HO%/5.:<H&*E P*#91&HF#5B,8[4P5*E.^AM%6)U[5,#QS5<&G[L
M=ZDW3)L\=:-U1;^*-WO0.Y(6'XTTM4984A;BBPG(D)IA.*C+TUFH)<AQ:HV:
MFF3FHF8BF9MCF:HG:D+U"[TC&4A';DU7D<*":<[XJI+(2,8[T'-.0R0@FJ<C
M?_JJ61NU596(X!HL3$=8WPT[5;6[*[Q#*'(SBO5X(K+Q1IYN%U!;J92&C(X6
M!QR/D_QKQJ1CS[>]-MK^[T^Z6YLKB2"4?Q(<9]CZUA4A<]7!8OV-XR5TSW3[
M4MU%ICE DR7(22/^ZX4@CZ57ELK;7=0>[N!_HMEE+>16VD/T9P>V.@_&O,7^
M(5ZQ226W43D@RR1G 8@$;P.S8./3I6#X@\7ZIK5NMEYOV73T&U;:$X!'^T>K
M5AR,]=XZERZ:FA\5O$MOJ=O;:+;WZZBMK,9C<*N"IP1M)'#'GJ*\OFN)9/+B
MD;*IP":TI4 ' X%9\L7)R*F=--&<,5+GYF9FH0%+Z52>>/Y"BF7,A^T/O8EO
M6BL^5G?[0)WQ=7'/_+5OYTU6)&35V;_CZG_ZZM_,T+]VJ&]RH&]Z<),5;7K2
MBD24O-QGFH992W /-:3]:@--(:*B+MZ\^]2 U>]*>M,F4BD"*>'Q5T?>IR]:
M#&21363'6I5D!JW3TZU1A***ZRC-3K*,]:G'6IEJDS"4$0+*,=:G1QNSN J0
M=JG3K5W,)00U9%./F&!4\4@ QFG)5B.FF8S@B2*0,!S5J-QGFB#[HJVG45:9
MSSB$;X[U.C '@YIZ?UJS'WJ[F$D1HV!C-2#OR*F7M4ZU9$HD,;$'KS5I6'J*
M5?O#Z5+3OH)0L(&]ZD#4X=*>.HI&R0T/4@?FE%**#5*PH8&IHVXIBU9CZ4&D
M1 :,XJ7M33UHN:V(]WO2;_>G^M-/6@3&F2F&3BI3TIAZ4$ZD9?/(IID]ZD[4
MSO02[D1?'0U&TF:G/2HFH,I7*[2=1FHFD&.2*LMWJ%Z1C),IO*#T-5G?!SFM
M U!)T_&G<S43.=NIW<U5ED /WJTWJM)UJ6S115C+D8$&J[L,=:U).]5V[UG)
MFT8F/(PSUJK(<]ZV7JN]2=$48<F2>O%5'7)YQ70/55^_TJ6;1.*O% NY![T5
1=U/_ )",WU'\A161ZZ>A_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "* )8# 2(  A$! Q$!_\0
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M0]+_ /3S75A/XU7_ *\U?_350_)_&[_DUG''_9/4/_3^1G^DM\ ?^2,_"?\
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M^%%HW_S-T?\ #U__ (*5?]'O?'W_ ,*+1O\ YFZ^@?T=N)=?^%?AO_P;5_\
ME9S?ZV8+^]]Y_J!_BO\ WS_]C17^8!;_ /!5O_@I7*7/_#:_Q\P.@/B/1>.?
M;PWUHI?\2[\2K_F;\-_^#JG_ ,J8GQ9@O[R/]/T18()X]R?\]LX_QQ4N,+@\
MGM]2>/YU\9?LU?M[_LB_M@Z>DG[//Q\\!_$'5S9O=W_@Q-5?P[\2M#BCC#9\
M0_"_Q+'X<^(_AX8) :_\*VRD[B'XY^S,G:  3[CM@\5^&8G#XS"8AT,72J49
M)/W:E*=*<6FT[QG&+M=.S5TU9IL^GC6A73M*+MV::[]&[[:]>Z/GGX\?LU?
M?]I_PF? GQ^^#O@?XM>&,R3V>F>-_#>D:F-#U(J"NJZ#J\L1U_PYKI8B--?\
M,W=K=1(IV2KR6_G+_:K_ .#8#X0^*1JOB/\ 8W^+WB3X/ZJTC7%G\*_BN^J?
M$7X:Y&T)I&B>-&D_X6;X>#Y;/B;Q;)\8;@'@6Q&[9_5YE?4<9[=R>H[^O3/6
MFD@@Y)[XR,8/OC@\_EFO:X>XPXCX9J*IDF;UZ4HW]Q5.>E-7NU.C-U*+=TES
M1C3G:_O,XL5EN$Q:_P!J@G>ZV2M>]G=)/]&?Y>'[5G_!+3]NK]C8ZQJOQF^
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M_1#O@Y_X;CP7_P#,_5VU^!GP8M!_HGPA^%MF.QM/ 7A&/T[KH2_S_I7Y;_\
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M /!3C_GR_9V_\/#K'_SMJ^4_XB%P*E=<6\,I6O=.25N]TK6\[V\ST?[#S?\
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MB;Q'JTWB'5]8_MSP_P#&?X1?$6XD/B+6=9\12+\1_&GCT-<Z^ZHD:KL/K/\
MP3]_X-\_@K^Q]\?C^V!\=?CM\7/VW/VKK75=0U+0_BA\83+8Z=H/BC7=*@\/
MR^.(=&UG7_&OBKQ#X\B\-2?V!;>)_&GQ3\8)X:B0OX0AM/%)^VI\57?_  <;
M?MP>,OVD_P!J#X _LQ_\$H=5_:<E_9K^,7Q,^&?B/5_AG\5O&6IZFNE>"/B5
MX]\ Z%XLUS0]"^"?BE]#3Q2W@J1UCG>0"=B(W\H1;.\\$?\ !R_XS^$GQH\
M_"3_ (*8_P#!-KXU_L#^'?B3<+'X?^*WB37/&FO^&;$/KF@Z/+KNM:)X\^"_
MPEC_ .$!\*?\)'I;>./%OA/Q9XPN/"SM$9?!REUV?=XG#\;PPTL"U3Y?9+FI
MPED+Q;IQBY<DE!PSR5-03]RSBXMV7*VY/3SWO?7EWWOLOZTZGZ>:%_P2$^'6
M@?\ !6KQK_P5DC^,/C:X^(/C'2!H=W\(3I7A]?!-ECX > ?@0)%UO:OB)I?[
M$\%6_B-DP%^TS%0AA13)'_P5#_X(Q?LD_P#!4JQT'7/BO::_\/OC5X.TL^%_
M"/QV^'2:=%XI'A9VN=9B\'>,M&UNWE\.^/?A[#XCU=_$L=M)'%XN\,7#>($\
M!>._!S>+/%_VSZN_;M_;Q^ 7_!/G]GG5?VC_ -H#6KZW\'VFK:3X7\)^'?#5
MK_:OC3XB>.M>,QT3PAX)TB8POX@U^6WTK6O$CQ12%;;PCH/B3Q@ZO9>%[F<?
MS8>$_P#@NI_P6[_:3T"^^/O[(W_!'ZVUK]FGR8M0TG4/$;?$3QIXD\4Z,I?=
MK/@/6DU_X23?$"*Y/F9_X5A\)/&R0X9;>3Q41FO'P&'S^O;-,)/V2RE1HJI4
MJTJ$='*,*455G!57%RD_9\E31/F@[/E-7Y];6;?F]/S.\B_X-<_BM\0+;1?A
MU^TS_P %D/VQ_CI^SOIV WP5^R>+-,TY+ 8VQ:0?'WQN^+OPTT)A_"(OA!,
M=VWKFOT\_;U_X(N_"W]O*']AG3_$?QP^+G@&T_82M-1M?!]T5TSXA^)OB!]H
MD^#ZK+XW\8>/HI/$FL:^LGP5TAKOQ07>X\4Q:[X@FO-[W >N2_X)-?\ !<7X
M2_\ !23Q+XO^!'C+X::]^S%^U_\ #F#5[SQ;\!/%^JR7R:UI?A_7O^$>\8ZI
MX*UK6M \)>)/[=\(:U"D/COX<>*_"/A?QGX0EN#,(O%5C')XH'S]_P %'O\
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MEF,X/$U95JS48-U:DE&+G/VD9J3<806S7NZ+5A=NU];*R\EJ[?BS\ /^"?\
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M).[.5]/45RSQ?/*4Y/WI-N7N1U;;;^SWOHM%TT$?YOO[ W_!4#P!_P $Q?\
M@II_P5V\7>/_ ()?'3XT6WQ:_:2^,GAC1]+^"6BZ)JVI>'_^$'_:;^/FMR'7
M%\1>(O"G!772"5!8C@ @E3TO_!1G]O[XF_\ !Q1\3_V=OV ?V//V6]?^'%]H
M?CG5OB#K'B+X]:IX8TOQKH>K)X5OO!VMZSK5OH$U[!\/OA'\,O#OB75_$'CB
M2#Q)XJ\;>/+@>%QX(\$)XP\(VUKXC_=7_@C!_P $_?VO?V5/^"AG_!5[XX_M
M ?")OA]\)/VF/BIXH\3?!;Q5_P +"^&?B:3Q_IFL_'WXP>/-(U9= \"_$'Q=
MXF\/RQ^'?&VBRO%XJ@\+2H-9FMVC:>.8)SO_  6K_P""3/[37C[]I']GS_@I
MO_P2]TNVL?VV_AKXP\-:;\1/#UEXB\&>"F^(=EH6E-H?@KXF3:[XW\1^#_#&
MNW/ACPYYGPT^(/A/Q3XE$?Q<^#^KZ'X*GD6V\'?\(IXO_5ZN>9!+B"HX\KS5
MT)0I\3RQ%7V3K_V'4A&,\/%>Q4?:/D=5/G4G\+:L/IU[M<JO:^K3O=NW3;K?
M=GYS?\'(W@O2[;]IG_@BS^R-\0M?U$?LTZ?I^E_#OQ)XDU>]ETLZYI.K?%#X
M$_"7XKZUK6J^9Y">(/#GP[TG1;HS"-G\*1^(O$%PLBQR[#_<CH&BZ'X9T?2/
M#WAS3=/T;0-$TK2]'TC0-,M5TS3]'TS288M'T?2](T:&/R=)T>"*#RK>.%!'
M%!&L:@Q*#'^&'_!23_@F7XD_X++_ +"?P<MOB]X)D_9#_;:\"Z))XT\&Z+XJ
MUGP5\2_#/PX^(NLZ2NC?$OX.>./$WP]USQ=H7B?X-_$Z32='2+Q3X0E7Q;;K
MI/PX\>WO@R6Y\+^*?@[=?E]\./VH_P#@Z=_9>\#:1^SGXH_8)^''[4VO^&;2
MX\&^!_C_ .(]<T?QCJ/B&PT0MI&D:UXX\7>!?VC?"$?B,R0PB9/%?C&'X1^,
MI;8O<^-VD\8W4AD^8Q=*.>9/EF#PF8T:68914Q7MX5:M.C&K&K5G4^L1E-PH
MUHRYIN:DU/WDX[:UUW;=E9J[M96MIJK):6NM[]SR#_@IKI>G?!C_ (.E/^"=
M'C?X%6\>A^/OBV/V8-5^+<N@!?,U!O&_Q*^+/P(\=ZWKC*SK]H\3?L[:./"L
MA^4KX1\/%]JJREOK'_@H;_P2._X*(_#+_@H7XF_X*K?\$E?'O@Z]^+'Q"M(6
M^)?P*\9:CX5TC4=3U=/!WASP9KNB:'/X]6W^&7CWX<_%+0/!6A:]XX\+^+?%
MG@GQ=X2\91'QCX'\:R3_ /",Q>#?1_\ @E)_P1V_:IT?]L'7_P#@JC_P54\5
MZ)XI_;!\0G5;SX>?#31]7TKQ%%\-]2UO0/\ A"&\0^-==\-22_#B+Q%X8^'2
M3?#;P;\./AI)XI\"^$O"[#Q5'XR\5>.9;67PCUO[3?QC_P"#BS]E?]J'XX^+
M_@]^SM\!OV\/V0O'OBTZW\(_"_AF\TSP[XP^"WA6 -H.D>"Y#<_$'PK\1V\3
M7,&DKXC\=7/_  B/QB\)3>*9W?P)-X.@E'@^'U9YC.6,RS"97F7#CJ9)PTL+
MB)XAN%+B5U*\I5(3E5C"-:5)5>3WN5SITN2G/G7O3TV:U;5MU963=G=7M?K9
MN]NWD/[,/_!PG^T%\//VF?AY^QM_P5U_8OU[]DGXH_%3Q#IGA3P?\6/#$.M:
M7\-[J_US7&\/Z-J6I>#?&K^(O)^'LWB/=X=;XL^#_B_\6?""7;1)E;.Q\3^*
MHM?_ (*F_P#!(C]N.[_;ST3_ (*L_P#!+'XB^$[#]I/3?#NDVGCGX5>-+C1K
M&^UW4M$\&?\ "I#JW@75?'?F?#+7$\5?#EH_#'C'PK\4'\)PV\7A[_A,_!7C
MB+QM)9_\(S\M1_L ?\%?/^"R'[:W[,WQ[_X*8?![P!^Q_P#LP?LSZQIOB+P[
M\,=*U;2=5\4ZWID'C+1/'&OZ#HVFZ+\0_%WB.#Q'\6-;\"^!_#?C;Q3XLN/!
M5OX3\'Z%"_@GP;]K$C^+?T4_;)^)/_!PQ^S5^U9\4/B5^S)\&?@-^VM^QEXV
M/A-O 7P;M)M!\.?$/X,:9H?A_0M"U^(W6O\ B?X6>*9/%'B[71-XCDGMI_C+
MX26,2M!X2\%X,HB3PN#S7#_V1/AR&<2HSAQ#0E74^')-V<:=*=:4U)NC>ZC4
MMSQCR3DVU-[IWN]4^;6]N[M9_$M[:GR7\)_^#B7]J[]E[XV> ?V=?^"S/[#D
M_P"R_>>-M6;0K/X__#^'6=+\"6>=5T#11XL;PAK_ (@\:>'_ !S\//#4FOPW
M'CWQ?\)OB_XUG\'85CX'D#(*_L#4*5R#C=@<\X/7&??_ .MUK^&;XI?L'_\
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M3B^*OBKX):YX(\4:KXB^"/PK^"NK:I\-?$>M:]K6L> M:.L>'?#.[0=9.O\
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7:=;?(]?'0?04M%%?%$A11119=D!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>cyngn-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu May 12 19:03:25 UTC 2022 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://cyngn.com/20211231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:cyngn="http://cyngn.com/20211231" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20211231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20211231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20211231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20211231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet" id="cyngn_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals" id="cyngn_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement" id="cyngn_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ShareholdersEquityType2or3" id="cyngn_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Consolidated Statements of Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals" id="cyngn_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>005 - Statement - Consolidated Statements of Stockholders&#8217; Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedCashFlow" id="cyngn_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals" id="cyngn_r_ConsolidatedCashFlow_Parentheticals">
        <link:definition>007 - Statement - Consolidated Statements of Cash Flows (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DescriptionofBusiness" id="cyngn_r_DescriptionofBusiness">
        <link:definition>008 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPolicies" id="cyngn_r_SummaryofSignificantAccountingPolicies">
        <link:definition>009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/BalanceSheetComponents" id="cyngn_r_BalanceSheetComponents">
        <link:definition>010 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/Leases" id="cyngn_r_Leases">
        <link:definition>011 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IntangibleAssetsNet" id="cyngn_r_IntangibleAssetsNet">
        <link:definition>012 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/Debt" id="cyngn_r_Debt">
        <link:definition>013 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CapitalStructure" id="cyngn_r_CapitalStructure">
        <link:definition>014 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders" id="cyngn_r_NetLossPerShareAttributabletoCommonStockholders">
        <link:definition>015 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/StockBasedCompensationExpense" id="cyngn_r_StockBasedCompensationExpense">
        <link:definition>016 - Disclosure - Stock-Based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RetirementSavingsPlan" id="cyngn_r_RetirementSavingsPlan">
        <link:definition>017 - Disclosure - Retirement Savings Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IncomeTaxes" id="cyngn_r_IncomeTaxes">
        <link:definition>018 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CommitmentsandContingencies" id="cyngn_r_CommitmentsandContingencies">
        <link:definition>019 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RisksandUncertainties" id="cyngn_r_RisksandUncertainties">
        <link:definition>020 - Disclosure - Risks and Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SubsequentEvents" id="cyngn_r_SubsequentEvents">
        <link:definition>021 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/AccountingPoliciesByPolicy" id="cyngn_r_AccountingPoliciesByPolicy">
        <link:definition>022 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables" id="cyngn_r_SummaryofSignificantAccountingPoliciesTables">
        <link:definition>023 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/BalanceSheetComponentsTables" id="cyngn_r_BalanceSheetComponentsTables">
        <link:definition>024 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IntangibleAssetsNetTables" id="cyngn_r_IntangibleAssetsNetTables">
        <link:definition>025 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CapitalStructureTables" id="cyngn_r_CapitalStructureTables">
        <link:definition>026 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" id="cyngn_r_NetLossPerShareAttributabletoCommonStockholdersTables">
        <link:definition>027 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/StockBasedCompensationExpenseTables" id="cyngn_r_StockBasedCompensationExpenseTables">
        <link:definition>028 - Disclosure - Stock-Based Compensation Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IncomeTaxesTables" id="cyngn_r_IncomeTaxesTables">
        <link:definition>029 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DescriptionofBusinessDetails" id="cyngn_r_DescriptionofBusinessDetails">
        <link:definition>030 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails" id="cyngn_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>031 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable" id="cyngn_r_ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable">
        <link:definition>032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable" id="cyngn_r_ScheduleofpropertyandequipmentestimatedusefullifeTable">
        <link:definition>033 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/BalanceSheetComponentsDetails" id="cyngn_r_BalanceSheetComponentsDetails">
        <link:definition>034 - Disclosure - Balance Sheet Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYs2oFZtOTTU4jS6iJhwAty6PIH4pPzDs97dkXlMe6U6IN1M+lk5vzKEXByUg/z1wUlxyqJGPe6Zz0mQ0VgkjxWaC3zpaLfOpSLlryildOmpaRwqomOPGOgMsNG3+0+fSRb8e5SoWpWZRilaPT9QB0JY74QrvbwuCaxJWCYmyj/yh4O5FaQ41lE] CSR-->
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofpropertyandequipmentTable" id="cyngn_r_ScheduleofpropertyandequipmentTable">
        <link:definition>035 - Disclosure - Balance Sheet Components (Details) - Schedule of property and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable" id="cyngn_r_ScheduleofaccruedexpensesandothercurrentliabilitiesTable">
        <link:definition>036 - Disclosure - Balance Sheet Components (Details) - Schedule of accrued expenses and other current liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/LeasesDetails" id="cyngn_r_LeasesDetails">
        <link:definition>037 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IntangibleAssetsNetDetails" id="cyngn_r_IntangibleAssetsNetDetails">
        <link:definition>038 - Disclosure - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable" id="cyngn_r_ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable">
        <link:definition>039 - Disclosure -  Intangible Assets, Net (Details) - Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable" id="cyngn_r_ScheduleofestimatedamortizationexpenseforallintangibleassetsTable">
        <link:definition>040 - Disclosure -  Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DebtDetails" id="cyngn_r_DebtDetails">
        <link:definition>041 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CapitalStructureDetails" id="cyngn_r_CapitalStructureDetails">
        <link:definition>042 - Disclosure - Capital Structure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable" id="cyngn_r_ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable">
        <link:definition>043 - Disclosure - Capital Structure (Details) - Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable" id="cyngn_r_ScheduleoffairvalueofthewarrantsTable">
        <link:definition>044 - Disclosure - Capital Structure (Details) - Schedule of fair value of the warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable" id="cyngn_r_ScheduleofbasicanddilutedlosspershareTable">
        <link:definition>045 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of basic and diluted loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable" id="cyngn_r_ScheduleofcalculationofdilutedsharesoutstandingTable">
        <link:definition>046 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of calculation of diluted shares outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/StockBasedCompensationExpenseDetails" id="cyngn_r_StockBasedCompensationExpenseDetails">
        <link:definition>047 - Disclosure - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofstockoptionTable" id="cyngn_r_ScheduleofstockoptionTable">
        <link:definition>048 - Disclosure - Stock-Based Compensation Expense (Details) - Schedule of stock option</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable" id="cyngn_r_ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable">
        <link:definition>049 - Disclosure - Stock-Based Compensation Expense (Details) - Schedule of weighted average fair value of each grant estimated on grant date</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IncomeTaxesDetails" id="cyngn_r_IncomeTaxesDetails">
        <link:definition>050 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable" id="cyngn_r_ScheduleoffederalstatutoryincometaxTable">
        <link:definition>051 - Disclosure - Income Taxes (Details) - Schedule of federal statutory income tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" id="cyngn_r_ScheduleofdeferredtaxassetsandliabilitiesTable">
        <link:definition>052 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SubsequentEventsDetails" id="cyngn_r_SubsequentEventsDetails">
        <link:definition>053 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract"/>
  <xs:element name="BalanceSheetComponentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_BalanceSheetComponentsAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract"/>
  <xs:element name="ScheduleOfFairValueOfTheWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfFairValueOfTheWarrantsAbstract"/>
  <xs:element name="ScheduleOfBasicAndDilutedLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
  <xs:element name="ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract"/>
  <xs:element name="ScheduleOfStockOptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfStockOptionAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract"/>
  <xs:element name="RetirementSavingsPlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RetirementSavingsPlanAbstract"/>
  <xs:element name="ScheduleOfFederalStatutoryIncomeTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
  <xs:element name="LossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_LossPerShareAbstract"/>
  <xs:element name="DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetsAbstract"/>
  <xs:element name="PPPLoanForgiveness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PPPLoanForgiveness"/>
  <xs:element name="GainOnForgivenessOfPaycheckProtectionProgramLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans"/>
  <xs:element name="TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount"/>
  <xs:element name="PPPLoanWasForgivenByTheSBAInTheAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount"/>
  <xs:element name="BalanceSheetComponentsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_BalanceSheetComponentsTextBlock"/>
  <xs:element name="RetirementSavingsPlanTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RetirementSavingsPlanTextBlock"/>
  <xs:element name="ConcentrationOfSupplierRiskPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
  <xs:element name="ConvertiblePreferredStockPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ConvertiblePreferredStockPolicyTextBlock"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock"/>
  <xs:element name="ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems"/>
  <xs:element name="PropertyAndEquipmentUsefulLifeLeaseholdImprovements" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements"/>
  <xs:element name="Automobiles" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_Automobiles"/>
  <xs:element name="CreditCardPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CreditCardPayable"/>
  <xs:element name="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable"/>
  <xs:element name="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems"/>
  <xs:element name="SeriesASharesIssuedAndOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SeriesASharesIssuedAndOutstanding"/>
  <xs:element name="CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable"/>
  <xs:element name="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems"/>
  <xs:element name="EarningsPerShareTotal" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_EarningsPerShareTotal"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding"/>
  <xs:element name="ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest"/>
  <xs:element name="WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted"/>
  <xs:element name="StocksIssuedDuringPeriodSharesStockOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised"/>
  <xs:element name="StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited"/>
  <xs:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt"/>
  <xs:element name="DeferredTaxAssetsTrueup" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetsTrueup"/>
  <xs:element name="FederalStatutoryIncomeTaxRateTotal" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_FederalStatutoryIncomeTaxRateTotal"/>
  <xs:element name="DeferredTaxAssetsSBC" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetsSBC"/>
  <xs:element name="DescriptionofBusinessDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_DescriptionofBusinessDetailsTable"/>
  <xs:element name="DescriptionofBusinessDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DescriptionofBusinessDetailsLineItems"/>
  <xs:element name="NetProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_NetProceeds"/>
  <xs:element name="PurchaseAnAdditionalSharesOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PurchaseAnAdditionalSharesOfCommonStock"/>
  <xs:element name="RedeemableWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RedeemableWarrants"/>
  <xs:element name="PurchaseWarrantsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PurchaseWarrantsDescription"/>
  <xs:element name="CommonStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockShares"/>
  <xs:element name="PreferredStockShareIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PreferredStockShareIssued"/>
  <xs:element name="UnrestrictedCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_UnrestrictedCashAndCashEquivalents"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="LeasesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_LeasesDetailsTable"/>
  <xs:element name="LeasesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_LeasesDetailsLineItems"/>
  <xs:element name="RentExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RentExpense"/>
  <xs:element name="MaturityDate" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_MaturityDate"/>
  <xs:element name="CapitalStructureDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_CapitalStructureDetailsTable"/>
  <xs:element name="CapitalStructureDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CapitalStructureDetailsLineItems"/>
  <xs:element name="CommonStockShareAuthorized" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockShareAuthorized"/>
  <xs:element name="CommonStockSharesIssurance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockSharesIssurance"/>
  <xs:element name="FairValueOfOptionsGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_FairValueOfOptionsGranted"/>
  <xs:element name="StockbasedCompensationExpenseOfStockOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StockbasedCompensationExpenseOfStockOptions"/>
  <xs:element name="StockOptionsExpectedVest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StockOptionsExpectedVest"/>
  <xs:element name="IncomeTaxesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_IncomeTaxesDetailsTable"/>
  <xs:element name="IncomeTaxesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_IncomeTaxesDetailsLineItems"/>
  <xs:element name="DeferredTaxAssetNetCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetNetCurrent"/>
  <xs:element name="NetOperatingLosses" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_NetOperatingLosses"/>
  <xs:element name="TotalUnrecognizedTaxBenefit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TotalUnrecognizedTaxBenefit"/>
  <xs:element name="TaxPositionTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TaxPositionTerm"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_SubsequentEventsDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SubsequentEventsDetailsLineItems"/>
  <xs:element name="AmortizationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AmortizationMember"/>
  <xs:element name="CYNMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CYNMember"/>
  <xs:element name="CommonStockWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockWarrantsMember"/>
  <xs:element name="LiquidityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_LiquidityMember"/>
  <xs:element name="PurchaseWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PurchaseWarrantsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>cyngn-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu May 12 19:03:25 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedBalanceSheet" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedIncomeStatement" roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedCashFlow" roleURI="http://cyngn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable" roleURI="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofcalculationofdilutedsharesoutstandingTable" roleURI="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermNotesPayable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_Revenues" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYs2oFZtOTTU4jS6iJhwAty6PIH4pPzDs97dkXlMe6U6IN1M+lk5vzKEXByUg/z1wUlxyqJGPe6Zz0mQ0VgkjxWaC3zpaLfOpSLlryildOmpaRwqomOPGOgMsNG3+0+fSRb8e5SoWpWZRilaPT9QB0JOuvL+28ORzQcZteO18QJaZt2qLrWxj99] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeExpenseNet" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherIncome" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cyngn_PPPLoanForgiveness" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanForgiveness"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="cyngn_PPPLoanForgiveness" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:href="cyngn-20211231.xsd#cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="us-gaap_RestrictedInvestmentsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherRestrictedAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="us-gaap_OtherRestrictedAssetsCurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable">
    <loc xlink:type="locator" xlink:label="cyngn_EarningsPerShareTotal" xlink:href="cyngn-20211231.xsd#cyngn_EarningsPerShareTotal"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cyngn_EarningsPerShareTotal" xlink:to="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cyngn_EarningsPerShareTotal" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>cyngn-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu May 12 19:03:25 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedBalanceSheet" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedIncomeStatement" roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ShareholdersEquityType2or3" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedCashFlow" roleURI="http://cyngn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedCashFlow_Parentheticals" roleURI="http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_DescriptionofBusiness" roleURI="http://cyngn.com/role/DescriptionofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SummaryofSignificantAccountingPolicies" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_BalanceSheetComponents" roleURI="http://cyngn.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_Leases" roleURI="http://cyngn.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IntangibleAssetsNet" roleURI="http://cyngn.com/role/IntangibleAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_Debt" roleURI="http://cyngn.com/role/Debt"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CapitalStructure" roleURI="http://cyngn.com/role/CapitalStructure"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_StockBasedCompensationExpense" roleURI="http://cyngn.com/role/StockBasedCompensationExpense"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_RetirementSavingsPlan" roleURI="http://cyngn.com/role/RetirementSavingsPlan"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IncomeTaxes" roleURI="http://cyngn.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CommitmentsandContingencies" roleURI="http://cyngn.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_RisksandUncertainties" roleURI="http://cyngn.com/role/RisksandUncertainties"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SubsequentEvents" roleURI="http://cyngn.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_AccountingPoliciesByPolicy" roleURI="http://cyngn.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_BalanceSheetComponentsTables" roleURI="http://cyngn.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IntangibleAssetsNetTables" roleURI="http://cyngn.com/role/IntangibleAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CapitalStructureTables" roleURI="http://cyngn.com/role/CapitalStructureTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_StockBasedCompensationExpenseTables" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IncomeTaxesTables" roleURI="http://cyngn.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable" roleURI="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofpropertyandequipmentestimatedusefullifeTable" roleURI="http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofpropertyandequipmentTable" roleURI="http://cyngn.com/role/ScheduleofpropertyandequipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofaccruedexpensesandothercurrentliabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable" roleURI="http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofestimatedamortizationexpenseforallintangibleassetsTable" roleURI="http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable" roleURI="http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleoffairvalueofthewarrantsTable" roleURI="http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofbasicanddilutedlosspershareTable" roleURI="http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofcalculationofdilutedsharesoutstandingTable" roleURI="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofstockoptionTable" roleURI="http://cyngn.com/role/ScheduleofstockoptionTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable" roleURI="http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleoffederalstatutoryincometaxTable" roleURI="http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofdeferredtaxassetsandliabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_DescriptionofBusinessDetails" roleURI="http://cyngn.com/role/DescriptionofBusinessDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_BalanceSheetComponentsDetails" roleURI="http://cyngn.com/role/BalanceSheetComponentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_LeasesDetails" roleURI="http://cyngn.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IntangibleAssetsNetDetails" roleURI="http://cyngn.com/role/IntangibleAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_DebtDetails" roleURI="http://cyngn.com/role/DebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CapitalStructureDetails" roleURI="http://cyngn.com/role/CapitalStructureDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_StockBasedCompensationExpenseDetails" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IncomeTaxesDetails" roleURI="http://cyngn.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SubsequentEventsDetails" roleURI="http://cyngn.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#DocumentAndEntityInformation" roleURI="http://cyngn.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_Assets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_Liabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestIncomeExpenseNet" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncome" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PPPLoanForgiveness" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanForgiveness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="cyngn_PPPLoanForgiveness" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockWarrantsMember" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="cyngn_CommonStockWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:href="cyngn-20211231.xsd#cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" xlink:href="cyngn-20211231.xsd#cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanWasForgivenByTheSBAInTheAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/DescriptionofBusiness">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/BalanceSheetComponents">
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_BalanceSheetComponentsAbstract" xlink:to="cyngn_BalanceSheetComponentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/IntangibleAssetsNet">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/Debt">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/CapitalStructure">
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_PartnersCapitalNotesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/StockBasedCompensationExpense">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/RetirementSavingsPlan">
    <loc xlink:type="locator" xlink:label="cyngn_RetirementSavingsPlanAbstract" xlink:href="cyngn-20211231.xsd#cyngn_RetirementSavingsPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_RetirementSavingsPlanTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_RetirementSavingsPlanTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RetirementSavingsPlanAbstract" xlink:to="cyngn_RetirementSavingsPlanTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/RisksandUncertainties">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ConvertiblePreferredStockPolicyTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ConvertiblePreferredStockPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_ConvertiblePreferredStockPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/BalanceSheetComponentsTables">
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_BalanceSheetComponentsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_BalanceSheetComponentsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/IntangibleAssetsNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/CapitalStructureTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="us-gaap_RestrictedInvestmentsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherRestrictedAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="us-gaap_OtherRestrictedAssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="us-gaap_RestrictedCashAndInvestmentsCurrent" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable">
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AutomobilesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_AutomobilesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements" xlink:href="cyngn-20211231.xsd#cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:to="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofpropertyandequipmentTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_Automobiles" xlink:href="cyngn-20211231.xsd#cyngn_Automobiles"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="cyngn_Automobiles" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_FurnitureAndFixturesGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_CreditCardPayable" xlink:href="cyngn-20211231.xsd#cyngn_CreditCardPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="cyngn_CreditCardPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYs2oFZtOTTU4jS6iJhwAty6PIH4pPzDs97dkXlMe6U6IN1M+lk5vzKEXByUg/z1wUlxyqJGPe6Zz0mQ0VgkjxWaC3zpaLfOpSLlryildOmpaRwqomOPGOgMsNG3+0+fSRb8e5SoWpWZRilaPT9QB0JTrnbZRfrtVvDwLLZ/nLuvco4ivRHDSsj] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:href="cyngn-20211231.xsd#cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AmortizationMember" xlink:href="cyngn-20211231.xsd#cyngn_AmortizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="cyngn_AmortizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConversionOfStockTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesASharesIssuedAndOutstanding" xlink:href="cyngn-20211231.xsd#cyngn_SeriesASharesIssuedAndOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="cyngn_SeriesASharesIssuedAndOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable">
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossPerShareAbstract" xlink:href="cyngn-20211231.xsd#cyngn_LossPerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="cyngn_LossPerShareAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_LossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_EarningsPerShareTotal" xlink:href="cyngn-20211231.xsd#cyngn_EarningsPerShareTotal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="cyngn_EarningsPerShareTotal" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofstockoptionTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfStockOptionAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfStockOptionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" xlink:href="cyngn-20211231.xsd#cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="cyngn-20211231.xsd#cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" xlink:href="cyngn-20211231.xsd#cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="cyngn-20211231.xsd#cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_InventoryValuationReserves" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsTrueup" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsTrueup"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="cyngn_DeferredTaxAssetsTrueup" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_FederalStatutoryIncomeTaxRateTotal" xlink:href="cyngn-20211231.xsd#cyngn_FederalStatutoryIncomeTaxRateTotal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="cyngn_FederalStatutoryIncomeTaxRateTotal" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable">
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="cyngn_DeferredTaxAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsSBC" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsSBC"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="cyngn_DeferredTaxAssetsSBC" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsSBC" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/DescriptionofBusinessDetails">
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_DescriptionofBusinessDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_DescriptionofBusinessDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_DescriptionofBusinessDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="dei_LegalEntityAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PurchaseWarrantsMember" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="cyngn_PurchaseWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CYNMember" xlink:href="cyngn-20211231.xsd#cyngn_CYNMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cyngn_CYNMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_LiquidityMember" xlink:href="cyngn-20211231.xsd#cyngn_LiquidityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="cyngn_LiquidityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_NetProceeds" xlink:href="cyngn-20211231.xsd#cyngn_NetProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_NetProceeds" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PurchaseAnAdditionalSharesOfCommonStock" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseAnAdditionalSharesOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_PurchaseAnAdditionalSharesOfCommonStock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_RedeemableWarrants" xlink:href="cyngn-20211231.xsd#cyngn_RedeemableWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_RedeemableWarrants" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PurchaseWarrantsDescription" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseWarrantsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_PurchaseWarrantsDescription" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesAuthorized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockShares" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_CommonStockShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreferredStockShareIssued" xlink:href="cyngn-20211231.xsd#cyngn_PreferredStockShareIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_PreferredStockShareIssued" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAppropriated" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAppropriated"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAppropriated" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_UnrestrictedCashAndCashEquivalents" xlink:href="cyngn-20211231.xsd#cyngn_UnrestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_UnrestrictedCashAndCashEquivalents" order="17" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_UnrestrictedCashAndCashEquivalents" xlink:href="cyngn-20211231.xsd#cyngn_UnrestrictedCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="cyngn_UnrestrictedCashAndCashEquivalents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RestrictedCash" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/BalanceSheetComponentsDetails">
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_BalanceSheetComponentsAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_BalanceSheetComponentsAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="cyngn_LeasesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_LeasesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_LeasesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_LeasesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_LeasesDetailsLineItems" xlink:to="cyngn_LeasesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_LeasesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_LeasesDetailsLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_RentExpense" xlink:href="cyngn-20211231.xsd#cyngn_RentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_LeasesDetailsLineItems" xlink:to="cyngn_RentExpense" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/IntangibleAssetsNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AdjustmentForAmortization" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/DebtDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_OtherBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_InvestmentInterestRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_MaturityDate" xlink:href="cyngn-20211231.xsd#cyngn_MaturityDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="cyngn_MaturityDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/CapitalStructureDetails">
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="cyngn_CapitalStructureDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockShareAuthorized" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockShareAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="cyngn_CommonStockShareAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_DividendsPayableAmountPerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockSharesIssurance" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockSharesIssurance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="cyngn_CommonStockSharesIssurance" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_FairValueOfOptionsGranted" xlink:href="cyngn-20211231.xsd#cyngn_FairValueOfOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="cyngn_FairValueOfOptionsGranted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockbasedCompensationExpenseOfStockOptions" xlink:href="cyngn-20211231.xsd#cyngn_StockbasedCompensationExpenseOfStockOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="cyngn_StockbasedCompensationExpenseOfStockOptions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockOptionsExpectedVest" xlink:href="cyngn-20211231.xsd#cyngn_StockOptionsExpectedVest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="cyngn_StockOptionsExpectedVest" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="cyngn_IncomeTaxesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_IncomeTaxesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_IncomeTaxesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_IncomeTaxesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="cyngn_IncomeTaxesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetNetCurrent" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="cyngn_DeferredTaxAssetNetCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_NetOperatingLosses" xlink:href="cyngn-20211231.xsd#cyngn_NetOperatingLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="cyngn_NetOperatingLosses" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TotalUnrecognizedTaxBenefit" xlink:href="cyngn-20211231.xsd#cyngn_TotalUnrecognizedTaxBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="cyngn_TotalUnrecognizedTaxBenefit" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TaxPositionTerm" xlink:href="cyngn-20211231.xsd#cyngn_TaxPositionTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="cyngn_TaxPositionTerm" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="cyngn_SubsequentEventsDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SubsequentEventsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_SubsequentEventsDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_SubsequentEventsDetailsLineItems" xlink:to="cyngn_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SubsequentEventDescription" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://cyngn.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="9" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>cyngn-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu May 12 19:03:25 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase/(decrease) in cash and cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract_lbl" xml:lang="en-US">Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RestrictedCashAndInvestmentsCurrent_lbl" xml:lang="en-US">Total Cash and cash equivalents and Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract_lbl" xml:lang="en-US">Schedule of property and equipment estimated useful life [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_BalanceSheetComponentsAbstract_lbl" xml:lang="en-US">Balance Sheet Components [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_BalanceSheetComponentsAbstract" xlink:to="cyngn_BalanceSheetComponentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule of property and equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of accrued expenses and other current liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract" xlink:to="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule of estimated amortization expense for all intangible assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract" xlink:to="cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalNotesAbstract_lbl" xml:lang="en-US">Partners&apos; Capital Notes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_PartnersCapitalNotesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract_lbl" xml:lang="en-US">Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract" xlink:to="cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfFairValueOfTheWarrantsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfFairValueOfTheWarrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfFairValueOfTheWarrantsAbstract_lbl" xml:lang="en-US">Schedule of fair value of the warrants [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfFairValueOfTheWarrantsAbstract" xlink:to="cyngn_ScheduleOfFairValueOfTheWarrantsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract_lbl" xml:lang="en-US">Schedule of basic and diluted loss per share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract_lbl" xml:lang="en-US">Schedule of calculation of diluted shares outstanding [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_EarningsPerShareTotal" xlink:href="cyngn-20211231.xsd#cyngn_EarningsPerShareTotal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cyngn_EarningsPerShareTotal_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_EarningsPerShareTotal" xlink:to="cyngn_EarningsPerShareTotal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfStockOptionAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfStockOptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfStockOptionAbstract_lbl" xml:lang="en-US">Schedule of stock option [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfStockOptionAbstract" xlink:to="cyngn_ScheduleOfStockOptionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of shares, outstanding at beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Number of shares, outstanding at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, outstanding at beginning balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted-average exercise price, outstanding at ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregate intrinsic value, outstanding at beginning balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl0" xml:lang="en-US">Aggregate intrinsic value, outstanding at ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Number of shares, vested and expected to vest at beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl0" xml:lang="en-US">Number of shares,vested and expected to vest at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl" xml:lang="en-US">Weighted-average exercise price, vested and expected to vest at beginning balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:to="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl0" xml:lang="en-US">Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:to="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at beginning balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl0" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Number of shares, vested and exercisable at beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0" xml:lang="en-US">Number of shares, vested and exercisable at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, Vested and exercisable at beginning balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted-average exercise price, Vested and exercisable at ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at beginning balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract_lbl" xml:lang="en-US">Schedule of weighted average fair value of each grant estimated on grant date [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RetirementSavingsPlanAbstract" xlink:href="cyngn-20211231.xsd#cyngn_RetirementSavingsPlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RetirementSavingsPlanAbstract_lbl" xml:lang="en-US">Retirement Savings Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RetirementSavingsPlanAbstract" xlink:to="cyngn_RetirementSavingsPlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract_lbl" xml:lang="en-US">Schedule of federal statutory income tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of deferred tax assets and liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Total property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Note payable, Paycheck Protection Program</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Convertible Series A, B and C preferred stock, Par $0.00001; 10,000,000 authorized as of December 31, 2021 and 21,982,491 shares authorized, issued and outstanding as of December 31, 2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Convertible preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Convertible preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Convertible preferred stock, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Convertible preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Convertible preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, Par $0.00001; 100,000,000 shares authorized, 26,487,680 shares issued and outstanding as of December 31, 2021 and 42,000,000 shares authorized, 951,794 shares issued and outstanding as of December 31, 2020</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common stock, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common stock, shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common stock, shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Common stock warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xml:lang="en-US">Interest (expense) income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other (expense) income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PPPLoanForgiveness" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanForgiveness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PPPLoanForgiveness_lbl" xml:lang="en-US">Paycheck Protection Program Note forgiveness</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PPPLoanForgiveness" xlink:to="cyngn_PPPLoanForgiveness_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Aggregate intrinsic value, exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110 (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Iinitial public offering, net of closing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Conversion of convertible preferred stock to common stock in connection with initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Conversion of convertible preferred stock to common stock in connection with initial public offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Issuance of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US">Accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xml:lang="en-US">Disposal of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from issuance of common stock upon initial public offering, net of offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from Paycheck Protection Program Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid during the year for taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosure of non-cash financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" xlink:href="cyngn-20211231.xsd#cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount_lbl" xml:lang="en-US">The Company&#8217;s Paycheck Protection Program Note was forgiven by the SBA in the amount of $1,602,936.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" xlink:to="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanWasForgivenByTheSBAInTheAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount_lbl" xml:lang="en-US">Paycheck protection program note was forgiven by the SBA in the amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount" xlink:to="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xml:lang="en-US">Gain on disposal of asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:href="cyngn-20211231.xsd#cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans_lbl" xml:lang="en-US">Gain on forgiveness of Paycheck Protection Program Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:to="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Convertible Series A Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl1" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Convertible Series B Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl0" xml:lang="en-US">Series B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Convertible Series C Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl0" xml:lang="en-US">Series C [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockWarrantsMember" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockWarrantsMember_lbl" xml:lang="en-US">Common Stock Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockWarrantsMember" xlink:to="cyngn_CommonStockWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Description of Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedInvestmentsCurrent_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedInvestmentsCurrent" xlink:to="us-gaap_RestrictedInvestmentsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherRestrictedAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherRestrictedAssetsCurrent_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherRestrictedAssetsCurrent" xlink:to="us-gaap_OtherRestrictedAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment estimated useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements" xlink:href="cyngn-20211231.xsd#cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements_lbl" xml:lang="en-US">Property and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements" xlink:to="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_BalanceSheetComponentsTextBlock_lbl" xml:lang="en-US">Balance Sheet Components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_BalanceSheetComponentsTextBlock" xlink:to="cyngn_BalanceSheetComponentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_Automobiles" xlink:href="cyngn-20211231.xsd#cyngn_Automobiles"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_Automobiles_lbl" xml:lang="en-US">Automobiles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_Automobiles" xlink:to="cyngn_Automobiles_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US">Furniture and fixtures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xml:lang="en-US">Computer and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CreditCardPayable" xlink:href="cyngn-20211231.xsd#cyngn_CreditCardPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CreditCardPayable_lbl" xml:lang="en-US">Credit card payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CreditCardPayable" xlink:to="cyngn_CreditCardPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Accrued payroll</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xml:lang="en-US">Total accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated amortization expense for all intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock_lbl" xml:lang="en-US">Capital Structure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:to="us-gaap_PartnersCapitalNotesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl" xml:lang="en-US">Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesASharesIssuedAndOutstanding" xlink:href="cyngn-20211231.xsd#cyngn_SeriesASharesIssuedAndOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SeriesASharesIssuedAndOutstanding_lbl" xml:lang="en-US">Shares Issued and Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesASharesIssuedAndOutstanding" xlink:to="cyngn_SeriesASharesIssuedAndOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl" xml:lang="en-US">Per Share Liquidation Preference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl0" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl" xml:lang="en-US">Aggregate Liquidation Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US">Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value of the warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueNetAssetLiability_lbl" xml:lang="en-US">Fair value of underlying securities (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Expected term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Risk-free rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of basic and diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Basic and diluted weighted average common shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossPerShareAbstract" xlink:href="cyngn-20211231.xsd#cyngn_LossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_LossPerShareAbstract_lbl" xml:lang="en-US">Loss per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossPerShareAbstract" xlink:to="cyngn_LossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of calculation of diluted shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" xlink:to="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock_lbl" xml:lang="en-US">Unvested restricted shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="us-gaap_WeightedAverageNumberOfSharesRestrictedStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Common shares issuable upon conversion of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock-based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted-average remaining contractual, outstanding at beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average remaining contractual, vested and expected to vest at beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average remaining contractual, vested and exercisable at beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of shares, granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" xlink:href="cyngn-20211231.xsd#cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted_lbl" xml:lang="en-US">Weighted-average exercise price, granted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" xlink:to="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" xlink:href="cyngn-20211231.xsd#cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted-average exercise price, exercised (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" xlink:to="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited_lbl" xml:lang="en-US">Weighted-average exercise price, cancelled/forfeited (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="cyngn-20211231.xsd#cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted-average remaining contractual, outstanding at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares_lbl" xml:lang="en-US">Weighted-average remaining contractual, vested and expected to vest at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt_lbl" xml:lang="en-US">Weighted-average remaining contractual, vested and exercisable at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average fair value of each grant estimated on grant date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of common stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RetirementSavingsPlanTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_RetirementSavingsPlanTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_RetirementSavingsPlanTextBlock_lbl" xml:lang="en-US">Retirement Savings Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RetirementSavingsPlanTextBlock" xlink:to="cyngn_RetirementSavingsPlanTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of federal statutory income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal tax at statutory rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xml:lang="en-US">Nondeductible expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">FIN 48 reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign Tax Rate Difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsTrueup" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsTrueup"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetsTrueup_lbl" xml:lang="en-US">True-up and Rate Change</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsTrueup" xlink:to="cyngn_DeferredTaxAssetsTrueup_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_FederalStatutoryIncomeTaxRateTotal" xlink:href="cyngn-20211231.xsd#cyngn_FederalStatutoryIncomeTaxRateTotal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_FederalStatutoryIncomeTaxRateTotal_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FederalStatutoryIncomeTaxRateTotal" xlink:to="cyngn_FederalStatutoryIncomeTaxRateTotal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax assets and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="cyngn_DeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses and Credit carryover</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">State taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0" xml:lang="en-US">State income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsSBC" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsSBC"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetsSBC_lbl" xml:lang="en-US">SBC</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsSBC" xlink:to="cyngn_DeferredTaxAssetsSBC_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xml:lang="en-US">Accruals And Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Gross deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Deferred Commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Risks and Uncertainties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="cyngn-20211231.xsd#cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of shares, exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number of shares, cancelled/forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AutomobilesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AutomobilesMember_lbl" xml:lang="en-US">Automobile [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AmortizationMember" xlink:href="cyngn-20211231.xsd#cyngn_AmortizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AmortizationMember_lbl" xml:lang="en-US">Amortization [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AmortizationMember" xlink:to="cyngn_AmortizationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Offering price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Original issuance price, per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_NetProceeds" xlink:href="cyngn-20211231.xsd#cyngn_NetProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_NetProceeds_lbl" xml:lang="en-US">Net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NetProceeds" xlink:to="cyngn_NetProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PurchaseAnAdditionalSharesOfCommonStock" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseAnAdditionalSharesOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PurchaseAnAdditionalSharesOfCommonStock_lbl" xml:lang="en-US">Additional shares of common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseAnAdditionalSharesOfCommonStock" xlink:to="cyngn_PurchaseAnAdditionalSharesOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RedeemableWarrants" xlink:href="cyngn-20211231.xsd#cyngn_RedeemableWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_RedeemableWarrants_lbl" xml:lang="en-US">Redeemable warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RedeemableWarrants" xlink:to="cyngn_RedeemableWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Initial exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PurchaseWarrantsDescription" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseWarrantsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PurchaseWarrantsDescription_lbl" xml:lang="en-US">Purchase warrants , description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseWarrantsDescription" xlink:to="cyngn_PurchaseWarrantsDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExcessStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesAuthorized" xlink:to="us-gaap_ExcessStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockShares" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockShares_lbl" xml:lang="en-US">Common stock shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockShares" xlink:to="cyngn_CommonStockShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreferredStockShareIssued" xlink:href="cyngn-20211231.xsd#cyngn_PreferredStockShareIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PreferredStockShareIssued_lbl" xml:lang="en-US">Preferred stock shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreferredStockShareIssued" xlink:to="cyngn_PreferredStockShareIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare_lbl" xml:lang="en-US">Preferred stock, per shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionPricePerShare" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAppropriated" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAppropriated"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAppropriated_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAppropriated" xlink:to="us-gaap_RetainedEarningsAppropriated_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_UnrestrictedCashAndCashEquivalents" xlink:href="cyngn-20211231.xsd#cyngn_UnrestrictedCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_UnrestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Unrestricted cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_UnrestrictedCashAndCashEquivalents" xlink:to="cyngn_UnrestrictedCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Common stock shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Deferred social security taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Future minimum payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RentExpense" xlink:href="cyngn-20211231.xsd#cyngn_RentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_RentExpense_lbl" xml:lang="en-US">Rent expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RentExpense" xlink:to="cyngn_RentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherBorrowings_lbl" xml:lang="en-US">Company borrowings</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYs2oFZtOTTU4jS6iJhwAty6PIH4pPzDs97dkXlMe6U6IN1M+lk5vzKEXByUg/z1wUlxyqJGPe6Zz0mQ0VgkjxWaC3zpaLfOpSLlryildOmpaRwqomOPGOgMsNG3+0+fSRb8e5SoWpWZRilaPT9QB0J2p+8hlv8Fdeo8FNxv+nTzB/k2xmqjPjD] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_MaturityDate" xlink:href="cyngn-20211231.xsd#cyngn_MaturityDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_MaturityDate_lbl" xml:lang="en-US">Maturity date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MaturityDate" xlink:to="cyngn_MaturityDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Interest accruing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockShareAuthorized" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockShareAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockShareAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockShareAuthorized" xlink:to="cyngn_CommonStockShareAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl" xml:lang="en-US">Dividends declared on common stock, per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockSharesIssurance" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockSharesIssurance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockSharesIssurance_lbl" xml:lang="en-US">Common stock issurance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockSharesIssurance" xlink:to="cyngn_CommonStockSharesIssurance_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_FairValueOfOptionsGranted" xlink:href="cyngn-20211231.xsd#cyngn_FairValueOfOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_FairValueOfOptionsGranted_lbl" xml:lang="en-US">Fair value of options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FairValueOfOptionsGranted" xlink:to="cyngn_FairValueOfOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockbasedCompensationExpenseOfStockOptions" xlink:href="cyngn-20211231.xsd#cyngn_StockbasedCompensationExpenseOfStockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_StockbasedCompensationExpenseOfStockOptions_lbl" xml:lang="en-US">Stock-based compensation expense of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockbasedCompensationExpenseOfStockOptions" xlink:to="cyngn_StockbasedCompensationExpenseOfStockOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockOptionsExpectedVest" xlink:href="cyngn-20211231.xsd#cyngn_StockOptionsExpectedVest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_StockOptionsExpectedVest_lbl" xml:lang="en-US">Stock options expected vest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockOptionsExpectedVest" xlink:to="cyngn_StockOptionsExpectedVest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod_lbl" xml:lang="en-US">weighted-average period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Effective tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetNetCurrent" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetNetCurrent_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetNetCurrent" xlink:to="cyngn_DeferredTaxAssetNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">Federal income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xml:lang="en-US">Expiration term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US">Federal net operating loss carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Research credit carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_NetOperatingLosses" xlink:href="cyngn-20211231.xsd#cyngn_NetOperatingLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_NetOperatingLosses_lbl" xml:lang="en-US">Net operating losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NetOperatingLosses" xlink:to="cyngn_NetOperatingLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Cumulative ownership, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Unrecognized tax benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_TotalUnrecognizedTaxBenefit" xlink:href="cyngn-20211231.xsd#cyngn_TotalUnrecognizedTaxBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TotalUnrecognizedTaxBenefit_lbl" xml:lang="en-US">Total unrecognized tax benefit (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TotalUnrecognizedTaxBenefit" xlink:to="cyngn_TotalUnrecognizedTaxBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_TaxPositionTerm" xlink:href="cyngn-20211231.xsd#cyngn_TaxPositionTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TaxPositionTerm_lbl" xml:lang="en-US">Tax position term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TaxPositionTerm" xlink:to="cyngn_TaxPositionTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventDescription_lbl" xml:lang="en-US">Subsequent events, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl" xml:lang="en-US">Concentration of Supplier Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets and Finite Lived Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ConvertiblePreferredStockPolicyTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ConvertiblePreferredStockPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ConvertiblePreferredStockPolicyTextBlock_lbl" xml:lang="en-US">Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConvertiblePreferredStockPolicyTextBlock" xlink:to="cyngn_ConvertiblePreferredStockPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss Per Share Attributable to Ordinary Shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xml:lang="en-US">Selling, General, and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">Initial Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_CYNMember" xlink:href="cyngn-20211231.xsd#cyngn_CYNMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CYNMember_lbl" xml:lang="en-US">&#8220;CYN&#8221; [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CYNMember" xlink:to="cyngn_CYNMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PurchaseWarrantsMember" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PurchaseWarrantsMember_lbl" xml:lang="en-US">Purchase Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseWarrantsMember" xlink:to="cyngn_PurchaseWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_LiquidityMember" xlink:href="cyngn-20211231.xsd#cyngn_LiquidityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_LiquidityMember_lbl" xml:lang="en-US">Liquidity [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LiquidityMember" xlink:to="cyngn_LiquidityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Federal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:href="cyngn-20211231.xsd#cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable_lbl" xml:lang="en-US">Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:to="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems_lbl" xml:lang="en-US">Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockTable_lbl" xml:lang="en-US">Conversion of Stock [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_ConversionOfStockTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockLineItems_lbl" xml:lang="en-US">Conversion of Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConversionOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable_lbl" xml:lang="en-US">Capital Structure (Details) - Schedule of fair value of the warrants [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:to="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems_lbl" xml:lang="en-US">Capital Structure (Details) - Schedule of fair value of the warrants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US">Investments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_DescriptionofBusinessDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DescriptionofBusinessDetailsTable_lbl" xml:lang="en-US">Description of Business (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="cyngn_DescriptionofBusinessDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_DescriptionofBusinessDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DescriptionofBusinessDetailsLineItems_lbl" xml:lang="en-US">Description of Business (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_DescriptionofBusinessDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_LeasesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_LeasesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_LeasesDetailsTable_lbl" xml:lang="en-US">Leases (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LeasesDetailsTable" xlink:to="cyngn_LeasesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_LeasesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_LeasesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_LeasesDetailsLineItems_lbl" xml:lang="en-US">Leases (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LeasesDetailsLineItems" xlink:to="cyngn_LeasesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CapitalStructureDetailsTable_lbl" xml:lang="en-US">Capital Structure (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="cyngn_CapitalStructureDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CapitalStructureDetailsLineItems_lbl" xml:lang="en-US">Capital Structure (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CapitalStructureDetailsLineItems" xlink:to="cyngn_CapitalStructureDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IncomeTaxesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_IncomeTaxesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IncomeTaxesDetailsTable_lbl" xml:lang="en-US">Income Taxes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IncomeTaxesDetailsTable" xlink:to="cyngn_IncomeTaxesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IncomeTaxesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_IncomeTaxesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IncomeTaxesDetailsLineItems_lbl" xml:lang="en-US">Income Taxes (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IncomeTaxesDetailsLineItems" xlink:to="cyngn_IncomeTaxesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SubsequentEventsDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SubsequentEventsDetailsTable" xlink:to="cyngn_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SubsequentEventsDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SubsequentEventsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SubsequentEventsDetailsLineItems_lbl" xml:lang="en-US">Subsequent Events (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SubsequentEventsDetailsLineItems" xlink:to="cyngn_SubsequentEventsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CommonStockShares_lbl0" xml:lang="en-US">Commo stock shares authorized.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockShares" xlink:to="cyngn_CommonStockShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxAssetNetCurrent_lbl0" xml:lang="en-US">Deferred Tax Assets Net Current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetNetCurrent" xlink:to="cyngn_DeferredTaxAssetNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxAssetsSBC_lbl0" xml:lang="en-US">The amount of SBC.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsSBC" xlink:to="cyngn_DeferredTaxAssetsSBC_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxAssetsTrueup_lbl0" xml:lang="en-US">The amount of true-up.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsTrueup" xlink:to="cyngn_DeferredTaxAssetsTrueup_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_FederalStatutoryIncomeTaxRateTotal_lbl0" xml:lang="en-US">The amount of federal statutory income tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FederalStatutoryIncomeTaxRateTotal" xlink:to="cyngn_FederalStatutoryIncomeTaxRateTotal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans_lbl0" xml:lang="en-US">Gain on forgiveness of Paycheck Protection Program loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:to="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_MaturityDate_lbl0" xml:lang="en-US">Debt instrument maturity date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MaturityDate" xlink:to="cyngn_MaturityDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_NetOperatingLosses_lbl0" xml:lang="en-US">Net operating losses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NetOperatingLosses" xlink:to="cyngn_NetOperatingLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_NetProceeds_lbl0" xml:lang="en-US">The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt originations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NetProceeds" xlink:to="cyngn_NetProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PPPLoanForgiveness_lbl0" xml:lang="en-US">PPP Loan forgiveness.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PPPLoanForgiveness" xlink:to="cyngn_PPPLoanForgiveness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount_lbl0" xml:lang="en-US">PPP loan was forgiven by the SBA in the amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount" xlink:to="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements_lbl0" xml:lang="en-US">Amount of leasehold improvements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements" xlink:to="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PurchaseAnAdditionalSharesOfCommonStock_lbl0" xml:lang="en-US">Purchase An Additional Shares of Common Stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseAnAdditionalSharesOfCommonStock" xlink:to="cyngn_PurchaseAnAdditionalSharesOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PurchaseWarrantsDescription_lbl0" xml:lang="en-US">Purchase warrants , description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseWarrantsDescription" xlink:to="cyngn_PurchaseWarrantsDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_RedeemableWarrants_lbl0" xml:lang="en-US">Redeemable warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RedeemableWarrants" xlink:to="cyngn_RedeemableWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_RentExpense_lbl0" xml:lang="en-US">Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RentExpense" xlink:to="cyngn_RentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_SeriesASharesIssuedAndOutstanding_lbl0" xml:lang="en-US">Series A shares issued and outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesASharesIssuedAndOutstanding" xlink:to="cyngn_SeriesASharesIssuedAndOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl1" xml:lang="en-US">Aggregate intrinsic value, outstanding at balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited_lbl0" xml:lang="en-US">Weighted-average exercise price, cancelled/forfeited.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt_lbl0" xml:lang="en-US">Weighted-average remaining contractual, vested and exercisable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares_lbl0" xml:lang="en-US">Weighted-average remaining contractual, vested and expected to vest at (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl1" xml:lang="en-US">Weighted-average exercise price, vested and expected to vest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:to="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl0" xml:lang="en-US">Weighted-average remaining contractual, outstanding at ending balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised_lbl0" xml:lang="en-US">Weighted-average exercise price, exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" xlink:to="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StockOptionsExpectedVest_lbl0" xml:lang="en-US">Amount of stock options that are expected to vest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockOptionsExpectedVest" xlink:to="cyngn_StockOptionsExpectedVest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StockbasedCompensationExpenseOfStockOptions_lbl0" xml:lang="en-US">Amount of stock-based compensation expense from stock options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockbasedCompensationExpenseOfStockOptions" xlink:to="cyngn_StockbasedCompensationExpenseOfStockOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Number of share options (or share units) exercised during the current period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_TaxPositionTerm_lbl0" xml:lang="en-US">Tax position term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TaxPositionTerm" xlink:to="cyngn_TaxPositionTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount_lbl0" xml:lang="en-US">The Company&#8217;s PPP loan was forgiven by the SBA in the amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" xlink:to="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_TotalUnrecognizedTaxBenefit_lbl0" xml:lang="en-US">Total unrecognized tax benefit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TotalUnrecognizedTaxBenefit" xlink:to="cyngn_TotalUnrecognizedTaxBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_UnrestrictedCashAndCashEquivalents_lbl0" xml:lang="en-US">Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_UnrestrictedCashAndCashEquivalents" xlink:to="cyngn_UnrestrictedCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted_lbl0" xml:lang="en-US">Weighted-average exercise price, granted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" xlink:to="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock_lbl0" xml:lang="en-US">ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" xlink:to="cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RentExpense_lbl1" xml:lang="en-US">RentExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RentExpense" xlink:to="cyngn_RentExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AmortizationMember_lbl0" xml:lang="en-US">AmortizationMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AmortizationMember" xlink:to="cyngn_AmortizationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_MaturityDate_lbl1" xml:lang="en-US">MaturityDate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MaturityDate" xlink:to="cyngn_MaturityDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_FairValueOfOptionsGranted_lbl0" xml:lang="en-US">FairValueOfOptionsGranted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FairValueOfOptionsGranted" xlink:to="cyngn_FairValueOfOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl0" xml:lang="en-US">ConcentrationOfSupplierRiskPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PurchaseWarrantsDescription_lbl1" xml:lang="en-US">PurchaseWarrantsDescription</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseWarrantsDescription" xlink:to="cyngn_PurchaseWarrantsDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockWarrantsMember_lbl0" xml:lang="en-US">CommonStockWarrantsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockWarrantsMember" xlink:to="cyngn_CommonStockWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockShareAuthorized_lbl0" xml:lang="en-US">CommonStockShareAuthorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockShareAuthorized" xlink:to="cyngn_CommonStockShareAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockOptionsExpectedVest_lbl1" xml:lang="en-US">StockOptionsExpectedVest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockOptionsExpectedVest" xlink:to="cyngn_StockOptionsExpectedVest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares_lbl1" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TotalUnrecognizedTaxBenefit_lbl1" xml:lang="en-US">TotalUnrecognizedTaxBenefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TotalUnrecognizedTaxBenefit" xlink:to="cyngn_TotalUnrecognizedTaxBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited_lbl1" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_NetOperatingLosses_lbl1" xml:lang="en-US">NetOperatingLosses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NetOperatingLosses" xlink:to="cyngn_NetOperatingLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RetirementSavingsPlanTextBlock_lbl0" xml:lang="en-US">RetirementSavingsPlanTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RetirementSavingsPlanTextBlock" xlink:to="cyngn_RetirementSavingsPlanTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetsTrueup_lbl1" xml:lang="en-US">DeferredTaxAssetsTrueup</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsTrueup" xlink:to="cyngn_DeferredTaxAssetsTrueup_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_FederalStatutoryIncomeTaxRateTotal_lbl1" xml:lang="en-US">FederalStatutoryIncomeTaxRateTotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FederalStatutoryIncomeTaxRateTotal" xlink:to="cyngn_FederalStatutoryIncomeTaxRateTotal_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ConvertiblePreferredStockPolicyTextBlock_lbl0" xml:lang="en-US">ConvertiblePreferredStockPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConvertiblePreferredStockPolicyTextBlock" xlink:to="cyngn_ConvertiblePreferredStockPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount_lbl1" xml:lang="en-US">TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" xlink:to="cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetsSBC_lbl1" xml:lang="en-US">DeferredTaxAssetsSBC</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsSBC" xlink:to="cyngn_DeferredTaxAssetsSBC_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl2" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl2" xml:lang="en-US">ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:to="cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements_lbl1" xml:lang="en-US">PropertyAndEquipmentUsefulLifeLeaseholdImprovements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements" xlink:to="cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TaxPositionTerm_lbl1" xml:lang="en-US">TaxPositionTerm</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TaxPositionTerm" xlink:to="cyngn_TaxPositionTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_UnrestrictedCashAndCashEquivalents_lbl1" xml:lang="en-US">UnrestrictedCashAndCashEquivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_UnrestrictedCashAndCashEquivalents" xlink:to="cyngn_UnrestrictedCashAndCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CYNMember_lbl0" xml:lang="en-US">CYNMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CYNMember" xlink:to="cyngn_CYNMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_Automobiles_lbl0" xml:lang="en-US">Automobiles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_Automobiles" xlink:to="cyngn_Automobiles_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PreferredStockShareIssued_lbl0" xml:lang="en-US">PreferredStockShareIssued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreferredStockShareIssued" xlink:to="cyngn_PreferredStockShareIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_LossPerShareAbstract_lbl0" xml:lang="en-US">LossPerShareAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossPerShareAbstract" xlink:to="cyngn_LossPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_EarningsPerShareTotal_lbl0" xml:lang="en-US">EarningsPerShareTotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_EarningsPerShareTotal" xlink:to="cyngn_EarningsPerShareTotal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SeriesASharesIssuedAndOutstanding_lbl1" xml:lang="en-US">SeriesASharesIssuedAndOutstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesASharesIssuedAndOutstanding" xlink:to="cyngn_SeriesASharesIssuedAndOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" xlink:to="cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_NetProceeds_lbl1" xml:lang="en-US">NetProceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NetProceeds" xlink:to="cyngn_NetProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockShares_lbl1" xml:lang="en-US">CommonStockShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockShares" xlink:to="cyngn_CommonStockShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PPPLoanForgiveness_lbl1" xml:lang="en-US">PPPLoanForgiveness</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PPPLoanForgiveness" xlink:to="cyngn_PPPLoanForgiveness_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetNetCurrent_lbl1" xml:lang="en-US">DeferredTaxAssetNetCurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetNetCurrent" xlink:to="cyngn_DeferredTaxAssetNetCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CreditCardPayable_lbl0" xml:lang="en-US">CreditCardPayable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CreditCardPayable" xlink:to="cyngn_CreditCardPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_LiquidityMember_lbl0" xml:lang="en-US">LiquidityMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LiquidityMember" xlink:to="cyngn_LiquidityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PurchaseWarrantsMember_lbl0" xml:lang="en-US">PurchaseWarrantsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseWarrantsMember" xlink:to="cyngn_PurchaseWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl1" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">DeferredTaxAssetsAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsAbstract" xlink:to="cyngn_DeferredTaxAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PurchaseAnAdditionalSharesOfCommonStock_lbl1" xml:lang="en-US">PurchaseAnAdditionalSharesOfCommonStock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PurchaseAnAdditionalSharesOfCommonStock" xlink:to="cyngn_PurchaseAnAdditionalSharesOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RedeemableWarrants_lbl1" xml:lang="en-US">RedeemableWarrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RedeemableWarrants" xlink:to="cyngn_RedeemableWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted_lbl1" xml:lang="en-US">WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" xlink:to="cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount_lbl1" xml:lang="en-US">PPPLoanWasForgivenByTheSBAInTheAmount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount" xlink:to="cyngn_PPPLoanWasForgivenByTheSBAInTheAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock_lbl0" xml:lang="en-US">ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt_lbl1" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" xlink:to="cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans_lbl1" xml:lang="en-US">GainOnForgivenessOfPaycheckProtectionProgramLoans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:to="cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_BalanceSheetComponentsTextBlock_lbl0" xml:lang="en-US">BalanceSheetComponentsTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_BalanceSheetComponentsTextBlock" xlink:to="cyngn_BalanceSheetComponentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">StocksIssuedDuringPeriodSharesStockOptionsExercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockSharesIssurance_lbl0" xml:lang="en-US">CommonStockSharesIssurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockSharesIssurance" xlink:to="cyngn_CommonStockSharesIssurance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockbasedCompensationExpenseOfStockOptions_lbl1" xml:lang="en-US">StockbasedCompensationExpenseOfStockOptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockbasedCompensationExpenseOfStockOptions" xlink:to="cyngn_StockbasedCompensationExpenseOfStockOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl1" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl2" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl0" xml:lang="en-US">Notes Payable, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl0" xml:lang="en-US">Payments to Acquire Equity Method Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl0" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AutomobilesMember_lbl0" xml:lang="en-US">Automobiles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock_lbl0" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="us-gaap_WeightedAverageNumberOfSharesRestrictedStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl1" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventDescription_lbl0" xml:lang="en-US">Subsequent Event, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl0" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl0" xml:lang="en-US">Restricted Cash, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl0" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl0" xml:lang="en-US">Schedule of Conversions of Stock [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl0" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl0" xml:lang="en-US">Machinery and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl0" xml:lang="en-US">Restricted Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndInvestmentsCurrent_lbl0" xml:lang="en-US">Restricted Cash and Investments, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherRestrictedAssetsCurrent_lbl0" xml:lang="en-US">Other Restricted Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherRestrictedAssetsCurrent" xlink:to="us-gaap_OtherRestrictedAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl0" xml:lang="en-US">Interest Income (Expense), Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl0" xml:lang="en-US">Accrued Liabilities and Other Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessStockSharesAuthorized_lbl0" xml:lang="en-US">Excess Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesAuthorized" xlink:to="us-gaap_ExcessStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock_lbl0" xml:lang="en-US">Partners&apos; Capital Notes Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:to="us-gaap_PartnersCapitalNotesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl1" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedInvestmentsCurrent_lbl0" xml:lang="en-US">Restricted Investments, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedInvestmentsCurrent" xlink:to="us-gaap_RestrictedInvestmentsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl0" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl0" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl0" xml:lang="en-US">Furniture and Fixtures, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl0" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl0" xml:lang="en-US">Proceeds from Sales of Assets, Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl0" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl0" xml:lang="en-US">Domestic Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl0" xml:lang="en-US">Trademarks [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl0" xml:lang="en-US">Accrued Payroll Taxes, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl0" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherBorrowings_lbl0" xml:lang="en-US">Other Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl0" xml:lang="en-US">Proceeds from Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetAssetLiability_lbl0" xml:lang="en-US">Fair Value, Net Asset (Liability)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl0" xml:lang="en-US">Property, Plant and Equipment, Other, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl0" xml:lang="en-US">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl1" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare_lbl0" xml:lang="en-US">Preferred Stock, Redemption Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionPricePerShare" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl0" xml:lang="en-US">Income Tax Examination, Year under Examination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl0" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl0" xml:lang="en-US">Dividends Payable, Amount Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next 12 Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod_lbl0" xml:lang="en-US">Present Value of Future Insurance Profits, Weighted Average Amortization Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreference_lbl1" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl0" xml:lang="en-US">Investment Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl0" xml:lang="en-US">Preferred Stock, Amount of Preferred Dividends in Arrears</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl0" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl0" xml:lang="en-US">Inventory Valuation Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl0" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl0" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAppropriated_lbl0" xml:lang="en-US">Retained Earnings, Appropriated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAppropriated" xlink:to="us-gaap_RetainedEarningsAppropriated_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl0" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>cyngn-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu May 12 19:03:25 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedBalanceSheet" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedIncomeStatement" roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ShareholdersEquityType2or3" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedCashFlow" roleURI="http://cyngn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ConsolidatedCashFlow_Parentheticals" roleURI="http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_DescriptionofBusiness" roleURI="http://cyngn.com/role/DescriptionofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SummaryofSignificantAccountingPolicies" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_BalanceSheetComponents" roleURI="http://cyngn.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_Leases" roleURI="http://cyngn.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IntangibleAssetsNet" roleURI="http://cyngn.com/role/IntangibleAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_Debt" roleURI="http://cyngn.com/role/Debt"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CapitalStructure" roleURI="http://cyngn.com/role/CapitalStructure"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_StockBasedCompensationExpense" roleURI="http://cyngn.com/role/StockBasedCompensationExpense"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_RetirementSavingsPlan" roleURI="http://cyngn.com/role/RetirementSavingsPlan"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IncomeTaxes" roleURI="http://cyngn.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CommitmentsandContingencies" roleURI="http://cyngn.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_RisksandUncertainties" roleURI="http://cyngn.com/role/RisksandUncertainties"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SubsequentEvents" roleURI="http://cyngn.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_AccountingPoliciesByPolicy" roleURI="http://cyngn.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_BalanceSheetComponentsTables" roleURI="http://cyngn.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IntangibleAssetsNetTables" roleURI="http://cyngn.com/role/IntangibleAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CapitalStructureTables" roleURI="http://cyngn.com/role/CapitalStructureTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_StockBasedCompensationExpenseTables" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IncomeTaxesTables" roleURI="http://cyngn.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable" roleURI="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofpropertyandequipmentestimatedusefullifeTable" roleURI="http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofpropertyandequipmentTable" roleURI="http://cyngn.com/role/ScheduleofpropertyandequipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofaccruedexpensesandothercurrentliabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable" roleURI="http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofestimatedamortizationexpenseforallintangibleassetsTable" roleURI="http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable" roleURI="http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleoffairvalueofthewarrantsTable" roleURI="http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofbasicanddilutedlosspershareTable" roleURI="http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofcalculationofdilutedsharesoutstandingTable" roleURI="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofstockoptionTable" roleURI="http://cyngn.com/role/ScheduleofstockoptionTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable" roleURI="http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleoffederalstatutoryincometaxTable" roleURI="http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_ScheduleofdeferredtaxassetsandliabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_DescriptionofBusinessDetails" roleURI="http://cyngn.com/role/DescriptionofBusinessDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_BalanceSheetComponentsDetails" roleURI="http://cyngn.com/role/BalanceSheetComponentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_LeasesDetails" roleURI="http://cyngn.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IntangibleAssetsNetDetails" roleURI="http://cyngn.com/role/IntangibleAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_DebtDetails" roleURI="http://cyngn.com/role/DebtDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_CapitalStructureDetails" roleURI="http://cyngn.com/role/CapitalStructureDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_StockBasedCompensationExpenseDetails" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_IncomeTaxesDetails" roleURI="http://cyngn.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#cyngn_r_SubsequentEventsDetails" roleURI="http://cyngn.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20211231.xsd#DocumentAndEntityInformation" roleURI="http://cyngn.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_Assets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_Liabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestIncomeExpenseNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncome" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PPPLoanForgiveness" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanForgiveness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="PPPLoanForgiveness" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockWarrantsMember" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="CommonStockWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnForgivenessOfPaycheckProtectionProgramLoans" xlink:href="cyngn-20211231.xsd#cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnForgivenessOfPaycheckProtectionProgramLoans" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" xlink:href="cyngn-20211231.xsd#cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="PPPLoanWasForgivenByTheSBAInTheAmount" xlink:href="cyngn-20211231.xsd#cyngn_PPPLoanWasForgivenByTheSBAInTheAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="PPPLoanWasForgivenByTheSBAInTheAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/DescriptionofBusiness">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/BalanceSheetComponents">
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="BalanceSheetComponentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/IntangibleAssetsNet">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/Debt">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/CapitalStructure">
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_PartnersCapitalNotesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/StockBasedCompensationExpense">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/RetirementSavingsPlan">
    <loc xlink:type="locator" xlink:label="RetirementSavingsPlanAbstract" xlink:href="cyngn-20211231.xsd#cyngn_RetirementSavingsPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="RetirementSavingsPlanTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_RetirementSavingsPlanTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RetirementSavingsPlanAbstract" xlink:to="RetirementSavingsPlanTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/RisksandUncertainties">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConcentrationOfSupplierRiskPolicyTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConcentrationOfSupplierRiskPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockPolicyTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ConvertiblePreferredStockPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConvertiblePreferredStockPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/BalanceSheetComponentsTables">
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/IntangibleAssetsNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/CapitalStructureTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_ScheduleOfConversionsOfStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="us-gaap_RestrictedInvestmentsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherRestrictedAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestrictedAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="us-gaap_OtherRestrictedAssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract" xlink:to="us-gaap_RestrictedCashAndInvestmentsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_MachineryAndEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AutomobilesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_AutomobilesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyAndEquipmentUsefulLifeLeaseholdImprovements" xlink:href="cyngn-20211231.xsd#cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems" xlink:to="PropertyAndEquipmentUsefulLifeLeaseholdImprovements" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofpropertyandequipmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="Automobiles" xlink:href="cyngn-20211231.xsd#cyngn_Automobiles"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="Automobiles" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_FurnitureAndFixturesGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="CreditCardPayable" xlink:href="cyngn-20211231.xsd#cyngn_CreditCardPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="CreditCardPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYs2oFZtOTTU4jS6iJhwAty6PIH4pPzDs97dkXlMe6U6IN1M+lk5vzKEXByUg/z1wUlxyqJGPe6Zz0mQ0VgkjxWaC3zpaLfOpSLlryildOmpaRwqomOPGOgMsNG3+0+fSRb8e5SoWpWZRilaPT9QB0JmCgp8H78jYzvOveAXamS69taxyKy6iFS] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_TrademarksMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:href="cyngn-20211231.xsd#cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract" xlink:to="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmortizationMember" xlink:href="cyngn-20211231.xsd#cyngn_AmortizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="AmortizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable" xlink:to="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract" xlink:to="us-gaap_ConversionOfStockTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockTable" xlink:to="us-gaap_ConversionOfStockLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesASharesIssuedAndOutstanding" xlink:href="cyngn-20211231.xsd#cyngn_SeriesASharesIssuedAndOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="SeriesASharesIssuedAndOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockAmountOfPreferredDividendsInArrears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_PreferredStockAmountOfPreferredDividendsInArrears" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheWarrantsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfFairValueOfTheWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable"/>
    <loc xlink:type="locator" xlink:label="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheWarrantsAbstract" xlink:to="CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable" xlink:to="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossPerShareAbstract" xlink:href="cyngn-20211231.xsd#cyngn_LossPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedLossPerShareAbstract" xlink:to="LossPerShareAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesRestrictedStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EarningsPerShareTotal" xlink:href="cyngn-20211231.xsd#cyngn_EarningsPerShareTotal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCalculationOfDilutedSharesOutstandingAbstract" xlink:to="EarningsPerShareTotal" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofstockoptionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfStockOptionAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfStockOptionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" xlink:href="cyngn-20211231.xsd#cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StocksIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="cyngn-20211231.xsd#cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="StocksIssuedDuringPeriodSharesStockOptionsExercised" order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" xlink:href="cyngn-20211231.xsd#cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="17.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:href="cyngn-20211231.xsd#cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_0" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding_0" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_0" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest_0" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" xlink:href="cyngn-20211231.xsd#cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_InventoryValuationReserves" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsTrueup" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsTrueup"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="DeferredTaxAssetsTrueup" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FederalStatutoryIncomeTaxRateTotal" xlink:href="cyngn-20211231.xsd#cyngn_FederalStatutoryIncomeTaxRateTotal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxAbstract" xlink:to="FederalStatutoryIncomeTaxRateTotal" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="cyngn-20211231.xsd#cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsSBC" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetsSBC"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsSBC" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsSBC" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/DescriptionofBusinessDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="DescriptionofBusinessDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_DescriptionofBusinessDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DescriptionofBusinessDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_DescriptionofBusinessDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionofBusinessDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LiquidityMember" xlink:href="cyngn-20211231.xsd#cyngn_LiquidityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="LiquidityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="dei_LegalEntityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CYNMember" xlink:href="cyngn-20211231.xsd#cyngn_CYNMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="CYNMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PurchaseWarrantsMember" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="PurchaseWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="DescriptionofBusinessDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceeds" xlink:href="cyngn-20211231.xsd#cyngn_NetProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="NetProceeds" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseAnAdditionalSharesOfCommonStock" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseAnAdditionalSharesOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="PurchaseAnAdditionalSharesOfCommonStock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedeemableWarrants" xlink:href="cyngn-20211231.xsd#cyngn_RedeemableWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="RedeemableWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseWarrantsDescription" xlink:href="cyngn-20211231.xsd#cyngn_PurchaseWarrantsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="PurchaseWarrantsDescription" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesAuthorized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockShares" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="CommonStockShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferredStockShareIssued" xlink:href="cyngn-20211231.xsd#cyngn_PreferredStockShareIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="PreferredStockShareIssued" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockRedemptionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionPricePerShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAppropriated" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAppropriated"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAppropriated" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrestrictedCashAndCashEquivalents" xlink:href="cyngn-20211231.xsd#cyngn_UnrestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="UnrestrictedCashAndCashEquivalents" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="UnrestrictedCashAndCashEquivalents" xlink:href="cyngn-20211231.xsd#cyngn_UnrestrictedCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="UnrestrictedCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_RestrictedCash" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/BalanceSheetComponentsDetails">
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsAbstract" xlink:href="cyngn-20211231.xsd#cyngn_BalanceSheetComponentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_LeasesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_LeasesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="LeasesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="LeasesDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RentExpense" xlink:href="cyngn-20211231.xsd#cyngn_RentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="RentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/IntangibleAssetsNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AdjustmentForAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/DebtDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_OtherBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_InvestmentInterestRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaturityDate" xlink:href="cyngn-20211231.xsd#cyngn_MaturityDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="MaturityDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/CapitalStructureDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalNotesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="CapitalStructureDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CapitalStructureDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_CapitalStructureDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnersCapitalNotesAbstract" xlink:to="CapitalStructureDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="CapitalStructureDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CommonStockShareAuthorized" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockShareAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="CommonStockShareAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_DividendsPayableAmountPerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="CommonStockSharesIssurance" xlink:href="cyngn-20211231.xsd#cyngn_CommonStockSharesIssurance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="CommonStockSharesIssurance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfOptionsGranted" xlink:href="cyngn-20211231.xsd#cyngn_FairValueOfOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="FairValueOfOptionsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockbasedCompensationExpenseOfStockOptions" xlink:href="cyngn-20211231.xsd#cyngn_StockbasedCompensationExpenseOfStockOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="StockbasedCompensationExpenseOfStockOptions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsExpectedVest" xlink:href="cyngn-20211231.xsd#cyngn_StockOptionsExpectedVest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="StockOptionsExpectedVest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_IncomeTaxesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_IncomeTaxesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="IncomeTaxesDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetNetCurrent" xlink:href="cyngn-20211231.xsd#cyngn_DeferredTaxAssetNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="DeferredTaxAssetNetCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetOperatingLosses" xlink:href="cyngn-20211231.xsd#cyngn_NetOperatingLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="NetOperatingLosses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalUnrecognizedTaxBenefit" xlink:href="cyngn-20211231.xsd#cyngn_TotalUnrecognizedTaxBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="TotalUnrecognizedTaxBenefit" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaxPositionTerm" xlink:href="cyngn-20211231.xsd#cyngn_TaxPositionTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsLineItems" xlink:to="TaxPositionTerm" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="cyngn-20211231.xsd#cyngn_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsLineItems" xlink:href="cyngn-20211231.xsd#cyngn_SubsequentEventsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="SubsequentEventsDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SubsequentEventDescription" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="cyngn-20211231.xsd#cyngn_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359090680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYNGN
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001874097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359999592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,945,981<span></span>
</td>
<td class="nump">$ 6,056,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">525,304<span></span>
</td>
<td class="nump">48,852<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">22,521,285<span></span>
</td>
<td class="nump">6,505,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">102,787<span></span>
</td>
<td class="nump">133,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">30,917<span></span>
</td>
<td class="nump">34,383<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">22,654,989<span></span>
</td>
<td class="nump">6,673,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">112,271<span></span>
</td>
<td class="nump">73,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">295,156<span></span>
</td>
<td class="nump">307,402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">407,427<span></span>
</td>
<td class="nump">380,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Note payable, Paycheck Protection Program</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">695,078<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">407,427<span></span>
</td>
<td class="nump">1,075,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible Series A, B and C preferred stock, Par $0.00001; 10,000,000 authorized as of December 31, 2021 and 21,982,491 shares authorized, issued and outstanding as of December 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, Par $0.00001; 100,000,000 shares authorized, 26,487,680 shares issued and outstanding as of December 31, 2021 and 42,000,000 shares authorized, 951,794 shares issued and outstanding as of December 31, 2020</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Common stock warrants</a></td>
<td class="nump">170,397<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">138,570,430<span></span>
</td>
<td class="nump">114,291,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(116,493,530)<span></span>
</td>
<td class="num">(108,694,001)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">22,247,562<span></span>
</td>
<td class="nump">5,597,734<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">$ 22,654,989<span></span>
</td>
<td class="nump">$ 6,673,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360147288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">26,487,680<span></span>
</td>
<td class="nump">951,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">26,487,680<span></span>
</td>
<td class="nump">951,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Convertible Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Convertible Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Convertible Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359980664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,990,407<span></span>
</td>
<td class="nump">5,120,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,409,651<span></span>
</td>
<td class="nump">3,252,649<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">9,400,058<span></span>
</td>
<td class="nump">8,373,628<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(9,400,058)<span></span>
</td>
<td class="num">(8,373,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest (expense) income</a></td>
<td class="num">(9,580)<span></span>
</td>
<td class="nump">39,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other (expense) income</a></td>
<td class="nump">7,173<span></span>
</td>
<td class="num">(5,020)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_PPPLoanForgiveness', window );">Paycheck Protection Program Note forgiveness</a></td>
<td class="nump">1,602,936<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">1,600,529<span></span>
</td>
<td class="nump">34,821<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,799,529)<span></span>
</td>
<td class="num">$ (8,338,807)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)</a></td>
<td class="num">$ (1.33)<span></span>
</td>
<td class="num">$ (8.78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted (in Dollars per share)</a></td>
<td class="nump">$ 5,861,730<span></span>
</td>
<td class="nump">$ 949,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PPPLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PPP Loan forgiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PPPLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360773304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders&#8217; Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Common Stock Warrants</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 114,159,150<span></span>
</td>
<td class="num">$ (100,355,194)<span></span>
</td>
<td class="nump">$ 13,804,186<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2019</a></td>
<td class="nump">21,982,491<span></span>
</td>
<td class="nump">949,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">131,732<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">131,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,338,807)<span></span>
</td>
<td class="num">(8,338,807)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">114,291,505<span></span>
</td>
<td class="num">(108,694,001)<span></span>
</td>
<td class="nump">5,597,734<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">21,982,491<span></span>
</td>
<td class="nump">951,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,295,855<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 23,295,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110 (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of convertible preferred stock to common stock in connection with initial public offering</a></td>
<td class="num">$ (220)<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of convertible preferred stock to common stock in connection with initial public offering (in Shares)</a></td>
<td class="num">(21,982,491)<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,139,247<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,139,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,397<span></span>
</td>
<td class="num">(170,397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,799,529)<span></span>
</td>
<td class="num">(7,799,529)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">$ 170,397<span></span>
</td>
<td class="nump">$ 138,570,430<span></span>
</td>
<td class="num">$ (116,493,530)<span></span>
</td>
<td class="nump">$ 22,247,562<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,487,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358218648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders&#8217; Equity (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Iinitial public offering, net of closing costs</a></td>
<td class="nump">$ 2,954,110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360048696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,799,529)<span></span>
</td>
<td class="num">$ (8,338,807)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">85,855<span></span>
</td>
<td class="nump">159,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,139,247<span></span>
</td>
<td class="nump">131,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain on disposal of asset</a></td>
<td class="num">(31,356)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans', window );">Gain on forgiveness of Paycheck Protection Program Notes</a></td>
<td class="num">(1,602,936)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(476,452)<span></span>
</td>
<td class="nump">33,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">39,255<span></span>
</td>
<td class="num">(43,335)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">3,496<span></span>
</td>
<td class="nump">137,535<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(8,642,419)<span></span>
</td>
<td class="num">(7,920,061)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of property and equipment</a></td>
<td class="num">(62,204)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities', window );">Disposal of assets</a></td>
<td class="nump">42,189<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(20,015)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock upon initial public offering, net of offering costs</a></td>
<td class="nump">23,295,890<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from Paycheck Protection Program Notes</a></td>
<td class="nump">892,115<span></span>
</td>
<td class="nump">695,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">14,220<span></span>
</td>
<td class="nump">623<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">24,202,225<span></span>
</td>
<td class="nump">695,701<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase/(decrease) in cash and cash equivalents and restricted cash</a></td>
<td class="nump">15,539,791<span></span>
</td>
<td class="num">(7,224,360)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">6,456,190<span></span>
</td>
<td class="nump">13,680,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of year</a></td>
<td class="nump">21,995,981<span></span>
</td>
<td class="nump">6,456,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for taxes</a></td>
<td class="nump">16,719<span></span>
</td>
<td class="nump">$ 10,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount', window );">The Company&#8217;s Paycheck Protection Program Note was forgiven by the SBA in the amount of $1,602,936.</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on forgiveness of Paycheck Protection Program loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company&#8217;s PPP loan was forgiven by the SBA in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230362725496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Parentheticals) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_PPPLoanWasForgivenByTheSBAInTheAmount', window );">Paycheck protection program note was forgiven by the SBA in the amount</a></td>
<td class="nump">$ 1,602,936<span></span>
</td>
<td class="nump">$ 1,602,936<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PPPLoanWasForgivenByTheSBAInTheAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PPP loan was forgiven by the SBA in the amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PPPLoanWasForgivenByTheSBAInTheAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358106616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>1.
Description of Business</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Headquartered
in Menlo Park, California, CYNGN Inc., together with its subsidiaries (collectively, &#8220;Cyngn&#8221; or the &#8220;Company&#8221;),
was incorporated in Delaware in 2013. Cyngn Singapore PTE. LTD., a Singaporean limited company organized in 2015 and Cyngn Philippines,
Inc., a Philippine corporation incorporated in 2018 are wholly owned subsidiaries. The Company is in the process of dissolving
these subsidiaries.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Cyngn
develops autonomous driving software that can be deployed on multiple vehicle types in various environments. The Company has been
operating autonomous vehicles (&#8220;AV&#8221;) in production environments since 16 Built and tested in difficult and diverse
real-world environments, the self-driving system (DriveMod), fleet management system, and Software Development Kit combine to
create a full-stack advanced autonomy solution designed to be modular, extendable, and safe. The Company operates one business
segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Initial
Public Offering</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
October&#160;22, 2021, the Company closed the initial public offering (the &#8220;IPO&#8221;) of 3,500,000 shares of its authorized
common stock at an offering price of $7.50 per share. Simultaneous with the closing of the IPO, the common stock began trading
on the NASDAQ Capital Market under the symbol &#8220;CYN.&#8221; The IPO generated net proceeds of $23.3 million after deducting
underwriting discounts, commissions and offering expenses. The Company also granted its underwriters the election to exercise
a 45-day over-allotment option to purchase an additional 525,000 shares of common stock at the IPO offering price, less underwriting
discounts. The underwriters elected not to exercise the over-allotment option in whole or in part. No price stabilization activities
have been carried out since the IPO, and due to the stock&#8217;s share price performance, the underwriters have, as stabilizing
manager on behalf of the Company, decided to end the stock trading stabilization period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Simultaneous
with the closing of its IPO, the Company also issued 140,000 warrants (the &#8220;Warrant&#8221;) to its underwriters. Each Warrant
entitles its holder the option to purchase at a future exercise date, one share of common stock at an initial exercise price of
$9.375 per share, subject to certain adjustments and restrictions relating to subsequent resale and transfers. The Purchase Warrants
are exercisable six (6) months after the IPO and expire five (5) years thereafter.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">At
the completion of the IPO, all shares of the Company&#8217;s outstanding convertible preferred stock shares automatically converted
to shares of common stock (see Note 7. Capital Structure).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Immediately
after the IPO, the Company filed an amended and restated certificate of incorporation, which became effective on October&#160;22,
2021. The amended and restated certificate of incorporation authorized 110,000,000 shares consisting of 100,000,000 shares of
common stock, at a par value of $0.00001, and 10,000,000 shares of preferred stock at a par value of $0.00001. The rights of the
holders of common stock are subject to and qualified by rights of the holders of the preferred stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Additionally,
the Company recognized $1.1 million of stock-based compensation expense related to stock options granted to employees with time-based
vesting conditions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Liquidity</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company has incurred losses from operations since inception. The Company incurred net losses of $7.8 million and $8.3 million
for the year ended December&#160;31, 2021 and 2020, respectively. Accumulated deficit amounted to $116.5 million and $108.7 million
as of December&#160;31, 2021 and 2020, respectively. Net cash used in operating activities was $8.6 million and $7.9 million for
the year ended December&#160;31, 2021 and 2020, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company&#8217;s liquidity is based on its ability to enhance its operating cash flow position, obtain capital financing from equity
interest investors and obtain funds from outside sources of financing to fund its general operations, research and development
activities and capital expenditures. The Company&#8217;s ability to continue as a going concern is dependent on management&#8217;s
ability to successfully execute its business plan, which includes generating progressive revenue streams while controlling operating
costs and expenses, to then result in positive operating cash flows. The Company&#8217;s unrestricted balance of cash and cash
equivalents was $21.9 million and $6.1 million as of December&#160;31, 2021 and 2020, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Based
on cash flow projections from operating and financing activities and existing balances of cash and cash equivalents, management
is of the opinion that the Company has sufficient funds for sustainable operations and it will be able to meet its payment obligations
and commitments from operations for at least one year from the issuance date of this prospectus. Based on the above considerations,
the Company&#8217;s consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and liquidation of liabilities during the normal course of operations.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358220328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>2.
Summary of Significant Accounting Policies</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Basis
of Presentation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
accompanying consolidated financial statements as of and for the years ended December&#160;31, 2021 and 2020 have been prepared
in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to applicable
rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include
all normal adjustments necessary for a fair presentation of the Company&#8217;s financial position at December&#160;31, 2021 and
2020, and operating results and cash flows for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">These
consolidated financial statements should be read in conjunction with the following: i) audited consolidated financial statements
as of and for the years ended December&#160;31, 2020 and 2019; ii) the discussion under &#8220;Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations&#8221; and&#8217; iii) our final prospectus (the &#8220;Prospectus&#8221;),
filed with the Securities and Exchange Commission or the SEC, pursuant to Rule&#160;424(b) under the Securities Act of 1933, as
amended or the Securities Act), on October&#160;21, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Principles
of Consolidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
consolidated financial statements include the accounts of CYNGN Inc. and its wholly owned subsidiaries. Intercompany accounts
and transactions have been eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Foreign
Currency Translation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other
than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average
exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments
and transactional gains and losses are immaterial to the consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Use
of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These
estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company&#8217;s
significant estimates and judgments include but are not limited to underwriter&#8217;s warrants and share-based compensation.
Estimates are based on historical experience and on various other assumptions believed to be reasonable, the results of which
form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those
estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Concentration
of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents. The Company&#8217;s
cash is placed with high-credit-quality financial institutions and at times exceeds federally insured limits. The Company has
not experienced any credit loss relating to its cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Concentration
of Supplier Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there
is any significant supplier concentration risk as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Cash
and Cash Equivalents and Restricted Cash</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company considers all highly liquid money market placements with a remaining maturity of three months or less to be cash equivalents.
The Company had $21.9 million and $6.1 million of unrestricted cash and cash equivalents as of December&#160;31, 2021 and 2020,
respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
addition, the Company had $50,000 and $400,000 in restricted cash as of December&#160;31, 2021 and 2020, respectively, which is
reported separately as current assets on the consolidated balance sheet. The Company&#8217;s restricted cash consists of cash
not available for immediate use that the Company is obligated to maintain in accordance with the terms of its credit card spending
arrangement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table provides a reconciliation of cash and cash equivalents and restricted cash to amounts shown in the consolidated
statements of cash flows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">21,945,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,056,190</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total Cash and cash equivalents and Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,995,981</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,456,190</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Fair
Value Measurements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
accounting guidance under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, <i>Fair Value Measurements</i>, defines
fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability
category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing
the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value
as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
1</i>&#8212;Unadjusted quoted prices in active markets for identical assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
2</i>&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially
the full term of the assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
3</i>&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value
of the assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Assets
and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair
value measurement of an instrument does not necessarily result in a change in the amount recorded on the consolidated balance
sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting
guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets
and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived
assets, intangible assets, share-based compensation and underwriter warrants measured at fair value upon initial recognition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
carrying amounts of the Company&#8217;s cash and cash equivalents, accounts payable and notes payable are reasonable estimates
of their fair values due to the short-term nature of these accounts. The fair values of the Company&#8217;s share-based compensation
and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent
external valuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Property
and Equipment</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Property
and equipment is stated at cost less accumulated depreciation. Repair and maintenance costs are expensed as incurred. Depreciation
is recorded on a straight-line basis over each asset&#8217;s estimated useful life.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 77%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
    and Equipment</b></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="width: 22%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    life</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 years</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of 3 years or lease term</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automobile</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Leases</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company accounts for leases in accordance with ASC 842, <i>Leases</i>. All contracts are evaluated to determine whether or not
they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for
consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not
hold any finance leases. The Company has elected to adopt the short-term lease exemption in ASC 842 and as such has not recognized
a &#8220;right of use&#8221; asset or lease liability in the consolidated balance sheets as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Long-Lived
Assets and Finite Lived Intangibles</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company has finite lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line
basis over their estimated remaining economic lives. The patents and trademarks are amortized over 15 years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company reviews its long-lived assets and finite lived intangibles for impairment whenever events or changes in circumstances
indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include
significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the
asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost
to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability
of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects
the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted
cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated.
An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Income
Taxes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized
for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">A
valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
Due to the Company&#8217;s lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance
as of December&#160;31, 2021 and 2020 (see Note 11. Income Taxes).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There
are no uncertain tax positions that would require recognition in the financial statements. If the Company were to incur an income
tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income
tax would be reported as income taxes. Management&#8217;s conclusions regarding uncertain tax positions may be subject to review
and adjustment at a later date based upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof
as well as other factors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; "><b><i>Convertible
Preferred Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; ">The
Company has applied the guidance in ASC 480-10-S99-3A, <i>SEC Staff Announcement: Classification and Measurement of Redeemable
Securities</i> and has classified all of its outstanding convertible preferred shares as permanent equity. The Company records
shares of convertible preferred stock at their respective issuance price, net of issuance costs. The Company&#8217;s convertible
preferred stock share&#8217;s redemption and conversion provisions are not exclusively at the option of the holder and are contingent
on certain deemed liquidation events within the Company&#8217;s control (see Note 7. Capital Structure).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Warrants</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company issued to its lead underwriter in the Company&#8217;s IPO warrants to purchase up to 140,000 shares of the Company&#8217;s
common stock. The Company accounts for warrants in accordance with ASC 480, <i>Distinguishing Liabilities from Equity</i>. The
Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments
in consideration of the cashless settlement provisions in the warrant agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company also applied the guidance in ASC 340-10-S99-1, <i>Other Assets and Deferred Costs</i>, that states specific incremental
costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against
the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance
of an equity contract and accordingly, classified the warrants as additional paid-in capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Stock-based
Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value
of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the
award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the
period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model,
which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest
rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense<b>)</b>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Net
Loss Per Share Attributable to Ordinary Shareholders</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company computes loss per share attributable to ordinary shareholders by dividing net loss attributable to ordinary shareholders
by the weighted-average number of ordinary shares outstanding. Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share,
the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to
include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable
to Common Stockholders).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Research
and Development Expense</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Research
and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials,
labor and stock-based compensation related to development of the Company&#8217;s products and services. Research and development
costs are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Selling,
General, and Administrative Expense</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Selling,
general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization,
travel, and advertising costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Commitments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and
the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than
any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than
any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company
as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; "><b><i>Segment
Reporting</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; ">The
Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages operations and business as one operating
segment for the purposes of allocating resources, makes operating decisions and evaluates financial performance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Revenue
Recognition</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
January&#160;1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts
with Customers </i>(&#8220;Topic 606&#8221;) and recognizes revenue upon the transfer of goods or services in an amount that reflects
the expected consideration received in exchange for those goods or services. The Company has not generated any revenue for the
years ended December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Recent
Accounting Pronouncements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There
were no significant updates to the recently issued accounting standards. Although there are several other new accounting standards
issued or proposed by the Financial Accounting Standards Board (&#8220;FASB&#8221;), the Company does not believe any of those
accounting standards have had or will have a material impact on its financial position or operating results.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358108056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_BalanceSheetComponentsTextBlock', window );">Balance Sheet Components</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>3.
Balance Sheet Components</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Property
and Equipment, Net</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Property
and equipment is comprised of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Automobiles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">279,617</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">325,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Computer and Equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,048</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,157</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,767</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">476,563</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(385,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(342,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">102,787</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">133,805</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Depreciation
expense for the year ended December&#160;31, 2021 and 2020 was $82,389 and $88,170, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Accrued
Expenses and Other Current Liabilities</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Accrued
expenses and other current liabilities are comprised of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">37,455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,761</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94,186</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">295,156</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">307,402</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
March&#160;27, 2020, the United States Congress passed the Coronavirus, Aid, Relief and Economic Security Act (the &#8220;CARES
Act&#8221;) in response to the economic impact of the coronavirus (&#8220;COVID-19&#8221;) pandemic in the United States (see
Note 13. Risks and Uncertainties). Section&#160;2302 of the CARES Act allowed employers to defer the remittance and payment of
the employer&#8217;s share of social security taxes that were otherwise required to be remitted between March&#160;27 and December&#160;31,
2020, and to pay the deferred taxes in two installments &#8212; with the first half due on December&#160;31, 2021, and the remainder
by December&#160;31, 2022. As of December&#160;31, 2021, the Company remitted $67,958 in social security taxes due that were deferred
between May&#160;1 and December&#160;31, 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Section&#160;2301
of the CARES Act also provided refundable employee retention credits (the &#8220;ERC&#8221;) against certain employment taxes.
The Company is currently evaluating its eligibility to claim the ERC and the impact of the credits on its consolidated statement
of operations.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_BalanceSheetComponentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_BalanceSheetComponentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358233672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>4.
Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company leases its office space under a recurring lease agreement which expired in February&#160;2022 and was subsequently renewed
and amended (see Note 14. Subsequent Events). Monthly payments are approximately $15,500 while future minimum payments under the
primary terms of the lease in effect at December&#160;31, 2021 are approximately $31,000 in 2022 until the expiration of the lease
in February&#160;2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Rent
expense for the year ended December&#160;31, 2021 and 2020 was $236,476 and $229,019, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359147752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>5.
Intangible Assets, Net</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of December&#160;31, 2021</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated<br/>
    Amortization</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,083</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,917</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible
    assets</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,083</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,917</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of December&#160;31, 2020</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated<br/>
    Amortization</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/>
Carrying<br/>
Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,617</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,383</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible
    assets</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,617</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,383</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Amortization
expense for each of the years ended December&#160;31, 2021 and 2020 was $3,466.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Estimated
amortization expense for all intangible assets subject to amortization in future years is expected to be:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Years ended December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,467</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,049</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,917</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358207976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>6.
Debt</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Paycheck
Protection Program Notes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
April&#160;2020, the Company entered into a Note with JPMorgan Chase (the &#8220;Lender&#8221;) under the U.S. Small Business
Administration (&#8220;SBA&#8221;) Paycheck Protection Program (&#8220;PPP&#8221;) established under Section&#160;1102 of the
CARES Act, pursuant to which the Company borrowed $695,078 (the &#8220;Note&#8221;). The Note accrues interest at a rate of 0.98%
per annum and matures in 24 months from the date of the Note. The Note may be repaid at any time with no prepayment penalty. All
of the funds received under the PPP had been used for qualified purposes. The Company applied for forgiveness of the Note in accordance
with PPP guidelines, and in October, 2021, received approval of the forgiveness application.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
February&#160;2021, the Company entered into a second Note (the &#8220;PPP2 Note&#8221;) with the Lender, pursuant to which the
Lender agreed to make a loan to the Company under the PPP offered by the SBA in a principal amount of $892,115 pursuant to Title
1 of the CARES Act. The PPP2 Note matures in five years with interest accruing at 0.98% per annum. Proceeds of the PPP2 Note are
available to be used to pay for payroll costs, including salaries, commissions, and similar compensation, group health care benefits,
and paid leaves; rent; utilities; and interest on certain other outstanding debt. All of the funds received under the PPP2 Note
were used for qualified purposes during 2021. The Company applied for forgiveness of the PPP2 Note in accordance with PPP guidelines,
and in November, 2021, received approval of the forgiveness application.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
PPP and PPP2 Notes that were forgiven by the SBA were recognized as gains and included in &#8216;Other income&#8217; or the non-operating
section of the Company&#8217;s consolidated statements of operations.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358167080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalNotesAbstract', window );"><strong>Partners' Capital Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalNotesDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>7.
Capital Structure</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Common
Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the Company is authorized to issue 100,000,000 shares with a par value of $0.00001 per share. As of
December&#160;31, 2020, the Company was authorized to issue 42,000,000 shares of Common Stock with a par value of $0.00001 per
share. As of December&#160;31, 2021 and December&#160;31, 2020, the Company had 26,487,680 and 951,794 shares of Common Stock
issued and outstanding, respectively. Holders of common stock have no preemptive, conversion or subscription rights and there
is no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders
of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred
stock that the Company may designate in the future.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Convertible
Preferred Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
October&#160;2021, the Company amended its Certificate of Incorporation and revised the number of preferred stock shares authorized
for issuance to 10,000,000 shares at a par value of $0.00001. As of December&#160;31, 2021, there were no shares issued and outstanding
against these shares. As of December&#160;31, 2020 and prior to the completion of the IPO, the Company was authorized to issue
up to 21,982,491 shares of preferred stock at a par value of $0.00001.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Conversion</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company&#8217;s convertible preferred stock shares that were outstanding at the completion of the IPO on October&#160;20, 2021
automatically converted to shares of common stock on a 1:1 basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences prior to the IPO were
as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Series</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Issued and<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share<br/> Liquidation<br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Liquidation<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Proceeds</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Series A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,157,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,157,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.6842</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,949,996</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,949,996</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Series B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,567,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,567,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.3939</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,290,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,290,015</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Series C</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,256,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,256,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">15.7933</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83,025,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83,025,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,265,042</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,265,042</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Warrants</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the fair value of the warrants was estimated using the Black-Scholes option-pricing model. The Company
used the following assumptions in the model:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.88</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.13</td><td style="text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Dividends</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
holders of preferred stock are entitled to receive dividends, when and if declared by the Company&#8217;s Board of Directors,
out of any legally available funds. The holders of preferred stock are entitled to receive dividends, prior and in preference
to dividends declared on common stock, at the rate of: Series A - $0.0411 per share per annum; Series B - $0.2036 per share per
annum; and Series C - $0.9476 per share per annum. Dividends are non-cumulative and will be paid pro rata, on an equal priority,
pari passu basis. After payment of preferred stock dividends, any additional dividends will be paid ratably among holders of common
stock and preferred stock on an as converted to Common Stock basis. As of December&#160;31, 2021 and 2020, respectively, no dividends
have been declared.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Voting</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
holder of each share of Preferred Stock is entitled to voting rights equal to the number of shares of common stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Preferred
stockholders shall cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred
Stock held by such holder are convertible. So long as any shares of Series A Preferred Stock remain outstanding, the holders of
the Series A Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. So long as any shares
of Series B Preferred Stock remain outstanding, the holders of the Series B Preferred Stock, voting as a separate class, are entitled
to elect one director of the Company. So long as any shares of Series C Preferred Stock remain outstanding, the holders of the
Series C Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. The holders of Common
Stock, voting as a separate class, are entitled to elect two directors of the Company. The holders of Preferred Stock and Common
Stock, on an as converted to basis, are entitled to elect any remaining members to the Board of Directors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Liquidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of preferred
stock on a pari passu basis, are entitled to receive, prior to and in preference over holders of common stock, an amount equal
to the original issuance price&#8212;Series A - $0.6842 per share; Series B - $3.3939 per share; and Series C - $15.7933 per share.
2) If the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of the
shares of Preferred Stock the full amount to which they are entitled, the holders of shares of Preferred Stock shall share ratably
in any distribution of the assets available for distribution in proportion to the respective amount which would otherwise be payable
in respect to the share of Preferred Stock held by them upon such distribution if all amounts payable on or with respect to such
shares were paid in full.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalNotesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalNotesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359135848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>8.
Net Loss Per Share Attributable to Common Stockholders</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table summarizes the computation of basic and diluted loss per share:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(7,799,529</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(8,338,807</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Basic and diluted weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,861,730</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">949,544</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(8.78</td><td style="text-align: left">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Basic
loss per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted loss
per share would include the effect of unvested restricted stock awards and the convertible preferred Stock; however, such items
were not considered in the calculation of the diluted weighted average common shares outstanding since they would be anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Potentially
dilutive securities excluded from the calculation of diluted shares outstanding are shown below:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year ended<br/> December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Unvested restricted shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,123,931</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,652,680</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Common shares issuable upon conversion of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,123,931</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,635,171</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358142664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>9.
Stock-based Compensation Expense</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Stock-Based
Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company measures employee and director stock-based compensation awards based on the award&#8217;s estimated fair value on the
date of grant. Expense associated with these awards is recognized using the straight-line attribution method over the requisite
service period for stock options, and is reported in our consolidated statements of comprehensive loss.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
fair value of our stock options is estimated, using the Black-Scholes option-pricing model. The resulting fair value is recognized
on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The
Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual
term of ten years. Vesting terminates at the end of the employment relationship.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Determining
the grant date fair value of options requires management to make assumptions and judgments. These estimates involve inherent uncertainties
and if different assumptions had been used, stock-based compensation expense could have been materially different from the amounts
recorded.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
assumptions and estimates for valuing stock options are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
    value per share of Company&#8217;s common stock.</i> The fair value of the Company&#8217;s stock options with service conditions
    is measured on the following basis according to when the stock options were granted: i) stock options granted prior to the
    IPO: due to the absence of a public market for Cyngn&#8217;s common stock prior to the IPO, our Board of Directors, with the
    assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock
    options by considering a number of objective and subjective factors, including our actual operating and financial performance,
    market conditions and performance of comparable publicly traded companies, developments and milestones in the company, and
    the likelihood of achieving a liquidity event among other factors; ii) stock options granted after the IPO: the closing fair
    market value of its common stock at the time of the grant.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
    volatility. </i>The Company determines the expected volatility based on historical average volatilities of similar publicly
    traded companies corresponding to the expected term of the stock options.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected
    term. </i>The Company does not have sufficient historical data relating to its common stock nor to its stock-option exercises.
    As such, the Company determines the expected term of awards which contain only service conditions using the simplified approach,
    wherein the expected term of an award is presumed to be the mid-point between the vesting date and the expiration date of
    the award.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk-free
    interest rate.</i> The risk-free interest rate is based on the U.S. Treasury yield curve with maturities that approximate
    the expected term of the stock options.</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Estimated
    dividend yield.</i> The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in
    the foreseeable future.</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Equity
Incentive Plans</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
February&#160;2013, the Board of Directors adopted the 2013 Equity Incentive Plan (&#8220;2013 Plan&#8221;). The 2013 Plan authorizes
the award of stock options, stock appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards,
and other stock or cash awards.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
October&#160;2021, our Board of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). Our
2021 Plan replaces our 2013 Plan. However, awards outstanding under our 2013 Plan will continue to be governed by their existing
terms.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021 and 2020, approximately 10,502,696 and 9,830,005 shares of common stock were reserved and available
for issuance under the 2021 Plan and 2013 Plan, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Options
issued under the Plan generally vest based on continuous service provided by the option holder over a four-year period. Compensation
expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at
the grant date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table sets forth the summary of options activity for the year ended December&#160;31, 2021 and 2020:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/>
average<br/>
exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/>
    average<br/> remaining<br/> contractual<br/> term (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> intrinsic<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Outstanding as of December&#160;31, 2020</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">6,971,301</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7.0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,399,827</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and expected to vest at December&#160;31, 2020</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,892,738</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.54</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,860,120</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and exercisable at December&#160;31, 2020</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,978,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.03</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">406,094</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,926,473</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(41,416</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">109,902</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,086,664</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Outstanding as of December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,769,694</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,746,916</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and expected to vest at December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,769,694</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,746,916</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and exercisable at December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,645,763</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.27</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.94</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,967,973</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
fair value of a stock option is estimated using an option-pricing model that takes into account as of the grant date the exercise
price and expected life of the option, the current price of the underlying stock and its expected volatility, expected dividends
on the stock, and the risk-free interest rate for the expected term of the option. The Company has used the simplified method
in calculating the expected term of all option grants based on the vesting period and contractual term. Compensation costs related
to share-based payment transactions are recognized in the financial statements upon satisfaction of the requisite service or vesting
requirements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
weighted average per share grant-date fair value of options granted during the years ended December&#160;31, 2021 and 2020 was
$2.78 and $0.07 respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following weighted average assumptions were used in estimating the grant date fair values in December&#160;31, 2021 and 2020:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Fair value of common stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.78</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.23</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.95</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.68</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.34</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For
the year ended December&#160;31, 2021 and 2020, the Company recorded stock-based compensation expense from stock options of approximately
$1,139,247 and $131,732, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, total unrecognized stock-based compensation cost related to outstanding unvested stock options that
are expected to vest was $7,031,949. This unrecognized stock-based compensation cost is expected to be recognized over a weighted-average
period of approximately 4.6 years. Income tax benefits recognized from stock-based compensation expense recognized for the year
ended December&#160;31, 2021 were immaterial due to cumulative losses and valuation allowances.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358183912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Savings Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_RetirementSavingsPlanAbstract', window );"><strong>Retirement Savings Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_RetirementSavingsPlanTextBlock', window );">Retirement Savings Plan</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>10.
Retirement Savings Plan</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Effective
November&#160;17, 2017, the Company established the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees
and their beneficiaries with the intention to provide a measure of retirement security for the future. This plan is subject to
the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and qualifies under Section&#160;401(k) of the Internal
Revenue Code. Cyngn Inc. did not offer and has not provided a company match for its 401(k) Plan.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RetirementSavingsPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RetirementSavingsPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RetirementSavingsPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RetirementSavingsPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358196120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>11.
Income Taxes</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For
the years ended December&#160;31, 2021 and 2020, the Company recorded income tax expense of $800. The effective tax rate is 0%
for the years ended December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For
financial reporting purposes, the Company&#8217;s effective tax rate used for the interim periods is based on the estimated full-year
income tax rate. Income tax expense differed from the amount computed by applying the federal statutory income tax rate of 21%
to pretax income for the year ended December&#160;31, 2021 as a result of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Federal tax at statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,635,786</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(543,984</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Nondeductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(308,449</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Research and development credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(897,331</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">FIN 48 reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Foreign Tax Rate Difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,779</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,330</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">True-up and Rate Change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,751</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,207,490</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">800</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
tax effects of temporary differences that give rise to significant portions of the Company&#8217;s deferred tax assets and liabilities
as of December&#160;31, 2021 and 2020 related to the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Intangibles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,772,704</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,299,275</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net operating losses and Credit carryover</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,425,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,834,590</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,979</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,694</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">SBC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">243,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,726</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Accruals And Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,005</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,034</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Gross deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,571,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,364,488</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,571,977</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,364,488</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in">Total deferred tax assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Deferred Commissions</td><td>&#160;</td>
    <td style="text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="text-align: right; border-bottom: Black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="text-align: right; border-bottom: Black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in">Total deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.375in; text-indent: -0.125in">Net deferred tax assets:</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Management
regularly assesses the ability to realize deferred tax assets recorded based upon the weight of available evidence, including
such factors as recent earnings history and expected future taxable income on a jurisdiction by jurisdiction basis. In the event
that the Company changes its determination as to the amount of realizable deferred tax assets, the Company will adjust its valuation
allowance with a corresponding charge to the provision for income taxes in the period in which such determination is made. The
Company&#8217;s management believes that, based on a number of factors, it is more likely than not, that all or some portion of
the deferred tax assets will not be realized; and accordingly, for the years ending December&#160;31, 2021 and December&#160;31,
2020, the Company has provided a valuation allowance against the Company&#8217;s U.S. net deferred tax assets. The net change
in the valuation allowance for the year ended December&#160;31, 2021 was an increase of $3,207,490.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the Company had net operating loss carryforwards for federal and state income tax purposes of approximately
$100,697,360 and $101,454,126, respectively, which will both begin to expire in <span style="-sec-ix-hidden: hidden-fact-68">2034</span> with $65,360,163 of our federal net operating
loss carryforward lasting indefinitely.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, the Company had federal and state research credit carryforwards of approximately $4,258,776 and $2,192,429,
respectively. The federal research credit carryforwards will begin to expire in <span style="-sec-ix-hidden: hidden-fact-69">2023</span> while the California research credits carry
forward have an indefinite life.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of net operating losses in the event of an
&#8220;ownership change&#8221; of a corporation. Accordingly, a company&#8217;s ability to use net operating losses may be limited
as prescribed under Internal Revenue Code Section&#160;382 (&#8220;IRC Section&#160;382&#8221;). Events which may cause limitations
in the amount of the net operating losses that the Company may use in any one year include, but are not limited to, a cumulative
ownership change of more than 50% over a three-year period. Utilization of the federal and state net operating losses may be subject
to substantial annual limitation due to the ownership change limitations provided by the IRC Section&#160;382 and similar state
provisions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As
of December&#160;31, 2021, and 2020, the total amount of gross unrecognized tax benefits was $1,797,238 and $1,412,668, respectively,
including no interest and penalties. As of December&#160;31, 2021, $1,797,238 of the total unrecognized tax benefits, if recognized,
would have an impact on the Company&#8217;s effective tax rate. The Company estimates that there will be no material changes in
its uncertain tax positions in the next 12 months. In accordance with FASB ASC 740, the Company has adopted the accounting policy
that interest and penalties recognized are classified as part of its income taxes. Total interest and penalties recognized in
the consolidated statement of operations was zero for 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company files income tax returns in the US federal and various state jurisdictions. The Company&#8217;s tax years for 2018 and
forward are subject to examination by the US tax authorities. The Company&#8217;s tax years for 2017 and forward are subject to
examination by various state tax authorities. However, due to the fact that the Company had loss and credits carried forward in
some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant taxing
authority through an adjustment to tax attributes carried forward to open years. The Company files U.S. and foreign income tax
returns with varying statutes of limitations. Due to the Company&#8217;s net carryover of unused operating losses, all years remain
subject to future examination by tax authorities.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359151336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>12.
Commitments and Contingencies</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Legal
Proceedings</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company is subject to legal and regulatory actions that arise from time to time. The assessment as to whether a loss is probable
or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment
about future events, and the outcome of litigation is inherently uncertain. There is no material pending or threatened litigation
against the Company that remains outstanding as of December&#160;31, 2021 and 2020.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358174840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>13.
Risks and Uncertainties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">COVID-19.
A novel strain of coronavirus (COVID-19) was first identified in December&#160;2019, and subsequently declared a pandemic by the
World Health Organization. While Cyngn&#8217;s business has experienced limited disruption due to this pandemic, our leadership
team continues to focus on the highest level of safety measures to protect our employees. The Company is aware COVID-19 continues
to present significant uncertainty in the future economic outlook for our customers and the markets we serve.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358167080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>14.
Subsequent Events</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
February&#160;17, 2022, the Company amended the lease agreement (the &#8220;Lease Amendment&#8221;). The Lease Amendment extended
the current lease for an additional 18 months, which commenced on March&#160;1, 2022, and expanded the leased space to a total
of 23,311 square feet from the previous 6,886 square feet.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359641688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Basis
of Presentation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
accompanying consolidated financial statements as of and for the years ended December&#160;31, 2021 and 2020 have been prepared
in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to applicable
rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include
all normal adjustments necessary for a fair presentation of the Company&#8217;s financial position at December&#160;31, 2021 and
2020, and operating results and cash flows for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">These
consolidated financial statements should be read in conjunction with the following: i) audited consolidated financial statements
as of and for the years ended December&#160;31, 2020 and 2019; ii) the discussion under &#8220;Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations&#8221; and&#8217; iii) our final prospectus (the &#8220;Prospectus&#8221;),
filed with the Securities and Exchange Commission or the SEC, pursuant to Rule&#160;424(b) under the Securities Act of 1933, as
amended or the Securities Act), on October&#160;21, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Principles
of Consolidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
consolidated financial statements include the accounts of CYNGN Inc. and its wholly owned subsidiaries. Intercompany accounts
and transactions have been eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Foreign
Currency Translation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other
than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average
exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments
and transactional gains and losses are immaterial to the consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Use
of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These
estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company&#8217;s
significant estimates and judgments include but are not limited to underwriter&#8217;s warrants and share-based compensation.
Estimates are based on historical experience and on various other assumptions believed to be reasonable, the results of which
form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those
estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Concentration
of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents. The Company&#8217;s
cash is placed with high-credit-quality financial institutions and at times exceeds federally insured limits. The Company has
not experienced any credit loss relating to its cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ConcentrationOfSupplierRiskPolicyTextBlock', window );">Concentration of Supplier Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Concentration
of Supplier Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there
is any significant supplier concentration risk as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Cash
and Cash Equivalents and Restricted Cash</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company considers all highly liquid money market placements with a remaining maturity of three months or less to be cash equivalents.
The Company had $21.9 million and $6.1 million of unrestricted cash and cash equivalents as of December&#160;31, 2021 and 2020,
respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In
addition, the Company had $50,000 and $400,000 in restricted cash as of December&#160;31, 2021 and 2020, respectively, which is
reported separately as current assets on the consolidated balance sheet. The Company&#8217;s restricted cash consists of cash
not available for immediate use that the Company is obligated to maintain in accordance with the terms of its credit card spending
arrangement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
following table provides a reconciliation of cash and cash equivalents and restricted cash to amounts shown in the consolidated
statements of cash flows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">21,945,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,056,190</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total Cash and cash equivalents and Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,995,981</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,456,190</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Fair
Value Measurements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
accounting guidance under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, <i>Fair Value Measurements</i>, defines
fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability
category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing
the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value
as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
1</i>&#8212;Unadjusted quoted prices in active markets for identical assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
2</i>&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially
the full term of the assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><i>Level
3</i>&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value
of the assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Assets
and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair
value measurement of an instrument does not necessarily result in a change in the amount recorded on the consolidated balance
sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting
guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets
and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived
assets, intangible assets, share-based compensation and underwriter warrants measured at fair value upon initial recognition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
carrying amounts of the Company&#8217;s cash and cash equivalents, accounts payable and notes payable are reasonable estimates
of their fair values due to the short-term nature of these accounts. The fair values of the Company&#8217;s share-based compensation
and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent
external valuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Property
and Equipment</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Property
and equipment is stated at cost less accumulated depreciation. Repair and maintenance costs are expensed as incurred. Depreciation
is recorded on a straight-line basis over each asset&#8217;s estimated useful life.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Leases</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company accounts for leases in accordance with ASC 842, <i>Leases</i>. All contracts are evaluated to determine whether or not
they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for
consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not
hold any finance leases. The Company has elected to adopt the short-term lease exemption in ASC 842 and as such has not recognized
a &#8220;right of use&#8221; asset or lease liability in the consolidated balance sheets as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets and Finite Lived Intangibles</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Long-Lived
Assets and Finite Lived Intangibles</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company has finite lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line
basis over their estimated remaining economic lives. The patents and trademarks are amortized over 15 years.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company reviews its long-lived assets and finite lived intangibles for impairment whenever events or changes in circumstances
indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include
significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the
asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost
to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability
of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects
the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted
cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated.
An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Income
Taxes</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized
for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">A
valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
Due to the Company&#8217;s lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance
as of December&#160;31, 2021 and 2020 (see Note 11. Income Taxes).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There
are no uncertain tax positions that would require recognition in the financial statements. If the Company were to incur an income
tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income
tax would be reported as income taxes. Management&#8217;s conclusions regarding uncertain tax positions may be subject to review
and adjustment at a later date based upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof
as well as other factors.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ConvertiblePreferredStockPolicyTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; "><b><i>Convertible
Preferred Stock</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; ">The
Company has applied the guidance in ASC 480-10-S99-3A, <i>SEC Staff Announcement: Classification and Measurement of Redeemable
Securities</i> and has classified all of its outstanding convertible preferred shares as permanent equity. The Company records
shares of convertible preferred stock at their respective issuance price, net of issuance costs. The Company&#8217;s convertible
preferred stock share&#8217;s redemption and conversion provisions are not exclusively at the option of the holder and are contingent
on certain deemed liquidation events within the Company&#8217;s control (see Note 7. Capital Structure).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Warrants</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company issued to its lead underwriter in the Company&#8217;s IPO warrants to purchase up to 140,000 shares of the Company&#8217;s
common stock. The Company accounts for warrants in accordance with ASC 480, <i>Distinguishing Liabilities from Equity</i>. The
Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments
in consideration of the cashless settlement provisions in the warrant agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company also applied the guidance in ASC 340-10-S99-1, <i>Other Assets and Deferred Costs</i>, that states specific incremental
costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against
the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance
of an equity contract and accordingly, classified the warrants as additional paid-in capital.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Stock-based
Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value
of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the
award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the
period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model,
which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest
rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense<b>)</b>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share Attributable to Ordinary Shareholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Net
Loss Per Share Attributable to Ordinary Shareholders</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company computes loss per share attributable to ordinary shareholders by dividing net loss attributable to ordinary shareholders
by the weighted-average number of ordinary shares outstanding. Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share,
the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to
include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable
to Common Stockholders).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Research
and Development Expense</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Research
and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials,
labor and stock-based compensation related to development of the Company&#8217;s products and services. Research and development
costs are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General, and Administrative Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Selling,
General, and Administrative Expense</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Selling,
general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization,
travel, and advertising costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Commitments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The
Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and
the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than
any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than
any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company
as of December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; "><b><i>Segment
Reporting</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif; ">The
Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages operations and business as one operating
segment for the purposes of allocating resources, makes operating decisions and evaluates financial performance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Revenue
Recognition</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
January&#160;1, 2019, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts
with Customers </i>(&#8220;Topic 606&#8221;) and recognizes revenue upon the transfer of goods or services in an amount that reflects
the expected consideration received in exchange for those goods or services. The Company has not generated any revenue for the
years ended December&#160;31, 2021 and 2020.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Recent
Accounting Pronouncements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There
were no significant updates to the recently issued accounting standards. Although there are several other new accounting standards
issued or proposed by the Financial Accounting Standards Board (&#8220;FASB&#8221;), the Company does not believe any of those
accounting standards have had or will have a material impact on its financial position or operating results.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ConcentrationOfSupplierRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ConcentrationOfSupplierRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ConvertiblePreferredStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ConvertiblePreferredStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358106616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">21,945,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,056,190</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">50,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">400,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total Cash and cash equivalents and Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,995,981</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,456,190</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock', window );">Schedule of property and equipment estimated useful life</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 77%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
    and Equipment</b></span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="width: 22%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful
    life</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 years</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of 3 years or lease term</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automobile</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358124408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Automobiles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">279,617</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">325,406</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133,102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">125,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Computer and Equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,048</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,157</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,767</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">476,563</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(385,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(342,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">102,787</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">133,805</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses and other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">37,455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,761</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94,186</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">295,156</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">307,402</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358236824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of December&#160;31, 2021</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated<br/>
    Amortization</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,083</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,917</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; ">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible
    assets</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,083</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,917</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; ">
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    of December&#160;31, 2020</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross<br/>
    Carrying<br/>
    Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated<br/>
    Amortization</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/>
Carrying<br/>
Amount</b></span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,617</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,383</span></td>
    <td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible
    assets</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,000</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,617</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,383</span></td>
    <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of estimated amortization expense for all intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Years ended December&#160;31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,467</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,467</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,049</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,917</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230362780488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalNotesAbstract', window );"><strong>Partners' Capital Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfConversionsOfStockTextBlock', window );">Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Series</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/> Issued and<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share<br/> Liquidation<br/> Preference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Liquidation<br/> Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Proceeds</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Series A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,157,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,157,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.6842</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,949,996</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,949,996</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Series B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,567,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,567,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.3939</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,290,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,290,015</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Series C</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,256,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,256,978</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">15.7933</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83,025,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83,025,031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,265,042</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,265,042</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of fair value of the warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.88</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.13</td><td style="text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfConversionsOfStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfConversionsOfStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358181672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(7,799,529</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(8,338,807</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Basic and diluted weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,861,730</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">949,544</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(8.78</td><td style="text-align: left">)</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock', window );">Schedule of calculation of diluted shares outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended<br/> December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year ended<br/> December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Unvested restricted shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,123,931</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,652,680</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Common shares issuable upon conversion of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,982,491</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,123,931</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,635,171</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358108056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of stock option</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/>
average<br/>
exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/>
    average<br/> remaining<br/> contractual<br/> term (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> intrinsic<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Outstanding as of December&#160;31, 2020</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">6,971,301</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7.0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,399,827</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and expected to vest at December&#160;31, 2020</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,892,738</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.54</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,860,120</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and exercisable at December&#160;31, 2020</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,978,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.03</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">406,094</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,926,473</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(41,416</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">109,902</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Cancelled/forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,086,664</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Outstanding as of December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,769,694</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,746,916</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and expected to vest at December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,769,694</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,746,916</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Vested and exercisable at December&#160;31, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,645,763</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.27</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.94</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,967,973</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of weighted average fair value of each grant estimated on grant date</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Fair value of common stock</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.78</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.23</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.95</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.68</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.34</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358111656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of federal statutory income tax</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Federal tax at statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,635,786</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(543,984</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Nondeductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(308,449</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Research and development credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(897,331</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">FIN 48 reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Foreign Tax Rate Difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,779</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Stock Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,330</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">True-up and Rate Change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,751</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,207,490</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">800</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Intangibles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,772,704</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,299,275</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net operating losses and Credit carryover</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,425,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,834,590</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,979</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,694</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">SBC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">243,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,726</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Accruals And Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,005</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38,034</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Gross deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,571,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,364,488</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,571,977</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,364,488</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in">Total deferred tax assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Deferred Commissions</td><td>&#160;</td>
    <td style="text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="text-align: right; border-bottom: Black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left; border-bottom: Black 1.5pt solid">&#160;</td><td style="text-align: right; border-bottom: Black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in">Total deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.375in; text-indent: -0.125in">Net deferred tax assets:</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230356330632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 22, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_PurchaseAnAdditionalSharesOfCommonStock', window );">Additional shares of common stock (in Shares)</a></td>
<td class="nump">525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_PurchaseWarrantsDescription', window );">Purchase warrants , description</a></td>
<td class="text">The Purchase Warrants
are exercisable six (6) months after the IPO and expire five (5) years thereafter.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessStockSharesAuthorized', window );">Common stock, shares authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CommonStockShares', window );">Common stock shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_PreferredStockShareIssued', window );">Preferred stock shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionPricePerShare', window );">Preferred stock, per shares (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAppropriated', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116.5<span></span>
</td>
<td class="nump">108.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_UnrestrictedCashAndCashEquivalents', window );">Unrestricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cyngn_PurchaseWarrantsMember', window );">Purchase Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_RedeemableWarrants', window );">Redeemable warrants (in Shares)</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Initial exercise price per share (in Dollars per share)</a></td>
<td class="nump">$ 9.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in Shares)</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price per share (in Dollars per share)</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cyngn_CYNMember', window );">&#8220;CYN&#8221; [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_NetProceeds', window );">Net proceeds</a></td>
<td class="nump">$ 23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cyngn_LiquidityMember', window );">Liquidity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_UnrestrictedCashAndCashEquivalents', window );">Unrestricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commo stock shares authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DescriptionofBusinessDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DescriptionofBusinessDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_NetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt originations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_NetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PreferredStockShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PreferredStockShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PurchaseAnAdditionalSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase An Additional Shares of Common Stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PurchaseAnAdditionalSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PurchaseWarrantsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase warrants , description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PurchaseWarrantsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RedeemableWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RedeemableWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_UnrestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_UnrestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of excess stock shares permitted to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21488-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAppropriated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21346-112643<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21332-112643<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(23)(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(30)(a)(3)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAppropriated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cyngn_PurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cyngn_PurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cyngn_CYNMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cyngn_CYNMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cyngn_LiquidityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cyngn_LiquidityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230361039144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_UnrestrictedCashAndCashEquivalents', window );">Unrestricted cash and cash equivalents</a></td>
<td class="nump">$ 21,900,000<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock shares (in Shares)</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_UnrestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_UnrestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230361881080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract', window );"><strong>Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsCurrent', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,945,981<span></span>
</td>
<td class="nump">$ 6,056,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestrictedAssetsCurrent', window );">Restricted cash</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total Cash and cash equivalents and Restricted cash</a></td>
<td class="nump">$ 21,995,981<span></span>
</td>
<td class="nump">$ 6,456,190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestrictedAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestrictedAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the current portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230357274808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements', window );">Property and Equipment, Useful Life</a></td>
<td class="text">Shorter of 3 years or lease term<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobile [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360015352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_BalanceSheetComponentsAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 82,389<span></span>
</td>
<td class="nump">$ 88,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Deferred social security taxes</a></td>
<td class="nump">$ 67,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 892,115<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_BalanceSheetComponentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_BalanceSheetComponentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359572104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Schedule of property and equipment - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfPropertyAndEquipmentAbstract', window );"><strong>Schedule of property and equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_Automobiles', window );">Automobiles</a></td>
<td class="nump">$ 279,617<span></span>
</td>
<td class="nump">$ 325,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">133,102<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Computer and Equipment</a></td>
<td class="nump">76,048<span></span>
</td>
<td class="nump">26,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">488,767<span></span>
</td>
<td class="nump">476,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(385,980)<span></span>
</td>
<td class="num">(342,758)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 102,787<span></span>
</td>
<td class="nump">$ 133,805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_Automobiles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_Automobiles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfPropertyAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfPropertyAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359432984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - Schedule of accrued expenses and other current liabilities - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract', window );"><strong>Schedule of accrued expenses and other current liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CreditCardPayable', window );">Credit card payable</a></td>
<td class="nump">$ 11,678<span></span>
</td>
<td class="nump">$ 37,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">82,478<span></span>
</td>
<td class="nump">175,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">201,000<span></span>
</td>
<td class="nump">94,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 295,156<span></span>
</td>
<td class="nump">$ 307,402<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CreditCardPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CreditCardPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230357329944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_LeasesDetailsLineItems', window );"><strong>Leases (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Future minimum payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_RentExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 236,476<span></span>
</td>
<td class="nump">$ 229,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_LeasesDetailsLineItems', window );"><strong>Leases (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Future minimum payments</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_LeasesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_LeasesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358181672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 3,466<span></span>
</td>
<td class="nump">$ 3,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230356251112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net (Details) - Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 52,000<span></span>
</td>
<td class="nump">$ 52,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(21,083)<span></span>
</td>
<td class="num">(17,617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">30,917<span></span>
</td>
<td class="nump">34,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4,083)<span></span>
</td>
<td class="num">(3,617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">2,917<span></span>
</td>
<td class="nump">3,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(17,000)<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359738536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets - Amortization [Member]<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems', window );"><strong>Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2022</a></td>
<td class="nump">$ 3,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2023</a></td>
<td class="nump">3,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2024</a></td>
<td class="nump">3,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2025</a></td>
<td class="nump">3,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">17,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 30,917<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cyngn_AmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cyngn_AmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359671208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Company borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 695,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_MaturityDate', window );">Maturity date</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 892,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest accruing</a></td>
<td class="nump">0.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_MaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_MaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360903336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CapitalStructureDetailsLineItems', window );"><strong>Capital Structure (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CommonStockShareAuthorized', window );">Preferred stock, shares authorized (in Shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in Shares)</a></td>
<td class="nump">26,487,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in Shares)</a></td>
<td class="nump">26,487,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CapitalStructureDetailsLineItems', window );"><strong>Capital Structure (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CapitalStructureDetailsLineItems', window );"><strong>Capital Structure (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized (in Shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends declared on common stock, per share</a></td>
<td class="nump">0.0411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Original issuance price, per share</a></td>
<td class="nump">$ 0.6842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CapitalStructureDetailsLineItems', window );"><strong>Capital Structure (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized (in Shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends declared on common stock, per share</a></td>
<td class="nump">0.2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Original issuance price, per share</a></td>
<td class="nump">$ 3.3939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CapitalStructureDetailsLineItems', window );"><strong>Capital Structure (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized (in Shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends declared on common stock, per share</a></td>
<td class="nump">0.9476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Original issuance price, per share</a></td>
<td class="nump">$ 15.7933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CapitalStructureDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CapitalStructureDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CommonStockShareAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CommonStockShareAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360877928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Details) - Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares Authorized | shares</a></td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SeriesASharesIssuedAndOutstanding', window );">Shares Issued and Outstanding | shares</a></td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Aggregate Liquidation Amount | $</a></td>
<td class="nump">$ 112,265,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Gross Proceeds | $</a></td>
<td class="nump">$ 112,265,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares Authorized | shares</a></td>
<td class="nump">10,157,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SeriesASharesIssuedAndOutstanding', window );">Shares Issued and Outstanding | shares</a></td>
<td class="nump">10,157,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Per Share Liquidation Preference | $ / shares</a></td>
<td class="nump">$ 0.6842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Aggregate Liquidation Amount | $</a></td>
<td class="nump">$ 6,949,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Gross Proceeds | $</a></td>
<td class="nump">$ 6,949,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares Authorized | shares</a></td>
<td class="nump">6,567,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SeriesASharesIssuedAndOutstanding', window );">Shares Issued and Outstanding | shares</a></td>
<td class="nump">6,567,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Per Share Liquidation Preference | $ / shares</a></td>
<td class="nump">$ 3.3939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Aggregate Liquidation Amount | $</a></td>
<td class="nump">$ 22,290,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Gross Proceeds | $</a></td>
<td class="nump">$ 22,290,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares Authorized | shares</a></td>
<td class="nump">5,256,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SeriesASharesIssuedAndOutstanding', window );">Shares Issued and Outstanding | shares</a></td>
<td class="nump">5,256,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Per Share Liquidation Preference | $ / shares</a></td>
<td class="nump">$ 15.7933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears', window );">Aggregate Liquidation Amount | $</a></td>
<td class="nump">$ 83,025,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Gross Proceeds | $</a></td>
<td class="nump">$ 83,025,031<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_SeriesASharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series A shares issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_SeriesASharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAmountOfPreferredDividendsInArrears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of cumulative preferred dividends in arrears.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21488-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAmountOfPreferredDividendsInArrears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359409288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Details) - Schedule of fair value of the warrants - Warrants [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems', window );"><strong>Capital Structure (Details) - Schedule of fair value of the warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value of underlying securities (in Dollars)</a></td>
<td class="nump">$ 2.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230357280584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of basic and diluted loss per share - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract', window );"><strong>Schedule of basic and diluted loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (7,799,529)<span></span>
</td>
<td class="num">$ (8,338,807)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Basic and diluted weighted average common shares outstanding</a></td>
<td class="nump">5,861,730<span></span>
</td>
<td class="nump">949,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_LossPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted</a></td>
<td class="num">$ (1.33)<span></span>
</td>
<td class="num">$ (8.78)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_LossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_LossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359439320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of calculation of diluted shares outstanding - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract', window );"><strong>Schedule of calculation of diluted shares outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Unvested restricted shares</a></td>
<td class="nump">3,123,931<span></span>
</td>
<td class="nump">10,652,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Common shares issuable upon conversion of preferred stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,982,491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_EarningsPerShareTotal', window );">Total</a></td>
<td class="nump">3,123,931<span></span>
</td>
<td class="nump">32,635,171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_EarningsPerShareTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_EarningsPerShareTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359609944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_CommonStockSharesIssurance', window );">Common stock issurance (in Shares)</a></td>
<td class="nump">10,502,696<span></span>
</td>
<td class="nump">9,830,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_FairValueOfOptionsGranted', window );">Fair value of options granted</a></td>
<td class="nump">$ 2.78<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_StockbasedCompensationExpenseOfStockOptions', window );">Stock-based compensation expense of stock options</a></td>
<td class="nump">1,139,247<span></span>
</td>
<td class="nump">$ 131,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_StockOptionsExpectedVest', window );">Stock options expected vest</a></td>
<td class="nump">$ 7,031,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod', window );">weighted-average period</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CommonStockSharesIssurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CommonStockSharesIssurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_FairValueOfOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_FairValueOfOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StockOptionsExpectedVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock options that are expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StockOptionsExpectedVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StockbasedCompensationExpenseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock-based compensation expense from stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StockbasedCompensationExpenseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of present value of future profits of insurance contract acquired in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 805<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6918812&amp;loc=d3e30762-158568<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359522520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Details) - Schedule of stock option<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfStockOptionAbstract', window );"><strong>Schedule of stock option [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, outstanding at beginning balance</a></td>
<td class="nump">6,971,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price, outstanding at beginning balance (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual, outstanding at beginning balance</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value, outstanding at beginning balance (in Dollars) | $</a></td>
<td class="nump">$ 1,399,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares, vested and expected to vest at beginning balance</a></td>
<td class="nump">10,892,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest', window );">Weighted-average exercise price, vested and expected to vest at beginning balance (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual, vested and expected to vest at beginning balance</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at beginning balance (in Dollars) | $</a></td>
<td class="nump">$ 5,860,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares, vested and exercisable at beginning balance</a></td>
<td class="nump">5,978,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price, Vested and exercisable at beginning balance (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual, vested and exercisable at beginning balance</a></td>
<td class="text">7 years 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at beginning balance (in Dollars) | $</a></td>
<td class="nump">$ 406,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, granted</a></td>
<td class="nump">2,926,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted', window );">Weighted-average exercise price, granted (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares, exercised</a></td>
<td class="num">(41,416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised', window );">Weighted-average exercise price, exercised (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Aggregate intrinsic value, exercised</a></td>
<td class="nump">109,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of shares, cancelled/forfeited</a></td>
<td class="num">(1,086,664)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited', window );">Weighted-average exercise price, cancelled/forfeited (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, outstanding at ending balance</a></td>
<td class="nump">8,769,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price, outstanding at ending balance (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted-average remaining contractual, outstanding at ending balance</a></td>
<td class="text">7 years 1 month 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value, outstanding at ending balance (in Dollars) | $</a></td>
<td class="nump">$ 15,746,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares,vested and expected to vest at ending balance</a></td>
<td class="nump">8,769,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest', window );">Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares', window );">Weighted-average remaining contractual, vested and expected to vest at ending balance</a></td>
<td class="text">7 years 1 month 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars) | $</a></td>
<td class="nump">$ 15,746,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares, vested and exercisable at ending balance</a></td>
<td class="nump">5,645,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price, Vested and exercisable at ending balance (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt', window );">Weighted-average remaining contractual, vested and exercisable at ending balance</a></td>
<td class="text">5 years 11 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars) | $</a></td>
<td class="nump">$ 14,967,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfStockOptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfStockOptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value, outstanding at balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, cancelled/forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average remaining contractual, vested and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average remaining contractual, vested and expected to vest at (in Shares)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, vested and expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average remaining contractual, outstanding at ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359431992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Details) - Schedule of weighted average fair value of each grant estimated on grant date - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract', window );"><strong>Schedule of weighted average fair value of each grant estimated on grant date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of common stock (in Dollars)</a></td>
<td class="nump">$ 2.78<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 24 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">29.34%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230359521368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DeferredTaxAssetNetCurrent', window );">Valuation allowance</a></td>
<td class="nump">$ 3,207,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State income tax expense</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Expiration term</a></td>
<td class="text">2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Federal net operating loss carryforward</a></td>
<td class="nump">$ 65,360,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_NetOperatingLosses', window );">Net operating losses</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Cumulative ownership, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 1,797,238<span></span>
</td>
<td class="nump">$ 1,412,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_TotalUnrecognizedTaxBenefit', window );">Total unrecognized tax benefit (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,797,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_TaxPositionTerm', window );">Tax position term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal income tax expense</a></td>
<td class="nump">$ 100,697,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Expiration term</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research credit carryforwards</a></td>
<td class="nump">$ 4,258,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_IncomeTaxesDetailsLineItems', window );"><strong>Income Taxes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State income tax expense</a></td>
<td class="nump">101,454,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research credit carryforwards</a></td>
<td class="nump">$ 2,192,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Net Current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_IncomeTaxesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_IncomeTaxesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_NetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_NetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_TaxPositionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax position term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_TaxPositionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_TotalUnrecognizedTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_TotalUnrecognizedTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationYearUnderExamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year being audited in the income tax examination, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationYearUnderExamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230360762856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of federal statutory income tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract', window );"><strong>Schedule of federal statutory income tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal tax at statutory rate</a></td>
<td class="num">$ (1,635,786)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes</a></td>
<td class="num">(543,984)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Nondeductible expenses</a></td>
<td class="num">(308,449)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development credit</a></td>
<td class="num">(897,331)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">FIN 48 reserve</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Rate Difference</a></td>
<td class="nump">1,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock Compensation</a></td>
<td class="nump">150,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DeferredTaxAssetsTrueup', window );">True-up and Rate Change</a></td>
<td class="nump">26,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">3,207,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_FederalStatutoryIncomeTaxRateTotal', window );">Total</a></td>
<td class="nump">$ 800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetsTrueup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of true-up.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetsTrueup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_FederalStatutoryIncomeTaxRateTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of federal statutory income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_FederalStatutoryIncomeTaxRateTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230356194504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of deferred tax assets and liabilities - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">$ 1,772,704<span></span>
</td>
<td class="nump">$ 2,299,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses and Credit carryover</a></td>
<td class="nump">32,425,152<span></span>
</td>
<td class="nump">28,834,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State taxes</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Fixed Assets</a></td>
<td class="nump">89,979<span></span>
</td>
<td class="nump">101,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_DeferredTaxAssetsSBC', window );">SBC</a></td>
<td class="nump">243,970<span></span>
</td>
<td class="nump">90,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Accruals And Others</a></td>
<td class="nump">40,005<span></span>
</td>
<td class="nump">38,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">34,571,977<span></span>
</td>
<td class="nump">31,364,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(34,571,977)<span></span>
</td>
<td class="num">(31,364,488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Deferred Commissions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets:</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetsSBC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of SBC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetsSBC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140230358232840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 17, 2022</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cyngn_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent events, description</a></td>
<td class="text">The Lease Amendment extended
the current lease for an additional 18 months, which commenced on March&#160;1, 2022, and expanded the leased space to a total
of 23,311 square feet from the previous 6,886 square feet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_SubsequentEventsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_SubsequentEventsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>ea159355-s1_cyngninc_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyngn="http://cyngn.com/20211231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cyngn-20211231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-22</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cyngn:CYNMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cyngn:PurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cyngn:LiquidityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cyngn:LiquidityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cyngn:AmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2020-04-29</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2021-02-21</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-17</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="c0">CYNGN INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c1" decimals="0" unitRef="usd">21945981</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="0" unitRef="usd">6056190</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c1" decimals="0" unitRef="usd">50000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c2" decimals="0" unitRef="usd">400000</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c1" decimals="0" unitRef="usd">525304</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c2" decimals="0" unitRef="usd">48852</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c1" decimals="0" unitRef="usd">22521285</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="0" unitRef="usd">6505042</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c1" decimals="0" unitRef="usd">102787</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="0" unitRef="usd">133805</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c1" decimals="0" unitRef="usd">30917</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c2" decimals="0" unitRef="usd">34383</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Assets contextRef="c1" decimals="0" unitRef="usd">22654989</us-gaap:Assets>
    <us-gaap:Assets contextRef="c2" decimals="0" unitRef="usd">6673230</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c1" decimals="0" unitRef="usd">112271</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c2" decimals="0" unitRef="usd">73016</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c1" decimals="0" unitRef="usd">295156</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c2" decimals="0" unitRef="usd">307402</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c1" decimals="0" unitRef="usd">407427</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="0" unitRef="usd">380418</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable contextRef="c2" decimals="0" unitRef="usd">695078</us-gaap:LongTermNotesPayable>
    <us-gaap:Liabilities contextRef="c1" decimals="0" unitRef="usd">407427</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c2" decimals="0" unitRef="usd">1075496</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c5" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c6" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c7" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c8" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c5" decimals="INF" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c7" decimals="INF" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c6" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c6" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c6" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c8" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c8" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c8" decimals="INF" unitRef="shares">21982491</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c2" decimals="0" unitRef="usd">220</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c1" decimals="5" unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="5" unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c1" decimals="INF" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c1" decimals="INF" unitRef="shares">26487680</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c1" decimals="INF" unitRef="shares">26487680</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="INF" unitRef="shares">42000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c2" decimals="INF" unitRef="shares">951794</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">951794</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c1" decimals="0" unitRef="usd">265</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c2" decimals="0" unitRef="usd">10</us-gaap:CommonStockValue>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c1" decimals="0" unitRef="usd">170397</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="c1" decimals="0" unitRef="usd">138570430</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="0" unitRef="usd">114291505</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c1" decimals="0" unitRef="usd">-116493530</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="0" unitRef="usd">-108694001</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c1" decimals="0" unitRef="usd">22247562</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="0" unitRef="usd">5597734</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c1" decimals="0" unitRef="usd">22654989</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="0" unitRef="usd">6673230</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" unitRef="usd">4990407</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c9" decimals="0" unitRef="usd">5120979</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="0" unitRef="usd">4409651</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c9" decimals="0" unitRef="usd">3252649</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="0" unitRef="usd">9400058</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c9" decimals="0" unitRef="usd">8373628</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="0" unitRef="usd">-9400058</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c9" decimals="0" unitRef="usd">-8373628</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet contextRef="c0" decimals="0" unitRef="usd">-9580</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c9" decimals="0" unitRef="usd">39841</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherIncome contextRef="c0" decimals="0" unitRef="usd">7173</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c9" decimals="0" unitRef="usd">-5020</us-gaap:OtherIncome>
    <cyngn:PPPLoanForgiveness contextRef="c0" decimals="0" unitRef="usd">1602936</cyngn:PPPLoanForgiveness>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="0" unitRef="usd">1600529</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c9" decimals="0" unitRef="usd">34821</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">-7799529</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c9" decimals="0" unitRef="usd">-8338807</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="2" unitRef="usdPershares">-1.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c9" decimals="2" unitRef="usdPershares">-8.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="c0" decimals="0" unitRef="usdPershares">5861730</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c9" decimals="0" unitRef="usdPershares">949544</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding contextRef="c10" decimals="INF" unitRef="shares">21982491</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="0" unitRef="usd">220</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c11" decimals="INF" unitRef="shares">949086</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="0" unitRef="usd">10</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="0" unitRef="usd">114159150</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="0" unitRef="usd">-100355194</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="0" unitRef="usd">13804186</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c17" decimals="INF" unitRef="shares">2708</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c19" decimals="0" unitRef="usd">623</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c9" decimals="0" unitRef="usd">623</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c19" decimals="0" unitRef="usd">131732</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c9" decimals="0" unitRef="usd">131732</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:ProfitLoss contextRef="c20" decimals="0" unitRef="usd">-8338807</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c9" decimals="0" unitRef="usd">-8338807</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding contextRef="c21" decimals="INF" unitRef="shares">21982491</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="0" unitRef="usd">220</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c22" decimals="INF" unitRef="shares">951794</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="0" unitRef="usd">10</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="0" unitRef="usd">114291505</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="0" unitRef="usd">-108694001</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="0" unitRef="usd">5597734</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c27" decimals="INF" unitRef="shares">53395</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c29" decimals="0" unitRef="usd">14220</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c0" decimals="0" unitRef="usd">14220</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="0" unitRef="usd">2954110</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c27" decimals="INF" unitRef="shares">3500000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c27" decimals="0" unitRef="usd">35</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c29" decimals="0" unitRef="usd">23295855</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="0" unitRef="usd">23295890</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c26" decimals="INF" unitRef="shares">-21982491</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c26" decimals="0" unitRef="usd">-220</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c27" decimals="INF" unitRef="shares">21982491</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c27" decimals="0" unitRef="usd">220</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c29" decimals="0" unitRef="usd">1139247</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c0" decimals="0" unitRef="usd">1139247</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c28" decimals="0" unitRef="usd">170397</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c29" decimals="0" unitRef="usd">-170397</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ProfitLoss contextRef="c30" decimals="0" unitRef="usd">-7799529</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-7799529</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding contextRef="c32" decimals="INF" unitRef="shares">26487680</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c32" decimals="0" unitRef="usd">265</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="0" unitRef="usd">170397</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c34" decimals="0" unitRef="usd">138570430</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c35" decimals="0" unitRef="usd">-116493530</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c1" decimals="0" unitRef="usd">22247562</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">-7799529</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c9" decimals="0" unitRef="usd">-8338807</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="0" unitRef="usd">85855</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c9" decimals="0" unitRef="usd">159040</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="0" unitRef="usd">1139247</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c9" decimals="0" unitRef="usd">131732</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfOtherAssets contextRef="c0" decimals="0" unitRef="usd">31356</us-gaap:GainLossOnSaleOfOtherAssets>
    <cyngn:GainOnForgivenessOfPaycheckProtectionProgramLoans contextRef="c0" decimals="0" unitRef="usd">1602936</cyngn:GainOnForgivenessOfPaycheckProtectionProgramLoans>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="0" unitRef="usd">476452</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c9" decimals="0" unitRef="usd">-33774</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="0" unitRef="usd">39255</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c9" decimals="0" unitRef="usd">-43335</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c0" decimals="0" unitRef="usd">3496</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c9" decimals="0" unitRef="usd">137535</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-8642419</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c9" decimals="0" unitRef="usd">-7920061</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c0" decimals="0" unitRef="usd">62204</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">42189</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="0" unitRef="usd">-20015</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c0" decimals="0" unitRef="usd">23295890</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c0" decimals="0" unitRef="usd">892115</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c9" decimals="0" unitRef="usd">695078</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="0" unitRef="usd">14220</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c9" decimals="0" unitRef="usd">623</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="0" unitRef="usd">24202225</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c9" decimals="0" unitRef="usd">695701</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="0" unitRef="usd">15539791</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c9" decimals="0" unitRef="usd">-7224360</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="0" unitRef="usd">6456190</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c15" decimals="0" unitRef="usd">13680550</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c1" decimals="0" unitRef="usd">21995981</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="0" unitRef="usd">6456190</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="0" unitRef="usd">16719</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c9" decimals="0" unitRef="usd">10813</us-gaap:InterestPaidNet>
    <cyngn:PPPLoanWasForgivenByTheSBAInTheAmount contextRef="c0" decimals="-9" unitRef="usd">1602936000000000</cyngn:PPPLoanWasForgivenByTheSBAInTheAmount>
    <cyngn:PPPLoanWasForgivenByTheSBAInTheAmount contextRef="c9" decimals="-9" unitRef="usd">1602936000000000</cyngn:PPPLoanWasForgivenByTheSBAInTheAmount>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;1.
Description of Business&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Headquartered
in Menlo Park, California, CYNGN Inc., together with its subsidiaries (collectively, &#x201c;Cyngn&#x201d; or the &#x201c;Company&#x201d;),
was incorporated in Delaware in 2013. Cyngn Singapore PTE. LTD., a Singaporean limited company organized in 2015 and Cyngn Philippines,
Inc., a Philippine corporation incorporated in 2018 are wholly owned subsidiaries. The Company is in the process of dissolving
these subsidiaries.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Cyngn
develops autonomous driving software that can be deployed on multiple vehicle types in various environments. The Company has been
operating autonomous vehicles (&#x201c;AV&#x201d;) in production environments since 16 Built and tested in difficult and diverse
real-world environments, the self-driving system (DriveMod), fleet management system, and Software Development Kit combine to
create a full-stack advanced autonomy solution designed to be modular, extendable, and safe. The Company operates one business
segment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Initial
Public Offering&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;On
October&#160;22, 2021, the Company closed the initial public offering (the &#x201c;IPO&#x201d;) of 3,500,000 shares of its authorized
common stock at an offering price of $7.50 per share. Simultaneous with the closing of the IPO, the common stock began trading
on the NASDAQ Capital Market under the symbol &#x201c;CYN.&#x201d; The IPO generated net proceeds of $23.3 million after deducting
underwriting discounts, commissions and offering expenses. The Company also granted its underwriters the election to exercise
a 45-day over-allotment option to purchase an additional 525,000 shares of common stock at the IPO offering price, less underwriting
discounts. The underwriters elected not to exercise the over-allotment option in whole or in part. No price stabilization activities
have been carried out since the IPO, and due to the stock&#x2019;s share price performance, the underwriters have, as stabilizing
manager on behalf of the Company, decided to end the stock trading stabilization period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Simultaneous
with the closing of its IPO, the Company also issued 140,000 warrants (the &#x201c;Warrant&#x201d;) to its underwriters. Each Warrant
entitles its holder the option to purchase at a future exercise date, one share of common stock at an initial exercise price of
$9.375 per share, subject to certain adjustments and restrictions relating to subsequent resale and transfers. The Purchase Warrants
are exercisable six (6) months after the IPO and expire five (5) years thereafter.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;At
the completion of the IPO, all shares of the Company&#x2019;s outstanding convertible preferred stock shares automatically converted
to shares of common stock (see Note 7. Capital Structure).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Immediately
after the IPO, the Company filed an amended and restated certificate of incorporation, which became effective on October&#160;22,
2021. The amended and restated certificate of incorporation authorized 110,000,000 shares consisting of 100,000,000 shares of
common stock, at a par value of $0.00001, and 10,000,000 shares of preferred stock at a par value of $0.00001. The rights of the
holders of common stock are subject to and qualified by rights of the holders of the preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Additionally,
the Company recognized $1.1 million of stock-based compensation expense related to stock options granted to employees with time-based
vesting conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company has incurred losses from operations since inception. The Company incurred net losses of $7.8 million and $8.3 million
for the year ended December&#160;31, 2021 and 2020, respectively. Accumulated deficit amounted to $116.5 million and $108.7 million
as of December&#160;31, 2021 and 2020, respectively. Net cash used in operating activities was $8.6 million and $7.9 million for
the year ended December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company&#x2019;s liquidity is based on its ability to enhance its operating cash flow position, obtain capital financing from equity
interest investors and obtain funds from outside sources of financing to fund its general operations, research and development
activities and capital expenditures. The Company&#x2019;s ability to continue as a going concern is dependent on management&#x2019;s
ability to successfully execute its business plan, which includes generating progressive revenue streams while controlling operating
costs and expenses, to then result in positive operating cash flows. The Company&#x2019;s unrestricted balance of cash and cash
equivalents was $21.9 million and $6.1 million as of December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Based
on cash flow projections from operating and financing activities and existing balances of cash and cash equivalents, management
is of the opinion that the Company has sufficient funds for sustainable operations and it will be able to meet its payment obligations
and commitments from operations for at least one year from the issuance date of this prospectus. Based on the above considerations,
the Company&#x2019;s consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and liquidation of liabilities during the normal course of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c36" decimals="0" unitRef="shares">3500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SaleOfStockPricePerShare contextRef="c36" decimals="2" unitRef="usdPershares">7.5</us-gaap:SaleOfStockPricePerShare>
    <cyngn:NetProceeds contextRef="c37" decimals="-5" unitRef="usd">23300000</cyngn:NetProceeds>
    <cyngn:PurchaseAnAdditionalSharesOfCommonStock contextRef="c38" decimals="0" unitRef="shares">525000</cyngn:PurchaseAnAdditionalSharesOfCommonStock>
    <cyngn:RedeemableWarrants contextRef="c39" decimals="0" unitRef="shares">140000</cyngn:RedeemableWarrants>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c39" decimals="3" unitRef="usdPershares">9.375</us-gaap:WarrantExercisePriceIncrease>
    <cyngn:PurchaseWarrantsDescription contextRef="c38">The Purchase Warrants
are exercisable six (6) months after the IPO and expire five (5) years thereafter.</cyngn:PurchaseWarrantsDescription>
    <us-gaap:ExcessStockSharesAuthorized contextRef="c1" decimals="0" unitRef="shares">110000000</us-gaap:ExcessStockSharesAuthorized>
    <cyngn:CommonStockShares contextRef="c1" decimals="0" unitRef="shares">100000000</cyngn:CommonStockShares>
    <us-gaap:PreferredStockLiquidationPreference contextRef="c40" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockLiquidationPreference>
    <cyngn:PreferredStockShareIssued contextRef="c1" decimals="0" unitRef="shares">10000000</cyngn:PreferredStockShareIssued>
    <us-gaap:PreferredStockRedemptionPricePerShare contextRef="c1" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockRedemptionPricePerShare>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="-5" unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c0" decimals="-5" unitRef="usd">7800000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c9" decimals="-5" unitRef="usd">8300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:RetainedEarningsAppropriated contextRef="c1" decimals="-5" unitRef="usd">116500000</us-gaap:RetainedEarningsAppropriated>
    <us-gaap:RetainedEarningsAppropriated contextRef="c2" decimals="-5" unitRef="usd">108700000</us-gaap:RetainedEarningsAppropriated>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="c0" decimals="-5" unitRef="usd">8600000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="c9" decimals="-5" unitRef="usd">7900000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <cyngn:UnrestrictedCashAndCashEquivalents contextRef="c41" decimals="-5" unitRef="usd">21900000</cyngn:UnrestrictedCashAndCashEquivalents>
    <cyngn:UnrestrictedCashAndCashEquivalents contextRef="c42" decimals="-5" unitRef="usd">6100000</cyngn:UnrestrictedCashAndCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;2.
Summary of Significant Accounting Policies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
accompanying consolidated financial statements as of and for the years ended December&#160;31, 2021 and 2020 have been prepared
in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and pursuant to applicable
rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include
all normal adjustments necessary for a fair presentation of the Company&#x2019;s financial position at December&#160;31, 2021 and
2020, and operating results and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;These
consolidated financial statements should be read in conjunction with the following: i) audited consolidated financial statements
as of and for the years ended December&#160;31, 2020 and 2019; ii) the discussion under &#x201c;Management&#x2019;s Discussion and
Analysis of Financial Condition and Results of Operations&#x201d; and&#x2019; iii) our final prospectus (the &#x201c;Prospectus&#x201d;),
filed with the Securities and Exchange Commission or the SEC, pursuant to Rule&#160;424(b) under the Securities Act of 1933, as
amended or the Securities Act), on October&#160;21, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Principles
of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
consolidated financial statements include the accounts of CYNGN Inc. and its wholly owned subsidiaries. Intercompany accounts
and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Foreign
Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other
than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average
exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments
and transactional gains and losses are immaterial to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These
estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company&#x2019;s
significant estimates and judgments include but are not limited to underwriter&#x2019;s warrants and share-based compensation.
Estimates are based on historical experience and on various other assumptions believed to be reasonable, the results of which
form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those
estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents. The Company&#x2019;s
cash is placed with high-credit-quality financial institutions and at times exceeds federally insured limits. The Company has
not experienced any credit loss relating to its cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Concentration
of Supplier Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there
is any significant supplier concentration risk as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents and Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company considers all highly liquid money market placements with a remaining maturity of three months or less to be cash equivalents.
The Company had $21.9 million and $6.1 million of unrestricted cash and cash equivalents as of December&#160;31, 2021 and 2020,
respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
addition, the Company had $50,000 and $400,000 in restricted cash as of December&#160;31, 2021 and 2020, respectively, which is
reported separately as current assets on the consolidated balance sheet. The Company&#x2019;s restricted cash consists of cash
not available for immediate use that the Company is obligated to maintain in accordance with the terms of its credit card spending
arrangement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
following table provides a reconciliation of cash and cash equivalents and restricted cash to amounts shown in the consolidated
statements of cash flows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,945,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,056,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;400,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total Cash and cash equivalents and Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,995,981&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,456,190&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
accounting guidance under Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;i&gt;Fair Value Measurements&lt;/i&gt;, defines
fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability
category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing
the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value
as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;i&gt;Level
1&lt;/i&gt;&#x2014;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;i&gt;Level
2&lt;/i&gt;&#x2014;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially
the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;i&gt;Level
3&lt;/i&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value
of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Assets
and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair
value measurement of an instrument does not necessarily result in a change in the amount recorded on the consolidated balance
sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting
guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets
and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived
assets, intangible assets, share-based compensation and underwriter warrants measured at fair value upon initial recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts payable and notes payable are reasonable estimates
of their fair values due to the short-term nature of these accounts. The fair values of the Company&#x2019;s share-based compensation
and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent
external valuations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Property
and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Property
and equipment is stated at cost less accumulated depreciation. Repair and maintenance costs are expensed as incurred. Depreciation
is recorded on a straight-line basis over each asset&#x2019;s estimated useful life.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; "&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 77%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property
    and Equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 22%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shorter of 3 years or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Automobile&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company accounts for leases in accordance with ASC 842, &lt;i&gt;Leases&lt;/i&gt;. All contracts are evaluated to determine whether or not
they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for
consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not
hold any finance leases. The Company has elected to adopt the short-term lease exemption in ASC 842 and as such has not recognized
a &#x201c;right of use&#x201d; asset or lease liability in the consolidated balance sheets as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Long-Lived
Assets and Finite Lived Intangibles&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company has finite lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line
basis over their estimated remaining economic lives. The patents and trademarks are amortized over 15 years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company reviews its long-lived assets and finite lived intangibles for impairment whenever events or changes in circumstances
indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include
significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the
asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost
to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability
of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects
the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted
cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated.
An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized
for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;A
valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
Due to the Company&#x2019;s lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance
as of December&#160;31, 2021 and 2020 (see Note 11. Income Taxes).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;There
are no uncertain tax positions that would require recognition in the financial statements. If the Company were to incur an income
tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income
tax would be reported as income taxes. Management&#x2019;s conclusions regarding uncertain tax positions may be subject to review
and adjustment at a later date based upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof
as well as other factors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;&lt;b&gt;&lt;i&gt;Convertible
Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;The
Company has applied the guidance in ASC 480-10-S99-3A, &lt;i&gt;SEC Staff Announcement: Classification and Measurement of Redeemable
Securities&lt;/i&gt; and has classified all of its outstanding convertible preferred shares as permanent equity. The Company records
shares of convertible preferred stock at their respective issuance price, net of issuance costs. The Company&#x2019;s convertible
preferred stock share&#x2019;s redemption and conversion provisions are not exclusively at the option of the holder and are contingent
on certain deemed liquidation events within the Company&#x2019;s control (see Note 7. Capital Structure).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company issued to its lead underwriter in the Company&#x2019;s IPO warrants to purchase up to 140,000 shares of the Company&#x2019;s
common stock. The Company accounts for warrants in accordance with ASC 480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;. The
Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments
in consideration of the cashless settlement provisions in the warrant agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company also applied the guidance in ASC 340-10-S99-1, &lt;i&gt;Other Assets and Deferred Costs&lt;/i&gt;, that states specific incremental
costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against
the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance
of an equity contract and accordingly, classified the warrants as additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Stock-based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value
of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the
award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the
period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model,
which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest
rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense&lt;b&gt;)&lt;/b&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Net
Loss Per Share Attributable to Ordinary Shareholders&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company computes loss per share attributable to ordinary shareholders by dividing net loss attributable to ordinary shareholders
by the weighted-average number of ordinary shares outstanding. Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share,
the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to
include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable
to Common Stockholders).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Research
and Development Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Research
and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials,
labor and stock-based compensation related to development of the Company&#x2019;s products and services. Research and development
costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Selling,
General, and Administrative Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Selling,
general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization,
travel, and advertising costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Commitments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and
the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than
any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than
any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company
as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;&lt;b&gt;&lt;i&gt;Segment
Reporting&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;The
Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages operations and business as one operating
segment for the purposes of allocating resources, makes operating decisions and evaluates financial performance.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;On
January&#160;1, 2019, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09, &lt;i&gt;Revenue from Contracts
with Customers &lt;/i&gt;(&#x201c;Topic 606&#x201d;) and recognizes revenue upon the transfer of goods or services in an amount that reflects
the expected consideration received in exchange for those goods or services. The Company has not generated any revenue for the
years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;There
were no significant updates to the recently issued accounting standards. Although there are several other new accounting standards
issued or proposed by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), the Company does not believe any of those
accounting standards have had or will have a material impact on its financial position or operating results.&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
accompanying consolidated financial statements as of and for the years ended December&#160;31, 2021 and 2020 have been prepared
in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and pursuant to applicable
rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include
all normal adjustments necessary for a fair presentation of the Company&#x2019;s financial position at December&#160;31, 2021 and
2020, and operating results and cash flows for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;These
consolidated financial statements should be read in conjunction with the following: i) audited consolidated financial statements
as of and for the years ended December&#160;31, 2020 and 2019; ii) the discussion under &#x201c;Management&#x2019;s Discussion and
Analysis of Financial Condition and Results of Operations&#x201d; and&#x2019; iii) our final prospectus (the &#x201c;Prospectus&#x201d;),
filed with the Securities and Exchange Commission or the SEC, pursuant to Rule&#160;424(b) under the Securities Act of 1933, as
amended or the Securities Act), on October&#160;21, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Principles
of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
consolidated financial statements include the accounts of CYNGN Inc. and its wholly owned subsidiaries. Intercompany accounts
and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Foreign
Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other
than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average
exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments
and transactional gains and losses are immaterial to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These
estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company&#x2019;s
significant estimates and judgments include but are not limited to underwriter&#x2019;s warrants and share-based compensation.
Estimates are based on historical experience and on various other assumptions believed to be reasonable, the results of which
form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those
estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Concentration
of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents. The Company&#x2019;s
cash is placed with high-credit-quality financial institutions and at times exceeds federally insured limits. The Company has
not experienced any credit loss relating to its cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <cyngn:ConcentrationOfSupplierRiskPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Concentration
of Supplier Risk&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there
is any significant supplier concentration risk as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cyngn:ConcentrationOfSupplierRiskPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents and Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company considers all highly liquid money market placements with a remaining maturity of three months or less to be cash equivalents.
The Company had $21.9 million and $6.1 million of unrestricted cash and cash equivalents as of December&#160;31, 2021 and 2020,
respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
addition, the Company had $50,000 and $400,000 in restricted cash as of December&#160;31, 2021 and 2020, respectively, which is
reported separately as current assets on the consolidated balance sheet. The Company&#x2019;s restricted cash consists of cash
not available for immediate use that the Company is obligated to maintain in accordance with the terms of its credit card spending
arrangement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
following table provides a reconciliation of cash and cash equivalents and restricted cash to amounts shown in the consolidated
statements of cash flows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,945,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,056,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;400,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total Cash and cash equivalents and Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,995,981&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,456,190&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <cyngn:UnrestrictedCashAndCashEquivalents contextRef="c1" decimals="-5" unitRef="usd">21900000</cyngn:UnrestrictedCashAndCashEquivalents>
    <cyngn:UnrestrictedCashAndCashEquivalents contextRef="c2" decimals="-5" unitRef="usd">6100000</cyngn:UnrestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCash contextRef="c1" decimals="0" unitRef="usd">50000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c2" decimals="0" unitRef="usd">400000</us-gaap:RestrictedCash>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,945,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,056,190&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;400,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total Cash and cash equivalents and Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,995,981&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,456,190&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:RestrictedInvestmentsCurrent contextRef="c1" decimals="0" unitRef="usd">21945981</us-gaap:RestrictedInvestmentsCurrent>
    <us-gaap:RestrictedInvestmentsCurrent contextRef="c2" decimals="0" unitRef="usd">6056190</us-gaap:RestrictedInvestmentsCurrent>
    <us-gaap:OtherRestrictedAssetsCurrent contextRef="c1" decimals="0" unitRef="usd">50000</us-gaap:OtherRestrictedAssetsCurrent>
    <us-gaap:OtherRestrictedAssetsCurrent contextRef="c2" decimals="0" unitRef="usd">400000</us-gaap:OtherRestrictedAssetsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c1" decimals="0" unitRef="usd">21995981</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c2" decimals="0" unitRef="usd">6456190</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
accounting guidance under Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;i&gt;Fair Value Measurements&lt;/i&gt;, defines
fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability
category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing
the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value
as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;i&gt;Level
1&lt;/i&gt;&#x2014;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;i&gt;Level
2&lt;/i&gt;&#x2014;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices
in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially
the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;i&gt;Level
3&lt;/i&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value
of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Assets
and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair
value measurement of an instrument does not necessarily result in a change in the amount recorded on the consolidated balance
sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting
guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets
and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived
assets, intangible assets, share-based compensation and underwriter warrants measured at fair value upon initial recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts payable and notes payable are reasonable estimates
of their fair values due to the short-term nature of these accounts. The fair values of the Company&#x2019;s share-based compensation
and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent
external valuations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Property
and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Property
and equipment is stated at cost less accumulated depreciation. Repair and maintenance costs are expensed as incurred. Depreciation
is recorded on a straight-line basis over each asset&#x2019;s estimated useful life.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <cyngn:ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; "&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 77%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property
    and Equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 22%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Useful
    life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shorter of 3 years or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Automobile&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</cyngn:ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c44">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c45">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <cyngn:PropertyAndEquipmentUsefulLifeLeaseholdImprovements contextRef="c46">Shorter of 3 years or lease term</cyngn:PropertyAndEquipmentUsefulLifeLeaseholdImprovements>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c47">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company accounts for leases in accordance with ASC 842, &lt;i&gt;Leases&lt;/i&gt;. All contracts are evaluated to determine whether or not
they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for
consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not
hold any finance leases. The Company has elected to adopt the short-term lease exemption in ASC 842 and as such has not recognized
a &#x201c;right of use&#x201d; asset or lease liability in the consolidated balance sheets as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Long-Lived
Assets and Finite Lived Intangibles&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company has finite lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line
basis over their estimated remaining economic lives. The patents and trademarks are amortized over 15 years.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company reviews its long-lived assets and finite lived intangibles for impairment whenever events or changes in circumstances
indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include
significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the
asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost
to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability
of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects
the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted
cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated.
An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c0">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized
for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;A
valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.
Due to the Company&#x2019;s lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance
as of December&#160;31, 2021 and 2020 (see Note 11. Income Taxes).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;There
are no uncertain tax positions that would require recognition in the financial statements. If the Company were to incur an income
tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income
tax would be reported as income taxes. Management&#x2019;s conclusions regarding uncertain tax positions may be subject to review
and adjustment at a later date based upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof
as well as other factors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <cyngn:ConvertiblePreferredStockPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;&lt;b&gt;&lt;i&gt;Convertible
Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;The
Company has applied the guidance in ASC 480-10-S99-3A, &lt;i&gt;SEC Staff Announcement: Classification and Measurement of Redeemable
Securities&lt;/i&gt; and has classified all of its outstanding convertible preferred shares as permanent equity. The Company records
shares of convertible preferred stock at their respective issuance price, net of issuance costs. The Company&#x2019;s convertible
preferred stock share&#x2019;s redemption and conversion provisions are not exclusively at the option of the holder and are contingent
on certain deemed liquidation events within the Company&#x2019;s control (see Note 7. Capital Structure).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cyngn:ConvertiblePreferredStockPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company issued to its lead underwriter in the Company&#x2019;s IPO warrants to purchase up to 140,000 shares of the Company&#x2019;s
common stock. The Company accounts for warrants in accordance with ASC 480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;. The
Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments
in consideration of the cashless settlement provisions in the warrant agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company also applied the guidance in ASC 340-10-S99-1, &lt;i&gt;Other Assets and Deferred Costs&lt;/i&gt;, that states specific incremental
costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against
the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance
of an equity contract and accordingly, classified the warrants as additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c43" decimals="0" unitRef="shares">140000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Stock-based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value
of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the
award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the
period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model,
which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest
rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense&lt;b&gt;)&lt;/b&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Net
Loss Per Share Attributable to Ordinary Shareholders&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company computes loss per share attributable to ordinary shareholders by dividing net loss attributable to ordinary shareholders
by the weighted-average number of ordinary shares outstanding. Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share,
the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to
include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable
to Common Stockholders).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Research
and Development Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Research
and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials,
labor and stock-based compensation related to development of the Company&#x2019;s products and services. Research and development
costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Selling,
General, and Administrative Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Selling,
general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization,
travel, and advertising costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Commitments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and
the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than
any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than
any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company
as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;&lt;b&gt;&lt;i&gt;Segment
Reporting&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; "&gt;The
Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages operations and business as one operating
segment for the purposes of allocating resources, makes operating decisions and evaluates financial performance.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;On
January&#160;1, 2019, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09, &lt;i&gt;Revenue from Contracts
with Customers &lt;/i&gt;(&#x201c;Topic 606&#x201d;) and recognizes revenue upon the transfer of goods or services in an amount that reflects
the expected consideration received in exchange for those goods or services. The Company has not generated any revenue for the
years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;There
were no significant updates to the recently issued accounting standards. Although there are several other new accounting standards
issued or proposed by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), the Company does not believe any of those
accounting standards have had or will have a material impact on its financial position or operating results.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cyngn:BalanceSheetComponentsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;3.
Balance Sheet Components&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Property
and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Property
and equipment is comprised of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Automobiles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;279,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;325,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;133,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;125,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Computer and Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;76,048&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,157&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Property and equipment, gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;488,767&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;476,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(385,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(342,758&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Total property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;102,787&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;133,805&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Depreciation
expense for the year ended December&#160;31, 2021 and 2020 was $82,389 and $88,170, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Accrued
Expenses and Other Current Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Accrued
expenses and other current liabilities are comprised of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Credit card payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;37,455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82,478&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued payroll&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;94,186&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Total accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;295,156&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;307,402&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;On
March&#160;27, 2020, the United States Congress passed the Coronavirus, Aid, Relief and Economic Security Act (the &#x201c;CARES
Act&#x201d;) in response to the economic impact of the coronavirus (&#x201c;COVID-19&#x201d;) pandemic in the United States (see
Note 13. Risks and Uncertainties). Section&#160;2302 of the CARES Act allowed employers to defer the remittance and payment of
the employer&#x2019;s share of social security taxes that were otherwise required to be remitted between March&#160;27 and December&#160;31,
2020, and to pay the deferred taxes in two installments &#x2014; with the first half due on December&#160;31, 2021, and the remainder
by December&#160;31, 2022. As of December&#160;31, 2021, the Company remitted $67,958 in social security taxes due that were deferred
between May&#160;1 and December&#160;31, 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Section&#160;2301
of the CARES Act also provided refundable employee retention credits (the &#x201c;ERC&#x201d;) against certain employment taxes.
The Company is currently evaluating its eligibility to claim the ERC and the impact of the credits on its consolidated statement
of operations.&lt;/span&gt;&lt;/p&gt;</cyngn:BalanceSheetComponentsTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Automobiles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;279,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;325,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;133,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;125,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Computer and Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;76,048&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,157&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Property and equipment, gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;488,767&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;476,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(385,980&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(342,758&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Total property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;102,787&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;133,805&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <cyngn:Automobiles contextRef="c1" decimals="0" unitRef="usd">279617</cyngn:Automobiles>
    <cyngn:Automobiles contextRef="c2" decimals="0" unitRef="usd">325406</cyngn:Automobiles>
    <us-gaap:FurnitureAndFixturesGross contextRef="c1" decimals="0" unitRef="usd">133102</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="c2" decimals="0" unitRef="usd">125000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentOther contextRef="c1" decimals="0" unitRef="usd">76048</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentOther contextRef="c2" decimals="0" unitRef="usd">26157</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c1" decimals="0" unitRef="usd">488767</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c2" decimals="0" unitRef="usd">476563</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c1" decimals="0" unitRef="usd">385980</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c2" decimals="0" unitRef="usd">342758</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c1" decimals="0" unitRef="usd">102787</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="0" unitRef="usd">133805</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c0" decimals="0" unitRef="usd">82389</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c9" decimals="0" unitRef="usd">88170</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Credit card payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;37,455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82,478&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Accrued payroll&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;94,186&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Total accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;295,156&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;307,402&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <cyngn:CreditCardPayable contextRef="c1" decimals="0" unitRef="usd">11678</cyngn:CreditCardPayable>
    <cyngn:CreditCardPayable contextRef="c2" decimals="0" unitRef="usd">37455</cyngn:CreditCardPayable>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c1" decimals="0" unitRef="usd">82478</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c2" decimals="0" unitRef="usd">175761</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c1" decimals="0" unitRef="usd">201000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c2" decimals="0" unitRef="usd">94186</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c1" decimals="0" unitRef="usd">295156</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c2" decimals="0" unitRef="usd">307402</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c1" decimals="0" unitRef="usd">67958</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;4.
Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company leases its office space under a recurring lease agreement which expired in February&#160;2022 and was subsequently renewed
and amended (see Note 14. Subsequent Events). Monthly payments are approximately $15,500 while future minimum payments under the
primary terms of the lease in effect at December&#160;31, 2021 are approximately $31,000 in 2022 until the expiration of the lease
in February&#160;2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Rent
expense for the year ended December&#160;31, 2021 and 2020 was $236,476 and $229,019, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="0" unitRef="usd">15500</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c48" decimals="0" unitRef="usd">31000</us-gaap:OperatingLeasePayments>
    <cyngn:RentExpense contextRef="c0" decimals="0" unitRef="usd">236476</cyngn:RentExpense>
    <cyngn:RentExpense contextRef="c9" decimals="0" unitRef="usd">229019</cyngn:RentExpense>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;5.
Intangible Assets, Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; "&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    of December&#160;31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;br/&gt;
    Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accumulated&lt;br/&gt;
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;br/&gt;
    Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,083&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,917&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; "&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(17,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,083&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,917&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; "&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    of December&#160;31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;br/&gt;
    Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accumulated&lt;br/&gt;
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;br/&gt;
Carrying&lt;br/&gt;
Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,617&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(17,617&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Amortization
expense for each of the years ended December&#160;31, 2021 and 2020 was $3,466.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Estimated
amortization expense for all intangible assets subject to amortization in future years is expected to be:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Years ended December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,049&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;30,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; "&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    of December&#160;31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;br/&gt;
    Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accumulated&lt;br/&gt;
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;br/&gt;
    Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4,083&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,917&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; "&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(17,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21,083&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,917&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; "&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    of December&#160;31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;br/&gt;
    Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accumulated&lt;br/&gt;
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;br/&gt;
Carrying&lt;br/&gt;
Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 64%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,617&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(14,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(17,617&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34,383&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c49" decimals="0" unitRef="usd">7000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c49" decimals="0" unitRef="usd">-4083</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c49" decimals="0" unitRef="usd">2917</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c50" decimals="0" unitRef="usd">45000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c50" decimals="0" unitRef="usd">-17000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c50" decimals="0" unitRef="usd">28000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c1" decimals="0" unitRef="usd">52000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c1" decimals="0" unitRef="usd">-21083</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c1" decimals="0" unitRef="usd">30917</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c51" decimals="0" unitRef="usd">7000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c51" decimals="0" unitRef="usd">-3617</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c51" decimals="0" unitRef="usd">3383</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c52" decimals="0" unitRef="usd">45000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c52" decimals="0" unitRef="usd">-14000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c52" decimals="0" unitRef="usd">31000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c2" decimals="0" unitRef="usd">52000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c2" decimals="0" unitRef="usd">-17617</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="0" unitRef="usd">34383</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AdjustmentForAmortization contextRef="c9" decimals="0" unitRef="usd">3466</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c0" decimals="0" unitRef="usd">3466</us-gaap:AdjustmentForAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Years ended December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,049&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;30,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="c53" decimals="0" unitRef="usd">3467</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="c53" decimals="0" unitRef="usd">3467</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="c53" decimals="0" unitRef="usd">3467</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="c53" decimals="0" unitRef="usd">3467</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="c53" decimals="0" unitRef="usd">17049</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="c53" decimals="0" unitRef="usd">30917</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;6.
Debt&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Paycheck
Protection Program Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
April&#160;2020, the Company entered into a Note with JPMorgan Chase (the &#x201c;Lender&#x201d;) under the U.S. Small Business
Administration (&#x201c;SBA&#x201d;) Paycheck Protection Program (&#x201c;PPP&#x201d;) established under Section&#160;1102 of the
CARES Act, pursuant to which the Company borrowed $695,078 (the &#x201c;Note&#x201d;). The Note accrues interest at a rate of 0.98%
per annum and matures in 24 months from the date of the Note. The Note may be repaid at any time with no prepayment penalty. All
of the funds received under the PPP had been used for qualified purposes. The Company applied for forgiveness of the Note in accordance
with PPP guidelines, and in October, 2021, received approval of the forgiveness application.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
February&#160;2021, the Company entered into a second Note (the &#x201c;PPP2 Note&#x201d;) with the Lender, pursuant to which the
Lender agreed to make a loan to the Company under the PPP offered by the SBA in a principal amount of $892,115 pursuant to Title
1 of the CARES Act. The PPP2 Note matures in five years with interest accruing at 0.98% per annum. Proceeds of the PPP2 Note are
available to be used to pay for payroll costs, including salaries, commissions, and similar compensation, group health care benefits,
and paid leaves; rent; utilities; and interest on certain other outstanding debt. All of the funds received under the PPP2 Note
were used for qualified purposes during 2021. The Company applied for forgiveness of the PPP2 Note in accordance with PPP guidelines,
and in November, 2021, received approval of the forgiveness application.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
PPP and PPP2 Notes that were forgiven by the SBA were recognized as gains and included in &#x2018;Other income&#x2019; or the non-operating
section of the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:OtherBorrowings contextRef="c54" decimals="0" unitRef="usd">695078</us-gaap:OtherBorrowings>
    <us-gaap:InvestmentInterestRate contextRef="c54" decimals="4" unitRef="pure">0.0098</us-gaap:InvestmentInterestRate>
    <cyngn:MaturityDate contextRef="c55">P24M</cyngn:MaturityDate>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c56" decimals="0" unitRef="usd">892115</us-gaap:DebtInstrumentFaceAmount>
    <cyngn:MaturityDate contextRef="c57">P5Y</cyngn:MaturityDate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c57" decimals="4" unitRef="pure">0.0098</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:PartnersCapitalNotesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;7.
Capital Structure&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021, the Company is authorized to issue 100,000,000 shares with a par value of $0.00001 per share. As of
December&#160;31, 2020, the Company was authorized to issue 42,000,000 shares of Common Stock with a par value of $0.00001 per
share. As of December&#160;31, 2021 and December&#160;31, 2020, the Company had 26,487,680 and 951,794 shares of Common Stock
issued and outstanding, respectively. Holders of common stock have no preemptive, conversion or subscription rights and there
is no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders
of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred
stock that the Company may designate in the future.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Convertible
Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
October&#160;2021, the Company amended its Certificate of Incorporation and revised the number of preferred stock shares authorized
for issuance to 10,000,000 shares at a par value of $0.00001. As of December&#160;31, 2021, there were no shares issued and outstanding
against these shares. As of December&#160;31, 2020 and prior to the completion of the IPO, the Company was authorized to issue
up to 21,982,491 shares of preferred stock at a par value of $0.00001.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Conversion&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company&#x2019;s convertible preferred stock shares that were outstanding at the completion of the IPO on October&#160;20, 2021
automatically converted to shares of common stock on a 1:1 basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences prior to the IPO were
as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Series&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;br/&gt; Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;br/&gt; Issued and&lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Per Share&lt;br/&gt; Liquidation&lt;br/&gt; Preference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Aggregate&lt;br/&gt; Liquidation&lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Proceeds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Series A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,157,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,157,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.6842&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,949,996&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,949,996&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Series B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,567,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,567,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.3939&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,290,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,290,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Series C&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,256,978&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,256,978&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;15.7933&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;83,025,031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;83,025,031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,982,491&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,982,491&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;112,265,042&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;112,265,042&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021, the fair value of the warrants was estimated using the Black-Scholes option-pricing model. The Company
used the following assumptions in the model:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.13&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Dividends&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
holders of preferred stock are entitled to receive dividends, when and if declared by the Company&#x2019;s Board of Directors,
out of any legally available funds. The holders of preferred stock are entitled to receive dividends, prior and in preference
to dividends declared on common stock, at the rate of: Series A - $0.0411 per share per annum; Series B - $0.2036 per share per
annum; and Series C - $0.9476 per share per annum. Dividends are non-cumulative and will be paid pro rata, on an equal priority,
pari passu basis. After payment of preferred stock dividends, any additional dividends will be paid ratably among holders of common
stock and preferred stock on an as converted to Common Stock basis. As of December&#160;31, 2021 and 2020, respectively, no dividends
have been declared.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Voting&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
holder of each share of Preferred Stock is entitled to voting rights equal to the number of shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Preferred
stockholders shall cast the number of votes equal to the number of whole shares of common stock into which the shares of Preferred
Stock held by such holder are convertible. So long as any shares of Series A Preferred Stock remain outstanding, the holders of
the Series A Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. So long as any shares
of Series B Preferred Stock remain outstanding, the holders of the Series B Preferred Stock, voting as a separate class, are entitled
to elect one director of the Company. So long as any shares of Series C Preferred Stock remain outstanding, the holders of the
Series C Preferred Stock, voting as a separate class, are entitled to elect one director of the Company. The holders of Common
Stock, voting as a separate class, are entitled to elect two directors of the Company. The holders of Preferred Stock and Common
Stock, on an as converted to basis, are entitled to elect any remaining members to the Board of Directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Liquidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of preferred
stock on a pari passu basis, are entitled to receive, prior to and in preference over holders of common stock, an amount equal
to the original issuance price&#x2014;Series A - $0.6842 per share; Series B - $3.3939 per share; and Series C - $15.7933 per share.
2) If the assets of the Company available for distribution to its stockholders shall be insufficient to pay the holders of the
shares of Preferred Stock the full amount to which they are entitled, the holders of shares of Preferred Stock shall share ratably
in any distribution of the assets available for distribution in proportion to the respective amount which would otherwise be payable
in respect to the share of Preferred Stock held by them upon such distribution if all amounts payable on or with respect to such
shares were paid in full.&lt;/span&gt;&lt;/p&gt;</us-gaap:PartnersCapitalNotesDisclosureTextBlock>
    <cyngn:CommonStockShareAuthorized contextRef="c1" decimals="0" unitRef="shares">100000000</cyngn:CommonStockShareAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c1" decimals="5" unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cyngn:CommonStockShareAuthorized contextRef="c2" decimals="0" unitRef="shares">42000000</cyngn:CommonStockShareAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="5" unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c1" decimals="0" unitRef="shares">26487680</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="0" unitRef="shares">951794</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c58" decimals="0" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c58" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c59" decimals="0" unitRef="shares">21982491</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c59" decimals="5" unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ScheduleOfConversionsOfStockTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Series&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;br/&gt; Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;br/&gt; Issued and&lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Per Share&lt;br/&gt; Liquidation&lt;br/&gt; Preference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Aggregate&lt;br/&gt; Liquidation&lt;br/&gt; Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Proceeds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Series A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,157,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,157,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.6842&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,949,996&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,949,996&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Series B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,567,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,567,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.3939&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,290,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,290,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Series C&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,256,978&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,256,978&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;15.7933&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;83,025,031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;83,025,031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,982,491&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,982,491&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;112,265,042&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;112,265,042&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfConversionsOfStockTextBlock>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="c3" decimals="INF" unitRef="shares">10157843</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <cyngn:SeriesASharesIssuedAndOutstanding contextRef="c3" decimals="INF" unitRef="shares">10157843</cyngn:SeriesASharesIssuedAndOutstanding>
    <us-gaap:PreferredStockLiquidationPreference contextRef="c3" decimals="4" unitRef="usdPershares">0.6842</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears contextRef="c60" decimals="0" unitRef="usd">6949996</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockLiquidationPreferenceValue contextRef="c3" decimals="0" unitRef="usd">6949996</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="c5" decimals="INF" unitRef="shares">6567670</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <cyngn:SeriesASharesIssuedAndOutstanding contextRef="c5" decimals="INF" unitRef="shares">6567670</cyngn:SeriesASharesIssuedAndOutstanding>
    <us-gaap:PreferredStockLiquidationPreference contextRef="c5" decimals="4" unitRef="usdPershares">3.3939</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears contextRef="c61" decimals="0" unitRef="usd">22290015</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockLiquidationPreferenceValue contextRef="c5" decimals="0" unitRef="usd">22290015</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="c7" decimals="INF" unitRef="shares">5256978</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <cyngn:SeriesASharesIssuedAndOutstanding contextRef="c7" decimals="INF" unitRef="shares">5256978</cyngn:SeriesASharesIssuedAndOutstanding>
    <us-gaap:PreferredStockLiquidationPreference contextRef="c7" decimals="4" unitRef="usdPershares">15.7933</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears contextRef="c62" decimals="0" unitRef="usd">83025031</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockLiquidationPreferenceValue contextRef="c7" decimals="0" unitRef="usd">83025031</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="c1" decimals="INF" unitRef="shares">21982491</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <cyngn:SeriesASharesIssuedAndOutstanding contextRef="c1" decimals="INF" unitRef="shares">21982491</cyngn:SeriesASharesIssuedAndOutstanding>
    <us-gaap:PreferredStockAmountOfPreferredDividendsInArrears contextRef="c0" decimals="0" unitRef="usd">112265042</us-gaap:PreferredStockAmountOfPreferredDividendsInArrears>
    <us-gaap:PreferredStockLiquidationPreferenceValue contextRef="c1" decimals="0" unitRef="usd">112265042</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.13&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:FairValueNetAssetLiability contextRef="c63" decimals="2" unitRef="usd">2.88</us-gaap:FairValueNetAssetLiability>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c64" decimals="3" unitRef="pure">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c64">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c64" decimals="4" unitRef="pure">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:DividendsPayableAmountPerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0411</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare contextRef="c5" decimals="4" unitRef="usdPershares">0.2036</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare contextRef="c7" decimals="4" unitRef="usdPershares">0.9476</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.6842</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="c5" decimals="4" unitRef="usdPershares">3.3939</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="c7" decimals="4" unitRef="usdPershares">15.7933</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;8.
Net Loss Per Share Attributable to Common Stockholders&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
following table summarizes the computation of basic and diluted loss per share:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year Ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Net loss attributable to common stockholders&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,799,529&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,338,807&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Basic and diluted weighted average common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,861,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;949,544&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.33&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(8.78&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Basic
loss per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted loss
per share would include the effect of unvested restricted stock awards and the convertible preferred Stock; however, such items
were not considered in the calculation of the diluted weighted average common shares outstanding since they would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Potentially
dilutive securities excluded from the calculation of diluted shares outstanding are shown below:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Unvested restricted shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,123,931&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,652,680&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Common shares issuable upon conversion of preferred stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-56"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,982,491&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,123,931&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,635,171&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year Ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Net loss attributable to common stockholders&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,799,529&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,338,807&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Basic and diluted weighted average common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,861,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;949,544&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.33&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(8.78&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="0" unitRef="usd">-7799529</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c9" decimals="0" unitRef="usd">-8338807</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c0" decimals="INF" unitRef="shares">5861730</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c9" decimals="INF" unitRef="shares">949544</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="2" unitRef="usdPershares">-1.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c9" decimals="2" unitRef="usdPershares">-8.78</us-gaap:EarningsPerShareBasic>
    <cyngn:ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Year ended&lt;br/&gt; December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Unvested restricted shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,123,931&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,652,680&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Common shares issuable upon conversion of preferred stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-56"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,982,491&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,123,931&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,635,171&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</cyngn:ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c0" decimals="INF" unitRef="shares">3123931</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c9" decimals="INF" unitRef="shares">10652680</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="c9" decimals="INF" unitRef="shares">21982491</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <cyngn:EarningsPerShareTotal contextRef="c0" decimals="INF" unitRef="shares">3123931</cyngn:EarningsPerShareTotal>
    <cyngn:EarningsPerShareTotal contextRef="c9" decimals="INF" unitRef="shares">32635171</cyngn:EarningsPerShareTotal>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;9.
Stock-based Compensation Expense&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Stock-Based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company measures employee and director stock-based compensation awards based on the award&#x2019;s estimated fair value on the
date of grant. Expense associated with these awards is recognized using the straight-line attribution method over the requisite
service period for stock options, and is reported in our consolidated statements of comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
fair value of our stock options is estimated, using the Black-Scholes option-pricing model. The resulting fair value is recognized
on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The
Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual
term of ten years. Vesting terminates at the end of the employment relationship.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Determining
the grant date fair value of options requires management to make assumptions and judgments. These estimates involve inherent uncertainties
and if different assumptions had been used, stock-based compensation expense could have been materially different from the amounts
recorded.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
assumptions and estimates for valuing stock options are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
    value per share of Company&#x2019;s common stock.&lt;/i&gt; The fair value of the Company&#x2019;s stock options with service conditions
    is measured on the following basis according to when the stock options were granted: i) stock options granted prior to the
    IPO: due to the absence of a public market for Cyngn&#x2019;s common stock prior to the IPO, our Board of Directors, with the
    assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock
    options by considering a number of objective and subjective factors, including our actual operating and financial performance,
    market conditions and performance of comparable publicly traded companies, developments and milestones in the company, and
    the likelihood of achieving a liquidity event among other factors; ii) stock options granted after the IPO: the closing fair
    market value of its common stock at the time of the grant.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Expected
    volatility. &lt;/i&gt;The Company determines the expected volatility based on historical average volatilities of similar publicly
    traded companies corresponding to the expected term of the stock options.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Expected
    term. &lt;/i&gt;The Company does not have sufficient historical data relating to its common stock nor to its stock-option exercises.
    As such, the Company determines the expected term of awards which contain only service conditions using the simplified approach,
    wherein the expected term of an award is presumed to be the mid-point between the vesting date and the expiration date of
    the award.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Risk-free
    interest rate.&lt;/i&gt; The risk-free interest rate is based on the U.S. Treasury yield curve with maturities that approximate
    the expected term of the stock options.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Estimated
    dividend yield.&lt;/i&gt; The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in
    the foreseeable future.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Equity
Incentive Plans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
February&#160;2013, the Board of Directors adopted the 2013 Equity Incentive Plan (&#x201c;2013 Plan&#x201d;). The 2013 Plan authorizes
the award of stock options, stock appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards,
and other stock or cash awards.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;In
October&#160;2021, our Board of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;). Our
2021 Plan replaces our 2013 Plan. However, awards outstanding under our 2013 Plan will continue to be governed by their existing
terms.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021 and 2020, approximately 10,502,696 and 9,830,005 shares of common stock were reserved and available
for issuance under the 2021 Plan and 2013 Plan, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Options
issued under the Plan generally vest based on continuous service provided by the option holder over a four-year period. Compensation
expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at
the grant date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
following table sets forth the summary of options activity for the year ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Weighted-&lt;br/&gt;
average&lt;br/&gt;
exercise&lt;br/&gt; price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Weighted-&lt;br/&gt;
    average&lt;br/&gt; remaining&lt;br/&gt; contractual&lt;br/&gt; term (years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Aggregate&lt;br/&gt; intrinsic&lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Outstanding as of December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;6,971,301&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;7.0&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;1,399,827&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and expected to vest at December&#160;31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,892,738&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,860,120&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and exercisable at December&#160;31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,978,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.03&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;406,094&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,926,473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(41,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;109,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,086,664&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Outstanding as of December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,769,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,746,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and expected to vest at December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,769,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,746,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and exercisable at December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,645,763&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5.94&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,967,973&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
fair value of a stock option is estimated using an option-pricing model that takes into account as of the grant date the exercise
price and expected life of the option, the current price of the underlying stock and its expected volatility, expected dividends
on the stock, and the risk-free interest rate for the expected term of the option. The Company has used the simplified method
in calculating the expected term of all option grants based on the vesting period and contractual term. Compensation costs related
to share-based payment transactions are recognized in the financial statements upon satisfaction of the requisite service or vesting
requirements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
weighted average per share grant-date fair value of options granted during the years ended December&#160;31, 2021 and 2020 was
$2.78 and $0.07 respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
following weighted average assumptions were used in estimating the grant date fair values in December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Fair value of common stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.78&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.95&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.68&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;For
the year ended December&#160;31, 2021 and 2020, the Company recorded stock-based compensation expense from stock options of approximately
$1,139,247 and $131,732, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021, total unrecognized stock-based compensation cost related to outstanding unvested stock options that
are expected to vest was $7,031,949. This unrecognized stock-based compensation cost is expected to be recognized over a weighted-average
period of approximately 4.6 years. Income tax benefits recognized from stock-based compensation expense recognized for the year
ended December&#160;31, 2021 were immaterial due to cumulative losses and valuation allowances.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <cyngn:CommonStockSharesIssurance contextRef="c0" decimals="0" unitRef="shares">10502696</cyngn:CommonStockSharesIssurance>
    <cyngn:CommonStockSharesIssurance contextRef="c9" decimals="0" unitRef="shares">9830005</cyngn:CommonStockSharesIssurance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Weighted-&lt;br/&gt;
average&lt;br/&gt;
exercise&lt;br/&gt; price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Weighted-&lt;br/&gt;
    average&lt;br/&gt; remaining&lt;br/&gt; contractual&lt;br/&gt; term (years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Aggregate&lt;br/&gt; intrinsic&lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Outstanding as of December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;6,971,301&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;7.0&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;1,399,827&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and expected to vest at December&#160;31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,892,738&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.54&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,860,120&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and exercisable at December&#160;31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,978,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.03&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;406,094&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,926,473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(41,416&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;109,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Cancelled/forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,086,664&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Outstanding as of December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,769,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,746,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and expected to vest at December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,769,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7.15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,746,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Vested and exercisable at December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,645,763&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5.94&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,967,973&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c2" decimals="INF" unitRef="shares">6971301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c2" decimals="2" unitRef="usdPershares">0.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c0">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding contextRef="c2" decimals="INF" unitRef="usd">1399827</cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c2" decimals="INF" unitRef="shares">10892738</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <cyngn:ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest contextRef="c2" decimals="2" unitRef="usdPershares">0.54</cyngn:ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c0">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c2" decimals="INF" unitRef="usd">5860120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c2" decimals="INF" unitRef="shares">5978428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c2" decimals="2" unitRef="usdPershares">0.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c0">P7Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c2" decimals="INF" unitRef="usd">406094</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c0" decimals="INF" unitRef="shares">2926473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <cyngn:WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted contextRef="c0" decimals="2" unitRef="usdPershares">3.2</cyngn:WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted>
    <cyngn:StocksIssuedDuringPeriodSharesStockOptionsExercised contextRef="c0" decimals="INF" unitRef="shares">41416</cyngn:StocksIssuedDuringPeriodSharesStockOptionsExercised>
    <cyngn:StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised contextRef="c0" decimals="2" unitRef="usdPershares">0.23</cyngn:StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c0" decimals="0" unitRef="shares">109902</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c0" decimals="INF" unitRef="shares">1086664</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited contextRef="c0" decimals="2" unitRef="usdPershares">0.2</cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c1" decimals="INF" unitRef="shares">8769694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c1" decimals="2" unitRef="usdPershares">1.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <cyngn:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="c0">P7Y1M24D</cyngn:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding contextRef="c1" decimals="INF" unitRef="usd">15746916</cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c1" decimals="INF" unitRef="shares">8769694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <cyngn:ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest contextRef="c1" decimals="2" unitRef="usdPershares">1.2</cyngn:ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest>
    <cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares contextRef="c0">P7Y1M24D</cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c1" decimals="INF" unitRef="usd">15746916</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c1" decimals="INF" unitRef="shares">5645763</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="c1" decimals="2" unitRef="usdPershares">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt contextRef="c0">P5Y11M8D</cyngn:ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c1" decimals="INF" unitRef="usd">14967973</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <cyngn:FairValueOfOptionsGranted contextRef="c0" decimals="2" unitRef="usd">2.78</cyngn:FairValueOfOptionsGranted>
    <cyngn:FairValueOfOptionsGranted contextRef="c9" decimals="2" unitRef="usd">0.07</cyngn:FairValueOfOptionsGranted>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Fair value of common stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.78&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.95&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.68&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="2" unitRef="usd">2.78</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c9" decimals="2" unitRef="usd">0.23</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0">P6Y1M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c9">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" unitRef="pure">0.0095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c9" decimals="4" unitRef="pure">0.0068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c0" decimals="3" unitRef="pure">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c9" decimals="4" unitRef="pure">0.2934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c9" decimals="2" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <cyngn:StockbasedCompensationExpenseOfStockOptions contextRef="c0" decimals="0" unitRef="usd">1139247</cyngn:StockbasedCompensationExpenseOfStockOptions>
    <cyngn:StockbasedCompensationExpenseOfStockOptions contextRef="c9" decimals="0" unitRef="usd">131732</cyngn:StockbasedCompensationExpenseOfStockOptions>
    <cyngn:StockOptionsExpectedVest contextRef="c0" decimals="0" unitRef="usd">7031949</cyngn:StockOptionsExpectedVest>
    <us-gaap:PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod contextRef="c0">P4Y7M6D</us-gaap:PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod>
    <cyngn:RetirementSavingsPlanTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;10.
Retirement Savings Plan&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Effective
November&#160;17, 2017, the Company established the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees
and their beneficiaries with the intention to provide a measure of retirement security for the future. This plan is subject to
the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and qualifies under Section&#160;401(k) of the Internal
Revenue Code. Cyngn Inc. did not offer and has not provided a company match for its 401(k) Plan.&lt;/span&gt;&lt;/p&gt;</cyngn:RetirementSavingsPlanTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;11.
Income Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;For
the years ended December&#160;31, 2021 and 2020, the Company recorded income tax expense of $800. The effective tax rate is 0%
for the years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;For
financial reporting purposes, the Company&#x2019;s effective tax rate used for the interim periods is based on the estimated full-year
income tax rate. Income tax expense differed from the amount computed by applying the federal statutory income tax rate of 21%
to pretax income for the year ended December&#160;31, 2021 as a result of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Federal tax at statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,635,786&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(543,984&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Nondeductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(308,449&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Research and development credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(897,331&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;FIN 48 reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-57"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Foreign Tax Rate Difference&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Stock Compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,330&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;True-up and Rate Change&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,207,490&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;800&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
tax effects of temporary differences that give rise to significant portions of the Company&#x2019;s deferred tax assets and liabilities
as of December&#160;31, 2021 and 2020 related to the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Intangibles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,772,704&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,299,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Net operating losses and Credit carryover&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,425,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,834,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Fixed Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89,979&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,694&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;SBC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;243,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Accruals And Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,005&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;38,034&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Gross deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,571,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,364,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,571,977&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(31,364,488&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-58"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-59"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Fixed Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-60"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-61"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Deferred Commissions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-63"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-64"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Net deferred tax assets:&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;Management
regularly assesses the ability to realize deferred tax assets recorded based upon the weight of available evidence, including
such factors as recent earnings history and expected future taxable income on a jurisdiction by jurisdiction basis. In the event
that the Company changes its determination as to the amount of realizable deferred tax assets, the Company will adjust its valuation
allowance with a corresponding charge to the provision for income taxes in the period in which such determination is made. The
Company&#x2019;s management believes that, based on a number of factors, it is more likely than not, that all or some portion of
the deferred tax assets will not be realized; and accordingly, for the years ending December&#160;31, 2021 and December&#160;31,
2020, the Company has provided a valuation allowance against the Company&#x2019;s U.S. net deferred tax assets. The net change
in the valuation allowance for the year ended December&#160;31, 2021 was an increase of $3,207,490.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021, the Company had net operating loss carryforwards for federal and state income tax purposes of approximately
$100,697,360 and $101,454,126, respectively, which will both begin to expire in &lt;span style="-sec-ix-hidden: hidden-fact-68"&gt;2034&lt;/span&gt; with $65,360,163 of our federal net operating
loss carryforward lasting indefinitely.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021, the Company had federal and state research credit carryforwards of approximately $4,258,776 and $2,192,429,
respectively. The federal research credit carryforwards will begin to expire in &lt;span style="-sec-ix-hidden: hidden-fact-69"&gt;2023&lt;/span&gt; while the California research credits carry
forward have an indefinite life.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of net operating losses in the event of an
&#x201c;ownership change&#x201d; of a corporation. Accordingly, a company&#x2019;s ability to use net operating losses may be limited
as prescribed under Internal Revenue Code Section&#160;382 (&#x201c;IRC Section&#160;382&#x201d;). Events which may cause limitations
in the amount of the net operating losses that the Company may use in any one year include, but are not limited to, a cumulative
ownership change of more than 50% over a three-year period. Utilization of the federal and state net operating losses may be subject
to substantial annual limitation due to the ownership change limitations provided by the IRC Section&#160;382 and similar state
provisions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;As
of December&#160;31, 2021, and 2020, the total amount of gross unrecognized tax benefits was $1,797,238 and $1,412,668, respectively,
including no interest and penalties. As of December&#160;31, 2021, $1,797,238 of the total unrecognized tax benefits, if recognized,
would have an impact on the Company&#x2019;s effective tax rate. The Company estimates that there will be no material changes in
its uncertain tax positions in the next 12 months. In accordance with FASB ASC 740, the Company has adopted the accounting policy
that interest and penalties recognized are classified as part of its income taxes. Total interest and penalties recognized in
the consolidated statement of operations was zero for 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company files income tax returns in the US federal and various state jurisdictions. The Company&#x2019;s tax years for 2018 and
forward are subject to examination by the US tax authorities. The Company&#x2019;s tax years for 2017 and forward are subject to
examination by various state tax authorities. However, due to the fact that the Company had loss and credits carried forward in
some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant taxing
authority through an adjustment to tax attributes carried forward to open years. The Company files U.S. and foreign income tax
returns with varying statutes of limitations. Due to the Company&#x2019;s net carryover of unused operating losses, all years remain
subject to future examination by tax authorities.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c9" decimals="0" unitRef="usd">800</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="0" unitRef="usd">800</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c9" decimals="2" unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="2" unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Federal tax at statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,635,786&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(543,984&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Nondeductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(308,449&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Research and development credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(897,331&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;FIN 48 reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-57"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Foreign Tax Rate Difference&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Stock Compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,330&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;True-up and Rate Change&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,207,490&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;800&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="0" unitRef="usd">-1635786</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c0" decimals="0" unitRef="usd">-543984</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c0" decimals="0" unitRef="usd">-308449</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c1" decimals="0" unitRef="usd">897331</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c0" decimals="0" unitRef="usd">1779</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c1" decimals="0" unitRef="usd">150330</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <cyngn:DeferredTaxAssetsTrueup contextRef="c0" decimals="0" unitRef="usd">26751</cyngn:DeferredTaxAssetsTrueup>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="0" unitRef="usd">3207490</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <cyngn:FederalStatutoryIncomeTaxRateTotal contextRef="c0" decimals="0" unitRef="usd">800</cyngn:FederalStatutoryIncomeTaxRateTotal>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style=" width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Intangibles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,772,704&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,299,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Net operating losses and Credit carryover&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,425,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,834,590&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Fixed Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89,979&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,694&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;SBC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;243,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Accruals And Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;40,005&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;38,034&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in"&gt;Gross deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,571,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,364,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; text-indent: -0.125in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,571,977&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(31,364,488&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-58"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-59"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Fixed Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-60"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-61"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in"&gt;Deferred Commissions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-63"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-64"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 0.375in; text-indent: -0.125in"&gt;Net deferred tax assets:&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c1" decimals="0" unitRef="usd">1772704</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c2" decimals="0" unitRef="usd">2299275</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c1" decimals="0" unitRef="usd">32425152</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c2" decimals="0" unitRef="usd">28834590</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c1" decimals="0" unitRef="usd">168</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c2" decimals="0" unitRef="usd">168</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c1" decimals="0" unitRef="usd">89979</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c2" decimals="0" unitRef="usd">101694</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <cyngn:DeferredTaxAssetsSBC contextRef="c1" decimals="0" unitRef="usd">243970</cyngn:DeferredTaxAssetsSBC>
    <cyngn:DeferredTaxAssetsSBC contextRef="c2" decimals="0" unitRef="usd">90726</cyngn:DeferredTaxAssetsSBC>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="c1" decimals="0" unitRef="usd">40005</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="c2" decimals="0" unitRef="usd">38034</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c1" decimals="0" unitRef="usd">34571977</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c2" decimals="0" unitRef="usd">31364488</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c1" decimals="0" unitRef="usd">34571977</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c2" decimals="0" unitRef="usd">31364488</us-gaap:DeferredTaxAssetsValuationAllowance>
    <cyngn:DeferredTaxAssetNetCurrent contextRef="c1" decimals="0" unitRef="usd">3207490</cyngn:DeferredTaxAssetNetCurrent>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="c65" decimals="0" unitRef="usd">100697360</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c66" decimals="0" unitRef="usd">101454126</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c1" decimals="0" unitRef="usd">65360163</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c65" decimals="0" unitRef="usd">4258776</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c66" decimals="0" unitRef="usd">2192429</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <cyngn:NetOperatingLosses contextRef="c0">P1Y</cyngn:NetOperatingLosses>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c1" decimals="2" unitRef="pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c1" decimals="0" unitRef="usd">1797238</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c2" decimals="0" unitRef="usd">1412668</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <cyngn:TotalUnrecognizedTaxBenefit contextRef="c9" decimals="0" unitRef="shares">1797238</cyngn:TotalUnrecognizedTaxBenefit>
    <cyngn:TaxPositionTerm contextRef="c0">P12M</cyngn:TaxPositionTerm>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;12.
Commitments and Contingencies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;&lt;i&gt;Legal
Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;The
Company is subject to legal and regulatory actions that arise from time to time. The assessment as to whether a loss is probable
or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment
about future events, and the outcome of litigation is inherently uncertain. There is no material pending or threatened litigation
against the Company that remains outstanding as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;13.
Risks and Uncertainties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;COVID-19.
A novel strain of coronavirus (COVID-19) was first identified in December&#160;2019, and subsequently declared a pandemic by the
World Health Organization. While Cyngn&#x2019;s business has experienced limited disruption due to this pandemic, our leadership
team continues to focus on the highest level of safety measures to protect our employees. The Company is aware COVID-19 continues
to present significant uncertainty in the future economic outlook for our customers and the markets we serve.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;&lt;b&gt;14.
Subsequent Events&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "&gt;On
February&#160;17, 2022, the Company amended the lease agreement (the &#x201c;Lease Amendment&#x201d;). The Lease Amendment extended
the current lease for an additional 18 months, which commenced on March&#160;1, 2022, and expanded the leased space to a total
of 23,311 square feet from the previous 6,886 square feet.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventDescription contextRef="c68">The Lease Amendment extended
the current lease for an additional 18 months, which commenced on March&#160;1, 2022, and expanded the leased space to a total
of 23,311 square feet from the previous 6,886 square feet.</us-gaap:SubsequentEventDescription>
    <us-gaap:LongTermNotesPayable
      contextRef="c1"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c1"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c2"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c1"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c3"
      id="hidden-fact-5"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c5"
      id="hidden-fact-6"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c5"
      id="hidden-fact-7"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c7"
      id="hidden-fact-8"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c7"
      id="hidden-fact-9"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c2"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c0"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c9"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:PPPLoanForgiveness
      contextRef="c9"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c12"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c16"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c17"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c18"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c16"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c17"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c18"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c16"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c17"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c18"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c19"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c23"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c26"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c27"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c28"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c30"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c26"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c28"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c30"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c28"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c29"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c30"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c0"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c26"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c27"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c28"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c30"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c0"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c26"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c27"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c28"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="c29"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c31"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="c9"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:GainOnForgivenessOfPaycheckProtectionProgramLoans
      contextRef="c9"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="c9"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c9"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c9"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c9"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount
      contextRef="c0"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="c0"
      id="hidden-fact-56"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:InventoryValuationReserves
      contextRef="c1"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="c1"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="c2"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c1"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c2"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="c1"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="c2"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c1"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c2"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c1"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c2"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExaminationYearUnderExamination contextRef="c0" id="hidden-fact-68">2034</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination contextRef="c67" id="hidden-fact-69">2023</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0">0001874097</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MH(POV38W]W+W*Z\#"BQ>*G-=_46[VA9/4+K51A:U,S H1+G_SU[J1!PX$'_
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M:#]2\+Z^4CJD7JV\DG%]M8\R=(V!9+;9=.2&AE,_CJ9AW'S[H6SMT^_3L25
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M[!$DW>Y#T0=:&EM")-(E:3O[[3ND%%F196V*-@^Q1,W\^9L1.1S-]EP\RP)
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MV G)ZMY9(:AIT_W'CST1>PXP.>" >@<T=8@..(2]0V@"[9"9L&ZPQ(L+SAX
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M3@?P>V4Q9J8OI&#XSX;+_P!02P,$%     @ Y(.L5#:(+^ .%   7S<  !D
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M2]V8*"##S%/E-P:T;-;"$5**"MG8[[4.[\ '=K@RB_C@9T0IRWP[H0',2HL
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M^T_UPF(T[5$*6;%VTFBRO+X:S=.7-\=A?5SPA^2M&SQ3J&1ES'T8O"FN1K-
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M;')V,B+;7N':@3=UO#:MC,<E+#["RG!26(#YM8'$W2 DZ._1U_\"4$L#!!0
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M8V>^Z!O2HWG?UC\SM>.-!H$EN4:3.35"U;?*?F+DWK6GK334[-RPHJ\+5-:
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M!XAI]"L4<5 #6?B>RY*O2^A:X!$)V4M><R:Y6&RA<4IX RD\,(< YO((*+J
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M" []# E@?Z.4;5_P@.[S_NW_ 5!+ P04    " #D@ZQ4V\UFK>,"  !2!@
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M/A$VW+J'!V]6?-.-8=2;BG\N%<Y,EA;@^\(8WSV0@NU_?;S['U!+ P04
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MKIZ 4W_0G0=;B?1W E\;1.DA;[SQ]:LQ8\G9Q^";^VCO"];T[.T /E/,;T[
M1Q>H/0_(:F.\L:73% !.O93GPC<5+R$=@PQ?OP]-(;(",BV)DI$H:KIK;LB4
M[J1SE1.=E#_3G(.M>(;@-'!Z.%[V] K8L#],4VI3*I\.]@-J9;0,:31_-D+7
M%H[[X_'Q?LS@;]\SWNL/B68=IH EI;5R;:MTUF[0S-O^^A7>3BDJ:"V4)>$K
M2DT&)T<1F+;SVXW35>BVI7;4NV%9T+!$XP/(O]+:[3;^@&[\SGX"4$L#!!0
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M!0I/"FTD=;@UF\16!F@>@J1(LC0]323E*IY-@FUI9A-=.\$5+ VQM934O"Y
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M89E4M,K2(LSC<O9AT)+;0:-GN.-/;FT@R;(PB5-(R"R.XYG3:K"$[JS>G_.
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M@E\NI$:!S_>:V[]?- ZN;^'R?U!+ P04    " #D@ZQ4,PFK( H#  #U!@
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MYVJG3>1$8Y/R:!3="M(SD]NFD#7"$]^BAK,G/J]0GX]\0]!6P"]V,%<]#/L
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M.HWSY1IX"-((X/>K--6[!^.@NHZ<_0M02P,$%     @ Y(.L5#FFB,FQ @
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M;IJY>E_PD\/.[(V)<[)2ZLE-OA63('*"0 !#QT#M8PM3$,(161G/'6?0'^F
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MKO1-#,(8Z/<+SM5N8X9]?[>/_@-02P,$%     @ Y(.L5!-]RX># @  Q 8
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M965T-#0N>&ULM5C;CN(X$/T5*^J'&6F6Q ZYC0 )NO?2TK06#9K=A]$^F*0
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MW)[3,&D%E P+Z)DM&)Y+P.Y<23,06W/QEOI.J,.K;J?-;'.YGU=7VG9Y]<_
M Q5;EDN4PD:;.J- NQ?59;L:*+XW%]PU5_JZ;!YW0!,0Y0+]?L.Y>AZ4#IJ_
M/&;_ 5!+ P04    " #D@ZQ4$K/)THL"  !]!@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6RUE=]/XS ,Q_\5J[J30#K6'V-L0MLDQD"'!!)BXGA
M/&2MNT:D22]Q-_;?7Y)NO2&-ZE[N98T3^^N/G=4=;Y1^-P4BP4<II)D$!5%U
M&88F+;!DIJ<JE/8D5[ID9$V]"DVED64^J!1A$D478<FX#*9CO_>HIV-5D^ 2
M'S68NBR9WLY0J,TDB(/]QA-?%>0VPNFX8BM<(#U7C]I:8:N2\1*EX4J"QGP2
M7,67LZ'S]PZ_.&[,P1I<)4NEWIUQETV"R &AP)2< K./-5ZC$$[(8OS>:09M
M2A=XN-ZKW_K:;2U+9O!:B1>>43$)1@%DF+-:T)/:_,1=/0.GERIA_"]L=KY1
M &EM2)6[8$M0<MD\V<>N#P<!2?Q%0+(+2#QWD\A3SAFQZ5BK#6CG;=7<PI?J
MHRT<E^Y2%J3M*;=Q-+UF%2<FP.[5*=4:X62.Q+@PIW &"_L?R&J!H'+(&=>P
M9J+V%A4(&Z8UDV2LX\M^^?J Y1+UVS@D2^=RA.F.9-:0)%^0Q D\*$F%@1N9
M8?99(+1EM;4E^]IF2:?B'-,>].,?D$1)_+R8P\FWTP[9?MNROI?M_\^6O=Y;
M5;@C+,U;!]-YRW3NF<Z_8+K]E*FV#=1BR^4*#*:UYL31P F7,%=",&U.CUU/
MDV'D,[AW>3U->J/1.%P?X1JT7(-.KIN/RKY^F,%:"49<<-H>2]TM,HA[4?2]
MHTL7+<W%O]$0ZO(81W?X +9HF]<!,FQ!AIU*3]R\G^4:$;BT+&@(-",\AM0M
M%/?B_M'.A <CH42]\H//0*IJ2<UT:'?;V7K5C)2_[LU@?F!ZQ:4!@;D-C7I#
M>UNZ&7:-0:KR V:IR(XKORSL]P&U<[#GN5*T-UR"]HLS_0-02P,$%     @
MY(.L5%FK7D3( @  4P<  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL
ME57;CMHP$/T5*^K#KM0E-R"P B0NK5IIMT*+MGVH^F"2@5CKQ-1VR/;O.W9"
M&EA 71Z(+S-GYLRQQZ-2R!>5 FCRFO%<C9U4Z]V]ZZHXA8RJCMA!CCL;(3.J
M<2JWKMI)H(EURK@;>%[?S2C+G<G(KBWE9"0*S5D.2TE4D654_ID!%^78\9W#
MPA/;IMHLN)/1CFYA!?IYMY0X<QN4A&60*R9R(F$S=J;^_3PR]M;@.X-2M<;$
M,%D+\6(F7Y.QXYF$@$.L#0+%SQ[FP+D!PC1^UYA.$](XML<'],^6.W)94P5S
MP7^P1*=C9^"0!#:TX/I)E%^@YM,S>+'@ROZ3LK;U'!(72HNL=L8,,I977_I:
MUZ'EX/<O. 2U0W#JT+W@$-8.H25:969I+:BFDY$4)9'&&M',P-;&>B,;EAL5
M5UKB+D,_/?F&!^5!*$66(,DJI1+(5&O)UH6F:PY$"S(7688%7VD1OZ2")R 5
MN5F IHRK6W)'5GBRD@)MQ<94E,6$Y@E)&"\T)(0;\!V"*PM^1YY7"W+SX7;D
M:DS?).'&=:JS*M7@0JI^0!Y%KE-%/N4)),< +O)NR <'\K/@*N("X@X)_8\D
M\ +_3$+S_W?WKJ03-EJ$%B^\@/>N0OZ<KI66> M^78G<;2)W;>3NE5-@\>F)
M]G&EO6II?TZX"KUGT4W?V$_NHF@X[ 7#D;MO%_2,X2 ,!P,O:@R/"/0: KVK
M!&9ORE7:"XP#N@>)_:BA8JJG"#8TI=&>Y=MSA*IH_5:>O4'?CT+OA,];NV%W
MV.MVS[/I-VSZ5P_"PY'4]U<$CAK$Z'WU.4>Z@ABTQ?$[87A"^8S5H&/4;OU.
MZ+NM_I2!W-JVK5"1(M?5;6U6FY=A:AOBR?H,7XRJP?^#J9Z;1RJW+%>$PP8A
MO4Z$RLBJA5<3+7:V"ZZ%QIYJARF^>B"- >YOA-"'B0G0O*.3OU!+ P04
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M.C$F3MCN82>*;\T#O.(*GW,SS+#A@M &N+_F7)TF.D#=PL=_ %!+ P04
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MFHPBI7W(K'W=C,:2HUE&$DMT\PN2:JC1S'N46[&)\GU?0U&D5 R95>QL=D]
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M-?",[H;(J%QCB5<+SHZ(Z]T*30^,J\9:B2NH/I6MY.IKH>SDZHXFK 3T#9]
MH/=KD+@@X@.Z0%MU_FE- +$,99 "QP0)B64M&7]!16,F\6EA2R5#@]E)2WG3
M4'HCE*Z'[AF5N4"?: KIGP"VTM\YX;TZ<>--(JXAN42^^Q%YCN<^;M?H_;L/
M$[!^%QO?P/HCL/\; O3C>B<D5PGV<X(UZ%@#PQJ,L'YNF30PECU"CB4,1;N!
MFQDX?0D/JPLW]&=1'"[LPX"062=D-BEDJYB-?R"&:!OCL$\["_QY' RSAAUK
M.,GZE>FDJ-5EW:G(PTF5'S$L(#P7X#MQ$,R'!42=@&A2P 8$8)[D"--4W>^#
M*ER5*D,2)1S20@XIB<Z5Q//(]]UA)7&G))[.A+NO*(A5[1/ #X-'/VFO"_J5
MJ' "2ZMJ0:P5FDC1>2=L/BV,<57MJ*X::*.39%UD&7"@R:#*^5EXW"@:.277
M>2M<SC_2DR7/Z):5.D.P+O&#I<@Y)Y\YON^,T/?JICM)_XW7<%%7)DM,#&YS
M3/>#_K=(?0U>&,U&LL/UWB1XDQ*>,*EQT]N(ZJYX)/PM2I_>]YPHF(_%X*T^
MNOYT#)C$9)#2/ZM)L?,WG=WK6B7PO>G- B6LIK)I8-UJU_^OFZ[WMKWY>;C'
M?%]0@0ADRM2YC!0S;_IQ,Y&L,CUPQZ3JJ&:8JW\8X'J#^IXQ)E\GFJ#[*UK]
M!E!+ P04    " #D@ZQ4"EMZ8I(#  #V#0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6REE]N.VS80AE^%$'J1 -V5J+,,V\"N%VESD781)^DU+8]M
M(I3HDO0A;U]2\LH'T>P:OK%%:>;7]X\H#C7<<?%3K@ 4VE>LEB-OI=1ZX/NR
M7$%%Y"-?0ZVO++BHB-)#L?3E6@"9-TD5\\,@2/V*T-H;#YMSKV(\Y!O%: VO
M LE-51'QZQD8WXT\[+V=^$J7*V5.^./AFBQA"NK[^E7HD=^IS&D%M:2\1@(6
M(^\)#R8X-0E-Q \*.WERC(R5&><_S>#S?.0%A@@8E,I($/VWA0DP9I0TQ[\'
M4:^[ITD\/7Y3_]28UV9F1,*$LW_H7*U&7NZA.2S(AJFO?/<G' PE1J_D3#:_
M:'>(#3Q4;J3BU2%9$U2T;O_)_E"(DP0<7TD(#PGA>Q.B0T+4&&W)&ELO1)'Q
M4/ =$B9:JYF#IC9-MG9#:_,8ITKHJU3GJ?'GNN05H&]D#Q)]> %%*),?T0.:
MZ@DSWS! ?&'* D+ '"FR1T1*4!*1>HX8)3/*J*(Z]P%]G[Z@#[]]'/I*<QEU
MOSPP/+<,X16&%R@?481_1V$08DOZY/WIP7FZKZO1E23L2A(V>M%5O9[;@4,V
MZF2C1C:^6FE%ZB6=,9"V$K7)29-LWKWM&&=9F 7QT-^>UJ(?%X9%$69)%W=&
M%W=TL9/N+[UBZ+5!$$7K)6)<VVZ?\417@BI4$B%^\2T(&WLKG9XP16$<)C@)
M+^#[@6&>1W%2!';ZI*-/G/131128YV6O;=*[+4[S"S1WS!E5VE&E3JI/=*]G
MT5,S@VQ8:>^6>5%DQ058/PH'."UB.UO6L67NBCU/;$A9_P'%49$%%TS]L"+(
MPM2.E'=(N1/IJ2S%AC")GO2T^UNM0%BKEO?N'0=!D%P0]J.B/(BN%*WH" LG
MX1]"OQ>VU=#&6?0)XB3#199=H%H"<93&<7YE^N'@N+8'3MX?A&U(VRV9[M>D
M+L&Z.@<]@H<KK-90-^U))\).VF]<$?;>ZKJUS.9G(->DA)&G=S<2Q!:\,;+V
MEON%SOT>VPR^H<^<M%)7L\'';H/=[>;_%A]W^BT%O%_HW.*Q96%WS^H*..%5
M1:796=JM.F5NL7J_T+G58W_#[@9G>3=.9HS5M%/P%M/W"YV;/K9/[.Z?9D]B
M60X&5KM.J5OLWB_4VO5/-N7FB^@+$4M:2\1@H96#QTS75;0?&>U \76S3Y]Q
MI7?]S>%*?YB!, 'Z^H)S]38P6__N4V_\'U!+ P04    " #D@ZQ4"^QB@WT"
M  "4!0  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6R55-MJ&S$0?<]7
M#%LH+1COQ8YC4ML0YT(#"82DEX?0!WDUZQ615AM)ZTW_OB.MO74A,>F+I)'F
MG#,C:6;6:O-D2T0'+TI6=AZ5SM6G<6SS$A6S0UUC12>%-HHY,LTZMK5!Q@-(
MR3A+DDFLF*BBQ2SLW9G%3#=.B@KO#-A&*69^+U'J=AZET6[C7JQ+YS?BQ:QF
M:WQ ][V^,V3%/0L7"BLK= 4&BWETEIXNC[U_</@AL+5[:_"9K+1^\L8UGT>)
M#P@EYLXS,)HV>(Y2>B(*XWG+&?62'KB_WK%?A=PIEQ6S>*[E3\%=.8^F$7 L
M6"/=O6Z_XC:?$&"NI0TCM)WOF!3SQCJMMF"RE:BZF;UL[V$/,$W> &1;0!;B
M[H1"E!?,L<7,Z!:,]R8VOPBI!C0%)RK_* _.T*D@G%L\-"N+SPU6#BXW-%KX
M=(&."6D_SV)' MXMSK=DRXXL>X,LA5M=N=+"9<61_XN/*; ^NFP7W3([2'B%
MJR&D)P/(DBP[P#?JLQT%OO$[LX7'6U0K-+\.<(][[G'@'OW_3<+C#3G#M4-E
M#TD=]U+'[TT#@]2 /J+-C:C]3W_MW0[S?2L1;I#^-IQ1O7$5B%\<^E<\<G28
M-\;X31F<J!4 HX+B7'@])B&=@@HO/X"V%'D)N5;$DB,'JKQ;9O+RXX=TDGQ)
MNZ<<$)Z31,V\!'B)0,W!UBQ'<!H8#8[)(UU -AJ,TI0*MF&&U'VK*HQ6 4:=
M:"-T8V$RF$XG^S[#URXZWJL4A68=^H&E<)O*=473[_8MYZRKM+_N7;^BK-:B
MLA1X0=!D>$)W;+H>T!E.UZ'N5MI1%8=E26T3C7>@\T)KMS.\0-^(%W\ 4$L#
M!!0    ( .2#K%0(_DQD30,  %85   -    >&PO<W1Y;&5S+GAM;-U846_:
M,!#^*U$Z39TT-82T@:R M"%5FK1-E=J'O56&.&#)<3+'=-!?/Y\=$J ^1ONP
MPH)H[/MRWWV^NR0N@TJM.+V;4ZJ\9<Y%-?3G2I6?@J":SFE.JHNBI$(C62%S
MHO14SH*JE)2D%3CE/.AV.G&0$R;\T4 L\IM<5=ZT6 @U]/N-R;.GK^G0#^-+
MW[-TXR*E0__A_/VO1:&NWWGV?/;Q[*SS\.%ZUWYN@ ]^X"2].H#TH@,'2FUA
M+$!\6(!][!AU[R#J/<P8<7^;N"7ZFV-R8#;WYA(A[W6<JBS;1B4P]_#02N\O
MM*$/ZHX=#;)"M(T;^=:@XY.<>H^$#_TQX6PB&7AE)&=\9<U=,$P+7DA/Z3M&
M"PK!4CU9.+0SN)EJGIR)0IK8-H+].ZDOWP'6,Q#(.&\$=GUK& U*HA25XD9/
MS,7&^ SRZO']JM0*9Y*LPNZ5WSJ8DPXR*61*91,F]->FT8#3#.1(-IO#615E
M *!21:X'*2.S0A"C8>U1#S3ME')^!T^:G]D6]S+;J*QI"]$,M:!Z:&GL!/@W
MV2SW)NWEJWB]DCT6ZLM"+T>8.;0+O94T8TLS7V:- (P]Q-E)6?+59\YF(J=V
M\0<'' W(VL^;%Y(]Z6C0*E-MH-+W'JE4;+II^2U)>4^7:MU.RPS7W#U!S?\V
MSS,JJ"1\4[3N_6/.\JL5UZ_FM]!L'BN[BITBH][Q:ZRW(\<N,CX%D2=1[OXI
MB$Q.0&3OS9Z:+Q$9'J7(H-X*;>RWMG9;C=6#7>W0_P&[:-X&]28+QA43]6S.
MTI2*9YLN3:_(1/_3N,6OKT]I1A9<W3?@T&_'WVG*%GG27'4+B:BO:L??8'EA
MW&RI=2PF4KJDZ;B>RMG$##T]T%'K QQVD1MSN!',QV)N!# L#J8 \[%>6)S_
M:3U]=#T6P[3UG4@?]>FC/M;+A8S-!XOC]DGTX5YIDD11'&,9'8^="L98WN(8
MOFXV3!MX8'$@TLMRC5<;[Y#]?8#5=%^'8"O%.Q%;*9YK0-QY X\D<5<;BP,>
M6!6PWH'X[CC04VZ?*(*J8MJP.QA'D@1#H!?=/1K'2'9B^+CK@]TE490D;@0P
MMX(HPA"X&W$$4P :,"2*S'MPYWT4K-]30?M+ZN@/4$L#!!0    ( .2#K%27
MBKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E
M\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!
M2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/
M06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3
MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MZRLH^Z)N-*\.?U<Y_-7FXW=02P,$%     @ Y(.L5 ^45$C: 0  62   !H
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MG[*^&[/\Z_?6[36M==D<\EGW<<#D$U!+ 0(4 Q0    ( .2#K%0'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ Y(.L5.[NY!GN    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ Y(.L5)E<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #D
M@ZQ4S5!Z?MX"   )"0  &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ Y(.L5/Z)6#1,!0  &10  !@
M         ("!(0L  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( .2#K%0D\U;[:P,  (<1   8              " @:,0  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #D@ZQ49S,Q?BL$  "(#0
M&               @(%$%   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ Y(.L5/L8( *)!0  ?AX  !@              ("!I1@  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( .2#K%0320GN.0(
M )\$   8              " @60>  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " #D@ZQ4Y!.&"RD&  "N%P  &               @('3
M(   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ Y(.L5,(I
MEL1> @  7@4  !@              ("!,B<  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( .2#K%0;[1?+2@H  '@8   8
M  " @<8I  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #D
M@ZQ4-H@OX X4  !?-P  &0              @(%&-   >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( .2#K%392/V0404  -H+   9
M          " @8M(  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#
M%     @ Y(.L5!Q4BDK: @  'P8  !D              ("!$TX  'AL+W=O
M<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #D@ZQ4W,N(UT #  "6
M!P  &0              @($D40  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;%!+ 0(4 Q0    ( .2#K%3\PN=E^P0  %,+   9              " @9M4
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ Y(.L5#4[
MIC2."   <A@  !D              ("!S5D  'AL+W=O<FMS:&5E=',O<VAE
M970Q-2YX;6Q02P$"% ,4    " #D@ZQ4LTN7[K\#  "["   &0
M    @(&28@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M .2#K%2EHNZH30D  .H7   9              " @8AF  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ Y(.L5-O-9JWC @  4@8  !D
M             ("!#'   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " #D@ZQ4[8BE]/ )   &&0  &0              @($F<P  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( .2#K%1$E<,PZ@(
M '8&   9              " @4U]  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ Y(.L5-'7(8<, P  8P8  !D              ("!
M;H   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #D@ZQ4
MB/[('(L"  "*!0  &0              @(&Q@P  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( .2#K%2=S<9YEQ4  !I$   9
M      " @7.&  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ Y(.L5!@\FO'S @  XP8  !D              ("!09P  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #D@ZQ4N=HEK"\#   \!P
M&0              @(%KGP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( .2#K%1HSFY4"0,  &@'   9              " @=&B  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ Y(.L5&C-"V<_
M P  %P<  !D              ("!$:8  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " #D@ZQ4,PFK( H#  #U!@  &0
M@(&'J0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( .2#
MK%151)S\J0,  &D(   9              " @<BL  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ Y(.L5$7_3%[8 P  <P@  !D
M         ("!J+   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " #D@ZQ4?(!QQB,%  ":%   &0              @(&WM   >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( .2#K%0YIHC)L0(  ,0'
M   9              " @1&Z  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ Y(.L5+:@@&)L @  >P8  !D              ("!^;P
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #D@ZQ4$%?Q
MCL\"  #4"@  &0              @(&<OP  >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( .2#K%0_QG+P:P(  "4&   9
M  " @:+"  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
MY(.L5*C>H8W0 @  YP<  !D              ("!1,4  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " #D@ZQ4$WW+AX,"  #$!@  &0
M            @(%+R   >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( .2#K%3V?T5:3 (  ' &   9              " @07+  !X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ Y(.L5!@[A[0X @
M% 4  !D              ("!B,T  'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " #D@ZQ4:O?FM"8#  "2"P  &0              @('W
MSP  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( .2#K%0V
MT:2,70(  (L&   9              " @533  !X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ Y(.L5+5V,\MU @  ! <  !D
M     ("!Z-4  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .2#K%1;_I7)PP(   H'   9              "
M@<7F  !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ Y(.L
M5/OLQL+V @  S@<  !D              ("!O^D  'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " #D@ZQ4(S835B,%  #Q&@  &0
M        @('L[   >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( .2#K%0'&<E0\@(  ,8(   9              " @4;R  !X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ Y(.L5$S3B5X/!   R0\
M !D              ("!;_4  'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " #D@ZQ4GN3SI#4#   A"0  &0              @(&U^0
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( .2#K%0*6WIB
MD@,  /8-   9              " @2']  !X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ Y(.L5 OL8H-] @  E 4  !D
M ("!Z@ ! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " #D
M@ZQ4"/Y,9$T#  !6%0  #0              @ &> P$ >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( .2#K%27BKL<P    !,"   +              "  18'
M 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .2#K%2JPH =4 0  .XC   /
M          "  ?\' 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #D@ZQ4
M#Y142-H!  !9(   &@              @ %\# $ >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #D@ZQ4(5VG)LT!   D(   $P
M        @ &.#@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     /@ ^ .D0
(  ",$ $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>69</ContextCount>
  <ElementCount>261</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>24</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Stockholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Stockholders??? Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Consolidated Statements of Stockholders??? Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Statement - Consolidated Statements of Cash Flows (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals</Role>
      <ShortName>Consolidated Statements of Cash Flows (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Capital Structure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CapitalStructure</Role>
      <ShortName>Capital Structure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Stock-Based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/StockBasedCompensationExpense</Role>
      <ShortName>Stock-Based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Retirement Savings Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RetirementSavingsPlan</Role>
      <ShortName>Retirement Savings Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RisksandUncertainties</Role>
      <ShortName>Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/BalanceSheetComponents</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/IntangibleAssetsNet</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Capital Structure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CapitalStructureTables</Role>
      <ShortName>Capital Structure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/CapitalStructure</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Stock-Based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/StockBasedCompensationExpenseTables</Role>
      <ShortName>Stock-Based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/StockBasedCompensationExpense</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/DescriptionofBusinessDetails</Role>
      <ShortName>Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/DescriptionofBusiness</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Balance Sheet Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/BalanceSheetComponentsDetails</Role>
      <ShortName>Balance Sheet Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Balance Sheet Components (Details) - Schedule of property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofpropertyandequipmentTable</Role>
      <ShortName>Balance Sheet Components (Details) - Schedule of property and equipment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Balance Sheet Components (Details) - Schedule of accrued expenses and other current liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable</Role>
      <ShortName>Balance Sheet Components (Details) - Schedule of accrued expenses and other current liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/Leases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure -  Intangible Assets, Net (Details) - Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable</Role>
      <ShortName>Intangible Assets, Net (Details) - Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure -  Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable</Role>
      <ShortName>Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/Debt</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Capital Structure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CapitalStructureDetails</Role>
      <ShortName>Capital Structure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/CapitalStructureTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Capital Structure (Details) - Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable</Role>
      <ShortName>Capital Structure (Details) - Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/CapitalStructureTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Capital Structure (Details) - Schedule of fair value of the warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable</Role>
      <ShortName>Capital Structure (Details) - Schedule of fair value of the warrants</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/CapitalStructureTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of basic and diluted loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of basic and diluted loss per share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of calculation of diluted shares outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of calculation of diluted shares outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/StockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/StockBasedCompensationExpenseTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Stock-Based Compensation Expense (Details) - Schedule of stock option</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofstockoptionTable</Role>
      <ShortName>Stock-Based Compensation Expense (Details) - Schedule of stock option</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/StockBasedCompensationExpenseTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Stock-Based Compensation Expense (Details) - Schedule of weighted average fair value of each grant estimated on grant date</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable</Role>
      <ShortName>Stock-Based Compensation Expense (Details) - Schedule of weighted average fair value of each grant estimated on grant date</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/StockBasedCompensationExpenseTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IncomeTaxesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Income Taxes (Details) - Schedule of federal statutory income tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of federal statutory income tax</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IncomeTaxesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of deferred tax assets and liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IncomeTaxesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ea159355-s1_cyngninc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/SubsequentEvents</ParentRole>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1" original="ea159355-s1_cyngninc.htm">ea159355-s1_cyngninc.htm</File>
    <File>cyngn-20211231.xsd</File>
    <File>cyngn-20211231_cal.xml</File>
    <File>cyngn-20211231_def.xml</File>
    <File>cyngn-20211231_lab.xml</File>
    <File>cyngn-20211231_pre.xml</File>
    <File>ea159355ex-fee_cyngninc.htm</File>
    <File>ea159355ex23-1_cyngninc.htm</File>
    <File>ea159355ex5-1_cyngninc.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img_001.jpg</File>
    <File>img_002.jpg</File>
    <File>img_003.jpg</File>
    <File>img_004.jpg</File>
    <File>img_005.jpg</File>
    <File>img_006.jpg</File>
    <File>img_007.jpg</File>
    <File>img_008.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="455">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>80
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea159355-s1_cyngninc.htm": {
   "axisCustom": 0,
   "axisStandard": 9,
   "contextCount": 69,
   "dts": {
    "calculationLink": {
     "local": [
      "cyngn-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cyngn-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea159355-s1_cyngninc.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cyngn-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyngn-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cyngn-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 373,
   "entityCount": 1,
   "hidden": {
    "http://cyngn.com/20211231": 3,
    "http://fasb.org/us-gaap/2022": 67,
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 72
   },
   "keyCustom": 45,
   "keyStandard": 216,
   "memberCustom": 5,
   "memberStandard": 19,
   "nsprefix": "cyngn",
   "nsuri": "http://cyngn.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://cyngn.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cyngn:BalanceSheetComponentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Balance Sheet Components",
     "role": "http://cyngn.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cyngn:BalanceSheetComponentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Leases",
     "role": "http://cyngn.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Intangible Assets, Net",
     "role": "http://cyngn.com/role/IntangibleAssetsNet",
     "shortName": "Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Debt",
     "role": "http://cyngn.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Capital Structure",
     "role": "http://cyngn.com/role/CapitalStructure",
     "shortName": "Capital Structure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Net Loss Per Share Attributable to Common Stockholders",
     "role": "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Stock-Based Compensation Expense",
     "role": "http://cyngn.com/role/StockBasedCompensationExpense",
     "shortName": "Stock-Based Compensation Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cyngn:RetirementSavingsPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Retirement Savings Plan",
     "role": "http://cyngn.com/role/RetirementSavingsPlan",
     "shortName": "Retirement Savings Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cyngn:RetirementSavingsPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Income Taxes",
     "role": "http://cyngn.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Consolidated Balance Sheets",
     "role": "http://cyngn.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Commitments and Contingencies",
     "role": "http://cyngn.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Risks and Uncertainties",
     "role": "http://cyngn.com/role/RisksandUncertainties",
     "shortName": "Risks and Uncertainties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Subsequent Events",
     "role": "http://cyngn.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://cyngn.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://cyngn.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Intangible Assets, Net (Tables)",
     "role": "http://cyngn.com/role/IntangibleAssetsNetTables",
     "shortName": "Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Capital Structure (Tables)",
     "role": "http://cyngn.com/role/CapitalStructureTables",
     "shortName": "Capital Structure (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "role": "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Stock-Based Compensation Expense (Tables)",
     "role": "http://cyngn.com/role/StockBasedCompensationExpenseTables",
     "shortName": "Stock-Based Compensation Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "role": "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c4",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Income Taxes (Tables)",
     "role": "http://cyngn.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Description of Business (Details)",
     "role": "http://cyngn.com/role/DescriptionofBusinessDetails",
     "shortName": "Description of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c38",
      "decimals": "0",
      "lang": null,
      "name": "cyngn:PurchaseAnAdditionalSharesOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "cyngn:UnrestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedInvestmentsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts",
     "role": "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedInvestmentsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cyngn:ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c44",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life",
     "role": "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cyngn:ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c44",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Balance Sheet Components (Details)",
     "role": "http://cyngn.com/role/BalanceSheetComponentsDetails",
     "shortName": "Balance Sheet Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:Automobiles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Balance Sheet Components (Details) - Schedule of property and equipment",
     "role": "http://cyngn.com/role/ScheduleofpropertyandequipmentTable",
     "shortName": "Balance Sheet Components (Details) - Schedule of property and equipment",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:Automobiles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:CreditCardPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Balance Sheet Components (Details) - Schedule of accrued expenses and other current liabilities",
     "role": "http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable",
     "shortName": "Balance Sheet Components (Details) - Schedule of accrued expenses and other current liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:CreditCardPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Leases (Details)",
     "role": "http://cyngn.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AdjustmentForAmortization",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Intangible Assets, Net (Details)",
     "role": "http://cyngn.com/role/IntangibleAssetsNetDetails",
     "shortName": "Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AdjustmentForAmortization",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Consolidated Statements of Operations",
     "role": "http://cyngn.com/role/ConsolidatedIncomeStatement",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure -  Intangible Assets, Net (Details) - Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets",
     "role": "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable",
     "shortName": "Intangible Assets, Net (Details) - Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c53",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure -  Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets",
     "role": "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable",
     "shortName": "Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c53",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c54",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Debt (Details)",
     "role": "http://cyngn.com/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c54",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:CommonStockShareAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Capital Structure (Details)",
     "role": "http://cyngn.com/role/CapitalStructureDetails",
     "shortName": "Capital Structure (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:CommonStockShareAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - Capital Structure (Details) - Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences",
     "role": "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable",
     "shortName": "Capital Structure (Details) - Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c63",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Capital Structure (Details) - Schedule of fair value of the warrants",
     "role": "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable",
     "shortName": "Capital Structure (Details) - Schedule of fair value of the warrants",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c63",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of basic and diluted loss per share",
     "role": "http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of basic and diluted loss per share",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cyngn:ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of calculation of diluted shares outstanding",
     "role": "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of calculation of diluted shares outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cyngn:ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:CommonStockSharesIssurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure - Stock-Based Compensation Expense (Details)",
     "role": "http://cyngn.com/role/StockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cyngn:CommonStockSharesIssurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - Stock-Based Compensation Expense (Details) - Schedule of stock option",
     "role": "http://cyngn.com/role/ScheduleofstockoptionTable",
     "shortName": "Stock-Based Compensation Expense (Details) - Schedule of stock option",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c10",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Consolidated Statements of Stockholders\u2019 Equity",
     "role": "http://cyngn.com/role/ShareholdersEquityType2or3",
     "shortName": "Consolidated Statements of Stockholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c10",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - Stock-Based Compensation Expense (Details) - Schedule of weighted average fair value of each grant estimated on grant date",
     "role": "http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable",
     "shortName": "Stock-Based Compensation Expense (Details) - Schedule of weighted average fair value of each grant estimated on grant date",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - Income Taxes (Details)",
     "role": "http://cyngn.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - Income Taxes (Details) - Schedule of federal statutory income tax",
     "role": "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable",
     "shortName": "Income Taxes (Details) - Schedule of federal statutory income tax",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities",
     "role": "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable",
     "shortName": "Income Taxes (Details) - Schedule of deferred tax assets and liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c68",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "053 - Disclosure - Subsequent Events (Details)",
     "role": "http://cyngn.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c68",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Consolidated Statements of Stockholders\u2019 Equity (Parentheticals)",
     "role": "http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals",
     "shortName": "Consolidated Statements of Stockholders\u2019 Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://cyngn.com/role/ConsolidatedCashFlow",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "-9",
      "first": true,
      "lang": null,
      "name": "cyngn:PPPLoanWasForgivenByTheSBAInTheAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "007 - Statement - Consolidated Statements of Cash Flows (Parentheticals)",
     "role": "http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals",
     "shortName": "Consolidated Statements of Cash Flows (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": "-9",
      "first": true,
      "lang": null,
      "name": "cyngn:PPPLoanWasForgivenByTheSBAInTheAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Description of Business",
     "role": "http://cyngn.com/role/DescriptionofBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea159355-s1_cyngninc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 24,
   "tag": {
    "cyngn_AmortizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AmortizationMember",
        "terseLabel": "Amortization [Member]"
       }
      }
     },
     "localname": "AmortizationMember",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cyngn_Automobiles": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Automobiles",
        "terseLabel": "Automobiles"
       }
      }
     },
     "localname": "Automobiles",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_BalanceSheetComponentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Components [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetComponentsAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_BalanceSheetComponentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BalanceSheetComponentsTextBlock",
        "terseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "BalanceSheetComponentsTextBlock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cyngn_CYNMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CYNMember",
        "terseLabel": "\u201cCYN\u201d [Member]"
       }
      }
     },
     "localname": "CYNMember",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cyngn_CapitalStructureDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure (Details) [Line Items]"
       }
      }
     },
     "localname": "CapitalStructureDetailsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure (Details) - Schedule of fair value of the warrants [Line Items]"
       }
      }
     },
     "localname": "CapitalStructureDetailsScheduleoffairvalueofthewarrantsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure (Details) - Schedule of fair value of the warrants [Table]"
       }
      }
     },
     "localname": "CapitalStructureDetailsScheduleoffairvalueofthewarrantsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_CapitalStructureDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure (Details) [Table]"
       }
      }
     },
     "localname": "CapitalStructureDetailsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_CommonStockShareAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockShareAuthorized",
        "terseLabel": "Preferred stock, shares authorized (in Shares)"
       }
      }
     },
     "localname": "CommonStockShareAuthorized",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_CommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commo stock shares authorized.",
        "label": "CommonStockShares",
        "terseLabel": "Common stock shares (in Shares)"
       }
      }
     },
     "localname": "CommonStockShares",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_CommonStockSharesIssurance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockSharesIssurance",
        "terseLabel": "Common stock issurance (in Shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssurance",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockWarrantsMember",
        "terseLabel": "Common Stock Warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "cyngn_ConcentrationOfSupplierRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ConcentrationOfSupplierRiskPolicyTextBlock",
        "terseLabel": "Concentration of Supplier Risk"
       }
      }
     },
     "localname": "ConcentrationOfSupplierRiskPolicyTextBlock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cyngn_ConvertiblePreferredStockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ConvertiblePreferredStockPolicyTextBlock",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockPolicyTextBlock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cyngn_CreditCardPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CreditCardPayable",
        "terseLabel": "Credit card payable"
       }
      }
     },
     "localname": "CreditCardPayable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_DeferredTaxAssetNetCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Net Current.",
        "label": "DeferredTaxAssetNetCurrent",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetNetCurrent",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_DeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeferredTaxAssetsAbstract",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_DeferredTaxAssetsSBC": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of SBC.",
        "label": "DeferredTaxAssetsSBC",
        "terseLabel": "SBC"
       }
      }
     },
     "localname": "DeferredTaxAssetsSBC",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_DeferredTaxAssetsTrueup": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of true-up.",
        "label": "DeferredTaxAssetsTrueup",
        "terseLabel": "True-up and Rate Change"
       }
      }
     },
     "localname": "DeferredTaxAssetsTrueup",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_DescriptionofBusinessDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business (Details) [Line Items]"
       }
      }
     },
     "localname": "DescriptionofBusinessDetailsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_DescriptionofBusinessDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business (Details) [Table]"
       }
      }
     },
     "localname": "DescriptionofBusinessDetailsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_EarningsPerShareTotal": {
     "auth_ref": [],
     "calculation": {
      "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "EarningsPerShareTotal",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EarningsPerShareTotal",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_FairValueOfOptionsGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FairValueOfOptionsGranted",
        "terseLabel": "Fair value of options granted"
       }
      }
     },
     "localname": "FairValueOfOptionsGranted",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_FederalStatutoryIncomeTaxRateTotal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of federal statutory income tax rate.",
        "label": "FederalStatutoryIncomeTaxRateTotal",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FederalStatutoryIncomeTaxRateTotal",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_GainOnForgivenessOfPaycheckProtectionProgramLoans": {
     "auth_ref": [],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on forgiveness of Paycheck Protection Program loans.",
        "label": "GainOnForgivenessOfPaycheckProtectionProgramLoans",
        "negatedLabel": "Gain on forgiveness of Paycheck Protection Program Notes"
       }
      }
     },
     "localname": "GainOnForgivenessOfPaycheckProtectionProgramLoans",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_IncomeTaxesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesDetailsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_IncomeTaxesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) [Table]"
       }
      }
     },
     "localname": "IncomeTaxesDetailsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Details) - Schedule of estimated amortization expense for all intangible assets [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsNetDetailsScheduleofestimatedamortizationexpenseforallintangibleassetsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_LeasesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Line Items]"
       }
      }
     },
     "localname": "LeasesDetailsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_LeasesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Table]"
       }
      }
     },
     "localname": "LeasesDetailsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_LiquidityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LiquidityMember",
        "terseLabel": "Liquidity [Member]"
       }
      }
     },
     "localname": "LiquidityMember",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cyngn_LossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LossPerShareAbstract",
        "terseLabel": "Loss per share:"
       }
      }
     },
     "localname": "LossPerShareAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_MaturityDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument maturity date.",
        "label": "MaturityDate",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "MaturityDate",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DebtDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cyngn_NetOperatingLosses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating losses.",
        "label": "NetOperatingLosses",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "NetOperatingLosses",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cyngn_NetProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt originations.",
        "label": "NetProceeds",
        "terseLabel": "Net proceeds"
       }
      }
     },
     "localname": "NetProceeds",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_PPPLoanForgiveness": {
     "auth_ref": [],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PPP Loan forgiveness.",
        "label": "PPPLoanForgiveness",
        "terseLabel": "Paycheck Protection Program Note forgiveness"
       }
      }
     },
     "localname": "PPPLoanForgiveness",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_PPPLoanWasForgivenByTheSBAInTheAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PPP loan was forgiven by the SBA in the amount.",
        "label": "PPPLoanWasForgivenByTheSBAInTheAmount",
        "terseLabel": "Paycheck protection program note was forgiven by the SBA in the amount"
       }
      }
     },
     "localname": "PPPLoanWasForgivenByTheSBAInTheAmount",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_PreferredStockShareIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PreferredStockShareIssued",
        "terseLabel": "Preferred stock shares (in Shares)"
       }
      }
     },
     "localname": "PreferredStockShareIssued",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_PropertyAndEquipmentUsefulLifeLeaseholdImprovements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of leasehold improvements.",
        "label": "PropertyAndEquipmentUsefulLifeLeaseholdImprovements",
        "terseLabel": "Property and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyAndEquipmentUsefulLifeLeaseholdImprovements",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_PurchaseAnAdditionalSharesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase An Additional Shares of Common Stock.",
        "label": "PurchaseAnAdditionalSharesOfCommonStock",
        "terseLabel": "Additional shares of common stock (in Shares)"
       }
      }
     },
     "localname": "PurchaseAnAdditionalSharesOfCommonStock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_PurchaseWarrantsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase warrants , description.",
        "label": "PurchaseWarrantsDescription",
        "terseLabel": "Purchase warrants , description"
       }
      }
     },
     "localname": "PurchaseWarrantsDescription",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_PurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchaseWarrantsMember",
        "terseLabel": "Purchase Warrants [Member]"
       }
      }
     },
     "localname": "PurchaseWarrantsMember",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cyngn_RedeemableWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable warrants.",
        "label": "RedeemableWarrants",
        "terseLabel": "Redeemable warrants (in Shares)"
       }
      }
     },
     "localname": "RedeemableWarrants",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_RentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "RentExpense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "RentExpense",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_RetirementSavingsPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Savings Plan [Abstract]"
       }
      }
     },
     "localname": "RetirementSavingsPlanAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_RetirementSavingsPlanTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RetirementSavingsPlanTextBlock",
        "terseLabel": "Retirement Savings Plan"
       }
      }
     },
     "localname": "RetirementSavingsPlanTextBlock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/RetirementSavingsPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cyngn_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accrued expenses and other current liabilities [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfAuthorizedIssuedAndOutstandingSharesOfTheConvertiblePreferredStockAndLiquidationPreferencesAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfBasicAndDilutedLossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of basic and diluted loss per share [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfBasicAndDilutedLossPerShareAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of calculation of diluted shares outstanding [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfCalculationOfDilutedSharesOutstandingAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock",
        "terseLabel": "Schedule of calculation of diluted shares outstanding"
       }
      }
     },
     "localname": "ScheduleOfCalculationOfDilutedSharesOutstandingTableTextBlock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cyngn_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of deferred tax assets and liabilities [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated amortization expense for all intangible assets [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfEstimatedAmortizationExpenseForAllIntangibleAssetsAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfFairValueOfTheWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of the warrants [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfTheWarrantsAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfFederalStatutoryIncomeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of federal statutory income tax [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFederalStatutoryIncomeTaxAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationOfSeparatelyIdentifiableIntangibleAssetsAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfPropertyAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property and equipment [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfPropertyAndEquipmentAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property and equipment estimated useful life [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock",
        "terseLabel": "Schedule of property and equipment estimated useful life"
       }
      }
     },
     "localname": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTableTextBlock",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cyngn_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToAmountsAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfStockOptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfStockOptionAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average fair value of each grant estimated on grant date [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageFairValueOfEachGrantEstimatedOnGrantDateAbstract",
     "nsuri": "http://cyngn.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cyngn_SeriesASharesIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A shares issued and outstanding.",
        "label": "SeriesASharesIssuedAndOutstanding",
        "terseLabel": "Shares Issued and Outstanding"
       }
      }
     },
     "localname": "SeriesASharesIssuedAndOutstanding",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value, outstanding at balance.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding",
        "periodEndLabel": "Aggregate intrinsic value, outstanding at ending balance (in Dollars)",
        "periodStartLabel": "Aggregate intrinsic value, outstanding at beginning balance (in Dollars)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberAggregateIntrinsicValueOutstanding",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, cancelled/forfeited.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited",
        "terseLabel": "Weighted-average exercise price, cancelled/forfeited (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceCancelledforfeited",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average remaining contractual, vested and exercisable.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt",
        "terseLabel": "Weighted-average remaining contractual, vested and exercisable at ending balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExercisableAt",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "cyngn_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average remaining contractual, vested and expected to vest at (in Shares)",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares",
        "terseLabel": "Weighted-average remaining contractual, vested and expected to vest at ending balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedaverageRemainingContractualVestedAndExpectedToVestAtinShares",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "cyngn_ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, vested and expected to vest.",
        "label": "ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest",
        "periodEndLabel": "Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share)",
        "periodStartLabel": "Weighted-average exercise price, vested and expected to vest at beginning balance (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationsArrangementByShareBasedPaymentAwardWeightedaverageExercisePriceVestedAndExpectedToVest",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cyngn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average remaining contractual, outstanding at ending balance.",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm",
        "terseLabel": "Weighted-average remaining contractual, outstanding at ending balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "cyngn_StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, exercised.",
        "label": "StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised",
        "terseLabel": "Weighted-average exercise price, exercised (in Dollars per share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockWeightedaverageExercisePriceExercised",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cyngn_StockOptionsExpectedVest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock options that are expected to vest.",
        "label": "StockOptionsExpectedVest",
        "terseLabel": "Stock options expected vest"
       }
      }
     },
     "localname": "StockOptionsExpectedVest",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_StockbasedCompensationExpenseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock-based compensation expense from stock options.",
        "label": "StockbasedCompensationExpenseOfStockOptions",
        "terseLabel": "Stock-based compensation expense of stock options"
       }
      }
     },
     "localname": "StockbasedCompensationExpenseOfStockOptions",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_StocksIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "StocksIssuedDuringPeriodSharesStockOptionsExercised",
        "negatedLabel": "Number of shares, exercised"
       }
      }
     },
     "localname": "StocksIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_SubsequentEventsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_SubsequentEventsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_SummaryofSignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Line Items]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeLineItems",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful life [Table]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofpropertyandequipmentestimatedusefullifeTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cyngn_TaxPositionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax position term.",
        "label": "TaxPositionTerm",
        "terseLabel": "Tax position term"
       }
      }
     },
     "localname": "TaxPositionTerm",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cyngn_TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company\u2019s PPP loan was forgiven by the SBA in the amount.",
        "label": "TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount",
        "terseLabel": "The Company\u2019s Paycheck Protection Program Note was forgiven by the SBA in the amount of $1,602,936."
       }
      }
     },
     "localname": "TheCompanysPPPLoanWasForgivenByTheSBAInTheAmount",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_TotalUnrecognizedTaxBenefit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total unrecognized tax benefit.",
        "label": "TotalUnrecognizedTaxBenefit",
        "terseLabel": "Total unrecognized tax benefit (in Shares)"
       }
      }
     },
     "localname": "TotalUnrecognizedTaxBenefit",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cyngn_UnrestrictedCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "UnrestrictedCashAndCashEquivalents",
        "terseLabel": "Unrestricted cash and cash equivalents"
       }
      }
     },
     "localname": "UnrestrictedCashAndCashEquivalents",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cyngn_WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, granted.",
        "label": "WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted",
        "terseLabel": "Weighted-average exercise price, granted (in Dollars per share)"
       }
      }
     },
     "localname": "WeightedaverageShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceGranted",
     "nsuri": "http://cyngn.com/20211231",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r25",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities and Other Liabilities",
        "terseLabel": "Total accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Accrued payroll"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofaccruedexpensesandothercurrentliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r8",
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r17",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r243",
      "r244",
      "r245",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r54",
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r185",
      "r210",
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Issuance of warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r10",
      "r70",
      "r126",
      "r135",
      "r141",
      "r150",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r282",
      "r288",
      "r302",
      "r322",
      "r324",
      "r333",
      "r346"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r24",
      "r70",
      "r150",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r282",
      "r288",
      "r302",
      "r322",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AutomobilesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles that are used primarily for transporting people.",
        "label": "Automobiles [Member]",
        "terseLabel": "Automobile [Member]"
       }
      }
     },
     "localname": "AutomobilesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r74",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r6",
      "r56"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r57",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r50",
      "r56",
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r303"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase/(decrease) in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r68",
      "r70",
      "r92",
      "r93",
      "r96",
      "r99",
      "r101",
      "r110",
      "r111",
      "r112",
      "r150",
      "r174",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r302",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r30",
      "r337",
      "r351"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r173",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r75",
      "r76",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in Dollars per share)",
        "verboseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Common stock, shares authorized (in Shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "verboseLabel": "Common stock, shares issued (in Shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "verboseLabel": "Common stock, shares outstanding (in Shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, Par $0.00001; 100,000,000 shares authorized, 26,487,680 shares issued and outstanding as of December 31, 2021 and 42,000,000 shares authorized, 951,794 shares issued and outstanding as of December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r115",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/RisksandUncertainties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Conversion of Stock [Line Items]"
       }
      }
     },
     "localname": "ConversionOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockTable": {
     "auth_ref": [
      "r59",
      "r60",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This table may be used to disclose all the information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction. It may include a description sufficient information to understand the nature and purpose of the conversion, as well as the financial instruments converted from and to (for example, preferred, common, treasury, etc.) the amounts converted, the new shares issued, and the value of the new shares issued, if applicable. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock [Table]"
       }
      }
     },
     "localname": "ConversionOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r205",
      "r206",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r14",
      "r15",
      "r209",
      "r211",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Shares Authorized"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r67",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest accruing"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r186",
      "r198",
      "r199",
      "r312",
      "r313",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Deferred social security taxes",
        "verboseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails",
      "http://cyngn.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r11",
      "r12",
      "r259",
      "r334",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "terseLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "negatedLabel": "Research and development credit"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Net deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating losses and Credit carryover"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal income tax expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State taxes",
        "verboseLabel": "State income tax expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails",
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Federal net operating loss carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Fixed Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r265",
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock Compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Accruals And Others"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Deferred Commissions"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Fixed Assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r54",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r54",
      "r124"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r73",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r218",
      "r219",
      "r238",
      "r239",
      "r240",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-based Compensation Expense"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends declared on common stock, per share"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r41",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r88",
      "r92",
      "r99",
      "r100",
      "r101",
      "r106",
      "r107",
      "r298",
      "r299",
      "r339",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)",
        "verboseLabel": "Basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r41",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r92",
      "r99",
      "r100",
      "r101",
      "r106",
      "r107",
      "r298",
      "r299",
      "r339",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share Attributable to Ordinary Shareholders"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r102",
      "r104",
      "r105",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r71",
      "r253",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r253",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r36",
      "r37",
      "r38",
      "r75",
      "r76",
      "r77",
      "r79",
      "r85",
      "r87",
      "r109",
      "r151",
      "r210",
      "r216",
      "r243",
      "r244",
      "r245",
      "r269",
      "r270",
      "r297",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r321",
      "r356",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Cumulative ownership, percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ExcessStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of excess stock shares permitted to be issued.",
        "label": "Excess Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in Shares)"
       }
      }
     },
     "localname": "ExcessStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r54",
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "terseLabel": "Fair value of common stock (in Dollars)"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "terseLabel": "Fair value of underlying securities (in Dollars)"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r9",
      "r159"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r154",
      "r156",
      "r159",
      "r161",
      "r330",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable",
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r159",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r154",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r159",
      "r330"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "Gain on disposal of asset"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "Initial Public Offering [Member]",
        "verboseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r163",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets and Finite Lived Intangibles"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r71",
      "r254",
      "r257",
      "r264",
      "r271",
      "r274",
      "r276",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationYearUnderExamination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year being audited in the income tax examination, in YYYY format.",
        "label": "Income Tax Examination, Year under Examination",
        "terseLabel": "Expiration term"
       }
      }
     },
     "localname": "IncomeTaxExaminationYearUnderExamination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r72",
      "r86",
      "r87",
      "r125",
      "r252",
      "r272",
      "r275",
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r35",
      "r250",
      "r251",
      "r257",
      "r258",
      "r263",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign Tax Rate Difference"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal tax at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Nondeductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r94",
      "r95",
      "r101"
     ],
     "calculation": {
      "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable": {
       "order": 2.0,
       "parentTag": "cyngn_EarningsPerShareTotal",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Common shares issuable upon conversion of preferred stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r153",
      "r157"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r340"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest (expense) income"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r48",
      "r51",
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the year for taxes"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r22",
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "FIN 48 reserve"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffederalstatutoryincometaxTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentInterestRate": {
     "auth_ref": [
      "r147",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of interest on investment.",
        "label": "Investment Interest Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "InvestmentInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r26",
      "r70",
      "r136",
      "r150",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r283",
      "r288",
      "r289",
      "r302",
      "r322",
      "r323"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r70",
      "r150",
      "r302",
      "r324",
      "r335",
      "r349"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r28",
      "r70",
      "r150",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r283",
      "r288",
      "r289",
      "r302",
      "r322",
      "r323",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Note payable, Paycheck Protection Program"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r52",
      "r55"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "auth_ref": [
      "r50",
      "r52",
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "terseLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r33",
      "r34",
      "r38",
      "r40",
      "r55",
      "r70",
      "r78",
      "r80",
      "r81",
      "r82",
      "r83",
      "r86",
      "r87",
      "r97",
      "r126",
      "r134",
      "r137",
      "r140",
      "r142",
      "r150",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r299",
      "r302",
      "r338",
      "r352"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r33",
      "r34",
      "r38",
      "r86",
      "r87",
      "r286",
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net losses"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r83",
      "r88",
      "r89",
      "r98",
      "r101",
      "r126",
      "r134",
      "r137",
      "r140",
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r126",
      "r134",
      "r137",
      "r140",
      "r142"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r317",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Future minimum payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofestimatedamortizationexpenseforallintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherBorrowings": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.",
        "label": "Other Borrowings",
        "terseLabel": "Company borrowings"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other (expense) income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestrictedAssetsCurrent": {
     "auth_ref": [
      "r23",
      "r377",
      "r378"
     ],
     "calculation": {
      "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable": {
       "order": 2.0,
       "parentTag": "us-gaap_RestrictedCashAndInvestmentsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other.",
        "label": "Other Restricted Assets, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "OtherRestrictedAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalNotesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partners' Capital Notes [Abstract]"
       }
      }
     },
     "localname": "PartnersCapitalNotesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PartnersCapitalNotesDisclosureTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.",
        "label": "Partners' Capital Notes Disclosure [Text Block]",
        "terseLabel": "Capital Structure"
       }
      }
     },
     "localname": "PartnersCapitalNotesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patent [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of cumulative preferred dividends in arrears.",
        "label": "Preferred Stock, Amount of Preferred Dividends in Arrears",
        "terseLabel": "Aggregate Liquidation Amount"
       }
      }
     },
     "localname": "PreferredStockAmountOfPreferredDividendsInArrears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r15",
      "r68",
      "r207",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Per Share Liquidation Preference",
        "verboseLabel": "Preferred stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r68",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Gross Proceeds"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value (in Dollars per share)",
        "verboseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockRedemptionPricePerShare": {
     "auth_ref": [
      "r204",
      "r211",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.",
        "label": "Preferred Stock, Redemption Price Per Share",
        "terseLabel": "Preferred stock, per shares (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred stock, shares authorized",
        "verboseLabel": "Convertible preferred stock, shares authorized (in Shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r15",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Convertible preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Convertible Series A, B and C preferred stock, Par $0.00001; 10,000,000 authorized as of December 31, 2021 and 21,982,491 shares authorized, issued and outstanding as of December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod": {
     "auth_ref": [
      "r155",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of present value of future profits of insurance contract acquired in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Present Value of Future Insurance Profits, Weighted Average Amortization Period",
        "terseLabel": "weighted-average period"
       }
      }
     },
     "localname": "PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance of common stock upon initial public offering, net of offering costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from Paycheck Protection Program Notes"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfAssetsInvestingActivities": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.",
        "label": "Proceeds from Sales of Assets, Investing Activities",
        "terseLabel": "Disposal of assets"
       }
      }
     },
     "localname": "ProceedsFromSalesOfAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r46",
      "r242"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r33",
      "r34",
      "r38",
      "r49",
      "r70",
      "r78",
      "r86",
      "r87",
      "r126",
      "r134",
      "r137",
      "r140",
      "r142",
      "r150",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r281",
      "r285",
      "r287",
      "r290",
      "r291",
      "r299",
      "r302",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r7",
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r167",
      "r324",
      "r342",
      "r350"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "verboseLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofpropertyandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Other, Gross",
        "terseLabel": "Computer and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r167",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofpropertyandequipmentestimatedusefullifeTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r249",
      "r328",
      "r383"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r6",
      "r62",
      "r332",
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "auth_ref": [
      "r24",
      "r377",
      "r378"
     ],
     "calculation": {
      "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Current",
        "totalLabel": "Total Cash and cash equivalents and Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r6",
      "r62"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestmentsCurrent": {
     "auth_ref": [
      "r377",
      "r378"
     ],
     "calculation": {
      "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable": {
       "order": 1.0,
       "parentTag": "us-gaap_RestrictedCashAndInvestmentsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the current portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.",
        "label": "Restricted Investments, Current",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "RestrictedInvestmentsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofreconciliationofcashandcashequivalentsandrestrictedcashtoamountsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r216",
      "r324",
      "r348",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAppropriated": {
     "auth_ref": [
      "r32",
      "r69",
      "r202",
      "r203",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies.",
        "label": "Retained Earnings, Appropriated",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAppropriated",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r75",
      "r76",
      "r77",
      "r79",
      "r85",
      "r87",
      "r151",
      "r243",
      "r244",
      "r245",
      "r269",
      "r270",
      "r297",
      "r356",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r65",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r39",
      "r70",
      "r122",
      "r123",
      "r133",
      "r138",
      "r139",
      "r143",
      "r144",
      "r145",
      "r150",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r302",
      "r341"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Common stock shares (in Shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Offering price per share (in Dollars per share)",
        "verboseLabel": "Original issuance price, per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfConversionsOfStockTextBlock": {
     "auth_ref": [
      "r59",
      "r60",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.",
        "label": "Schedule of Conversions of Stock [Table Text Block]",
        "terseLabel": "Schedule of authorized, issued and outstanding shares of the convertible preferred stock and liquidation preferences"
       }
      }
     },
     "localname": "ScheduleOfConversionsOfStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted loss per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of federal statutory income tax"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r154",
      "r158",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r154",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of gross carrying amount and accumulated amortization of separately identifiable intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r62",
      "r332",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of cash and cash equivalents and restricted cash to amounts"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of fair value of the warrants"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of weighted average fair value of each grant estimated on grant date"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of estimated amortization expense for all intangible assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General, and Administrative Expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r13",
      "r15",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "netLabel": "Series A Preferred Stock [Member]",
        "terseLabel": "Convertible Series A Preferred Stock",
        "verboseLabel": "Series A [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [
      "r13",
      "r15",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Convertible Series B Preferred Stock",
        "verboseLabel": "Series B [Member]"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [
      "r13",
      "r15",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Convertible Series C Preferred Stock",
        "verboseLabel": "Series C [Member]"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable",
      "http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate",
        "verboseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable",
      "http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Number of shares, cancelled/forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of shares, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of shares, outstanding at ending balance",
        "periodStartLabel": "Number of shares, outstanding at beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-average exercise price, outstanding at ending balance (in Dollars per share)",
        "periodStartLabel": "Weighted-average exercise price, outstanding at beginning balance (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "periodEndLabel": "Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars)",
        "periodStartLabel": "Aggregate intrinsic value, vested and expected to vest at beginning balance (in Dollars)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "periodEndLabel": "Number of shares, vested and exercisable at ending balance",
        "periodStartLabel": "Number of shares, vested and exercisable at beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-average exercise price, Vested and exercisable at ending balance (in Dollars per share)",
        "periodStartLabel": "Weighted-average exercise price, Vested and exercisable at beginning balance (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "periodEndLabel": "Number of shares,vested and expected to vest at ending balance",
        "periodStartLabel": "Number of shares, vested and expected to vest at beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r220",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r246",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term",
        "verboseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable",
      "http://cyngn.com/role/ScheduleofweightedaveragefairvalueofeachgrantestimatedongrantdateTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars)",
        "periodStartLabel": "Aggregate intrinsic value, vested and exercisable at beginning balance (in Dollars)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual, vested and exercisable at beginning balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual, outstanding at beginning balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual, vested and expected to vest at beginning balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r63",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r68",
      "r70",
      "r92",
      "r93",
      "r96",
      "r99",
      "r101",
      "r110",
      "r111",
      "r112",
      "r150",
      "r174",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r302",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ScheduleofauthorizedissuedandoutstandingsharesoftheconvertiblepreferredstockandliquidationpreferencesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r31",
      "r36",
      "r37",
      "r38",
      "r75",
      "r76",
      "r77",
      "r79",
      "r85",
      "r87",
      "r109",
      "r151",
      "r210",
      "r216",
      "r243",
      "r244",
      "r245",
      "r269",
      "r270",
      "r297",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r321",
      "r356",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r109",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r15",
      "r16",
      "r210",
      "r211",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of convertible preferred stock to common stock in connection with initial public offering (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110 (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r210",
      "r216",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in Shares)",
        "verboseLabel": "Aggregate intrinsic value, exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofstockoptionTable",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r31",
      "r210",
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Conversion of convertible preferred stock to common stock in connection with initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r210",
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Iinitial public offering, net of closing costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Issuance of common stock in connection with initial public offering, net of closing costs of $2,954,110"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r15",
      "r16",
      "r216",
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r210",
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r19",
      "r20",
      "r70",
      "r146",
      "r150",
      "r302",
      "r324"
     ],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventDescription": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.",
        "label": "Subsequent Event, Description",
        "terseLabel": "Subsequent events, description"
       }
      }
     },
     "localname": "SubsequentEventDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r310",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r310",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r310",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademark [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofgrosscarryingamountandaccumulatedamortizationofseparatelyidentifiableintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r113",
      "r114",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Increase",
        "terseLabel": "Initial exercise price per share (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleoffairvalueofthewarrantsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Common stock warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r91",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Basic and diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofbasicanddilutedlosspershareTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable": {
       "order": 1.0,
       "parentTag": "cyngn_EarningsPerShareTotal",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Unvested restricted shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://cyngn.com/role/ScheduleofcalculationofdilutedsharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21332-112643"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21346-112643"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21564-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(30)(a)(3)(ii))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(23)(a)(4)(i))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "805",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6918812&loc=d3e30762-158568"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r384": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r385": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r386": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001213900-22-025976-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-025976-xbrl.zip
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M''LW#4:M,B"RS<6/U,#1H-'WK^2H;[;B\* [NDP]H] =B==0@X,3?TZ7CR?
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MDT*26/> /-T3W)+<_OIY[+/JFP4:H^<2=;UC5W&G5>6G$D/NCE].+)ELFY^
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M,EN6W\6Q_Q2$[.K>_4'! UEZM+N4J? &AYH#*A2=3@0CV/="KW*9#B0XDZ>
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MY^XEQH=#'3BH$M,@&L%H73D<4"=7B?=TWVE*"H+=V27N*SM)3MIR4T9FT@U
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MO /)2*\,E0QCEOG9/JK>7::"(?K.U5$5=OV"4I$$7JX-<'('J5PI7RX0>+E
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M77YC#Z$UN0 1!7S(0%V2RR[;*B+A:.4,''5BK<HY^.\IR!,:5RYS[!: 0XT
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MBE?38FB@<G%E413^9VR3ITOY-M\;&%BKD(L#A8K0T5U1V&*I>FWJ=1">)I3
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M&JB8%NJ<TB<S76?C@KU-V_%3B$6_95#M\WU9"ODTIPLEC8U;W/5F&0>>8CL
MTMCY#G9,;F67C2?%XC)Y'MT\QG^G7C+WQ6O\^L[CBD>#J);.WR/G.=HRVT(\
M.^28$*9JOB"328HKI#4$*U6@31C5<OJ'3T2+RGAN)ZMMHCC0IV=,!%!EM08
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M>D.9WW;#!B\B,"8KSA]VI9,@ XB&\X%NBJP?D1C4%RR<<VH$>XVR'CL4L?/
M7.?[O9<\QSMM);53FGE!F%[[]W2;AS3>'0J@O&A+2WAH43EFFZ=TEX=AL*,W
M$'1IZ-5Q 8FC4](90DI? U^9'[OUVJT7NV)U\EFQ_N?D!2EA@'&'9NIP!0>I
M "$"$@*@D']P8! =7 ZEN-&DV1%_K;SJRP+W/HCH>4;WQLWK'4$S>_P0UNZN
M4%K+#@> "(<([;Z'(MBNMGN;X?8VI,A_YF90G?TL\H*_]7Z($WZM^>#ME[$G
MQZ[N9+]: J?RG/%97G03S(L<]"/"IR+BV@N3K<7ZM!2,5@48"P+:AJ@6^X?7
MFE$M*K$NISOHS!=V*KSF<*E.C(;JU\MPSYQ#<>J-%H"6?V\<M2R%5#.WPD!:
M4L&VK* 5Z-0A$V9("!46Q[I4I]1>&$V<\<>],$FZLWZ@6<_^J&P-;P_!W3_S
MM-6BH^TN3CQ(@BEG\51J56G8+PF!&\?3XG@H R![I@,DKZJL]=HL;ZY>MB8F
M;'UHFDUJ"(BG4.881KL#0:T-]:5Y:5TC91G QM[%EX9B[F@LUYMVZ-QRMG'Q
M#T"G8KOT!I8<N?912ZDH0PR/@TO<0A2+.+UQR&'0QB6E9=%I\=;;/WG0 I)4
M_.K'(4D1MKP@]&9<ZEJ@6<CA94 -Q1BID:N]-4B.UM@?0-[6Q#_Q#D'FA==9
MDOM9GM">(MQY0?( 97GC779/'XO([#$V_*0EW)WV4\!4%ACG4Y)J3N4I#G,3
M/CG\BTU/'JOP?50U-Y^4-)(ZIE)Z].$Z:=VQ!O#D99R^(D^%=E'11]?5\PK.
MY"W0T_EV15?+#M<0X7'"C-R[."DLW&721(<7=*'FS<%1WLS*@>E:7EW,>=DN
MT6I$@0EE:*X]<(YS.P4>;"YVC:Y@B[P,&BSH4L:&P5$]HWA"*ZXGG-6<E:T7
M$C,"6(C8E@;_>AME0?8\*$@I];^XBQ]>LB%"AM@/M>CT)G)PE>FNJ8I=Y9_(
ME(Q# 5 1&M@LQ</2+&NT#(YWQWG*SKBTC',8<\\8GL=A^,X@, K.-\:!&BA'
M-JPGS-?3D0RK[1TS<MA>8G6SC[7>S>9RH"I&@&,O2S(#>U7RI+&AS4GC('1Y
ML4ADUVZ0\<#-&4+8=W:L.P!PCM#=R7Z-4:N-U8>6DZ\W$GY(:]K)K=13L6[9
MU:C6"02U#<AK%P!8+"-)O8[;/"0E'*;E'6"$U NQ@CH/^H0C/>J6A5YXRRV+
MLU@RT.$MH;^ZMA>:]J!$4#=JJC=*O\A1M#7U6].-/<L4@YT9\_+UC5DN]X8C
MLUUSBFC0M=OE"J_Y#(^1SG>^#@Z+)Q7T##D3U@P^?TQ7#XJ)QRJ*P6F<J8PA
M2&QD1:%'5B,T&I5B1 [;_A!5Y[I-GMW'B8F'>5(WPNXR;A_!Y$ ,-B(DU0!D
M][0IUZ2]"6583XB[+6:ULD!5HQT>1@H0#)I2KND(&F!#,_Y3C:Y]JD1WSK%G
MCFX&9\>-!HB1TK":0\: ,SK1F,>3W+KQVOF,-5,X34M7PV'HNEB5TC!A3=,O
M-H"]K?I03#S>63LPC3-%,@2)C:RL1J68<FM0<)3*91;N;&,_AR ?'M<COUW$
M^WT<\2@-WN8O515\YQ^2E >EI/Q+X@D3ZF>Z_0(W-K6+@^36($=S=K4Y3/#3
MHOXHF*"0-?*!9B<Y^T64J2A?CA"VMTC=@7R@8M@7N#M!C8_LO5:/^\RZ:3PS
MTNOC$Q4;;NXI)%CE3#'!P]#QR<H(#[ /D[S&</[7#@MZWR0YS0]F)&<W?OHB
M/WR!&O<BA=^ [$U$%W@9'29]48\7ZI+FS 9YKNS<*R^C-W'FA69<V!5U?=-R
M(A((^S]CVBEA<^&>!<-H]IEE2AKWI_,[+X@NHC,V+&!& X5RH9?>LW]/_1\O
MDSBC/)B2_727>/OWL1<I3V^8B,01)(.64P$SR\E(/1LIIB,AS/<%9AS&:.S[
MK+4DH'M.?\MDCWNCF,BI#8';C.VVE"E"7DAK7XPA6_1MUP2_SX4^<@B&%S,V
M+@X46J]&=]# 6VWJ@G$5EY^R?0#??H%W0>T#WJ>P"CF4HX8!P[:43^E626(X
M4WPOO6?BO OC1P+X$F^[Y6W[V.ER&R=)_ C]QX](1/G!PS\_>,$66JQG]T&R
M9?]*,HC"8;J-43$J%-ACD-V3+>P5=CFY"R(.**XF:U!$RKLVN9R;P9>7EZ#\
M&FI2Q3?V)8%/FP<)XM;H ]XGKPHYE*U1 /.]EY;P'#^SO7!]O#F/V'\WW,S2
M$1].9?+HI14#R.TS3YEC4\ ^R"IC#9\M>BR5G#(A#L+Y459);A9(_LBK*[Z'
MZHH0Z7 ?A]OS_2&)'T0C1Q4C-Y4U'9;#2- 8A\FZ\5A*&&E+*O>:K^@WMHDV
MU>$C'$07NX;/2+DCRU9KFXC4$Q Q _!7S"%RN3 OKH9X2E@YAD#NS>9NO[A&
M1L @SZHDXR-F+53#,/>>&ADU8Y28(ZC(*W:1IGMX"BFA4C&A_K)B [([K0][
MG^8J_%!,B2MX2A#EB(;/F8077BXJ0@61GW.',I2&XB?0MB@)=01_"_,MW'MN
M\XQ$<4;"8!] <:DL/B*[/(D"'DS4*NE\Q,P.CUU-4SY@&R3,$@^?F?G-IJO^
MQ5:(_8#7J>(6.E@J>R_*=QZ/XSDB*4]\38B?4*_,6/*@B/0V]\&6KWYDM*"H
MYGR#]#(AZ?#%^:%V31-V*]H(-7V>ICG=LI/X(L_2C+&-\58E+V(@V90// $?
MRWD=UZ-Q/0V#R$F>WLSH@;*+.5#'L 6ATPL3&O[I!K3+';>,CI_K3RZ]9_C5
MAJG,[057]6D#BP\YY.UO[NX2>L>VV7F4)4&4!OYW4$2B@^UKF;8H1T*I.#%4
M5.4X:G*?L(U^Z[&!/L4T:!#H)A$L+.9AO-U8(_L]#>[NH8[> TV\._KVB29^
MD-++)/#I"<A1&-(M.XIV%,X9E6XJ9WE13,-.,S$/.Q;81$?$+Z=Z6<V%>D@X
MHM>,4FG#J$]+:78PO*(0^LEVU4G,]AO8(5[X'4TS?CX4Z(.UMU&Z9'I2F913
M@D>RG/.(//!9A=54SXM\DCJGXG*R.I:3[F^JCC ],&.;;F]B^-4F"R)]4(^5
M^(HEP L/OP9[X+,@*GP>G_\[2+2<QFC"K6/Y>@R%=.(!I$!89<P.F@L:D5Z?
M7;L0\4Q%=E'>(:GBV^%]>3MLMI=8;]0[]88F^ZGZMW/_HN*GWC4,1UJ=4E(A
ML@C<1)!;\+0+_\5IGD 9!IH$\5;H>_Y'W28L_V%_PRK_O<64N'EH(!&C.8GK
MWN4' !8"72K94L7J/<,BHCL60X4?EV&L.1-Q6"[!3<%#)160-FQ/-17.X:(V
M8@&N(:->\-G8X5!/5S=Z@!B:%CM1#1ESW!6,'$,X'#<$@)%J=48EC .Z5[C_
M.)MA<+4?/XN3XC=Y%&3IY[4.)EN^(G]&\440/3GPY9$?TBRHHA  &](ZU[PW
MWM-EG/*7<9VE![D;A^([DK$/D;G4 ;O/ 2E>&-?)FWL*2L"+GM-)T5,0<EA,
M]+O??O7F]9=_3HEM1!4"OT920<)0*SJB*%8><_\Q2J@?WT607\:$\9A&=!>H
MN0M#F)*LQ_"$A%LQ"GNSJ?&1\&D(>83 #@ GS9BARPRJ$R^]9U=Y^ \$=SUX
MH5FH&X_?!7<+_X'60TD]-V';D!F<$!^P3;Q'QE%V_N4IL[:_("<B7!C"$VAZ
MQ,,3BH"#9H2". K]9TAVN&>K06S/'E;=4JY^4Q%\<.M%/Z8P^2Z(V!TZ\$(>
M6!]D.3]4CL2;-]OZ"?%$U;MBX!WC!*2_^.P@8C="=BBQ43Z/]>HL5$#<1+2
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M!LCB^M"^O-#?4=D'DM=OC&.WA%1ZX+;1<.C=%':9/@4$.6J PR -%6C [KR
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M(N.1!F7$@O2JHI4FA>IUQ4&18V&'$92RR)@PCCG&+HQ;NO>2'P=LO?J[_NY
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M%4%&1!KH:>K2F&N7$H(@N/3ZD%!O>Q%]YR4!;#7@W6NURNT45.)3$#$'8:9
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M/JJ'@?S$DOPB7.T^T H/\,I:4&*"*<HH2DV#!$LQ,%S 89*66)P$#ABH3F
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MW3:V:W+)]@1RLKI9K#"U#]?20IKC"9J%M9V\[9"H$^02TK4;'!G'>X"(ZEI
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MC,JPNPL?JI>0BNK<KS O:4?^+LP>._N PKS.]6S'_GQW-KGRV?\G:U[#)%E
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M3K#D#X:9KB5JIS>.HT\%^>7E(D!UR<H0W^#'PIQHX+,?'5PX?3&+N#+Y<2F
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MM)T<KYS@RUV/BO* Z\"KA\U#=.4S7F-^7^<2.7BRYI8*CI. C!4/I0.92$R
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M-OH=OP+'R9.RJR!9DO<E?DOC)=%[QDM9<N;)IU--H$GV& 08+**97W_NK1>
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MZ=P?*$ZZ'QQA#P8I[)W?TBH^7-DT7 '%YU2@DLDOY70$/>=N6]NVN81SV9L
MZW_<FVA09' T*E^I==TMS]IR IO[HS5WEC!\P06K"^GHQY+0]S),=TP)/@$+
M)R\KD#$:*!BUH2D<B"1J Q+B8%BAOFG:&M,P:-61K:912!>957F<2LCV8WA,
MW:G7P0OP+K@(>"5S^F%[S<(70^J90+?B"@97;<LZ2&]H4$#X-/D=,G%J2+W8
MRR*L(FK7N(3N?E!+@G4:=A]CVJIB,Y=?@<T(6*PFCU^B(FK *-[)<K)+D?J.
MY5E8#OT1U 6;O+C3BU,C1LOW8DVL7GW_\M>3UR=OCM__F];^[OW;TW<OGY]]
M..V#$7S]UOH)IV]=CKNQN=,/O_Q?V NM_.PM0KR]^_7E61_B[9OLK?_9OC%0
MY,;67APC4!\N^_7QOVT2=@#Y\Z?$-*X=+B(<[:.#.\G1T?WH=*XJ3<EY5!3D
M?Y3IQZOA"NR2N2$_- 4V]\.%^_=,\4W;M\6=BZB,NZ.Y$RG]S7,.]<#WFX,%
MH2M0P@(U (8"JE[4R94O[^&:7_C\J(.YR!=K1&8SL#BDYMM3"KJC<&DDE>=D
MBL";DGBIJOA<Y:V._WJP?P#_.41%SI=3YZ%OE:1_LF]^T]R*[R0/'ATD=XZ.
MY-FT.+!56E@N6AUEVU#@"I::P UPQU%R__YA<O3H,.K=06JU7<*J]"==I:;6
M7!*O]Z8MA=-6JL+ 04VE*WA>4A;R#BYYQ9?\)I=(24@2:P4+E>?1"TP!IU\6
MFM\>]XXB5F0]N04L*Y-J?Q9X.9W084)6&^P.KET:-NRXG1,V";N\G]R]=YC<
M/[S3/Q>WRRC<I:QAVPZ%KR^_N_@RNXN&=G>T_^AAPIL2\CJ&RW+FQZ-'),\?
M[,>_H4TK)B8N=. ;<'.K1#:"U2>H.'(V8?-U$DG\PWU,<XZ$^PX<3XZA]'9-
M=G=(5_:$-S8KK]_^Q'@%#!4)M<I&AGFPP AIH<4$IK MT@8]=^F>ZYARI9WG
MD T?X9']Q-&V?=OM7B\9>!WE^F\Z6AGPLM#_J72JJ:C4-W2 E$^USNIX2JTZ
M5*"94X)A*[W)G2$Y[\<?4#3B<T/!$1!X-$#@\)*E6MOVHE35\R2>ERM]CM6!
M*XQ\PKKMFCEWT9%\W3<,L-!(GE=^3QCM&*0R#%=0>,#BC*WPPV>FQAZT(1J$
M?YQ3HQ'1;B_T@':(+US.#/4D81Q?K>L(93$HGW-54>*+B*LF+2+)K'A1HH(,
M@C)J@MH5B'4[FWS!!J++;$#:K^CU5&&&T1DKGW,*E\0O,(YC)BW'X;GP%/-[
M&-6[_\#VV 4/WL?*\TZXJ2RV;BF!G^H+UW$J=YT&=_77<?1P:!T1+)VRB:2!
M"\S;8%%O0B?$X276V;4!0E.56R 8 [JHT89I>.MD:EA]*9V*EZ03EI03C7'F
MXD(A2-1!5X,$BS&-XM9QLY3*:?@DV9=M*NIOZA:(OUQ1/$QVU(G5#7'!%\3K
MG"%W^O+Y*"J_TY[>ME7W P'%8<<%VUYH+;Y1=:;^$S]72].H/'ZMJH^Z"7HY
MZO5B4N;6%'O^[S?[EJ7>R@B3 [+:#ME/RU7=2 F:[=4=,*7+_K)68.G^]=[^
MP=W]D02N[)[ F$.U0GEH"FZW2[#CR>;I:XSI1NLUB+.I(?'B\MAU]R&4.Z]P
MX%"%*81_ERT03-GF&?Q0D;\2H<2O=/@BTI[%^H*'ID!STQ9SY)SRBM?PX(7Z
M2'^I0+>=Z[JA360:S#N03*,TNO)[>CIY=D(?#MMVP#S9$"CP6<O\'+5//#>S
M.7S;6:49#MS4'[F%1V3:>_A!_$JE3>G-A0DHNJ(0+Y\,A[L#=@/5+"G2LZV,
M=9IV##4JQUA[0@8U7)N,JBZF;-3)'F+9@\\P_81ZA9$0_R" BD&;*[IDFK*@
MYC*IV E3BMXLHPHZA: 8YXQ6 !3F_SG=S$8"&;I"EXPK\C:RGTW5-G,0A(Q^
MP!&8_?@85@+JNH('%HT0;2EV70&67K7FMKNT B,1V^0QD /&X4B>NY$.00\W
M1#CI$<77CRFS6:QK=6I7B10VWGY!G=/16.?T)ZQS&EGE.R21SXY_^?5E]/95
M_/SMF[.7;\Z^TX"]ZYPT'A)>/V@2#M:'7%0EM%G[(T]X=+"M\U36*V.8#O8/
MC\#^Z-DD>_)C?]X#Y2IVK?]SF:MPILGG9Z@,<L/D&<H9)EM76/*Y@X&WP=-G
M5=D6V9Y4L52SR<VC@[O)T9V'R=&]>[<V#^\;'-A3<-0J[+'XB_K_#@X.;SP[
MIB WV2SOG,WR]+;JU@!==(1#IV+,%QW&#]CJ$8+7.YOLM%T@COU7[_-P][[Y
M';)6$8>:,L5??01WKMJ7OGOC61AK^.H-WMV];WSOQK-3;%L!F^]-"5[)>SU3
M%54JO"JK%?QU[]>R_,A)'*D$_OIS.KIWU2CA_HUG'S@-]TXRX%^_R?N[1PT/
M:&Y'+WT.AS)<M9=TRV<&RFJ^_A ?7#5*>0@,,Y#6_/J=/MP]<GG$^2R+"_#U
M"N+@BGWMPX,;SUZK JPV6^5$DS=>^/@R$OYQH?(U5C,"?[QR[;#/RX*A+.F:
M][IN\X8N>;O4G+#]!@KGRP3I52":P\/P2+_Z!.Y=.9(!\]'/\,!/_\)4&NT+
ME)V8QU<\&>]K-[Z#G_X.RDZ*D:_CMZL"Q.;<+$FKP)*5*>)?=*&GAMB'?T\'
M^"W)Y<ND[ \X$[!![>[?4W$'R 4XE5JD1DX0/M2WKM)O(S3N[YXK<@AFZ@M=
MIY59VDH76Q\A_0-?>R97S3<Y!(MTJ(SKZW?Z91;5E?CZ8);^"GX)%L,TS;<P
MMNY?.3'P$+4&& ;?P&;^PLU=B2\,EN1OU*R)12;/@>S!C@+!CRGY$Y^^OW[?
M_>B ,%?U)TSR>MOQ&_K:K_9ZXOYG-K)=)F5VYPE8R*3I'N/;!4;B2?PO[/FY
MWL@!X;'8 WD2GZV7L.]?RY6NZ*XG,0YKXX-[4^)QF$XRR]Y)!S5FY[Y1\R7]
MGXI-]O<;$@]GUMSMI-KQ+V\_G$5G_SPYW=:Z/";6KD E#&A%JO0LBQRK@_*U
MK<L/:]NP/DAQO=$F1@25=JL&^VCFZEP:XK#L'8OAFI(*V.D7A,G0-O.R@O=3
M*2>VZ#5E9)L?\ :J*@_?[5LHL-"4*LFQR4*&><#M";_^HC5N0D1DI;;0%@6<
M<],V.MK B\#J+8L4X>K@PZL0+H+JNX+R+%^3OU$Q;P?4;/8#\ *CBQ>X"6AQ
MZ07VZB7Y9Z9*VP6V#Z8$<A$)U!0B,GE0B_#AL.2VR-5JVN;[L93""3AZ;L#,
M60]5'KD:.*P/7ZA,#[41-KW=$V!4(J7I&XM-XA0T2L/M96:QS.VX9X'$0FL/
MR^HF6F,-GD"5V+I+-9TJ _Y_;5"3T?*Q;6Q+RXK4;9;8CM8V6-%)MWPH#'K/
M9$V1-<&'L=*TWZVM.L0'&9(]+!U>A^T6Q#M8,AHQ:@@OPW<V5SBIH=92=$H%
M@LYG&RSUV@I7PFZ^#$B MR[;BEJ$C*_%3J* @*47J+/7_?@=;(10\+<=![RM
M1(J3/MQP]9NK78"8$W[')RW@V."\(VI[XD[B<E+K2GH)*XU[YVA%V+&2>"@6
M.C.9(75Q1^QG#C+:NL&Q:/S*[^E#D0/-1;:X%=X5M,8)L</MI*LT"4"@5"D2
M7^G^_ 80&_T?M;7[R4:3>C"-(1I0F L-FPRA!%3\ DAYA0TS:0DLR3'\D<J^
MUYZ^I,SR[N@>7N0>CO[A->&_SC>AH-/C^)XGV %*=95XCQXB5%=T38X%-N)]
M\2/QQ7?6"_>N=W3ZX?7KX_?_[KG@W^N[?>]OM)/$1DY>S65_U*N6(QA9O<77
MUGFMV7 ?,"+0B U]1$KS87NXV+X7M*9%KC4-;EDH*L':VA\9_[*E?:T+G10V
MOKDF3.GE1+#&?C-G H91FK=4#H9/\UC?#A;2(^=4DJN$K6K_TW"'M::Y;^!)
M^F[F.;P='E]?T/L7!5.UOF,Q1C"9BZ"*4H5.%^U?9]%%GWG_&A#]#^3>;RP\
MQ92/WIZ# VKTZ@>)SF^[CY\J/+_M5G[3$?I(B.S6-F51+G"D\[F>FS37\<WC
M?]V"%:3SHLS+V=K.,F#AAP.!2^!EF0Z=915&)$B892U& 8"16\34H'' &P]G
M%(Z)SHT^UQ%'F>R;,+4'CRG*<Q<D*[3.&$I+%]0#H;+251<$3P]>;E\DX2#$
M^Y!5<B2CG6#LJX%+([D+!S/@%*!B9N_2GVB^9IFIM47E#2X1>1/G:H)QO3E(
M2Y!W<-JYFM$,B.Z.5':N9"2[M/C# Q#7IF@B>^3PS=HI"-2V(LP6E'_4@-TN
MX08<XNCU"36\-OT!Z[M+BM>(JTX<%4:U:02CKUDO9=I 968&;)'BW, W97*@
MD"T9$75#\/YN)H<"S;?$F")1?XK56/!HK1LA48I_$L;1N8(W(F\$3X85,$9-
MTRJ9U)U:[2H6#X:9*8(S:Z6BR9*ZS1-P,!N6(=H7'I+I&HX4S*4%&$EU?//M
MBQ>W8HO LU"_ S],V2Y@WB;$"%#"N9EJ#X 3<.OQO^@=%OH.K(^&+ U0[B A
M:%MT1CGQ+T)BX.*!F\'429E="WH((@ZTD]RD<56J#/W>_0A]['R=Q+6:ZF;-
MH-7%M%+P[I9X+>1JBAE1:!(!-> 9DQSLL?"T:1H%_!Y?1WPL)R-X!]VWQZJ)
M:OCN>C_&\EN2F3%!@W?V7E/0?6IH*STY,]&I:LF^<;? X9J<TR,W=<T] 3E*
M9@P^@U0MBYD #ZD(I3)1!1B2<'^YT!*LYF7KVD(8P0/@ISX[1+1[2W!G%IC$
M$"PM:ZD*3I*]/N4%9>5^_(JG;N#U2836:/AVV/^*XN"FZG\'_#2I*IA>.,E0
M\UNUJ@WM$'X[0Q2HP@*4%$/?_%K(D6LD$G\#YHTV*!N])7@I(08BD65@#.3E
M4C#D7QZ?,J'F""NHB#E9AR+_[EF=&:C_#,1'1_%:9K=!8%U'.3LQA'(CH_Z\
MGM8(\/21\E<*;@7OI#$I;&N:@\1%[2P.31*G>=EFK*%MZNT<A/,^K5K2KPC]
MX-C#H,,5U67>>@]RY4P@%IZX?@)[.@=J/[]88LJV>8>2O6.H7;2X/*^A&4.9
MQ!JM$T[*(>?]#FQ9:!ROLR)%@PXF/=3"Y(E3&%I:)]90NKM_,++8%=L*$%Y$
M:"-U:P2R(J1K^IYEF=>.]$#UFTQ2BLT< 7X8V80,![2&>;XMW/SX6AS0T+?^
M01W5WV_J@KSI8#^H8^P?[.6?_CWG#>[*R@_W+UKUY6G@.X=PGYIG+U!=O"ZS
MI[?-LX06BJ;6HLQ:1-G<](6'5&5=3AO,DUXP&C+:DC_;#,"'::*1N4;FVESY
MT<XP%Y43T )/P"V?S1OB,@[4BW&U-R4J)K4J6A=M+W"-#+B^;,5F;#7B/X[_
MQ78D^&P^5%_I1=E0D:!S(FWDZA:]G3 :9>P"_/8V6:7_Q>O02'V"OQ]9=V3=
M[[_R.SO(NB\)Q])SKL&$, :P I8=" >1A2PQ%IY+6N&D%,I.X2-R6#U59=P\
M/KDE3)[.3:'!5545(E_2VV^^_O46SNHUA01C,*MHBA;T+S"\+N8T))0J*',T
MM)OY@NUT4.$ZY[\&KF1M%A*BBV&U"[TJJX_Q3>#@.2+MEU5VN])52YX;O;Y>
M%^#  5/%=:H+59F2_41XP"T.I==NL^3PRO@,6_ +T@R+-BC$,M$(J9@;#D."
MGVDR%E8%?)A*P[;KL(KO(D&T^T[#CFX%V_+2=13X^$)<A'CO$@^QQ!.II'PH
MH2(%Y> <5I1$KDJ@09/6SI8D+<A1[D;5'S$C8A8R&M"]'(<5 5%6Y8KR1/OQ
MAX)"+P+/&:S!OCBAV(I0(R6C&N,"PSQCPM2A!HU57>NF[E6W$\G:9T8^K$NU
MS;: =]*:O ES5VNL,1],TW#(!Y/8/D".[/UIB?.KSW7BES,K2EA@:L-&=@>1
MG&A64F4W#3>BOX<Y@OWXE[6OQP5#XA-M/C#IL:C74#$WAM/, O>*Y@7N#0[:
MX'>&'[ELEXWLC)&<*[:5WW1$11>4!6+YC"D$J<-V!&ECB;6=MD(UN#2(*2WK
M==WH!;<'M,ONY(R-N)"E''X7<'#$:=:*T[?'_ZHY>T$PNEAO88B2X'<S'=-(
M SVC8>\YY4*5714EM<*04A"8];*'7YJ"<4GY"'A=)(%@2G12EDHO\W+-D5?;
MVX)WU+5EZ 5![TO.5,*A^/-4+=5$<B6]% PGL?!4K2--#1XZLAXT'2ML8(*:
MG79#J0QL_36D_GE98ML'>Z,F&\ZK#7CA5)DOZ;%$1I[9W!E^)).V>1--!6D8
M%#CU2A S<V.&_A$<VW,(@LK.J]B(>F]L1!VJ-#ZN@/C3S2KCP['(>%=KO<8B
MXV%MO\/*'C5*VI!R"90("'QP,EDE5J /BQ:-XZIL9V#MKLH82R_BA6[F909"
MSVM(QLX'DQ1+G"P*"^B^%TY9X8OP MNU$TGUJ_609Y)P7(+;6XC52,ZF#"@D
MO0J^()H2N(XE6=^_EQ,J&4CBF:*.-_0I$W&OP93!2MJVZFE*?*(I(DY)<I95
M"E8T58AAA59JEG@&9";@J_U6Q?)9DYL*=L'O<(Q[$X7%,G)B=<S_M*.Q4C#2
M;4&O?\Y^=#QM<,6!F;'2L7R7@0]! _"<,<Z):OXR*CZU7A".(<#/CJ95?/-4
MJ=-;[-E;I>]<&2X>UAEU5\$!.4<*#8"R$&"_]];/ZC[X/3YX/S[.<6PHK& 5
M- =+?ZQ4DO%/8YE70)^ZL$X179G0 L2?L]X3?#1N(03C!,&Q\K4=<A 6=7!\
MQ2^<MX841#:K-:.R8):EM*E6&5T&]ED24:NLHE&S;U^^'AV3*[85)#6;8_:R
MA8E:S/@\+U=U4'X I(*U2T13]>U.# $1BL'?3N>JYK9=)-PJ$]XAVI.Z1S^R
MK=;Z(T8.N"X,RSAKJ>VW(G)6E2LL%(/CPK Z%V@5LY) (&']>W00FP)2*CZY
MO)1+70TW,38@X'C^+5K_8-;OD6^/RC9RN7;@6JIH/^EX'%2^5\W@4?\5IZA!
M=# .1= SJ>QBH*QCI/TKMA4K7R.)]J!X76NNP\71IA3T4>?*Y%R@#,1 H5G!
M+& Q[GLMG#QT%4%(]K 7( ?NN A\X"1X E;PX!)(FJL<.T+6'+NB8FP*68%
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M7+''':#;XY7<;HZBFJHEF3P9M%_E:QJ>-<<Q/(B,R\,VFC+]F$04':A,&F
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M0RA42G?-YC9M8Z-,08XL;@N;E)KJC"8 !&UN+K$:%*%A6KI.*["1*'TY"+O
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M^:I,!1JHK"+]2:'+G/2)>F/_G0SMHLQ<A2PC0RZYM)(3N]@^8*:V<-(]"U/
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M0[G(/(P 7G@T4A,0.1!OSJ/0B35"2AER">*<5Q3'2(4GP,LNN0.[#V#>J00
M,X6<=2%T!(QP00I,4&!) X);K5EB@BQN$)]TKMVGH(_4FY#6>4Q1KMSW<RK#
M]VUQZZ)7)+F=!B/)?"$"^SK7@N&2\BPQ^+ I^F/![/'*KI25*).=3 +':5+;
MH4DTC%>X<2UYKB8(F FRAN7Q@!"&'_%YAUT6ME'THF^;=%LEI%_:J^U0T"%
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MW,$1&3OXC_+G-L%XB>D1'COQ2P:@="9 <T\<@B\VA(1-1X$LF0P,@@[/-L7
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M(:Z@;:6%MS%C/S<YI>8)/L$V75]J54+A>@J?SY]/&!7A$0MN:F7RM><]##A
M0.,\ZJI0556NN%>&BNDB0F4&![NB'W(:J>SE$D&H=& :@U ;2QA&_K9>=B<=
MX)IT@N@_7&LQ>4J:R*HMUC:&ODFDN#C#A+I'4LXG4+U/OYZGEWVF#5%2.XS5
M4927GD>/D'NCEKG60UJXA V";G)!")?7L/]I<1VWR$(7+B.RLK1BB><"FO'"
MD0RE#0O)%2"%L9?NU.MF&V:Z#U9>1$Z1[37JQNSL@EVZFE?AU*=7F[:MA;[
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M4ZXF8[H24P7C"$L[):,8SP3KBT8L52248#0#I>2!LWPSK%1R<ZZDA:HZ&FI
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M?:K#11LN9$_N*6*Q=#RZ].;\T&HB?[0-XYB<7=U+7K%/[EYMJ+@)PE_S:<(
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MIYVUU?C]EA+F:Z_ 41+5UE#S:P+N5D8C>?"5U=F$IXL@7M/5JS!];IN_:#]
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M.OPA6"IL^+$3#SL,FU<;A(GQQ'/XR33_()8/[#8L.!,DZZ*ZI*ORQ; 83/\
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MMX.@RP_3AQSWKP'RI4;H2O<C8M"/P/LA7CQFB6L<#RI<^2A]>+TKFY4KKY#
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M&! 2K/9-/J[.D_\OFT/H<?S3::+R)<M.,?0#,<$PI5BF"8VK:<]!F ]HP,J
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MG%=@NYK4(&4/QFV,]T>^"%#.69'V3:OF3^[M)>O25]>C4#IX'*2ES!H*)4Y
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ML3,>4$)WSVKX%UPU]^]9$GOJK.\Z")#"A )7V:4?S4@5&[;!Y5ETHN7T-VY
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M:3&JG@71'<,84(8%7<NP3.>;]![O]IS?@]V=_OC"O;4M*1#>L=?QV=EP^/W
MW2E4:-9ELA::*5F4(2E-@^N&H:-,E9-(G2[C^ BHD43:77\O!MHI-$G80P)"
M247)( =%-D ([Z*&:6#M!&F^E8Y7P676IL_/%G+8+%'RL-D@1<>J-?'4@\P[
M5^%/C@F&?9" +B?R%Q7&0:&$0L]0,BBTA9A'E3*'7,+7Q>#/3U^[69%'NX)!
M8RV.H7PDR/T%NAL\<\'<1@&G4&4A+R*O\;(H9R:+7_3=O]@+<B@>D34QGI%(
M^0V=:!6Z>PK^B*-%E ;E)JU1!*0MJ'Z 7(,39R7\:$D,:TMOV'[JD'A0E9%3
M"G;QYZ5[#A%8]NRQ:)A2*9SFT1#YAT*$7 M5CQ-M=B\$#V-'P-5E9O:K(!V8
M5E//,1G/%K4T@PWHN$$0#X\W+_*]@61&Z9"!)A[-RPREF(C!VM J$V$-5PWG
M%/ZD-%JT05* T7F+$M)I6$>_0^"K58D?CSG#>M\LQ[TXGD!X?!%X$=TAM8U+
MK1&3'S\_B]^1(4#^3N)6:7-UE%JA!JLXF2!+XX:&;X_Z1S$9WTRTDN+#_8.G
M,('?'CQ\W'_2_,O1?L]68K#O:1-'1_O?642NWLT9TZ IMQ:<+EE!U]]XPB-\
M9T<HH*GXK72(2M'G)V9T6QD*5W1X**(Z"-5 =QU6M I$!#&EU6X_OJ AB52B
M=:LU'KZ2+MB9B3-H+D'N#--2Y"+/$_K3K3-4.F0CT9U59&C-Y6A5'0)EFY<.
M<OSAX&"%-M)9BQL#!9X)74G:G*J0-XXOR<QQ:^CK.C-Z)YXJ4$P.-+'X?/ZC
M!JTR!#W1?LW>@G0\_5Q<816UD,*VO3JMM(E[8)AC>,%N9I;.4FR@164:*GX@
M0&9A-.P#\.G$\&H%:>Q+"0*'5U[$H%6Z[W7!&)4?@-^X$" <0A8-KYAYZ9)B
M8-.\3&U7O:47BK2U/&?TM;4BKM%<N\OI&="@7A8YF1;+V@!+5MF.^CPWM@^;
M]Z4V1E6K>C?C13X4<!Q]N!]I WX#S=T8H3#Z!+D\H)E@?PI05XH^VG7< I@9
M]M6_9Z;HH-V\T?,>A2WI/A@(NN5]<SI+T5H<'R3ER ]#E8>\-U:KE52B4!MI
MC& 3\?QH3CDM'A3R[J)UGBM-Q9(9H;EK@SFHK6AW6CHV= 7@2% T,'5M B;L
M=G(#"';RQ&6:QPM^YTP<% 5)TJ_1K-T(M_B@PRUNP"T^V.]PBY]Y#P2/<M>\
M_Q\&/_X4A)Y=*GT;+2,:5AH) HN@CT';:YCRQ:H5#,-LAV41KGP.BWO]Q)F
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M\_TBN_WLVJAD,VU-RA^28IW5U014M0J*F&3S@(M@XUA]WXA^P;I/D>)PRMI
M;!JG23G20X"-J"*M^$P395)C/B#F%<R)DY[Q)Y<EIK'*#@+^R"<%;H'#9(\G
M8O6D5XR9 -J\A#IL-IW47%1C#Y5<SSW1QT*"RM7FE*SE^*SA%3,T*!0XC(4%
M2)!T.7<F9=FZXO!78\3O]E-9]R'2[ 6\AZ4)F36 V'%]7]).KHD6YZ5X_B-W
MW#NT@4@+8.E+TVB#9-%?(5(U\I;*NLEC!H5R"H;\A33$%[F6\GF:%77H'_)^
M<]X0G@=\HI=,-0PI8#2=29%"W+J(=QGN;Z4 <^%\ F>)AH_.XRL"ZY#F*TH
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MXIN#.5#'P\ _39%9MS7@YKUOYN=^&E66T+,>YH*"V=A40,"DY.>Q$^763>@
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MFUT[H[]U)E&,_CLM9$?B*?DR]JDDL#OCOZTKL/'F0@""EAXL8S9V.(V7L?[
M(];""@W@#CV#$8_5<Z\XPJGPSQMN01^W4E15+Q+^=P%9;C"Y6I81=&P %!F'
M6IE.MDZ1NTTVCWYL'[P]*O79&7(OXV.6ZE2:C3H3M'T;4TS03W+$BZK:\0A(
M9,'47IK."FW[(FR\O*3Y\JXU1.0T52"!%J0Y^*(]:[LW+R-#/ADJ0)9>.9FA
M3B]M*3WT]%Z"GH+^$B4C)A]DUXDOV6WXK=L#M.'?2<T84<.YZZJXZWN;GLN^
MG+_E03[IK3;?9D 1)QS_UW31:16+R.=K=D*.#GK2\,K@QE(1C72H;_I&K-\X
MD"G[4@] YXU]4_9(^8*W?B<0D2]Z[R]79;O5 ,)J"(#%0',X[*]VNPNO!")O
MAKWR2IIM7$FNV1H$V5_DI7[!26S':W$K7KNG2^K6I^U'HZ*;KR;;0<CYE&_W
M^X_CF0+AZ1*/G_:??@<;]^U!\ <NP]%O]NUOHIO>[D"21:YKD=LUUF3HW=_S
MP(.B4"V9>/!GN2E \OUHC0Z=5<,]-<F("Y3<#)Y9.H.#'C>X<7CH^0JD.L"T
M?R"A&?(&1@*,]O9P:=T[C$6_$TFU0YZ+/;@]&QB*X];(F\VS)*\"8@HCI(&
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M"2>0D^K'ST/RBF107'K666L^UL#!;D#2S'R33(#OJ)K9VVQ:"&:V<(K9M,)
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MT @7;55D"Z5S ^W?HB[R8@:6I$LS38<97")^QJ8/**Y*,RGVN/V(46+GO14
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M@^VTD2@_N]?T>;,'9=\S $'>T!4%(M8KEV!G%>]_D61:T'[-&HHVC/LUK>C
M+'J-!$+S)@BC?GV+BU2)]N[_7.1F>84_VJ3_D=:=5KZ](=]^7)G:^)K!@ST
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MT-!T"GI36X>6A%<YGI2N(L-_^&C_X<YX-]X1%]0F@-Y9$\WG\Z[U1*KF7:-
M,:U:<)$%MZ6P#"@6,ODJ"(V$$UI&"SEFZ03)3%*A6.#9.Z1IQF3C/1>ZZ%$Z
M-F11%"7/K:/N,M'-+R,V#[3.8U!'Y9:5FM[WSRG6!D5%]-=7.(C_Z,7'58H_
MO4FX.&,_R]_/DNI#HG_I1?J)GQ,*[E+YQ-MD"-A)?%9!8H./^:L"?YA!Y@Y'
M,Y?P[>G,LX>">A6_^NGY^__Y?_DG[F4M<&H"/T!/M=3DI.T25I&9B!V"O*A;
M4XM;!I(?.3N&LA[:,[2TE9PA@#5%B1G35<6A8ZM/L[%V'D4[LF!<!,-5)8J#
M*00.E@T[0.M6+/DFR01/^)'U0[_FJB'%\B@C"4@OBX+R% 9+7B6[1,-6V6NU
MNZ;'#6>ZT6@TBQS2)3/Q_QC4X781C]W.I;MD<XV-HJ;K)9QKP2<T2G<ON0N]
M[\13G>617_ELX5'#;(K=2/-/CD!EQ/L."Y2=975N[=)F NMF&,'N-')=2YOI
M<F)]4_((O%F/:-=6H/VG0"J=,]RU67R6OAU.!TEMU@^0-[#P?5\\CY\</A)V
M0$W979&S;P;+<./  LC]G(A@%.;[P!N8_N%,FBU67)DRB%G76GNQY=Y:*Q@*
M*32:'5 DVOADY4*1MVW3TJQ<JEJY%M@D^<$/]\F@/X^?/G[:>O"4GMB9J'63
M[_CYJVAJDM%_%TG)(,[F_$KVCU_I>*D=4%Y],6@+18K _\A-2'K^,WH[C(L0
M\9%-PNG05[<@NJ" &501=#OU*U;.<?>@(S-&^M5>WTTXWY0VQ\8;+FT;;.*^
MW C.H^L.V-XUQVM/#M?"':ZKYV3KN'6_L*<K3L:H>0#'FX_\2;($=4(UX&\.
M*,K]8P%0''(IP "*Q;:S&Y\@W&YX4MQ=N[*&HUO,I5H OQYHC;XPPX#T].C
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ME\>7:1&VVFI+6YHS[]/8Y!0\['8;M]NX?]O(C^[&QFWO1-FW\-5+SIAX+ 2
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M/92X@XY:[G>$'YOL@#?7DAF&Z$0>9EC%//"#C%H(N8F?&'V(1#BHFIC)M";
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M6;E1W D_MTZE@V\2P?].<:5 6XC?DL>:9C8%*_?\1(:XA@06DX4BA']Y K6
MI^9LW8:U+;4J4/ZL0)LE2.M!P2R9I1F#H:&#.Q>Q2/H8^H2/,()8+-E$OVX?
MN0XQ'A3F209,0U)?;E<OI2:2QCJE%Y)<!\:'4*6L/W\#=C%"1D/,+_9O7;*3
M\:[?*.<4D[Q^J67J(F!<(_AH.HJRFQ$5FWFLO@.;@TODP9T -05N.CJ:M4KA
M:G!GYHDTXHSGGQ429LU<\P<WGJ;$,T#%(:1()X8I6'60_ 2!G)B9<"<_4H_N
M,-(QE:POX2&Y<(XKX!&FBI1O5;<WM_""$F9-LA@+ Y1DXVAGQ=D_]>UN+O=2
MJSI++0DQ)QDULOPPTF+?N!4%M=3P194%ZPT%F&PV'=F?%S!6C/4E,:<E:+'(
MFKQ4P2E-G#QS4E%.1\  @,11$:F:((E#O!U2U2%EP@M<G^'69R92$W)]6,9>
MK\G8J\K8Z[SHC+W=XD7/PH'[!?5C981]078TR&+IW?HJ C*>L)G"U+XV\KP:
MCVT="5)U:5>8)BYUZT!TS+L8I12B@O")3NA$"YE[TE!B.[?@-BW\C&(]%<:?
M922T#0FJ6.7BQ9S@)L6N!#9.BE8>J\8Z*03U5E2:W9E)CV$WJ<S>J,/"0=T,
M-$P+,0MPJ:)E?REH?[Y:(4?*Z->V_K61\L8N$'^,VCFFF<"B?6D]X)U = !Q
MIU!3>1+2WP"V@O[;DG[IZ@W7D+(Y>G5AH_LBO4-S6>K>>B#99Z683'ES$PMT
M^LFT2DNG57+*).DW4O-&%XLG#7G^UBXF5"(@A)E42< ,JV566O>F4=I&&J5>
MBCNS2@*.N3<?T9[/1[3>HV[%[>N-OE3R_.=>(_M;H6N)?#WH%K$7QB:-;CC&
M#^&/&U+T9(9N[T<SVQ/[!,1ER"B4&4NT[E&++TJAY?8Z"L)#;OD8K")$,&;\
MD7Q/&4%#7Z*J'-'&R*F?) (1K.*@E!."A@RJ?(V$K2.]H6^)0<3$+5@PA!F.
M%],W3@XO*]UFDTF(0+J;"[Q%<0.5MX$VGX?XY!2TT3F(G]QDX/YE?V",+>MK
M%J#+Z,N<=R/&+ZBMDON?*)8QUQSW3$E.*9KR.1L.%"V4N+4?,1WA&CS(*D[&
M_BK?*?. <HL:<QP3[ W&/K4S$KCG2N Z]B?<'5?CCZO@KK!_(W0QV@']<_F3
MO++!RK^B92DLI=)%-6QO)U9%,2FBU+Q5I8?JEW0%DDIIJ)X??+A!UZC>4C,D
M[@GDV/\$52JT/[I>(**! U03!*A'G6<D2D?NF(CI'RY.[J/W#B-!0="R/R8M
M2S\$?\P^\#%NY3\G=>T7_]<EKA*BI%5?I^(]LLR4AK*+IF$&Y=/R-U<$T?71
MC;^)5'<2X.]T4L1SHY9' <X?-1ZH*@]4M_% /1%([DS-:>]YU)R^N[@Z_WKY
M!2M*K<_O[?.S+Y?79Q_LJ^O/Y_]L*DR?<OY8$,P0CR0_FL-8QP6O109FW@*S
M^/2E^70.6:Q:2:"O"?-V*$N&$%>M#L-QFIBK<TV<?FBWX.MV!YU<-II%HF5?
MH $D>ZN5@<'Z2:'X"=U+>YW7W(Y1-]BA%UHS/:+0A@(%3/H0QR[8 &AMH-..
MXH*,ILPC8?RXHE*-PL[**#-34Q$B67LQ"Q"HY($*(]!.QUG 07@Y"UF:1@$]
M(<83^DY^:'9O9_!9QC[F>2($*>.KQC(%*O>*:H].S%6 ^.HHQ+*RO"[,)I?D
M@-[)(<7$#[\1N"JVKC.3M6;JYF:/A+HP+<#OM68+UKA)'8'*!F2Z4B$Q$*/,
MCDA@! 2@IM0K^$4.W7<W$J%T_0T=[#85N''NR)T'Z:Z![MJPJOM950FZ.N9C
MY8UJ-&]1M3%N4-6N#4/H10>U! PPAI.HOP:/LV9YG(/L@C+%")A<9:CQV_G/
M(5U*=+ZBJ3F0"2PJ[U!Z3C 3""XV^_LG,;E6\4)%&?";+.:+FW,:BYWX#=W6
M?DV7(<%)8(94JKA>X/^5^0.=HS$ FHV"3 K<A3QRKJAWCD=2I$JB3RA^:'$4
M(4E!+&0J>;:89_5[#F2M!(N#LF8(LB'T9  -Z/+6!VXK=.*N$8\KG:K,_+72
M*,]$)]QQ%#*(U>U2VP&Z:^:[2\;/-X6GA0S=@&7/TS\-'';UB%7Z2$7#!KZ+
M'J6]1WE&+V?;(QQL<^MJI9ACCH$ZWL;0J">-H?1>9"HL,A%@B!(+8>9&EQL)
MGXT;;E4H#<Z<G)55)_-]CKGDEZ=6S8XD<,_0_T[/#T0".\U)JX[%C2R<,A;K
M&/S5T=96[,MP/:GIB,&3FQA*']:CS6GO3M& <"S64LC843J]4Y!'LSR_H.US
M\Q7[3Z%*#/*2\'E&*LN;\X[W()1(%JHY.#KG5V5/Z]V=.UV*H*O4X6$@OJN4
MB9)"X4F4)#XA>'-ZL"S6\&"17%YD%?(@BKR=2OLTWG<9H>F>#UZ4@>$X*\MH
M,+GKLI/VT)1C!8N/,HZ%ZLF1*Z$RK=,\F#GYG6D#F-.[I7TZ#P _2Z T;XL"
M6CHAA=O_< 9XX$[A,8>+4V+Z)QN>J,-P-KHLE^#-IX:_Q4!C(R)K)5) 1'XU
M(%\LQF9JQ&3=Z.P>-*82V)XYU"7NEG,&HB20$"0GLL/Z/KQ6Q_Z^4)D'-1SS
M^'%XBIHO)6CCLMN6PWZ._:?9. )TK?WW&7D$U>?2T==<^MJO21(8U_8^ O-+
M"_>5L+]:]EEJ4;D"S!+$92J+!SLG;6PZ92)IY3+)!ZF#7=$7 F25J0$+P+@<
M:\:X5*.BUE#PCY;TQ'S<_JP+=*RJ]%(AG:D7QT*WJS*>(15,%4,^:D$JPQ)U
M4E1VQ_SX'*-R8.)1#)0;Q>/"]Y8:$1T,"%%6B5!&_N.A$*3H)JE"0Y(%O; 8
M6E^>B9R/D.@,S'X4AP)5>YGUZ@:!!<H;59.JH4P56P_)^C;6ZBE&J![S=,UH
MXLR_9X;0:+_Y!/N"%'.:)N)".18Z(R<<7U"74<Z)%4?L\A;(5%;N##;[ID;]
MVI4UU943@B#@SGW%)#_SA44FB5^%IKW!)=UC]QMF4^>W\:\,"\\5D(0B>PNI
MF.)I$^ .DM&1:5/%D@TP 2VQ@&OZ0U_,N=[Y0E'UI7W%@_(T.-'>8$*4X^=A
M8F"^ X?M'U=<>G/O:K\F\][):DH!$R!_ 7EM D'Y^Z5W"_YXC_+K:O]@EK%K
MJCFXCVJL6:I9YKZH_X(5/B$-CJJ?EYUKF;)@(23!K-I10>?J3JKUCEQ9Z%J
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MW-@77"WB::QEA9%OUE3)G>"$0TO%LEB$N'[Q#9X[\5/<$,S-=SVL^2>-6;_
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M8J8?3"W9BW% H6F9P--'=J'"9"5A*DS:3:*A&Q/@Q S\Y-"PN6D_%_@NJ(T
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M))ODU-HZJ:0 H>3301:CFI2.A)0/0 $Q:-.I0#%"\B1UOS_4C3S'^K;O:=S
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M53$@/>4NZ ECF=T#JC7&':9L31GQ%>#P5$G"9L*\<G2F:U6P+-0,5.>S,N<
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M';(J^SMA>:QU0<</6]#&#O$#ANT0H<KVQQB<4JCC:USR%:HZ'#,\D'58E N
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M07@"0Q8)QHE"EANNJ'?$F' *N13I/JT..&'4-4QZ^."NQ]8"[.< ^_$<'QC
M6G'C&")&2"87.P-;%W+VZCPD:H07RS:1-*(YO1UY'/8<!%YGZKW^HS8XXO$O
M@U/&0\JHOAM<L:0D R[ .;1!>/)(!^? F>Q^ P-D8C'%(P<2;R^$YR,9HN (
MJ#=$;!B>\SS'F/B>A*;FX#_\.YFJQS$A$ZALJ4E@@6^X!F>*3"$E+""E=?'\
MQ9+6V!VU'5F8\<5C"3QRYRJB$')&-@F*?1"78 NB$?,7EMF2U.0Q3,R)1(XC
M""U4H0X!<V)<,H6;>&2+HX$(H&W*%PI3[U;2YQ2Z'L'=UATT85T!A"6*T+&
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M8,>O )7SS=791#E' IX3)E($Q!3X[@]FF388.,Y?FG(! X-=8AFZ!'P2>./
MK0YC H 0(: DF.\JVBVQ&MY8NOZ$@SHAKTIL7)YOPZ\[.2RPVAKR6U"5H-NH
MW2,?FP3ZV'^ ->+(H/7^P-_!:$(U"?3))9S''P2[!U_]U!V@C\OE(9^YJ+-V
M4X%BU?=&@S6R4&(50MO[P(4ROHRDIT2>A=<1B"SYFF%SQZF'V&T<(##H=?:F
M;B(CC!>8"P+NB],_V$#.8[@Q4Z2W:9(P78/BS+?<%1>5,%<!<8U[PQ'R.6).
M FU<8K.O D>E(;YS7//BKD!S$?$@]Z+Y;COY%4.>]>QZ+YIR4;+9&;REO@2K
M'OO!KWERMG3;/-\0/)\43LY00QEN=X;#GU,;BWT+[%\XB&EW>\>_W^BV1EJK
MU2O%!4?FC5T**5&#53Z"W!FVM4[[L$&T$_;-XX'DN$HJ^E*HV=*ZR;;QI^#9
M6/A=9DH;5" S"W#K\I!C%Z8\3*9ONZ,-DD5@)\KHS<5RMZ*-3X CE#!4=F/
MA!1-JQD8#+1!>\OKT0.W=#S*S>OF'Y92'-UD],IYT>2-5G&\T>L.M=&V16JG
MTJ5K"(5 7PC/+FX !=QLY15ONSW4!MW$]E1;\:[I#54+P;<J!/]<120,@]IA
MMV'UO6'Q)B,?"J9BJY$\=:<SUM(I))L=J!B4*I@>[<8H8?XGA_MYW3WY6XB
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M5-?V$XF3;225&I542B&2*B!4U8!VMZH-[]:UX6FUX>VW6AM>L&,T:*@7^M+
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M-#\HX:K%);$2^L%:F#6<=(!MD.=9/IA&4I^7LL<,+7 6@8:(J"N+/^ -4ZK
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M0513QZ!>1B+SZ5EW9@'$6094"(7R/JJ/]C-[0LQ0BH$:'ENX$CO)PR==8R9
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MK]-<X]_PFBQVYS;7%X;Y\NNF==)O79#=G"Q(YU%_, )"XXB)B:1[;@=[.3B
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MDQT@'RB#2&G+_U!VDNY11;HM28=:!UA\V$R[-]F>I/LD1A6BT2-%M=@6PV%
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MI)D,6DFA([4CO]0)KB8RW#/<"DR<10U!$3^\J0%5"CH#X0LB*-V8AJ3_Q0*
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M#!7745L<!V;O73/+6FNBPSGXN)*B"EDTN+M4P!&$0\@E/65'+VT/@4HI=R2
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M00JM2/V#Z5B<L."^69UJ<U!NW['VK=W<>#VQ'7_+G)IM3T4E ^)1Q%P!3_N
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M]0DYGG(9G,KX.FZ1<(XP:O&AG!UK)#O;]@?\RER7<<&XINOYVKN"-4-4Z7J
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MK8YP?Y'P2F J'/9DL&>76G:$A231DI4,@2'JZ0,24D4.H]2B)]Z;P!'51.0
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M)V,8!)V:LF8EUYV+^MYE3+VVP1QOM1HJYPR55/^'6A(4*PEVK%CK9%:LY1
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MT5EG3+EA=Y<7V-EA/E?'EF6CLEG0K"Y$4I7H\H B_X\X\-LW-F-L@7ZQ<H<
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MU,F=7#]^\TEMI\_^E4,%.N7<TLB:S2R3J[9+^3?1(%X FA75*&![D,7QA0?
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M'$7!$G0S>&2&#H:'(SH;@*'RR*>Y1]Z&!5/DPQ3I25*D 19<GNA?P >_+\)
M,-5&4T,$\:PH\-%DF_R-(+>X)W<^I]$CHJ8(?LV$ST_#/B:8]NJ_D[HM2'AP
M[CR-OYA:K>&KE5A)MC8:V9[?O(W_XES^)Y[?M%:]@?RD.5=/7XO)*+YGWLQ_
M+/IZBOF"=1?V9H"M4(NW:,.58)RI\&*+1?)U:*@%]GZ9V):)6IV-$[78$S*V
M.RK7]U^]V-HFS/&RTE8TB]U+P?;K.N9=,'C+_*K.ZORJ#5&U_#6:2^(VK$>=
MZFP2&>* Y1%4-CO3?C!;H=J-"WKF\B<;\>#6S01@C%_.J+^&X__<;UL1M#A%
M]FZR\.V2P^$:Q.OFGHVYQB0%L&_/B&_"9MP?2K[,'^$"D?WQE?P.F$ZDI0D\
M2G4?YJ@\8Z_K*MIX%>V@KJ)-JZ+MU56T)UI%V]DR]:RS:>K9';8@\-A=V/1I
M2P5K[8NJY ,1AY$BIZE](05C^):999V5F66;H'(E61#BYXTI_4V#8]L+?K=D
M_*J#);L?AUR!]1S"$]O)F&-*ROX^IP3UMV)PU?#^NYA7]4[^9IWCV]IGC0%5
MD F(\A)0="Y1NI9$/I8+.+$UPR0UI S_;0_6'%A.M]$-WLD3R -?C2U>2;W.
MR.F!=;(3GAKU9%EC2A#S \54MFJ&[@;-#;+/I%BGV%&L"!368V)P06Q>&;P!
MM,?D,LF)8=CUQ6^[SF>,^1L7JJC$A\8R$[T4M4/BJ Z)+1.N.ILF7 &\(N^U
MK; UD[.3;V+3]U9+DJ(B+$4X4?R M5A=X5'8F 96O&@'I*TDLPI;GU(6,7J7
M(X-;/!)^P< 6F[#3")I/:"&:.K[ Q/&<(#>\IRGOITG)20Z61&&E,[G#3=A;
MVD\E\5H0&4&5M/!H7P7^AU0A_=G" (8O5:^&]Y]]@1J7]/XL3#^:0:**4K%@
M,2EM3]SS/M5H5]2(F3[0@BPP42:%16GHS(DX2D2;T_@43YLYGK$4)=]8.!RG
M^GF9"G,+@L]\5N<]CNK$F["P&UX*56:VV5SSDLHP^=:Y)(XBTUGD\# GR-BW
MU6GRHHR?7)0?Q4H/UE 9\*?-4[IK,&I>P4*&$](#BE&"\R) :T.$J7 [E!CZ
M,!]],&"-"<HVU0J)-.2)A5W]03Y]>!6VU[Z1K+TADK766E99]I!_S]B-P!V:
MXX!31(4C+W\;,<.88XL5\XG::^'? *B1_[>X %!TQNX4(=KXA8,X7X1%^M6U
M_7=06N!(,_SKYP[Q-\+S[8[]Y]*" &*+9P:;$(JH34"2)<0Y$Q^'-^Z./T7>
M2XC!R_EP<6,<>S#8Q<A" )C_]:;Y9N4OTR(5;SXEO!B;[:!*6WWOVN6^V_"U
M0=P%@U/%PC%/& P=6<N[3=V:X%Q;H4>93MLHYK3Y, SV!'O $93F^ P.9MD?
M9/OI\6VST5::K;[2['3>);%0,+->]Y?X.1$#-\7'H0?;L!YUFHT>/[C/,W])
MOX?EIY)[>?/I+RO>.5AZVD8P!C(CO5NCNGFS1FYH18Z8VHG1<_#F>P.EJ_82
M;1A7 B7MN.GH7C(X-O<*QU:SH[0;W>+@F)>0LIGU-J1QY=DFM:L1 Y%_4NL:
M_R!9=YD7,PY  L&0<_\PH$]=B:/\AGWU5E^EVFHI:J.Y]BK7G?88D-H"R7>!
M%"!]6@_7S2"U3Y&QFA:6Q-IF)'+!NUOPBM% 3<\E03.9X3I)G9_Y;O:F/1/A
M2L.&6G6NQJ]>5VFT^VO1:\65Y@75:5W3#AQ@VVMJ=A6ULUZ%V.J:]BD&,TG<
M!X8<<[HHO"EK187AR@M>P^?;_;[2ZZZ_X1.3B%N#"_A6I]MZ?6+Q*W.<#Q@1
M]&8>;Y80+4"M/-]]NR^Z'(80^Q(!&/S;8*)5Z3!2N+L2+S/,DWY'&?37:VJY
M>?2[$[_-'=C& 6ZSW51ZG0(5HW?[$[9K&$HF/WFP<-K7?(4D-MF1-.Z$5Z(:
MRO8WEH%28/ JO?Z>E+@3O*!]J!79%]1J*?U&9Y]:]GN*+1VS)_]^,K3S1N\Z
M&T;[VM4-*4<%D^0W&O&KS3#%-U^&K_RB.?)?,@FEL3VA1#>YFC#Z3:75'R3G
M".$>L[<VV/O6^HK:2RI=2F3JI[%X'5G2^Z;=[H:TVZE2_M"0>@R,);\C$N$V
M'W-S@3T:3#<ZN:I.*=H2AWH;XE"WNOS?QR@6Q2C1GEA@5+0O!1_N6^<:[1/[
M^AMB7V^G7*/[T92-/9SE)_*PG5MM@>H?6J<<.2(LY0&_J;.0RIS:4Z&MUEE(
M=192G85$<62;C75LJ66/X9?$?TN>1;-U-A(_Z@6<5 B:#%>'JG1[Z[V;KS@E
M:0-@MGI*N[/>;52!O"2AE@3M32L:A$UJ5\*&RW1QM',0Q(F%7[< E-KK*+VN
M^OHBKSYM@!"QP2RK?'!NS\1WR\'TH/W,@53-AIHKRZT2H9$*I"%M<T>#MJ+V
MUV??EB8%:?>HJ+8D#;,]."<;ARM4$ _-,7E5(Q]EL(5!1U$[>\*Y$[RI0C6!
MC6ZJU0 =.$="=QTZW=IY.=C0>=FOKNO\QI1^QQ$^'/[-'H5$&[P]Q7? .^#)
M]RXUV[BPS"<;^WO.-8=&XU$#"]LRM6?=]F"1H3Y6Y#OL8#'AF>0 &VNFCV!U
M&ANXD(<C5WZ+OQ,=,2Z&=Y?W$GP:])G238HF6AC %=T]F/\:OZ/%1(Q^#I8.
M.FQ<W/SC^LN9.@A>!W :,_JMF7(B',,GT1@^M74NW^G.#RYWOL.=VZZFFTB(
M[\YQ_XA, D2M1C,8DX3[IU-A&],7E%]\U+3M\,%*$S'XV89-N"YU5\ %0*\5
MTY9X_ROQHZ ]*Y_0B .3+>K9X?@ =%%]X!VTJ"\*2<@7W<$5_O!T.Y@VR!?$
M1B7,?<'^W+%+EOE$M26_I\1OGF8B6KA',1H1#D$OIK41D"\6_,<!L6U0 QJZ
M3;7YD7=MIUB*;CNN/-6,B3S&,8SFBLB[$@Q@A/UJB.4V3KQ,?;AY+@\S^H;'
M&ZH$Q\\.F>\@;K^P1_<:@&!["(,K;<2&U-YL-=_N]I1!2I8;0C3]FA%TX57[
M]R"%-^HWCTN_SE?4M&S#KDSYQ4 E8<9'\L19EBJEL"S'PFQ$'&".S?TF8/E3
M'$RP(R1*FG&*5$,>.B?&O"_O+L+V@$\:<@19\$WQ"N)QA,OG4K0U'[9ZX$H]
MCEO@S9RQ"1&N .+C21=S&X +C0Q-G]'&8;F 6RQ) K$YT>H(FPBB3D<9VPYR
M>FJZ;DTB#:O7]#DZ^2ZW96T1K38:=8_HM![1_;I'].;4LVW_]:T[BF'%"&,W
M?E>UKSA#.G]#,5^UR'Y+93*]VN<2W_J)9&\5T3\L)X+X[<-RXU,EI=3R+"B#
MCD<RW*)9$S)FWS!0H\=8FXQM'D%K0$6!G@2EPV8DV^67J3Z:HN^0+"#0/Z[8
MHQUV5T;K@70'S.]UO$>'V"<J'Z"#,##;)#Y,D"<)A\/9U3;8?L'C\N4SJHE@
M#_X.YYC"KX49QQ/*M#GH4C]ISA)\M;<LXC@RW(H=9,20.DHGQ=N/( -5;^)1
M9P1_TE-P( YR;)#,QS2"+L;LF>-K7!S^J.=-)@Q527=E:O6&D&GW#P>:5GH@
M!,]%&(,]-PU9-*C615/J* 2D5$RK3:X4DRLWXZLDR/@0<# RRE9[P/,K<&LB
MV3HC -#J*NU>,@"PG\J#33;6'"@--5D2D5%W4!Z+KH@^M=>FJYE@%!ML"$3D
M.E]T9V18#C#NC57+'*^JC'[9.9?"X\C\/*()::UO;H$ZOM*Y&;I5EE^CYDG=
M+S!?T5Z@6BD&5) R&*GZCTZ9)J<\FVLV5V9TW)X^T<EOIH?8J!'DN/;CB-("
MIRXL* I56UN@ZJ:#IL.2@BL=HT9?<13)\H+Q2H+<4RPW?_6F10KYL2I6S9"G
M2F&CFH<<.>_YM[IJ/YLEE^V-'-;D(19UWB)/ &+4/T1$9J9FR*LA<BVY5!^3
MV12[.5(/<NZA0V=<&5!<"9&J7VWN#+":S%\AF3=/B\JIM]6OC_9[?M0+H>J%
MG_"H_<D2^^D=Y%0Q-=)G*8:=@>EQ^E=[,@<Y51Q%Y\KKY:4%5M+LHEP)@ZW;
M_F6%#R _,(^E4=UJ+C487HTD*PKX-C[C8?7 ,N[Z+SDVG%KM>9SM9D<'=^AQ
ME.%J6=, M;>B7JI:>%!-[*WFKBM&<]F]0_=$=!%]-ZKE1LD01W[^UYNS1$-B
MI=%/:T=<+1QY5[4-UZ1XHN(OLU%G4QFDSM.I%A8D<;=P+^BZBMD*J></MC9F
M,\W^D=>,*]G=KBDA+<SVWG\JP $/XQ>]'H:5=79(@=Q>DV^O&O!S$FA>H:W6
M%'D,BLS6\_=$DMOK^>KFAG=I2"!3NR_-+FM"+2>A'H-.LZV ?G5)<0?=?[^.
M_(*M@T,9!]2O)\QUI%/Q?,>*HD.%>5ZF=^,TV-TNTU*W-A0ZS5/B=Q7>:DV+
MI;(1]D.,VYL(377C6$!ID+\V$6H2K8JXS#0.6HV-8P0E1N]5+?!BW3V2O3T*
MZV"WU8+TAL++;-I;E-FTWJRH -ZMGJ8N?ZGSXNORE\.5OS3J+,Z:S%\AF9]8
MPG9=_G)J!SE53*W+7ZIRD QY<*K(&=2]Q!GH:3#/0N-C_W%Q<7EY=577M]3U
M+0?:]2DE^':.$NRJZUOJ79\TS:W)>RM;4*NE=$\@Y;ZN;ZE)L1SB+SMXI;1.
MH)CL /4M=75+26ZVPO'W5Y.BN\-TN+JZI?);K2FR?)EK>R+)':I;VM6EUCIU
MK2;4:HG.;!M@U43L2B+Y<;WW=5%+.;"@PJSN%63I'L4^J(M:2K+5FA9+91J4
MSC+H;1P * WRUY9!3:)5$9?9-D%[X\! B=%[55%+_LLO8 !6L@IF15W,?H?'
M=+:H:FF_J>3$'JQHB0J?V'PZIHVF_CA#G%/G%#:H;H<V=<,Q @8'-UY9]BJY
M&:?4?4W:W&(K+:7=34[02WQ03X@LBI:[6]!RI[JT? GKX!C5L12;21:E:LTP
M4@:1.=[COW%0JVO%IYGIIC\"EG, W:&7C7#L&3S[R.J992FEC)MAZ+JQ8WDF
MA5E919-7=(-1#B5F:NXV0BQ>&KF!1W"MZS'I-5Q24S^GJZEG+PS53GR-,8XC
M$_H+WWSZ5Y88XXI0N&;*&WWOH[\/VD&(0FM2W==LT<_]7G?6N,A>WG7J%E/
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MP-US\ IHB67($VUJ!A#B,P,F!? >PUXCT!WK8]FT<*$)"EYX/:9]XR<"$F,
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M1_J4O$(GO-T.[QZDZVMBZFKSHWS][>KF[O?AP_7--_G;S8-\=_G?WZ_O+K_
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MT1(K'"2E<%-U&1)Z:*G./6"$(]%!1.;YV#:.#AC[BRX!!=LEZ+P;ODU)10H
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M-(YLQZ&/][.C3IX=W7BN/SYP']OJ)+?5/2Z@4G;4*P&@>LEM]8\+J)0=#4H
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MV4\+(U,.A[PIO\CZ_'-(S2G_8_F.7?\/4$L#!!0    ( .2#K%1*GY!A+P8
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M;96-)<?F^S')%V;,]VK^ U!+ P04    " #D@ZQ429O>Y4VF  !+K   "P
M &EM9U\P,#$N:G!GQ+IU4%U?MRVX"<$]2' 2(+@$=PZ$X,$M. 0+[NX0(+A#
M< CN[JX')WB"N]O! X=S'K_OOJ]?=]=]MUZ_KNI>N\8_>^V:56/--><<<ZT-
M_PW? '#EI&2E  0$!,#H^0'@RX $@(J,C(*,A(J"@H*&AHJ.28"%B8&!2?(*
M'X> @I2*DH*4G/P-+1O]&VH6&G)R!CY&EO<<W-S<5/0"(OR<PFQ<W)S_&$%
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MU+(;@]4V<7,R4+"7='S!NDTL@.,A'9>KH6+56[_F8BU:M+),;EJ[MWG<]<.
MG5%^X)0JLUP+533H4K:Q^M$8#N0G))(*<D/,HV"$<.#;#P.<DQS:B?UDD'OQ
M)PN!;0IGQ8O]\.MJ(DO#)1WA4Y[J'R9KTW44_20; =Z+T8.;ON8*EGYD[#^Z
MB+.-R]+F8W:;CHQ18&U&7OOI)S T27)1C(Y0GJ7P,KVRZMR7"(K+"6[Q'I$*
M&0.S'I[T)J42=FP&K&$O.,50W#CF8AA=X0">91=)C?RJJGD$2K(Q9HGAGETP
MH(5?! =&^H^I;A%CX8"$G#T8&1QX*OL&H70Y06EN>OGA2+2X"'UB\>8)U"\H
MO%15RBQIB:9\5J(7/4[@(' D*6M;89GJS,*[%%TPT_PQQLP<%, SX&,/@EBY
M&CX<HL"BY12"V ZI7G>051TM+)GGE(R]6QT["<=JB$![B _4#\TKT3ETPU\W
M5*S1Z0G937Y@BKD9]&#2A0/\_XH7V8]$Y84[<F1=IVN_#W6Z\6P:3J5[VK*R
MRTO9,BPYF1IGG6ALC[1H6E8 <"=?+JN<(&BP&^FX+=URP:N)S<PWGN57QQ>I
MZY=1%K\W%I4JK7D-J&;8>/2EU @+VT+C^U+>O$(1']F)N,0YK=3JUTD-7=2D
M)()@)34SVEOP!'TYHI9"+"$WH<PI]#:-E^8V%U#1Q]$PCO-'9\V-%88#(?L;
M5 _H4W @( $.0'C6E_0'?<V05C!U2+:U:;YP)!O'@W\MIGDX]8UT\7N,$C4$
M##0UA2@/O>^FOJ8HGV4C7)B4;$*O^S[\W0V%W(^@3<]745K_OG;C'-LJMFC]
MJ/C4,5,NKN_2T^)7'$>.7>.<)>E03M5AS1&IV8S>TB?.A&*)X\4XWUB>74/4
MO8L!2KPV!?T*FH7!\?6EG]#<I*;MN^:K*)-E@?/T[@O_4<'8R'79EQZNC53W
MJ1L^:;WK]4\YK;%]/RB:2K<I<"07*UQL/USKKJUC]E2%63L'\)D B6"ZBE6/
M8,7ZQ1,7V2*SKBYI#WSCMT&8S2(HE(U[5'A0#OLM.!"QQ!OOR!WGF:X^13Y]
M(ZWY3JEE2D6;DG*AT?L\LHMX&BJ!P5:;W^]J+]Q9K$;"^.8A%G(>P"I^X"W:
M67T((YDNFG?53F?FEPO['P&4/ OCO*=7GZMT>510U&IM338.5Z@(9@$#IM7D
MZ<';]B"T&\.[/#@P7:X!HY3W:UI U.ZXR%\BXP\IT][1"^L[76_OXLITS[/"
M,9D^L\NK;T@_VM.(0%4>H8UQP!,;H7U T-/,@H3UDA85I?MVU887.,2G&;EH
MF?0@?.^!.NITB33.5$/QRG2L!6-O7:-J ^X$AOKCM&*@@6"_Y-VITB.#5S6_
M%$ZZ\"%LT10#[Y<:&XSTV<U<$*.BL-,$H >Z81*K@<//97"5X A@^!GQ_QF8
MHF'1Q5:)2TJ^EN27?T;IFBV.R6*B1(YN"!!RV$**%"K%*V0M2.:,H@8IP&_G
ML9VZ%97V%>==;(7T:KPI%&>$RK7>-*A:O R.URK)Q;90NO?<I*!7#H7UBS<T
MMX4T2S,A)HOP[[6IYMX0-"BC</I1W L?^2_1]Z=[MJVVNR=QM"_:KTYMZC-H
M( )&JM-BY%$Y&% \EFB:>[N1K'#S=TJT,)X9RP?7[&1CK.@H-*0*YB;^Q)^Q
MXIHEN>B\@KQ910KN/,D%#K*>C.F;B3 =@2/P6EK15T'-:)Z5-MMOO-5N,-.]
M=^ ?*Y?^7#K<RDC6CQCZJD/6S+^)O"U33>.;I2A#([%$9^5K0T>'D(*6"/^0
M6TY+YY9S*R.HWR@P@75F"V=OF$U;&U(I355=;'"E_'&Q]'X&T'PV46A7QBIO
M\,:1*R\\>/"+M+E]L*UP^]41S4SMPK:J-#=_Q/ BXNN2B]=X>I^.% _)%]Q.
M,(3S!:IA\8N,BJ\ZAM]9_ ;+M:7=;3M J72.+2X\>9* <[I60 =SWA'>^F'Z
MN\K*%:-O*>^=6HE%GK"LK=I$<ZHL+S];N=6NZLB(>Q0<_!:@*B%TBP#V6$0I
M[B7DNT,?P&(-04=$Z^0EV.H/,=9Y;0U-74T)2V>H^T'BC5O)$LPX'W"0BWX&
M"$RP]X@23+LB^!=_Y76[DQ R4Q_1@P/N(/>+JI@(AA??2-DR;,OUK6J6I%(7
MY<J%MX4*T-\C/'RI_I=W]JHWJ-"M%]=MYZZ9Y2.KN!CUN/P[I/C\>)K-3"R+
M=:0MS6P).SLDK"1?A6A0]F@\VXM*%\WAK<:N?%=@Z__2G&$?Y*E\\R*-+:1P
MJJ*W0MX$P^K]VQCF!%%7M<RH!Z?_<!*KFLSL3:>@ DBU43Y#EJ.+?A(;6_J(
M&7UQLSK8IOIM>]/%3:86[G"=-'5PLI$3ZGXMX;R*&)Z2+=(X#M( (XLB;YM,
M7G)8'DJE\RT5C@]-D95\B;:'WQ!9H5""9.P9E09*"$CN\&ONBPB&_P*<_]7D
MO\%8)S@4=>)0AD:_%$ AZ;@4-K".>9@A.NO^YHJKWD:RV>3PIF+$C\M#AV^)
M]+23 ^$E##GK1U7LQY^M4Y@>4Y\@>DX9--2R>'N,4@O@$LKD2-"@ N>83H9<
MUZPKL_?WS-)QH4L4"(#MN,Y=P=7YL^XZ%O=0Y^2%ON M(]@5!1,GCT+22AE!
MDN#_7RBXJ^O5]AS*TD:2$KD!.#ICK6WN:2K(YG:$_BTB2IV )[C_B7V@S7U
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M"V?OK]^697WFU&QI: 0MO@,\4%)3H#EWA<C]_:?7FD<ENIY&1^=3/;8>=_\
M6O)KU+A>CK>=Q#>IB\YRVF\6)X.MV'T*S3SK(QQT+.^F6&":,<G)E_*?B5J_
M#\0&&B .%-W\25F7K F2XH-$?9C-M%WMI8;=!D^52SM\?OWH*T;Y6GO[*KO<
MMKC=@6;'A[$DGEF\>AC_#K#2RET>IF2)\U%WQ75DCIU1$?S4JKQ9RO3IP>Q9
M=GHK^N1JF.]-M[EWM#L0-OH!R[Z9KSDH-F?9IN'CQ['#Q"8^<Z)FG^D^YQ27
ML=1W ")><KT&,;,YKHL+ -O,47V/OZKPLG+R2"V==QAT=V CS[C_FR*S[QT
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MU^B>VL9<0@MEV2G=NI/(YYJ2^80=UX^V(Q&VK,I2RD_:;''1[MS?5%>*!G9
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M\A9P8]WS#Z72G@"W2GZ>-PTVJ#%]( [HZ6F98% QXPQW"RPYT7_YJ264BYZ
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MB8W,E\IU3U#URJS92OCQ\A+4*(F[T^1O-^$62RKSCI^ZW3^^Q];')_,"C&&
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MHH@OB9/4!<U<)&:\LE78\YF(1<_XKPM&]>ZDKA_85-PD[QUL2"%^,L&'&](
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M[PZ :BGU,<-Z6N WM2^IK4[&345WVB3*%_<3W(8Q]WB:DI_$IX40= ^S-GP
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M,/\"];]FHOQ__#O\6?E?4$L#!!0    ( .2#K%1%VF5K'3$  +LS   +
M:6UG7S P,BYJ<&>=>0507<&6[<$E>'"WX!#<G>#!W8.[.P0/!'<)[FY!+QX(
M[N[N7 CN_LE[?^9-U7]3]6?ZU*K37:?KGKNJSUY[[>[7A=<- $U&0EH"@("
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MKZX_D]"*D$RG/&?:P3\R<+\()2-!9'ZI.EX_;!I4R(1]944'@[6#M#,&XU8
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M9=WEF9[0!>OGWSLI"@P[I**7\E8@=Q%;UPLMI"^%5:&2ID\(0S)_=*; T>C
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M"DP9!.[GT!#[I%.=0EC*@[6ED:'.RQR^-L]A -$:.8.3S-D2E9'L/G>NNS3
M?"[3K*(N/ A99\_12B]+7SIGP'$\&Q8*%=_I4FTSL/75N4C30MNT@I,374=3
MENY^&3,.UT!!GK[HS.7(-5^:W;GBO+XP7ICE(LO_,4!?SV>;!,TC>.[DZ',;
MIV-';UT(>2L(I>,.J[GPR*L_V"1\K%\8M? ^=)Y ]:0;(GG<"$[I6/9P0DY:
MP-7/X^1&0 .+GY#L81;W^AW"KF9.6XBD77CTF]\":^0^%A]]EN1X!1">*U3
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MST=^V<8K?@5^&YH2;8"R\+;,:2@(W%E66)W@/CL>S>41?YC4IR%<E,HS[K3
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MBJ*5/@  'T$   L   !I;6=?,# S+FIP9\V[950=S[<F?' )$AR"!@[!W3U
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M]A&9.@K#-5E !^FG]OX+7H'F^@-8QK*3E%1\#,!=<#  %[WI"W\8>ZP?7?)
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MQ]7246KC5[OJ6XF-J6[G*1*'#UB9D;K9IT%TH;#9?9!T\#KD%-]]> -LO\L
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M&_/0:/,S*%.BD]A4)&%(.XY@YC28,$-O"0UB>.T*&IVCYXM"I#Z9,P3'=Y^
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M60DA&0%A$:&_)L' Q\<G(B2BN7>/1HB%GD7H?VUW+0 9'H8<< +"8 4PR3!
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M3.>S69>;,")/55;S-5(;0XE2&T,7/:?N\HO--J!H0UM_9:SQY].* 8+8#"7
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M@$2'@$*'^.@'D ( $# 0_ZL _J= 0$)!P\#"P2,@(GT:-'X!0$) 04%"0\'
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ML9T50)/[^(&]GDO8)QH%^$NC[7Q;$*ML^\GG3T7,;G;B!</H;_?8-+0V8A0
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M+M[LCE3805BE_1PC0,Q[06?S!EE#0/:.YW28\!\;2(+!)&<1ORX8"G"/ GQ
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M4 "Q!W(RDS=#PJ;45JE2VDS(OG 5V6^K-:X9S=DM="E: C_4G5FXTS201<)
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MO)&/;Q/[C]WN3B90@*-575$9(ESS^ZW+--RD913@>J78;PFL2-6" IRUZ:$
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MR"^_O3C0*XQ>W3;'3=;\=*DI5K>]E)T2,QZ^$3CF]6[2#N40I_3L"T)J0X<
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MAZSW[-;N$& \@JL_UL\:Y!''^EP5([ME00 *V;;[XV<_Q_JA?P\Z\D6>WH4
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M*>^4<5QNP(\-8=6!/@6B4R@@9N6'=P@4\)"V_R()!0#EJ[,?(=E0@ 2[6=
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MNW9#GP"R&6>]JVPY.Y,SEXZD:JJ/0E:;DA$-7LHX%91/#/ICR85P?@:*"@<
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MW.R-!_.FO,T)P&QV %49GW.')Y'%8-K9G0]3LF\(^%OL4=Y*E[=)(N5\RX;
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MMQN>-"%D;NQX&*X)SO+E9M&#:T.!^)'B^75;W^RH-T5K:G]ZN[.^7ODCLO\
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MY9 R>X--$0SG/ JA-.EK(%GW1L1D \_RJW:WMG)&X:XC!"Y&XXJ$5=#IF&W
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MMTW'_ S45S)=76E6T<C'RXVW(&]/2N2=).HIG1"I:#B9T=PT2Y&#VJ&6<R2
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MQ(IN>329IA;F@#@OBXS#0=/V'!^UGI_N&O*XKF88!&:]5^*ISH=A_P!?1_\
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M[68]*A:S]JVS$*3R<T63'<Y][+_9JO):8ZK72- ,53N(!Z5G*"*4C >R0C!
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M1)+81.?V>=<[:[IP_P"V3U'_ ,,[:\>NO:;_ -^GHHI@,_X9SU[_ *#VG?\
M?MZM6/[/>LV]RLLNMZ?)LY4>4_6BBAJX&\/@SJC',FL6I/LC8IX^#>HC_F*6
MO_?#445E[&!7,RO>_!35+N'9_:UDK Y1O+;(_P#K5T>F>!?$=C90P2ZKI\WE
MJ%YB:BBG[.(N9D\_PY6_0B_BTZ4GNL; _G4?_"KX5ME@26%8E& I4L /QHHH
M]G$+LPY_@D)-9M+N*ZM(X(FW2HL9!?'3VKLO^$1NATN81_P$T44_9Q"[ ^$K
MK_GZA_[Y-'_"(W7_ #]0_P#?)HHH]G$+L3_A$;O_ )^H?^^31_PB%U_S]0_]
M\FBBCV<0NP_X1"Z_Y^H?^^32?\(A=_\ /U#_ -\FBBCV<0NS%\2?#2^UVSA@
MCU&WA,<F_)0G/&*Y>3X$:D_/]M6@/KY+445220B(? 350V?[=M,>GDM2GX!Z
MEDD:Y:#/_3)J**8#HO@-J<8P=;M#_P!LFIS? G4R,#7+4?\ ;)J** +<?P2O
MXXU0:Q;8'_3)J<WP5U ]-8MO^_;444K#NQ1\%]0'_,8MO^_;4\?!J_'35K;_
M +]M1119!S,E3X/WZ?\ ,6MO^_;5;7X3SR6UQ;76H020SQE& 0\'L1[BBBBP
M<S.3;]GW5G0*WB"V8#@9B?C]::?V?-7)P/$%H%/5?*:BBF(DA^ .L6TPE@\0
MVJ.,X(A:D_X9]U//_(>M#]8FHHH"P^/X :FC9.NVA_[8M2O\ ]5,8$>O6JL&
MR6\IJ** +LWP4U>:.V/]LV2S1##.(F^8]B.<@UII\./&: 8\4V?RC )MVR/Q
MHHJE.2ZBL=MX?T;5[+3O(UF_@O+A6.V6)"N5]"#WK4-@3_$***7,QW$&GG^\
M*/[//]X444<S'<0Z<3_&*B?2&?\ Y:+^5%%%V%V0G06)_P!:OY4W_A'V_P">
MR_E112'S,0^'F/\ RV7\C2'PZQ_Y;+^1HHI6#F8T^''/_+=?R-(?#3G_ );I
M^1HHHL@YV-/AAR/]>GY&F'PJYS_I"?D:**7*@YV-_P"$2DSD7* _2JUQX$AN
MU(N!;2@]=\>3111RH.=F'=_!G1[O)&V$GO$2*Q+GX#-DFSUH+Z++%G'XBBBG
M9"YF1Q_ _58_^8Y:L/0Q-4O_  I*_/WM7MC_ -LFHHHL@N1/\"+B3[^I69]_
M*:J[?L^S-TUF%?HC44460B(_L^WZG]WKUL1_M0M3E^ 6I*P/]N6AP<_ZEJ**
M8'__V5!+ P04    " #D@ZQ4VRX/P+=L  "4;0  "P   &EM9U\P,#@N:G!G
MG/=E5%Q-\#V,#A8D2 @0G$&&!"=8<"9 \, $=TB0X.XZ.,%=@P1W=W=W=W=W
M'X:7Y_>7]\O]<._M66M6KU/5=7KW/EVUZV7^91WP3EI<2AR @(  ^/GZ [PL
M 40!:&_>H+Y!04-%145'1\/ Q,?"?/L6D_@]'@X^.0F0@IR$C(P2Q/*)DIJ)
MAHR,CIN>Z3,;)R<G\!.O( ^[  L')_M_01#0T=$QWV(286$1L5.14;'__SQ>
MV@&X: B\"%5("-0 1%P$)%R$EVX $ ! 0$'XGP'XWP,!$0D9Y0TJ&CK&VU>'
MFG< 1 0D)$1D)!049.17J\>K'8",B_*>BDWX#9[\+U1J&WQV[Z@,-!J1B@X"
MA8ES$(>>K0\ZQ@="(F(2VH^?Z.@9.+F^<//P\HE^$Q.7D)225E125E%54]?0
M-S#\;61L8FIG[^#HY.SBZNOG'Q#X)R@X.B8V+CXA,2DY,RL[)S<OOZ"PLJJZ
MIK:NOJ&QLZN[I[>O?V!P<FIZ9G9N?F%Q8W-K>V=W;__@\.+RZOKF]N[^X?$_
M7 @ )(3_,_X_XL)]Q86(C(R$C/H?+@1$I_\<<)%1J-C>O!>61_UE@T?-[HV&
M+Q*54=&!3L.A<$Z@9SN!\0'$N4%[\1^T_T'V_QTPG_^_D/U?8/\OKD4 )A+"
M*WE(N  PX*K%2'X:3]68^307"0WWW1VE_5T^2\X%0:P4U\(T9="].DBA<"T(
M_T1AZSB-/GS/\HQV,\;X+)3,,ZZH\+YW]NZ$72R7F+;QTF_ ^6D3\;--C3BV
MK6N,QDQ*G'BIOO0[:PT:VO3NBBQ^ENS"J""UQ"6,P"P*/K<9%P=!'<++W<;&
ML'/L.1 9;E1':>G>)DIU;1F^([=IQW8:NQ'1E8%(* Y9+T(_N2UC],S-EYD;
M/.<-W\0L<::E$(*OV3%GH=-N4G<P6<$4?JJV);YTV M "[JF]#I- V\]0I\.
M"^1E%B%MFQ2#P,&0MB62_^U@G_Z_?)>A:PYR,?C_A1!=Z'J0:?N_CY6@YH?0
MJV?P\XW2A1C81.@%\,>-S^/_A("\ #SDGRL*7@!CUR^ NQ6%S(3J=&CWZRY8
MVQL=PK[;MZ;#'[/A\],O@+W_V<6$Q/_88\&Q#:_+H&,W?<\W$K>C.2\ \!SP
M;D8Q,^)_O8+'4=?;[LE(X060?O "."M4GN6B8G@!Y$&F':Q<LXUU6]//</;D
MN#YY#,3QJ.\[P-EG6(_=9;E:2I8C.ZG\_"*\T+]"")($QX*9F7NZ]^2#,;>&
MG0=+/>N+A 2V>J: DI3@!RS3U9PM&<TI!SZ3TCO"'V^=PG=EQ\W?6Z$:=S"/
M.Q0KJ2II>1)<LL<?]6 7'CI\40D=+*8QQR=7LYE:S:J?A@G_[J_C)JP]/FKY
M]J_ \(:8G#&G[M[7#!^1(T_+=T_"?E5KG6$PF$"98Y(=E:;$;I5V=F.VM&1Q
ME?]/1A":VI[U-ANO?E,!Z"H&$B\8_ K-ZO %<(U;_P)H+0#7W4 ?T5[I44X7
M8Y&\11)]<E-] ?SS>SWA&>#28MTS,@OXK' L,UQY'@OGY$03[H,'MX=:F<Z_
M "+]7P]4_040AF];VFX,M3Q<NW[W7\Q\^.I,VSZ5S2M?*M M,;*B<L+>EB+H
M&.R_F/Q/;BK_)[Z1O 3#\9O V]N2%X P^G]'#ZZKL7I$^X]I%0]@V.M*DM<]
MO,9,_!]_/D$G%79*^$1*6-=]R]&7U \"VR\ 9R@?F;Z%UWZSMI,-:M#9>_I5
MGBY$ CG 5AJ#;T^9A+'E*N--+=%P#JDQ#(JKXFX,WBQHH=AZ4,F9"SLQJO-N
MJ\IQ2S1?G5!11_"?:4>N#)?:\DY.EK*ER</E+0S[]*S6$2SH:A^T$0[_EB"D
M"3(7W2KEV:.8P9\RO1T@72:M5Y%/7!1C(',-O2E-F^ISC#)Y 1C&R"4AAV ,
M,N]@%&RGY,5C6^-<_*X2D-DT=CA2HPZ?-=8VBMX8KD3MXB%6YMG&=-JKT8Z*
MJ'G]5'O@$RVO'V$#]/4@JJV@>Z>Z3X=%\F*1;NIW,!GP(G<67"?G?SC[SWCX
MGW'BU?AZCV2 B]QM5W>LSS?"TZQV+P"@XBN?.L%,OHMC#49/XO<1]T]_X8]9
MKS/HT'3;W8P*S!AF7(ECIMC$] (PT86.+:^]LKVHNG9UQ_U\HYR?V2]8_!0/
MK;:R^5^QE+#$[VJF7WU4,D,H;VOX_S.];L_JZ3#BA'\<O/7?K$@1(LW[8T9]
MS59;85-Y.A=H'&N_SDON3Z"K"K[@_!MQ^@+8IP[^4V?@H*3S-#YW@0,+V'T!
M.("O<=5KEIWWNF9G^>1BBMI!5U8TBFR_^T?9VD\FZVVTN5(/.4:R8)SX\F(&
MQJ]_ 'R57>_U9[<>=,8#$C<(F:[+$(K6(Z)K>@Z']GE:W48!981*Y6>!/=Q\
M!]N^??1_F$/\,JDBMXS\/#IN28D@FW\#^@=R;>5-DV<[E:U^779O+:+9A1<]
M>,K,SYU\@1V>9'PKD_1SI3[9QFN7AV$O@"J2RQ< 8>/R?=JI) V$[C.$79PX
M*E!E;WH*=V0W>#IMEG/R.%O>\G=2]G(7Z!T:4H[4K^S6'"L7,OF,QK!O%>M1
ME[Y7V!X%*!,18A;W3IV+@<%<OW(/S@ IO9.>-X->J#HSL^G><%8DRH.1UWL)
M?#9U?)MF)>:*YXY_\>\ )<2#)?!>R>+<J'=HLG.A-4%&+,":$^=_$I)VESOE
M1>,+8)@69W(#W%O4UGE&W,/.N!^1WM*=[TPT<"3''\.<!.EKN_PR]II_*5\
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MZJEI3Q[(IA>I[A.HSE6 *F/1>%:U7&2$>L#Q,H:A@#)MA4^YI>-76,>V8YE
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M56*DX=%4^UU'ZA+>DOFGW"J@0SN\$Y@_?G)EW6W*_"U<)+B7G[P&;\](M/C
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M"$.W$W[,4/F,TM#F% O3&&SCK0%S?JWA?(YE$HD'I%P3N,EZL1=WOVNA :X
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M'?8]8@PM*6I2;B>HV'Z^MBCPPD8E-_W.BWQL[L%88F8\^7[@?0%;-("<^PL
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M<F!5BF0]YQY]1Z2#[9MG6=9Q,W,\HW#VDYDF;!OYD@#+"'YZ[A[JGBXL(K\
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M@;3X;V"Y6:*; &%QMQV(]:QY22QP>?Z_Y-7+K0WT2\ECCD+6<WSQ*3G'J/\
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M*DR1$7 P3&Q'U=L#]*;&P4,PZX;'_H(JQ$%,BC&5\X#_ ("BY_G0V0QKIO\
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MA7=VL<<421H@5%& !6=;QI&BHF%51@ 5H0OQS71&-D>-7JRJ/4OQ[<CBKD8
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MGK6?/"&!&*TY!D53D7)-)G)4B8-S;!B>,5SFH:>DH(()]QVKLITQQC@UCW<
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M4YR>34ZC-,%3*!^-485)$J**E2HEJ5>E-'',L)VJRK8JHIJ=3P!6J.>1;5L
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MQKS%_B%>L4DEMU$Y(,LD9P&(!&\#LV#CTZ5@^(/%^J:U;K9>;]ET]!M6VA.
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MN0>]%7=3_P"0C-]1_(45D>NGH?_94$L! A0#%     @ Y(.L5"):OP]]$@
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M,34Y,S4U+7,Q7V-Y;F=N:6YC+FAT;5!+ 0(4 Q0    ( .2#K%1*GY!A+P8
M '-6   ;              "  46Q P!E83$U.3,U-65X+69E95]C>6YG;FEN
M8RYH=&U02P$"% ,4    " #D@ZQ4U]85#$0"  "K!P  &P
M@ &MMP, 96$Q-3DS-35E>#(S+3%?8WEN9VYI;F,N:'1M4$L! A0#%     @
MY(.L5$D,H/A""   7B,  !H              ( !*KH# &5A,34Y,S4U97@U
M+3%?8WEN9VYI;F,N:'1M4$L! A0#%     @ Y(.L5$F;WN5-I@  2ZP   L
M             ( !I,(# &EM9U\P,#$N:G!G4$L! A0#%     @ Y(.L5$7:
M96L=,0  NS,   L              ( !&FD$ &EM9U\P,#(N:G!G4$L! A0#
M%     @ Y(.L5*CVBJ*5/@  'T$   L              ( !8)H$ &EM9U\P
M,#,N:G!G4$L! A0#%     @ Y(.L5!HB@5^,'P  2B(   L
M ( !'MD$ &EM9U\P,#0N:G!G4$L! A0#%     @ Y(.L5!,!?YF 9P  R6@
M  L              ( !T_@$ &EM9U\P,#4N:G!G4$L! A0#%     @ Y(.L
M5/%_T!UD-P  VSP   L              ( !?& % &EM9U\P,#8N:G!G4$L!
M A0#%     @ Y(.L5'N@9?A?7   B5T   L              ( !"9@% &EM
M9U\P,#<N:G!G4$L! A0#%     @ Y(.L5-LN#\"W;   E&T   L
K     ( !D?0% &EM9U\P,#@N:G!G4$L%!@     1 !$ . 0  '%A!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
